[{"title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","googleId":"E-vjoGcBuowJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/4/424/36196","googleCitationCount":2400,"googleAuthor":"H Döhner","doi":"10.1182/blood-2016-08-733196","elsevierAuthor":"Döhner H.","publicationName":"Blood","elsevierCoverDate":"2017-01-26","elsevierCoverDisplayDate":"26 January 2017","elsevierCitationCount":"1657","altmetricAuthors":["Hartmut Döhner","Elihu Estey","David Grimwade","Sergio Amadori","Frederick R. Appelbaum","Thomas Büchner","Hervé Dombret","Benjamin L. Ebert","Pierre Fenaux","Richard A. Larson","Ross L. Levine","Francesco Lo-Coco","Tomoki Naoe","Dietger Niederwieser","Gert J. Ossenkoppele","Miguel Sanz","Jorge Sierra","Martin S. Tallman","Hwei-Fang Tien","Andrew H. Wei","Bob Löwenberg","Clara D. Bloomfield"],"twitterCount":92,"altmetricId":14144008},{"title":"Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia","googleId":"e71laQw6V68J","googleLink":"https://ashpublications.org/blood/article-abstract/130/6/722/36814","googleCitationCount":751,"googleAuthor":"AT Fathi","doi":"10.1182/blood-2017-04-779405","elsevierAuthor":"Stein E.M.","publicationName":"Blood","elsevierCoverDate":"2017-08-10","elsevierCoverDisplayDate":"10 August 2017","elsevierCitationCount":"527","altmetricAuthors":["Eytan M. Stein","Courtney D. DiNardo","Daniel A. Pollyea","Amir T. Fathi","Gail J. Roboz","Jessica K. Altman","Richard M. Stone","Daniel J. DeAngelo","Ross L. Levine","Ian W. Flinn","Hagop M. Kantarjian","Robert Collins","Manish R. Patel","Arthur E. Frankel","Anthony Stein","Mikkael A. Sekeres","Ronan T. Swords","Bruno C. Medeiros","Christophe Willekens","Paresh Vyas","Alessandra Tosolini","Qiang Xu","Robert D. Knight","Katharine E. Yen","Sam Agresta","Stephane de Botton","Martin S. Tallman"],"twitterCount":56,"altmetricId":20856262},{"title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","googleId":"rkKJHiGs1AEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2745/37141","googleCitationCount":520,"googleAuthor":"M Hallek","doi":"10.1182/blood-2017-09-806398","elsevierAuthor":"Schuh A.H.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8","altmetricAuthors":["Michael Hallek","Bruce D. Cheson","Daniel Catovsky","Federico Caligaris-Cappio","Guillermo Dighiero","Hartmut Döhner","Peter Hillmen","Michael Keating","Emili Montserrat","Nicholas Chiorazzi","Stephan Stilgenbauer","Kanti R. Rai","John C. Byrd","Barbara Eichhorst","Susan O’Brien","Tadeusz Robak","John F. Seymour","Thomas J. Kipps"],"twitterCount":92,"altmetricId":34338182},{"title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","googleId":"NCGG1DGmVzcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/16/1800/36474","googleCitationCount":503,"googleAuthor":"SS Neelapu","doi":"10.1182/blood-2017-03-769620","elsevierAuthor":"Snider J.T.","publicationName":"American Journal of Managed Care","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"5","altmetricAuthors":["Michael Crump","Sattva S. Neelapu","Umar Farooq","Eric Van Den Neste","John Kuruvilla","Jason Westin","Brian K. Link","Annette Hay","James R. Cerhan","Liting Zhu","Sami Boussetta","Lei Feng","Matthew J. Maurer","Lynn Navale","Jeff Wiezorek","William Y. Go","Christian Gisselbrecht"],"twitterCount":60,"altmetricId":23397408},{"title":"Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party","googleId":"z589FarS5lMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/12/1275/36625","googleCitationCount":432,"googleAuthor":"","doi":"10.1182/blood-2017-09-801498","elsevierAuthor":"Schuurhuis G.J.","publicationName":"Blood","elsevierCoverDate":"2018-03-22","elsevierCoverDisplayDate":"22 March 2018","elsevierCitationCount":"278","altmetricAuthors":["Gerrit J. Schuurhuis","Michael Heuser","Sylvie Freeman","Marie-Christine Béné","Francesco Buccisano","Jacqueline Cloos","David Grimwade","Torsten Haferlach","Robert K. Hills","Christopher S. Hourigan","Jeffrey L. Jorgensen","Wolfgang Kern","Francis Lacombe","Luca Maurillo","Claude Preudhomme","Bert A. van der Reijden","Christian Thiede","Adriano Venditti","Paresh Vyas","Brent L. Wood","Roland B. Walter","Konstanze Döhner","Gail J. Roboz","Gert J. Ossenkoppele"],"twitterCount":94,"altmetricId":31602945},{"title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy","googleId":"AEpV1U7zoPIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2295/36661","googleCitationCount":417,"googleAuthor":"LA Hanafi","doi":"10.1182/blood-2017-06-793141","elsevierAuthor":"Hay K.A.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"310","altmetricAuthors":["Kevin A. Hay","Laïla-Aïcha Hanafi","Daniel Li","Juliane Gust","W. Conrad Liles","Mark M. Wurfel","José A. López","Junmei Chen","Dominic Chung","Susanna Harju-Baker","Sindhu Cherian","Xueyan Chen","Stanley R. Riddell","David G. Maloney","Cameron J. Turtle"],"twitterCount":72,"altmetricId":26290788},{"title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","googleId":"E8aMl3vI9MwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3322/107614","googleCitationCount":459,"googleAuthor":"RA Gardner","doi":"10.1182/blood-2017-02-769208","elsevierAuthor":"Gardner R.A.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"346","altmetricAuthors":["Rebecca A. Gardner","Olivia Finney","Colleen Annesley","Hannah Brakke","Corinne Summers","Kasey Leger","Marie Bleakley","Christopher Brown","Stephanie Mgebroff","Karen S. Kelly-Spratt","Virginia Hoglund","Catherine Lindgren","Assaf P. Oron","Daniel Li","Stanley R. Riddell","Julie R. Park","Michael C. Jensen"],"twitterCount":48,"altmetricId":18850867},{"title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","googleId":"usyL4ZQfnBoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1365/105711","googleCitationCount":301,"googleAuthor":"V Pengo","doi":"10.1182/blood-2018-04-848333","elsevierAuthor":"Pengo V.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"223","altmetricAuthors":["Vittorio Pengo","Gentian Denas","Giacomo Zoppellaro","Seena Padayattil Jose","Ariela Hoxha","Amelia Ruffatti","Laura Andreoli","Angela Tincani","Caterina Cenci","Domenico Prisco","Tiziana Fierro","Paolo Gresele","Arturo Cafolla","Valeria De Micheli","Angelo Ghirarduzzi","Alberto Tosetto","Anna Falanga","Ida Martinelli","Sophie Testa","Doris Barcellona","Maria Gerosa","Alessandra Banzato"],"twitterCount":685,"altmetricId":44947070},{"title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","googleId":"X4IYF3gmtwoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1522/36655","googleCitationCount":302,"googleAuthor":"","doi":"10.1182/blood-2017-08-798322","elsevierAuthor":"Paul S.","publicationName":"Acta Haematologica","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"19","altmetricAuthors":["Nicola Gökbuget","Hervé Dombret","Massimiliano Bonifacio","Albrecht Reichle","Carlos Graux","Christoph Faul","Helmut Diedrich","Max S. Topp","Monika Brüggemann","Heinz-August Horst","Violaine Havelange","Julia Stieglmaier","Hendrik Wessels","Vincent Haddad","Jonathan E. Benjamin","Gerhard Zugmaier","Dirk Nagorsen","Ralf C. Bargou"],"twitterCount":21,"altmetricId":32227957},{"title":"Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience","googleId":"7lP1ZQaRlWcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1910/36756","googleCitationCount":250,"googleAuthor":"JA Burger","doi":"10.1182/blood-2017-10-810044","elsevierAuthor":"O’Brien S.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"184","altmetricAuthors":["Susan O’Brien","Richard R. Furman","Steven Coutre","Ian W. Flinn","Jan A. Burger","Kristie Blum","Jeff Sharman","William Wierda","Jeffrey Jones","Weiqiang Zhao","Nyla A. Heerema","Amy J. Johnson","Ying Luan","Danelle F. James","Alvina D. Chu","John C. Byrd"],"twitterCount":62,"altmetricId":32894845},{"title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","googleId":"jC3Vez8tg2IJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/6/742/36791","googleCitationCount":292,"googleAuthor":"GL Norddahl","doi":"10.1182/blood-2017-02-769869","elsevierAuthor":"Zink F.","publicationName":"Blood","elsevierCoverDate":"2017-08-10","elsevierCoverDisplayDate":"10 August 2017","elsevierCitationCount":"214","altmetricAuthors":["Florian Zink","Simon N. Stacey","Gudmundur L. Norddahl","Michael L. Frigge","Olafur T. Magnusson","Ingileif Jonsdottir","Thorgeir E. Thorgeirsson","Asgeir Sigurdsson","Sigurjon A. Gudjonsson","Julius Gudmundsson","Jon G. Jonasson","Laufey Tryggvadottir","Thorvaldur Jonsson","Agnar Helgason","Arnaldur Gylfason","Patrick Sulem","Thorunn Rafnar","Unnur Thorsteinsdottir","Daniel F. Gudbjartsson","Gisli Masson","Augustine Kong","Kari Stefansson"],"twitterCount":52,"altmetricId":19965765},{"title":"Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma","googleId":"YWSx3sip4-MJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/8/974/36976","googleCitationCount":292,"googleAuthor":"","doi":"10.1182/blood-2017-05-785246","elsevierAuthor":"Chari A.","publicationName":"Blood","elsevierCoverDate":"2017-08-24","elsevierCoverDisplayDate":"24 August 2017","elsevierCitationCount":"217","altmetricAuthors":["Ajai Chari","Attaya Suvannasankha","Joseph W. Fay","Bertrand Arnulf","Jonathan L. Kaufman","Jainulabdeen J. Ifthikharuddin","Brendan M. Weiss","Amrita Krishnan","Suzanne Lentzsch","Raymond Comenzo","Jianping Wang","Kerri Nottage","Christopher Chiu","Nushmia Z. Khokhar","Tahamtan Ahmadi","Sagar Lonial"],"twitterCount":23,"altmetricId":21256326},{"title":"Thrombotic thrombocytopenic purpura","googleId":"OPNZaP5j7l8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2836/36273","googleCitationCount":266,"googleAuthor":"P Coppo","doi":"10.1182/blood-2016-10-709857","elsevierAuthor":"Joly B.S.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"166","altmetricAuthors":["Bérangère S. Joly","Paul Coppo","Agnès Veyradier"],"twitterCount":56,"altmetricId":18921759},{"title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","googleId":"MMaBdEJk_gcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/25/2728/36884","googleCitationCount":240,"googleAuthor":"AC Horne","doi":"10.1182/blood-2017-06-788349","elsevierAuthor":"Bergsten E.","publicationName":"Blood","elsevierCoverDate":"2017-12-21","elsevierCoverDisplayDate":"21 December 2017","elsevierCitationCount":"152","altmetricAuthors":["Elisabet Bergsten","AnnaCarin Horne","Maurizio Aricó","Itziar Astigarraga","R. Maarten Egeler","Alexandra H. Filipovich","Eiichi Ishii","Gritta Janka","Stephan Ladisch","Kai Lehmberg","Kenneth L. McClain","Milen Minkov","Scott Montgomery","Vasanta Nanduri","Diego Rosso","Jan-Inge Henter"],"twitterCount":63,"altmetricId":26424429},{"title":"Efficacy of venetoclax as targeted therapy for relapsed/refractory t (11; 14) multiple myeloma","googleId":"OkC53CAA17oJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/22/2401/36573","googleCitationCount":243,"googleAuthor":"JL Kaufman","doi":"10.1182/blood-2017-06-788786","elsevierAuthor":"Kumar S.","publicationName":"Blood","elsevierCoverDate":"2017-11-30","elsevierCoverDisplayDate":"30 November 2017","elsevierCitationCount":"163","altmetricAuthors":["Shaji Kumar","Jonathan L. Kaufman","Cristina Gasparetto","Joseph Mikhael","Ravi Vij","Brigitte Pegourie","Lofti Benboubker","Thierry Facon","Martine Amiot","Philippe Moreau","Elizabeth A. Punnoose","Stefanie Alzate","Martin Dunbar","Tu Xu","Suresh K. Agarwal","Sari Heitner Enschede","Joel D. Leverson","Jeremy A. Ross","Paulo C. Maciag","Maria Verdugo","Cyrille Touzeau"],"twitterCount":52,"altmetricId":27282639},{"title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase","googleId":"Hm6xthMzMPAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2437/35948","googleCitationCount":271,"googleAuthor":"SJ Kim","doi":"10.1182/blood-2016-12-756841","elsevierAuthor":"Kwong Y.L.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"188","altmetricAuthors":["Yok-Lam Kwong","Thomas S. Y. Chan","Daryl Tan","Seok Jin Kim","Li-Mei Poon","Benjamin Mow","Pek-Lan Khong","Florence Loong","Rex Au-Yeung","Jabed Iqbal","Colin Phipps","Eric Tse"],"twitterCount":73,"altmetricId":16307282},{"title":"Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL","googleId":"rL4zz46xOG8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/26/3419/36220","googleCitationCount":225,"googleAuthor":"W Ding","doi":"10.1182/blood-2017-02-765685","elsevierAuthor":"Ding W.","publicationName":"Blood","elsevierCoverDate":"2017-06-29","elsevierCoverDisplayDate":"29 June 2017","elsevierCitationCount":"158","altmetricAuthors":["Wei Ding","Betsy R. LaPlant","Timothy G. Call","Sameer A. Parikh","Jose F. Leis","Rong He","Tait D. Shanafelt","Sutapa Sinha","Jennifer Le-Rademacher","Andrew L. Feldman","Thomas M. Habermann","Thomas E. Witzig","Gregory A. Wiseman","Yi Lin","Erik Asmus","Grzegorz S. Nowakowski","Michael J. Conte","Deborah A. Bowen","Casey N. Aitken","Daniel L. Van Dyke","Patricia T. Greipp","Xin Liu","Xiaosheng Wu","Henan Zhang","Charla R. Secreto","Shulan Tian","Esteban Braggio","Linda E. Wellik","Ivana Micallef","David S. Viswanatha","Huihuang Yan","Asher A. Chanan-Khan","Neil E. Kay","Haidong Dong","Stephen M. Ansell"],"twitterCount":49,"altmetricId":19189796},{"title":"PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma","googleId":"c25GBdmi0WQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/23/3071/36041","googleCitationCount":225,"googleAuthor":"","doi":"10.1182/blood-2017-01-764209","elsevierAuthor":"Nayak L.","publicationName":"Blood","elsevierCoverDate":"2017-06-08","elsevierCoverDisplayDate":"8 June 2017","elsevierCitationCount":"174","altmetricAuthors":["Lakshmi Nayak","Fabio M. Iwamoto","Ann LaCasce","Srinivasan Mukundan","Margaretha G. M. Roemer","Bjoern Chapuy","Philippe Armand","Scott J. Rodig","Margaret A. Shipp"],"twitterCount":51,"altmetricId":18245974},{"title":"Clinical updates in adult immune thrombocytopenia","googleId":"cmdW4XGQ0CwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2829/36293","googleCitationCount":216,"googleAuthor":"MP Lambert","doi":"10.1182/blood-2017-03-754119","elsevierAuthor":"Lambert M.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"135","altmetricAuthors":["Michele P. Lambert","Terry B. Gernsheimer"],"twitterCount":43,"altmetricId":18921764},{"title":"The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL","googleId":"4X4ex8QcoFgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/23/2446/40003","googleCitationCount":137,"googleAuthor":"P Hillmen","doi":"10.1182/blood-2018-05-850461","elsevierAuthor":"Flinn I.W.","publicationName":"Blood","elsevierCoverDate":"2018-12-06","elsevierCoverDisplayDate":"6 December 2018","elsevierCitationCount":"91","altmetricAuthors":["Ian W. Flinn","Peter Hillmen","Marco Montillo","Zsolt Nagy","Árpád Illés","Gabriel Etienne","Julio Delgado","Bryone J. Kuss","Constantine S. Tam","Zoltán Gasztonyi","Fritz Offner","Scott Lunin","Francesco Bosch","Matthew S. Davids","Nicole Lamanna","Ulrich Jaeger","Paolo Ghia","Florence Cymbalista","Craig A. Portell","Alan P. Skarbnik","Amanda F. Cashen","David T. Weaver","Virginia M. Kelly","Barry Turnbull","Stephan Stilgenbauer"],"twitterCount":46,"altmetricId":49219661},{"title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","googleId":"KXKLSsanZgsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/587/39419","googleCitationCount":157,"googleAuthor":"BA Walker","doi":"10.1182/blood-2018-03-840132","elsevierAuthor":"Manni S.","publicationName":"Frontiers in Oncology","elsevierCoverDate":"2020-05-15","elsevierCoverDisplayDate":"15 May 2020","elsevierCitationCount":"0","altmetricAuthors":["Brian A. Walker","Konstantinos Mavrommatis","Christopher P. Wardell","T. Cody Ashby","Michael Bauer","Faith E. Davies","Adam Rosenthal","Hongwei Wang","Pingping Qu","Antje Hoering","Mehmet Samur","Fadi Towfic","Maria Ortiz","Erin Flynt","Zhinuan Yu","Zhihong Yang","Dan Rozelle","John Obenauer","Matthew Trotter","Daniel Auclair","Jonathan Keats","Niccolo Bolli","Mariateresa Fulciniti","Raphael Szalat","Philippe Moreau","Brian Durie","A. Keith Stewart","Hartmut Goldschmidt","Marc S. Raab","Hermann Einsele","Pieter Sonneveld","Jesus San Miguel","Sagar Lonial","Graham H. Jackson","Kenneth C. Anderson","Herve Avet-Loiseau","Nikhil Munshi","Anjan Thakurta","Gareth J. Morgan"],"twitterCount":47,"altmetricId":43568290},{"title":"Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial","googleId":"ywR-oRml3z8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/393/103899","googleCitationCount":167,"googleAuthor":"PD le Coutre","doi":"10.1182/blood-2016-09-739086","elsevierAuthor":"Cortes J.E.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"113","altmetricAuthors":["Jorge E. Cortes","Dong-Wook Kim","Javier Pinilla-Ibarz","Philipp D. le Coutre","Ronald Paquette","Charles Chuah","Franck E. Nicolini","Jane F. Apperley","H. Jean Khoury","Moshe Talpaz","Daniel J. DeAngelo","Elisabetta Abruzzese","Delphine Rea","Michele Baccarani","Martin C. Müller","Carlo Gambacorti-Passerini","Stephanie Lustgarten","Victor M. Rivera","Frank G. Haluska","François Guilhot","Michael W. Deininger","Andreas Hochhaus","Timothy P. Hughes","Neil P. Shah","Hagop M. Kantarjian"],"twitterCount":52,"altmetricId":34731373},{"title":"Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma","googleId":"VTK0Z6bOqAMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/267/36926","googleCitationCount":203,"googleAuthor":"PL Zinzani","doi":"10.1182/blood-2016-12-758383","elsevierAuthor":"Zinzani P.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"163","altmetricAuthors":["Pier Luigi Zinzani","Vincent Ribrag","Craig H. Moskowitz","Jean-Marie Michot","John Kuruvilla","Arun Balakumaran","Yayan Zhang","Sabine Chlosta","Margaret A. Shipp","Philippe Armand"],"twitterCount":36,"altmetricId":20031403},{"title":"Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma","googleId":"nC2fjARYPcgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1183/36457","googleCitationCount":181,"googleAuthor":"AF Herrera","doi":"10.1182/blood-2017-10-811224","elsevierAuthor":"Herrera A.","publicationName":"Blood","elsevierCoverDate":"2018-03-15","elsevierCoverDisplayDate":"15 March 2018","elsevierCitationCount":"130","altmetricAuthors":["Alex F. Herrera","Alison J. Moskowitz","Nancy L. Bartlett","Julie M. Vose","Radhakrishnan Ramchandren","Tatyana A. Feldman","Ann S. LaCasce","Stephen M. Ansell","Craig H. Moskowitz","Keenan Fenton","Carol Anne Ogden","David Taft","Qu Zhang","Kazunobu Kato","Mary Campbell","Ranjana H. Advani"],"twitterCount":95,"altmetricId":30334244},{"title":"Clinical significance of somatic mutation in unexplained blood cytopenia","googleId":"V19bNXJIurIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3371/107625","googleCitationCount":200,"googleAuthor":"L Malcovati","doi":"10.1182/blood-2017-01-763425","elsevierAuthor":"Malcovati L.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"156","altmetricAuthors":["Luca Malcovati","Anna Gallì","Erica Travaglino","Ilaria Ambaglio","Ettore Rizzo","Elisabetta Molteni","Chiara Elena","Virginia Valeria Ferretti","Silvia Catricalà","Elisa Bono","Gabriele Todisco","Antonio Bianchessi","Elisa Rumi","Silvia Zibellini","Daniela Pietra","Emanuela Boveri","Clara Camaschella","Daniela Toniolo","Elli Papaemmanuil","Seishi Ogawa","Mario Cazzola"],"twitterCount":29,"altmetricId":19193730},{"title":"Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma","googleId":"fN5I4Kls-a8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/23/2456/40023","googleCitationCount":137,"googleAuthor":"A Perrot","doi":"10.1182/blood-2018-06-858613","elsevierAuthor":"Perrot A.","publicationName":"Blood","elsevierCoverDate":"2018-12-06","elsevierCoverDisplayDate":"6 December 2018","elsevierCitationCount":"105","altmetricAuthors":["Aurore Perrot","Valerie Lauwers-Cances","Jill Corre","Nelly Robillard","Cyrille Hulin","Marie-Lorraine Chretien","Thomas Dejoie","Sabrina Maheo","Anne-Marie Stoppa","Brigitte Pegourie","Lionel Karlin","Laurent Garderet","Bertrand Arnulf","Chantal Doyen","Nathalie Meuleman","Bruno Royer","Jean-Richard Eveillard","Lotfi Benboubker","Mamoun Dib","Olivier Decaux","Arnaud Jaccard","Karim Belhadj","Sabine Brechignac","Brigitte Kolb","Cecile Fohrer","Mohamad Mohty","Margaret Macro","Paul G. Richardson","Victoria Carlton","Martin Moorhead","Tom Willis","Malek Faham","Kenneth C. Anderson","Jean-Luc Harousseau","Xavier Leleu","Thierry Facon","Philippe Moreau","Michel Attal","Hervé Avet-Loiseau","Nikhil Munshi"],"twitterCount":125,"altmetricId":48850775},{"title":"Role of RUNX1 in hematological malignancies","googleId":"6LNRwht3yigJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2070/36427","googleCitationCount":206,"googleAuthor":"","doi":"10.1182/blood-2016-10-687830","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"0","altmetricAuthors":["Raman Sood","Yasuhiko Kamikubo","Paul Liu"],"twitterCount":21,"altmetricId":18816546},{"title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","googleId":"Tg67Np0BHccJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2661/37193","googleCitationCount":148,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood-2017-12-818948","elsevierAuthor":"Stein E.M.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"104","altmetricAuthors":["Eytan M. Stein","Guillermo Garcia-Manero","David A. Rizzieri","Raoul Tibes","Jesus G. Berdeja","Michael R. Savona","Mojca Jongen-Lavrenic","Jessica K. Altman","Blythe Thomson","Stephen J. Blakemore","Scott R. Daigle","Nigel J. Waters","A. Benjamin Suttle","Alicia Clawson","Roy Pollock","Andrei Krivtsov","Scott A. Armstrong","Jorge DiMartino","Eric Hedrick","Bob Löwenberg","Martin S. Tallman"],"twitterCount":8,"altmetricId":40683853},{"title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","googleId":"Ttb1RV90FW0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2877/39185","googleCitationCount":129,"googleAuthor":"J Picarsic","doi":"10.1182/blood-2018-03-839753","elsevierAuthor":"Abla O.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"83","altmetricAuthors":["Oussama Abla","Eric Jacobsen","Jennifer Picarsic","Zdenka Krenova","Ronald Jaffe","Jean-Francois Emile","Benjamin H. Durham","Jorge Braier","Frédéric Charlotte","Jean Donadieu","Fleur Cohen-Aubart","Carlos Rodriguez-Galindo","Carl Allen","James A. Whitlock","Sheila Weitzman","Kenneth L. McClain","Julien Haroche","Eli L. Diamond"],"twitterCount":84,"altmetricId":42375764},{"title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","googleId":"3TZPe9H9QW0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2243/36673","googleCitationCount":174,"googleAuthor":"EK Waller","doi":"10.1182/blood-2017-07-793786","elsevierAuthor":"Miklos D.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"110","altmetricAuthors":["David Miklos","Corey S. Cutler","Mukta Arora","Edmund K. Waller","Madan Jagasia","Iskra Pusic","Mary E. Flowers","Aaron C. Logan","Ryotaro Nakamura","Bruce R. Blazar","Yunfeng Li","Stephen Chang","Indu Lal","Jason Dubovsky","Danelle F. James","Lori Styles","Samantha Jaglowski"],"twitterCount":74,"altmetricId":26290661},{"title":"PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR","googleId":"eKl6IJHv59UJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/1039/36337","googleCitationCount":252,"googleAuthor":"","doi":"10.1182/blood-2016-09-738245","elsevierAuthor":"Chong E.","publicationName":"Blood","elsevierCoverDate":"2017-02-23","elsevierCoverDisplayDate":"23 February 2017","elsevierCitationCount":"206","altmetricAuthors":["Elise A. Chong","J. Joseph Melenhorst","Simon F. Lacey","David E. Ambrose","Vanessa Gonzalez","Bruce L. Levine","Carl H. June","Stephen J. Schuster"],"twitterCount":37,"altmetricId":15184128},{"title":"HUS and atypical HUS","googleId":"CgrA1AAW1ZQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2847/36275","googleCitationCount":172,"googleAuthor":"","doi":"10.1182/blood-2016-11-709865","elsevierAuthor":"Sakari Jokiranta T.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"99","altmetricAuthors":["T. Sakari Jokiranta"],"twitterCount":49,"altmetricId":18924778},{"title":"Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies","googleId":"Phcv2JDVDXsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120325842","googleCitationCount":158,"googleAuthor":"C Chester","doi":"10.1182/blood-2017-06-741041","elsevierAuthor":"Chester C.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"129","altmetricAuthors":["Cariad Chester","Miguel F. Sanmamed","Jun Wang","Ignacio Melero"],"twitterCount":12,"altmetricId":28715122},{"title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","googleId":"zvWVUyEev8MJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2515/36958","googleCitationCount":139,"googleAuthor":"R Romee","doi":"10.1182/blood-2017-12-823757","elsevierAuthor":"Romee R.","publicationName":"Blood","elsevierCoverDate":"2018-06-07","elsevierCoverDisplayDate":"7 June 2018","elsevierCitationCount":"113","altmetricAuthors":["Rizwan Romee","Sarah Cooley","Melissa M. Berrien-Elliott","Peter Westervelt","Michael R. Verneris","John E. Wagner","Daniel J. Weisdorf","Bruce R. Blazar","Celalettin Ustun","Todd E. DeFor","Sithara Vivek","Lindsey Peck","John F. DiPersio","Amanda F. Cashen","Rachel Kyllo","Amy Musiek","András Schaffer","Milan J. Anadkat","Ilana Rosman","Daniel Miller","Jack O. Egan","Emily K. Jeng","Amy Rock","Hing C. Wong","Todd A. Fehniger","Jeffrey S. Miller"],"twitterCount":79,"altmetricId":33443441},{"title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion","googleId":"qo9QMXAxsPUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/677/36802","googleCitationCount":167,"googleAuthor":"F Locatelli","doi":"10.1182/blood-2017-04-779769","elsevierAuthor":"Locatelli F.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"135","altmetricAuthors":["Franco Locatelli","Pietro Merli","Daria Pagliara","Giuseppina Li Pira","Michela Falco","Daniela Pende","Roberto Rondelli","Barbarella Lucarelli","Letizia Pomponia Brescia","Riccardo Masetti","Giuseppe Maria Milano","Valentina Bertaina","Mattia Algeri","Rita Maria Pinto","Luisa Strocchio","Raffaella Meazza","Lavinia Grapulin","Rupert Handgretinger","Alessandro Moretta","Alice Bertaina","Lorenzo Moretta"],"twitterCount":29,"altmetricId":20926620},{"title":"Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B","googleId":"SlZWOYuoJ98J","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/1022/39176","googleCitationCount":151,"googleAuthor":"","doi":"10.1182/blood-2017-09-804419","elsevierAuthor":"Miesbach W.","publicationName":"Blood","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"109","altmetricAuthors":["Wolfgang Miesbach","Karina Meijer","Michiel Coppens","Peter Kampmann","Robert Klamroth","Roger Schutgens","Marco Tangelder","Giancarlo Castaman","Joachim Schwäble","Halvard Bonig","Erhard Seifried","Federica Cattaneo","Christian Meyer","Frank W. G. Leebeek"],"twitterCount":26,"altmetricId":30543001},{"title":"CD38 antibodies in multiple myeloma: back to the future","googleId":"555YzaDWP9QJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/13/107710","googleCitationCount":153,"googleAuthor":"NWCJ van de Donk","doi":"10.1182/blood-2017-06-740944","elsevierAuthor":"Van De Donk N.W.C.J.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"104","altmetricAuthors":["Niels W. C. J. van de Donk","Paul G. Richardson","Fabio Malavasi"],"twitterCount":65,"altmetricId":28643951},{"title":"Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma","googleId":"vW4QgQEXtdAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/18/2471/36258","googleCitationCount":170,"googleAuthor":"C Herbaux","doi":"10.1182/blood-2016-11-749556","elsevierAuthor":"Herbaux C.","publicationName":"Blood","elsevierCoverDate":"2017-05-04","elsevierCoverDisplayDate":"4 May 2017","elsevierCitationCount":"133","altmetricAuthors":["Charles Herbaux","Jordan Gauthier","Pauline Brice","Elodie Drumez","Loic Ysebaert","Hélène Doyen","Luc Fornecker","Krimo Bouabdallah","Guillaume Manson","Hervé Ghesquières","Reza Tabrizi","Eric Hermet","Julien Lazarovici","Anne Thiebaut-Bertrand","Adrien Chauchet","Hélène Demarquette","Eileen Boyle","Roch Houot","Ibrahim Yakoub-Agha","Franck Morschhauser"],"twitterCount":38,"altmetricId":17092898},{"title":"Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel","googleId":"qwi--Gwd3XsJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1753/35813","googleCitationCount":166,"googleAuthor":"L Malcovati","doi":"10.1182/blood-2016-06-724500","elsevierAuthor":"De Witte T.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"115","altmetricAuthors":["Theo de Witte","David Bowen","Marie Robin","Luca Malcovati","Dietger Niederwieser","Ibrahim Yakoub-Agha","Ghulam J. Mufti","Pierre Fenaux","Guillermo Sanz","Rodrigo Martino","Emilio Paolo Alessandrino","Francesco Onida","Argiris Symeonidis","Jakob Passweg","Guido Kobbe","Arnold Ganser","Uwe Platzbecker","Jürgen Finke","Michel van Gelder","Arjan A. van de Loosdrecht","Per Ljungman","Reinhard Stauder","Liisa Volin","H. Joachim Deeg","Corey Cutler","Wael Saber","Richard Champlin","Sergio Giralt","Claudio Anasetti","Nicolaus Kröger"],"twitterCount":39,"altmetricId":15796634},{"title":"Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML","googleId":"ZxyXPy_haXIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1703/39364","googleCitationCount":112,"googleAuthor":"R Gabdoulline","doi":"10.1182/blood-2018-02-829911","elsevierAuthor":"Thol F.","publicationName":"Blood","elsevierCoverDate":"2018-10-18","elsevierCoverDisplayDate":"18 October 2018","elsevierCitationCount":"76","altmetricAuthors":["Felicitas Thol","Razif Gabdoulline","Alessandro Liebich","Piroska Klement","Johannes Schiller","Christian Kandziora","Lothar Hambach","Michael Stadler","Christian Koenecke","Madita Flintrop","Mira Pankratz","Martin Wichmann","Blerina Neziri","Konstantin Büttner","Bennet Heida","Sabrina Klesse","Anuhar Chaturvedi","Arnold Kloos","Gudrun Göhring","Brigitte Schlegelberger","Verena I. Gaidzik","Lars Bullinger","Walter Fiedler","Albert Heim","Iyas Hamwi","Matthias Eder","Jürgen Krauter","Richard F. Schlenk","Peter Paschka","Konstanze Döhner","Hartmut Döhner","Arnold Ganser","Michael Heuser"],"twitterCount":37,"altmetricId":47896955},{"title":"Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy","googleId":"7v8VC-sQAN8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/121/107692","googleCitationCount":151,"googleAuthor":"JA Hill","doi":"10.1182/blood-2017-07-793760","elsevierAuthor":"Hill J.A.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"113","altmetricAuthors":["Joshua A. Hill","Daniel Li","Kevin A. Hay","Margaret L. Green","Sindhu Cherian","Xueyan Chen","Stanley R. Riddell","David G. Maloney","Michael Boeckh","Cameron J. Turtle"],"twitterCount":82,"altmetricId":27529864},{"title":"Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma","googleId":"1jcoMEnGQXgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/301/38303","googleCitationCount":142,"googleAuthor":"MA Dimopoulos","doi":"10.1182/blood-2017-07-795047","elsevierAuthor":"Facon T.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"102","altmetricAuthors":["Thierry Facon","Meletios A. Dimopoulos","Angela Dispenzieri","John V. Catalano","Andrew Belch","Michele Cavo","Antonello Pinto","Katja Weisel","Heinz Ludwig","Nizar J. Bahlis","Anne Banos","Mourad Tiab","Michel Delforge","Jamie D. Cavenagh","Catarina Geraldes","Je-Jung Lee","Christine Chen","Albert Oriol","Javier De La Rubia","Darrell White","Daniel Binder","Jin Lu","Kenneth C. Anderson","Philippe Moreau","Michel Attal","Aurore Perrot","Bertrand Arnulf","Lugui Qiu","Murielle Roussel","Eileen Boyle","Salomon Manier","Mohamad Mohty","Herve Avet-Loiseau","Xavier Leleu","Annette Ervin-Haynes","Guang Chen","Vanessa Houck","Lotfi Benboubker","Cyrille Hulin"],"twitterCount":66,"altmetricId":29083246},{"title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","googleId":"Gz1xFg_lcMwJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/22/2420/36575","googleCitationCount":152,"googleAuthor":"CD Carey","doi":"10.1182/blood-2017-03-770719","elsevierAuthor":"Carey C.D.","publicationName":"Blood","elsevierCoverDate":"2017-11-30","elsevierCoverDisplayDate":"30 November 2017","elsevierCitationCount":"126","altmetricAuthors":["Christopher D. Carey","Daniel Gusenleitner","Mikel Lipschitz","Margaretha G. M. Roemer","Edward C. Stack","Evisa Gjini","Xihao Hu","Robert Redd","Gordon J. Freeman","Donna Neuberg","F. Stephen Hodi","Xiaole Shirley Liu","Margaret A. Shipp","Scott J. Rodig"],"twitterCount":30,"altmetricId":25133680},{"title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","googleId":"AcBE25t2gEMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1955/36746","googleCitationCount":133,"googleAuthor":"MP Ledoux","doi":"10.1182/blood-2017-11-818286","elsevierAuthor":"Ghez D.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"115","altmetricAuthors":["David Ghez","Anne Calleja","Caroline Protin","Marine Baron","Marie-Pierre Ledoux","Gandhi Damaj","Mathieu Dupont","Brigitte Dreyfus","Emmanuelle Ferrant","Charles Herbaux","Kamel Laribi","Ronan Le Calloch","Marion Malphettes","Franciane Paul","Laetitia Souchet","Malgorzata Truchan-Graczyk","Karen Delavigne","Caroline Dartigeas","Loïc Ysebaert"],"twitterCount":143,"altmetricId":32542520},{"title":"International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease","googleId":"akXyCTf7xsYJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1646/36100","googleCitationCount":218,"googleAuthor":"DC Fajgenbaum","doi":"10.1182/blood-2016-10-746933","elsevierAuthor":"Fajgenbaum D.C.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"142","altmetricAuthors":["David C. Fajgenbaum","Thomas S. Uldrick","Adam Bagg","Dale Frank","David Wu","Gordan Srkalovic","David Simpson","Amy Y. Liu","David Menke","Shanmuganathan Chandrakasan","Mary Jo Lechowicz","Raymond S. M. Wong","Sheila Pierson","Michele Paessler","Jean-François Rossi","Makoto Ide","Jason Ruth","Michael Croglio","Alexander Suarez","Vera Krymskaya","Amy Chadburn","Gisele Colleoni","Sunita Nasta","Raj Jayanthan","Christopher S. Nabel","Corey Casper","Angela Dispenzieri","Alexander Fosså","Dermot Kelleher","Razelle Kurzrock","Peter Voorhees","Ahmet Dogan","Kazuyuki Yoshizaki","Frits van Rhee","Eric Oksenhendler","Elaine S. Jaffe","Kojo S. J. Elenitoba-Johnson","Megan S. Lim"],"twitterCount":44,"altmetricId":15490772},{"title":"Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia","googleId":"no-hAO6uBlcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2317/36672","googleCitationCount":141,"googleAuthor":"","doi":"10.1182/blood-2017-06-786129","elsevierAuthor":"Mueller K.T.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"105","altmetricAuthors":["Karen Thudium Mueller","Shannon L. Maude","David L. Porter","Noelle Frey","Patricia Wood","Xia Han","Edward Waldron","Abhijit Chakraborty","Rakesh Awasthi","Bruce L. Levine","J. Joseph Melenhorst","Stephan A. Grupp","Carl H. June","Simon F. Lacey"],"twitterCount":37,"altmetricId":26420298},{"title":"Vitamin B12 deficiency from the perspective of a practicing hematologist","googleId":"Y-tNRDNbGfAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/19/2603/36140","googleCitationCount":152,"googleAuthor":"R Green","doi":"10.1182/blood-2016-10-569186","elsevierAuthor":"Green R.","publicationName":"Blood","elsevierCoverDate":"2017-05-11","elsevierCoverDisplayDate":"11 May 2017","elsevierCitationCount":"77","altmetricAuthors":["Ralph Green"],"twitterCount":77,"altmetricId":18357808},{"title":"Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis","googleId":"uuhGcoLKU1sJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/7/900/36992","googleCitationCount":156,"googleAuthor":"GP Kaufman","doi":"10.1182/blood-2017-01-763599","elsevierAuthor":"Kaufman G.","publicationName":"Blood","elsevierCoverDate":"2017-08-17","elsevierCoverDisplayDate":"17 August 2017","elsevierCitationCount":"126","altmetricAuthors":["Gregory P. Kaufman","Stanley L. Schrier","Richard A. Lafayette","Sally Arai","Ronald M. Witteles","Michaela Liedtke"],"twitterCount":87,"altmetricId":21072231},{"title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","googleId":"LB_7YQffihsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2115/39506","googleCitationCount":98,"googleAuthor":"A Dispenzieri","doi":"10.1182/blood-2018-07-862334","elsevierAuthor":"Van Rhee F.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"63","altmetricAuthors":["Frits van Rhee","Peter Voorhees","Angela Dispenzieri","Alexander Fosså","Gordan Srkalovic","Makoto Ide","Nikhil Munshi","Stephen Schey","Matthew Streetly","Sheila K. Pierson","Helen L. Partridge","Sudipto Mukherjee","Dustin Shilling","Katie Stone","Amy Greenway","Jason Ruth","Mary Jo Lechowicz","Shanmuganathan Chandrakasan","Raj Jayanthan","Elaine S. Jaffe","Heather Leitch","Naveen Pemmaraju","Amy Chadburn","Megan S. Lim","Kojo S. Elenitoba-Johnson","Vera Krymskaya","Aaron Goodman","Christian Hoffmann","Pier Luigi Zinzani","Simone Ferrero","Louis Terriou","Yasuharu Sato","David Simpson","Raymond Wong","Jean-Francois Rossi","Sunita Nasta","Kazuyuki Yoshizaki","Razelle Kurzrock","Thomas S. Uldrick","Corey Casper","Eric Oksenhendler","David C. Fajgenbaum"],"twitterCount":52,"altmetricId":47676159},{"title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group","googleId":"s5EYNz3JPOQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3352/107622","googleCitationCount":150,"googleAuthor":"","doi":"10.1182/blood-2016-12-758979","elsevierAuthor":"Reshmi S.C.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"109","altmetricAuthors":["Shalini C. Reshmi","Richard C. Harvey","Kathryn G. Roberts","Eileen Stonerock","Amy Smith","Heather Jenkins","I-Ming Chen","Marc Valentine","Yu Liu","Yongjin Li","Ying Shao","John Easton","Debbie Payne-Turner","Zhaohui Gu","Thai Hoa Tran","Jonathan V. Nguyen","Meenakshi Devidas","Yunfeng Dai","Nyla A. Heerema","Andrew J. Carroll","Elizabeth A. Raetz","Michael J. Borowitz","Brent L. Wood","Anne L. Angiolillo","Michael J. Burke","Wanda L. Salzer","Patrick A. Zweidler-McKay","Karen R. Rabin","William L. Carroll","Jinghui Zhang","Mignon L. Loh","Charles G. Mullighan","Cheryl L. Willman","Julie M. Gastier-Foster","Stephen P. Hunger"],"twitterCount":30,"altmetricId":18853674},{"title":"Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?","googleId":"jlzvBJHyooMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/23/2463/36769","googleCitationCount":133,"googleAuthor":"","doi":"10.1182/blood-2017-08-801662","elsevierAuthor":"Lenting P.J.","publicationName":"Blood","elsevierCoverDate":"2017-12-07","elsevierCoverDisplayDate":"7 December 2017","elsevierCitationCount":"95","altmetricAuthors":["Peter J. Lenting","Cécile V. Denis","Olivier D. Christophe"],"twitterCount":42,"altmetricId":27585741},{"title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","googleId":"STZGyrWRXk4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1548/35938","googleCitationCount":216,"googleAuthor":"E Gluckman","doi":"10.1182/blood-2016-10-745711","elsevierAuthor":"Gluckman E.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"166","altmetricAuthors":["Eliane Gluckman","Barbara Cappelli","Francoise Bernaudin","Myriam Labopin","Fernanda Volt","Jeanette Carreras","Belinda Pinto Simões","Alina Ferster","Sophie Dupont","Josu de la Fuente","Jean-Hugues Dalle","Marco Zecca","Mark C. Walters","Lakshmanan Krishnamurti","Monica Bhatia","Kathryn Leung","Gregory Yanik","Joanne Kurtzberg","Nathalie Dhedin","Mathieu Kuentz","Gerard Michel","Jane Apperley","Patrick Lutz","Bénédicte Neven","Yves Bertrand","Jean Pierre Vannier","Mouhab Ayas","Marina Cavazzana","Susanne Matthes-Martin","Vanderson Rocha","Hanadi Elayoubi","Chantal Kenzey","Peter Bader","Franco Locatelli","Annalisa Ruggeri","Mary Eapen"],"twitterCount":76,"altmetricId":14721948},{"title":"Anemia at older age: etiologies, clinical implications, and management","googleId":"v6yqyf2nro8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/505/104393","googleCitationCount":130,"googleAuthor":"","doi":"10.1182/blood-2017-07-746446","elsevierAuthor":"Stauder R.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"76","altmetricAuthors":["Reinhard Stauder","Peter Valent","Igor Theurl"],"twitterCount":70,"altmetricId":28987562},{"title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death","googleId":"Y_Af8DU1rXgJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2111/36385","googleCitationCount":153,"googleAuthor":"E Muchtar","doi":"10.1182/blood-2016-11-751628","elsevierAuthor":"Muchtar E.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"132","altmetricAuthors":["Eli Muchtar","Morie A. Gertz","Shaji K. Kumar","Martha Q. Lacy","David Dingli","Francis K. Buadi","Martha Grogan","Suzanne R. Hayman","Prashant Kapoor","Nelson Leung","Amie Fonder","Miriam Hobbs","Yi Lisa Hwa","Wilson Gonsalves","Rahma Warsame","Taxiarchis V. Kourelis","Stephen Russell","John A. Lust","Yi Lin","Ronald S. Go","Steven Zeldenrust","Robert A. Kyle","S. Vincent Rajkumar","Angela Dispenzieri"],"twitterCount":65,"altmetricId":15847100},{"title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","googleId":"rGEf5YiIIasJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1442/36639","googleCitationCount":134,"googleAuthor":"","doi":"10.1182/blood-2017-12-820852","elsevierAuthor":"Weiss E.S.","publicationName":"Blood","elsevierCoverDate":"2018-03-29","elsevierCoverDisplayDate":"29 March 2018","elsevierCitationCount":"97","altmetricAuthors":["Eric S. Weiss","Charlotte Girard-Guyonvarc’h","Dirk Holzinger","Adriana A. de Jesus","Zeshan Tariq","Jennifer Picarsic","Eduardo J. Schiffrin","Dirk Foell","Alexei A. Grom","Sandra Ammann","Stephan Ehl","Tomoaki Hoshino","Raphaela Goldbach-Mansky","Cem Gabay","Scott W. Canna"],"twitterCount":28,"altmetricId":31625277},{"title":"Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study","googleId":"ibG1-ZjD23YJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/23/2527/36754","googleCitationCount":133,"googleAuthor":"","doi":"10.1182/blood-2017-04-748707","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2018-02-08","elsevierCoverDisplayDate":"8 February 2018","elsevierCitationCount":"0","altmetricAuthors":["Raymond S. M. Wong","Mansoor N. Saleh","Abderrahim Khelif","Abdulgabar Salama","Maria Socorro O. Portella","Paul Burgess","James B. Bussel"],"twitterCount":30,"altmetricId":27585956},{"title":"Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study","googleId":"oVQu7B3H2tQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/7/846/36207","googleCitationCount":196,"googleAuthor":"","doi":"10.1182/blood-2016-09-742205","elsevierAuthor":"Rea D.","publicationName":"Blood","elsevierCoverDate":"2017-02-16","elsevierCoverDisplayDate":"16 February 2017","elsevierCitationCount":"158","altmetricAuthors":["Delphine Rea","Franck E. Nicolini","Michel Tulliez","François Guilhot","Joelle Guilhot","Agnès Guerci-Bresler","Martine Gardembas","Valérie Coiteux","Gaelle Guillerm","Laurence Legros","Gabriel Etienne","Jean-Michel Pignon","Bruno Villemagne","Martine Escoffre-Barbe","Jean-Christophe Ianotto","Aude Charbonnier","Hyacinthe Johnson-Ansah","Marie-Pierre Noel","Philippe Rousselot","François-Xavier Mahon"],"twitterCount":44,"altmetricId":14595003},{"title":"Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma","googleId":"nq0x2Wsi6fkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/10/1189/36356","googleCitationCount":140,"googleAuthor":"A Badros","doi":"10.1182/blood-2017-03-775122","elsevierAuthor":"Badros A.","publicationName":"Blood","elsevierCoverDate":"2017-09-07","elsevierCoverDisplayDate":"7 September 2017","elsevierCitationCount":"108","altmetricAuthors":["Ashraf Badros","Elizabeth Hyjek","Ning Ma","Alexander Lesokhin","Ahmet Dogan","Aaron P. Rapoport","Mehmet Kocoglu","Emily Lederer","Sunita Philip","Todd Milliron","Cameron Dell","Olga Goloubeva","Zeba Singh"],"twitterCount":52,"altmetricId":19766708},{"title":"Age-related clonal hematopoiesis","googleId":"KLfSQtHm2rAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/496/104398","googleCitationCount":121,"googleAuthor":"LI Shlush","doi":"10.1182/blood-2017-07-746453","elsevierAuthor":"Shlush L.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"95","altmetricAuthors":["Liran I. Shlush"],"twitterCount":7,"altmetricId":29050213},{"title":"A randomized phase III study of ibrutinib (PCI-32765)-based therapy vs. standard fludarabine, cyclophosphamide, and rituximab (FCR) chemoimmunotherapy in …","googleId":"zPEWyi_8HAMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/LBA-4/375111","googleCitationCount":96,"googleAuthor":"TD Shanafelt","doi":"10.1182/blood-2018-120779","elsevierCitationCount":0,"altmetricAuthors":["Tait D. Shanafelt","Victoria Wang","Neil E. Kay","Curtis A. Hanson","Susan M. O'Brien","Jacqueline C Barrientos","Harry P. Erba","Richard M. Stone","Mark R. Litzow","Martin S. Tallman"],"twitterCount":0,"altmetricId":52535403},{"title":"Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study","googleId":"cLUZkQ77jzYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2357/37110","googleCitationCount":112,"googleAuthor":"IE Ahn","doi":"10.1182/blood-2017-12-820910","elsevierAuthor":"Ahn I.E.","publicationName":"Blood","elsevierCoverDate":"2018-05-24","elsevierCoverDisplayDate":"24 May 2018","elsevierCitationCount":"83","altmetricAuthors":["Inhye E. Ahn","Mohammed Z. H. Farooqui","Xin Tian","Janet Valdez","Clare Sun","Susan Soto","Jennifer Lotter","Stephanie Housel","Maryalice Stetler-Stevenson","Constance M. Yuan","Irina Maric","Katherine R. Calvo","Pia Nierman","Thomas E. Hughes","Nakhle S. Saba","Gerald E. Marti","Stefania Pittaluga","Sarah E. M. Herman","Carsten U. Niemann","Lone B. Pedersen","Christian H. Geisler","Richard Childs","Georg Aue","Adrian Wiestner"],"twitterCount":45,"altmetricId":33707906},{"title":"The genetics and molecular biology of T-ALL","googleId":"h1yw4hIJD1oJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/9/1113/36559","googleCitationCount":142,"googleAuthor":"J Cools","doi":"10.1182/blood-2016-10-706465","elsevierAuthor":"Girardi T.","publicationName":"Blood","elsevierCoverDate":"2017-03-02","elsevierCoverDisplayDate":"2 March 2017","elsevierCitationCount":"99","altmetricAuthors":["Tiziana Girardi","Carmen Vicente","Jan Cools","Kim De Keersmaecker"],"twitterCount":29,"altmetricId":15722691},{"title":"Sorafenib as maintenance therapy post allogeneic stem cell transplantation for FLT3-ITD positive AML: results from the randomized, double-blind, placebo-controlled …","googleId":"cmlnwS8dVUoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/661/266168","googleCitationCount":89,"googleAuthor":"","doi":"10.1182/blood-2018-99-112614","elsevierCitationCount":0,"altmetricAuthors":["Andreas Burchert","Gesine Bug","Jürgen Finke","Matthias Stelljes","Christoph Rollig","Ralph Wäsch","Martin Bornhäuser","Tobias Berg","Fabian Lang","Gerhard Ehninger","Hubert Serve","Robert Zeiser","Eva-Maria Wagner","Nicolaus Kroeger","Christine Wolschke","Michael Schleuning","Ahmet Elmaagacli","Katharina S. Götze","Christoph Schmid","Edgar Jost","Dominik Wolf","Alexandra Böhm","Christian Thiede","Torsten Haferlach","Wolfgang Bethge","Susanne Harnisch","Michael Wittenberg","Susanne Rospleszcz","Andreas Neubauer","Markus Brugger","Konstantin Strauch","Carmen Schade-Brittinger","Stephan K Metzelder"],"twitterCount":1,"altmetricId":65582316},{"title":"Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib","googleId":"S1tBohtid0AJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2307/36662","googleCitationCount":123,"googleAuthor":"","doi":"10.1182/blood-2017-08-801191","elsevierAuthor":"Rao V.K.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"101","altmetricAuthors":["V. Koneti Rao","Sharon Webster","Virgil A. S. H. Dalm","Anna Šedivá","P. Martin van Hagen","Steven Holland","Sergio D. Rosenzweig","Andreas D. Christ","Birgitte Sloth","Maciej Cabanski","Aniket D. Joshi","Stefan de Buck","Julie Doucet","Danilo Guerini","Christoph Kalis","Ilona Pylvaenaeinen","Nicolas Soldermann","Anuj Kashyap","Gulbu Uzel","Michael J. Lenardo","Dhavalkumar D. Patel","Carrie L. Lucas","Christoph Burkhart"],"twitterCount":4,"altmetricId":26856927},{"title":"Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults","googleId":"JqKLPCyyS1MJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/572/36151","googleCitationCount":184,"googleAuthor":"N Jain","doi":"10.1182/blood-2016-07-726588","elsevierAuthor":"Jain N.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"123","altmetricAuthors":["Nitin Jain","Kathryn G. Roberts","Elias Jabbour","Keyur Patel","Agda Karina Eterovic","Ken Chen","Patrick Zweidler-McKay","Xinyan Lu","Gloria Fawcett","Sa A. Wang","Sergej Konoplev","Richard C. Harvey","I-Ming Chen","Debbie Payne-Turner","Marcus Valentine","Deborah Thomas","Guillermo Garcia-Manero","Farhad Ravandi","Jorge Cortes","Steven Kornblau","Susan O’Brien","Sherry Pierce","Jeffrey Jorgensen","Kenna R. Mills Shaw","Cheryl L. Willman","Charles G. Mullighan","Hagop Kantarjian","Marina Konopleva"],"twitterCount":32,"altmetricId":14487257},{"title":"Erythroferrone inhibits the induction of hepcidin by BMP6","googleId":"yIDQiSybwBcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1473/39343","googleCitationCount":91,"googleAuthor":"J Arezes","doi":"10.1182/blood-2018-06-857995","elsevierAuthor":"Arezes J.","publicationName":"Blood","elsevierCoverDate":"2018-10-04","elsevierCoverDisplayDate":"4 October 2018","elsevierCitationCount":"67","altmetricAuthors":["João Arezes","Niall Foy","Kirsty McHugh","Anagha Sawant","Doris Quinkert","Virginie Terraube","Alette Brinth","May Tam","Edward R. LaVallie","Stephen Taylor","Andrew E. Armitage","Sant-Rayn Pasricha","Orla Cunningham","Matthew Lambert","Simon J. Draper","Reema Jasuja","Hal Drakesmith"],"twitterCount":17,"altmetricId":46539928},{"title":"Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia","googleId":"j7uubKxFYAMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1469/35906","googleCitationCount":180,"googleAuthor":"IE Ahn","doi":"10.1182/blood-2016-06-719294","elsevierAuthor":"Ahn I.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"124","altmetricAuthors":["Inhye E. Ahn","Chingiz Underbayev","Adam Albitar","Sarah E. M. Herman","Xin Tian","Irina Maric","Diane C. Arthur","Laura Wake","Stefania Pittaluga","Constance M. Yuan","Maryalice Stetler-Stevenson","Susan Soto","Janet Valdez","Pia Nierman","Jennifer Lotter","Liqiang Xi","Mark Raffeld","Mohammed Farooqui","Maher Albitar","Adrian Wiestner"],"twitterCount":21,"altmetricId":15216722},{"title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","googleId":"whNdaMenG1oJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/3/347/36021","googleCitationCount":179,"googleAuthor":"L Sedek","doi":"10.1182/blood-2016-07-726307","elsevierAuthor":"Theunissen P.","publicationName":"Blood","elsevierCoverDate":"2017-01-19","elsevierCoverDisplayDate":"19 January 2017","elsevierCitationCount":"131","altmetricAuthors":["Prisca Theunissen","Ester Mejstrikova","Lukasz Sedek","Alita J. van der Sluijs-Gelling","Giuseppe Gaipa","Marius Bartels","Elaine Sobral da Costa","Michaela Kotrová","Michaela Novakova","Edwin Sonneveld","Chiara Buracchi","Paola Bonaccorso","Elen Oliveira","Jeroen G. te Marvelde","Tomasz Szczepanski","Ludovic Lhermitte","Ondrej Hrusak","Quentin Lecrevisse","Georgiana Emilia Grigore","Eva Froňková","Jan Trka","Monika Brüggemann","Alberto Orfao","Jacques J. M. van Dongen","Vincent H. J. van der Velden"],"twitterCount":8,"altmetricId":14200047},{"title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","googleId":"FT--ZHVolIIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/25/2709/36882","googleCitationCount":123,"googleAuthor":"B Pro","doi":"10.1182/blood-2017-05-780049","elsevierAuthor":"Pro B.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"0","altmetricAuthors":["Barbara Pro","Ranjana Advani","Pauline Brice","Nancy L. Bartlett","Joseph D. Rosenblatt","Tim Illidge","Jeffrey Matous","Radhakrishnan Ramchandren","Michelle Fanale","Joseph M. Connors","Keenan Fenton","Dirk Huebner","Juan M. Pinelli","Dana A. Kennedy","Andrei Shustov"],"twitterCount":82,"altmetricId":26962684},{"title":"Therapeutic targeting of acute myeloid leukemia stem cells","googleId":"B1mnwanW7S0J","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1627/36074","googleCitationCount":135,"googleAuthor":"CT Jordan","doi":"10.1182/blood-2016-10-696039","elsevierAuthor":"Pollyea D.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"100","altmetricAuthors":["Daniel A. Pollyea","Craig T. Jordan"],"twitterCount":19,"altmetricId":18042332},{"title":"Axicabtagene ciloleucel (Axi-cel) CD19 chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory large B-cell lymphoma: real world experience","googleId":"N3gMHvb-I6UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/91/265997","googleCitationCount":91,"googleAuthor":"","doi":"10.1182/blood-2018-99-114152","elsevierAuthor":"Kharfan-Dabaja M.A.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"September 2019","elsevierCitationCount":"0","altmetricAuthors":["Loretta J. Nastoupil","Michael D. Jain","Jay Y. Spiegel","Armin Ghobadi","Yi Lin","Saurabh Dahiya","Matthew A. Lunning","Lazaros J. Lekakis","Patrick M. Reagan","Olalekan O. Oluwole","Joseph P. McGuirk","Abhinav Deol","Alison R. Sehgal","Andre Goy","Brian T. Hill","Charalambos Andreadis","Javier Munoz","Jason R. Westin","Julio C. Chavez","Amanda F Cashen","Nora N Bennani","Aaron P. Rapoport","Julie M. Vose","David B. Miklos","Sattva S. Neelapu","Frederick L. Locke"],"twitterCount":6,"altmetricId":57495100},{"title":"Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation","googleId":"Oz1kzOPKeuMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/16/1857/36493","googleCitationCount":124,"googleAuthor":"SO Ciurea","doi":"10.1182/blood-2017-05-785659","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2018-12-27","elsevierCoverDisplayDate":"27 December 2018","elsevierCitationCount":"0","altmetricAuthors":["Stefan O. Ciurea","Jolie R. Schafer","Roland Bassett","Cecele J. Denman","Kai Cao","Dana Willis","Gabriela Rondon","Julianne Chen","Doris Soebbing","Indreshpal Kaur","Alison Gulbis","Sairah Ahmed","Katayoun Rezvani","Elizabeth J. Shpall","Dean A. Lee","Richard E. Champlin"],"twitterCount":36,"altmetricId":24295536},{"title":"How I treat disseminated intravascular coagulation","googleId":"TJc-EMAiLfUJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/8/845/104418","googleCitationCount":120,"googleAuthor":"M Levi","doi":"10.1182/blood-2017-10-804096","elsevierAuthor":"Levi M.","publicationName":"Blood","elsevierCoverDate":"2018-02-22","elsevierCoverDisplayDate":"22 February 2018","elsevierCitationCount":"62","altmetricAuthors":["Marcel Levi","Marie Scully"],"twitterCount":50,"altmetricId":30643045},{"title":"Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma","googleId":"S1SSL8qPru4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/40/39282","googleCitationCount":101,"googleAuthor":"P Caimi","doi":"10.1182/blood-2017-11-815183","elsevierAuthor":"LaCasce A.S.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"67","altmetricAuthors":["Ann S. LaCasce","R. Gregory Bociek","Ahmed Sawas","Paolo Caimi","Edward Agura","Jeffrey Matous","Stephen M. Ansell","Howland E. Crosswell","Miguel Islas-Ohlmayer","Caroline Behler","Eric Cheung","Andres Forero-Torres","Julie Vose","Owen A. O’Connor","Neil Josephson","Yinghui Wang","Ranjana Advani"],"twitterCount":69,"altmetricId":39610999},{"title":"How I treat acquired aplastic anemia","googleId":"9gEb9J72XzgJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1428/35931","googleCitationCount":173,"googleAuthor":"","doi":"10.1182/blood-2016-08-693481","elsevierAuthor":"Bacigalupo A.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"117","altmetricAuthors":["Andrea Bacigalupo"],"twitterCount":71,"altmetricId":15557457},{"title":"Diagnosis and classification of hematologic malignancies on the basis of genetics","googleId":"tofRwts1eUEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/410/37114","googleCitationCount":125,"googleAuthor":"J Taylor","doi":"10.1182/blood-2017-02-734541","elsevierAuthor":"Taylor J.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"69","altmetricAuthors":["Justin Taylor","Wenbin Xiao","Omar Abdel-Wahab"],"twitterCount":50,"altmetricId":20934049},{"title":"Aging of hematopoietic stem cells","googleId":"JXCbrFQT-U4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/479/104419","googleCitationCount":109,"googleAuthor":"SS Lazare","doi":"10.1182/blood-2017-06-746412","elsevierAuthor":"De Haan G.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"78","altmetricAuthors":["Gerald de Haan","Seka Simone Lazare"],"twitterCount":13,"altmetricId":29047224},{"title":"Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma","googleId":"3_1VxXlRH4cJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1380/35994","googleCitationCount":170,"googleAuthor":"HT Kim","doi":"10.1182/blood-2016-09-738385","elsevierAuthor":"Merryman R.W.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"123","altmetricAuthors":["Reid W. Merryman","Haesook T. Kim","Pier Luigi Zinzani","Carmelo Carlo-Stella","Stephen M. Ansell","Miguel-Angel Perales","Abraham Avigdor","Ahmad S. Halwani","Roch Houot","Tony Marchand","Nathalie Dhedin","Willy Lescaut","Anne Thiebaut-Bertrand","Sylvie François","Aspasia Stamatoullas-Bastard","Pierre-Simon Rohrlich","Hélène Labussière Wallet","Luca Castagna","Armando Santoro","Veronika Bachanova","Scott C. Bresler","Amitabh Srivastava","Harim Kim","Emily Pesek","Marie Chammas","Carol Reynolds","Vincent T. Ho","Joseph H. Antin","Jerome Ritz","Robert J. Soiffer","Philippe Armand"],"twitterCount":40,"altmetricId":15378769},{"title":"Prognostic role of circulating exosomal miRNAs in multiple myeloma","googleId":"TGBSZGYtHP4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2429/35954","googleCitationCount":127,"googleAuthor":"CJ Liu","doi":"10.1182/blood-2016-09-742296","elsevierAuthor":"Manier S.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"100","altmetricAuthors":["Salomon Manier","Chia-Jen Liu","Hervé Avet-Loiseau","Jihye Park","Jiantao Shi","Federico Campigotto","Karma Z. Salem","Daisy Huynh","Siobhan V. Glavey","Bradley Rivotto","Antonio Sacco","Aldo M. Roccaro","Juliette Bouyssou","Stéphane Minvielle","Philippe Moreau","Thierry Facon","Xavier Leleu","Edie Weller","Lorenzo Trippa","Irene M. Ghobrial"],"twitterCount":12,"altmetricId":16510242},{"title":"Chimeric antigen receptor T-cell therapies for multiple myeloma","googleId":"xzuxe4YELQQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/24/2594/36866","googleCitationCount":113,"googleAuthor":"JN Kochenderfer","doi":"10.1182/blood-2017-06-793869","elsevierAuthor":"Mikkilineni L.","publicationName":"Blood","elsevierCoverDate":"2017-12-14","elsevierCoverDisplayDate":"14 December 2017","elsevierCitationCount":"87","altmetricAuthors":["Lekha Mikkilineni","James N. Kochenderfer"],"twitterCount":105,"altmetricId":26325526},{"title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","googleId":"uQkRoWC0CPgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2413/37097","googleCitationCount":100,"googleAuthor":"V Spina","doi":"10.1182/blood-2017-11-812073","elsevierAuthor":"Sollini M.","publicationName":"European Journal of Hybrid Imaging","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"1","altmetricAuthors":["Valeria Spina","Alessio Bruscaggin","Annarosa Cuccaro","Maurizio Martini","Martina Di Trani","Gabriela Forestieri","Martina Manzoni","Adalgisa Condoluci","Alberto Arribas","Lodovico Terzi-Di-Bergamo","Silvia Laura Locatelli","Elisa Cupelli","Luca Ceriani","Alden A. Moccia","Anastasios Stathis","Luca Nassi","Clara Deambrogi","Fary Diop","Francesca Guidetti","Alessandra Cocomazzi","Salvatore Annunziata","Vittoria Rufini","Alessandro Giordano","Antonino Neri","Renzo Boldorini","Bernhard Gerber","Francesco Bertoni","Michele Ghielmini","Georg Stüssi","Armando Santoro","Franco Cavalli","Emanuele Zucca","Luigi Maria Larocca","Gianluca Gaidano","Stefan Hohaus","Carmelo Carlo-Stella","Davide Rossi"],"twitterCount":67,"altmetricId":33258499},{"title":"Philadelphia chromosome–like acute lymphoblastic leukemia","googleId":"D2ieljrH9VcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/19/2064/36686","googleCitationCount":107,"googleAuthor":"SK Tasian","doi":"10.1182/blood-2017-06-743252","elsevierAuthor":"Tasian S.K.","publicationName":"Blood","elsevierCoverDate":"2017-11-09","elsevierCoverDisplayDate":"9 November 2017","elsevierCitationCount":"63","altmetricAuthors":["Sarah K. Tasian","Mignon L. Loh","Stephen P. Hunger"],"twitterCount":41,"altmetricId":26939506},{"title":"Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML","googleId":"H_-Y8SuLmrEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1415/36624","googleCitationCount":98,"googleAuthor":"JF Zeidner","doi":"10.1182/blood-2017-09-805895","elsevierAuthor":"Swords R.T.","publicationName":"Blood","elsevierCoverDate":"2018-03-29","elsevierCoverDisplayDate":"29 March 2018","elsevierCitationCount":"78","altmetricAuthors":["Ronan T. Swords","Steven Coutre","Michael B. Maris","Joshua F. Zeidner","James M. Foran","Jose Cruz","Harry P. Erba","Jesus G. Berdeja","Wayne Tam","Saran Vardhanabhuti","Iwona Pawlikowska-Dobler","Hélène M. Faessel","Ajeeta B. Dash","Farhad Sedarati","Bruce J. Dezube","Douglas V. Faller","Michael R. Savona"],"twitterCount":25,"altmetricId":31992709},{"title":"The NCI Genomic Data Commons as an engine for precision medicine","googleId":"z0AFF__dd18J","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/453/37127","googleCitationCount":112,"googleAuthor":"RL Grossman","doi":"10.1182/blood-2017-03-735654","elsevierAuthor":"Jensen M.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"81","altmetricAuthors":["Mark A. Jensen","Vincent Ferretti","Robert L. Grossman","Louis M. Staudt"],"twitterCount":21,"altmetricId":20975330},{"title":"The chronic myeloid leukemia stem cell: stemming the tide of persistence","googleId":"g_KxC7BKdSEJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1595/36129","googleCitationCount":162,"googleAuthor":"TL Holyoake","doi":"10.1182/blood-2016-09-696013","elsevierAuthor":"Holyoake T.L.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"121","altmetricAuthors":["Tessa L. Holyoake","David Vetrie"],"twitterCount":15,"altmetricId":16191507},{"title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","googleId":"wey0myfSgUoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120322941","googleCitationCount":92,"googleAuthor":"XR Xu","doi":"10.1182/blood-2017-05-743187","elsevierAuthor":"Xu X.R.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"72","altmetricAuthors":["Xiaohong Ruby Xu","George M. Yousef","Heyu Ni"],"twitterCount":23,"altmetricId":38331592},{"title":"Chimeric antigen receptor–modified T cells: CD19 and the road beyond","googleId":"JqIEvAwb2DEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2621/37176","googleCitationCount":83,"googleAuthor":"AI Salter","doi":"10.1182/blood-2018-01-785840","elsevierAuthor":"Salter A.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"63","altmetricAuthors":["Alexander I. Salter","Margot J. Pont","Stanley R. Riddell"],"twitterCount":21,"altmetricId":40871314},{"title":"Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo","googleId":"BRpy8z3dbJ8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/14/1991/35879","googleCitationCount":119,"googleAuthor":"A Lin","doi":"10.1182/blood-2016-10-744441","elsevierAuthor":"Vono M.","publicationName":"Blood","elsevierCoverDate":"2017-04-06","elsevierCoverDisplayDate":"6 April 2017","elsevierCitationCount":"79","altmetricAuthors":["Maria Vono","Ang Lin","Anna Norrby-Teglund","Richard A. Koup","Frank Liang","Karin Loré"],"twitterCount":18,"altmetricId":16184758},{"title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","googleId":"eDH2rS16EckJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/16/2291/35922","googleCitationCount":114,"googleAuthor":"S Subramaniam","doi":"10.1182/blood-2016-11-749879","elsevierAuthor":"Subramaniam S.","publicationName":"Blood","elsevierCoverDate":"2017-04-20","elsevierCoverDisplayDate":"20 April 2017","elsevierCitationCount":"91","altmetricAuthors":["Saravanan Subramaniam","Kerstin Jurk","Lukas Hobohm","Sven Jäckel","Mona Saffarzadeh","Kathrin Schwierczek","Philip Wenzel","Florian Langer","Christoph Reinhardt","Wolfram Ruf"],"twitterCount":5,"altmetricId":19565038},{"title":"A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma","googleId":"0WsfvX70FZwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3294/107599","googleCitationCount":111,"googleAuthor":"","doi":"10.1182/blood-2016-09-740787","elsevierAuthor":"Martin T.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"82","altmetricAuthors":["Thomas Martin","Rachid Baz","Don M. Benson","Nikoletta Lendvai","Jeffrey Wolf","Pamela Munster","Alexander M. Lesokhin","Claudine Wack","Eric Charpentier","Frank Campana","Ravi Vij"],"twitterCount":21,"altmetricId":19965773},{"title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","googleId":"r_gtEplH82gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1478/39337","googleCitationCount":84,"googleAuthor":"A Dispenzieri","doi":"10.1182/blood-2018-04-839480","elsevierAuthor":"Fermand J.","publicationName":"Blood","elsevierCoverDate":"2018-10-04","elsevierCoverDisplayDate":"4 October 2018","elsevierCitationCount":"56","altmetricAuthors":["Jean-Paul Fermand","Frank Bridoux","Angela Dispenzieri","Arnaud Jaccard","Robert A. Kyle","Nelson Leung","Giampaolo Merlini"],"twitterCount":88,"altmetricId":45115190},{"title":"TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma","googleId":"fWVlNvs7JqcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1689/39360","googleCitationCount":89,"googleAuthor":"C Guillerey","doi":"10.1182/blood-2018-01-825265","elsevierAuthor":"Guillerey C.","publicationName":"Blood","elsevierCoverDate":"2018-10-18","elsevierCoverDisplayDate":"18 October 2018","elsevierCitationCount":"70","altmetricAuthors":["Camille Guillerey","Heidi Harjunpää","Nadège Carrié","Sahar Kassem","Tricia Teo","Kim Miles","Sophie Krumeich","Marianne Weulersse","Marine Cuisinier","Kimberley Stannard","Yuan Yu","Simone A. Minnie","Geoffrey R. Hill","William C. Dougall","Hervé Avet-Loiseau","Michele W. L. Teng","Kyohei Nakamura","Ludovic Martinet","Mark J. Smyth"],"twitterCount":38,"altmetricId":44753014},{"title":"Chronic graft-versus-host disease: biological insights from preclinical and clinical studies","googleId":"6OfUu5YyiGwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/1/13/35804","googleCitationCount":154,"googleAuthor":"K MacDonald","doi":"10.1182/blood-2016-06-686618","elsevierAuthor":"MacDonald K.P.A.","publicationName":"Blood","elsevierCoverDate":"2017-01-05","elsevierCoverDisplayDate":"5 January 2017","elsevierCitationCount":"101","altmetricAuthors":["Kelli P. A. MacDonald","Geoffrey R. Hill","Bruce R. Blazar"],"twitterCount":50,"altmetricId":13536593},{"title":"Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT","googleId":"eBA0UDxCufkJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2978/39137","googleCitationCount":88,"googleAuthor":"BW Haak","doi":"10.1182/blood-2018-01-828996","elsevierAuthor":"Haak B.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"64","altmetricAuthors":["Bastiaan W. Haak","Eric R. Littmann","Jean-Luc Chaubard","Amanda J. Pickard","Emily Fontana","Fatima Adhi","Yangtsho Gyaltshen","Lilan Ling","Sejal M. Morjaria","Jonathan U. Peled","Marcel R. van den Brink","Alexander I. Geyer","Justin R. Cross","Eric G. Pamer","Ying Taur"],"twitterCount":24,"altmetricId":38329963},{"title":"Primary analysis of Juliet: a global, pivotal, phase 2 trial of CTL019 in adult patients with relapsed or refractory diffuse large B-cell lymphoma","googleId":"--M2DnFfnSYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/577/115519","googleCitationCount":113,"googleAuthor":"CS Tam","doi":"10.1182/blood.V130.Suppl_1.577.577","elsevierCitationCount":0,"altmetricAuthors":["Stephen J. Schuster","Michael R. Bishop","Constantine S. Tam","Edmund K. Waller","Peter Borchmann","Joseph P. McGuirk","Ulrich Jaeger","Samantha Jaglowski","Charalambos Andreadis","Jason R. Westin","Isabelle Fleury","Veronika Bachanova","Stephen Ronan Foley","P. Joy Ho","Stephan Mielke","John M. Magenau","Harald Holte","Koen Van Besien","Marie Jose Kersten","Takanori Teshima","Kensei Tobinai","Paolo Corradini","Oezlem Anak","Lida Bubuteishvili Pacaud","Christopher del Corral","Rakesh Awasthi","Feng Tai","Gilles Salles","Richard Thomas Maziarz","Schuster, Stephen J.","Bishop, Michael R.","Tam, Constantine S.","Waller, Edmund K.","Borchmann, Peter","McGuirk, Joseph P.","Jaeger, Ulrich","Jaglowski, Samantha","Andreadis, Charalambos","Westin, Jason R.","Fleury, Isabelle","Bachanova, Veronika","Foley, Stephen Ronan","Ho, P. Joy","Mielke, Stephan","Magenau, John M.","Holte, Harald","Van Besien, Koen","Kersten, Marie Jose","Teshima, Takanori","Tobinai, Kensei","Corradini, Paolo","Anak, Oezlem","Bubuteishvili Pacaud, Lida","del Corral, Christopher","Awasthi, Rakesh","Tai, Feng","Salles, Gilles","Maziarz, Richard Thomas"],"twitterCount":0,"altmetricId":42302004},{"title":"LGL leukemia: from pathogenesis to treatment","googleId":"On35GMvKZRsJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/9/1082/36568","googleCitationCount":116,"googleAuthor":"","doi":"10.1182/blood-2016-08-692590","elsevierAuthor":"Lamy T.","publicationName":"Blood","elsevierCoverDate":"2017-03-02","elsevierCoverDisplayDate":"2 March 2017","elsevierCitationCount":"83","altmetricAuthors":["Thierry Lamy","Aline Moignet","Thomas P. Loughran"],"twitterCount":53,"altmetricId":15781095},{"title":"Integrin αIIbβ3 outside-in signaling","googleId":"k3rN58gEZuUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/14/1607/107662","googleCitationCount":102,"googleAuthor":"MT van den Bosch","doi":"10.1182/blood-2017-03-773614","elsevierAuthor":"Durrant T.N.","publicationName":"Blood","elsevierCoverDate":"2017-10-05","elsevierCoverDisplayDate":"5 October 2017","elsevierCitationCount":"68","altmetricAuthors":["Tom N. Durrant","Marion T. van den Bosch","Ingeborg Hers"],"twitterCount":3,"altmetricId":23913536},{"title":"Treating sickle cell disease by targeting HbS polymerization","googleId":"9cTF9rH9FnwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/20/2719/36133","googleCitationCount":106,"googleAuthor":"WA Eaton","doi":"10.1182/blood-2017-02-765891","elsevierAuthor":"Eaton W.","publicationName":"Blood","elsevierCoverDate":"2017-05-18","elsevierCoverDisplayDate":"18 May 2017","elsevierCitationCount":"79","altmetricAuthors":["William A. Eaton","H. Franklin Bunn"],"twitterCount":14,"altmetricId":19675259},{"title":"JCARH125, anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: initial proof of concept results from a phase 1/2 multicenter study (EVOLVE)","googleId":"BvedO4ZYwksJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/957/266016","googleCitationCount":71,"googleAuthor":"S Mailankody","doi":"10.1182/blood-2018-99-113548","elsevierCitationCount":0,"altmetricAuthors":["Sham Mailankody","Myo Htut","Kelvin P. Lee","William Bensinger","Todd Devries","Julia Piasecki","Safiyyah Ziyad","Michelle Blake","John Byon","Andrzej Jakubowiak"],"twitterCount":0,"altmetricId":55319135},{"title":"The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia","googleId":"kCY-XSC7Mu8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/9/1124/36596","googleCitationCount":106,"googleAuthor":"M Sanchez-Martin","doi":"10.1182/blood-2016-09-692582","elsevierAuthor":"Sanchez-Martin M.","publicationName":"Blood","elsevierCoverDate":"2017-03-02","elsevierCoverDisplayDate":"2 March 2017","elsevierCitationCount":"75","altmetricAuthors":["Marta Sanchez-Martin","Adolfo Ferrando"],"twitterCount":19,"altmetricId":15741692},{"title":"Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma","googleId":"AYdnzZFCR84J","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2546/39526","googleCitationCount":66,"googleAuthor":"NJ Bahlis","doi":"10.1182/blood-2018-06-858852","elsevierAuthor":"Bahlis N.","publicationName":"Blood","elsevierCoverDate":"2018-12-13","elsevierCoverDisplayDate":"13 December 2018","elsevierCitationCount":"46","altmetricAuthors":["Nizar J. Bahlis","Heather Sutherland","Darrell White","Michael Sebag","Suzanne Lentzsch","Rami Kotb","Christopher P. Venner","Cristina Gasparetto","Aldo Del Col","Paola Neri","Donna Reece","Michael Kauffman","Sharon Shacham","T. J. Unger","Jacqueline Jeha","Jean-Richard Saint-Martin","Jatin Shah","Christine Chen"],"twitterCount":50,"altmetricId":50134185},{"title":"Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus","googleId":"LzqpIAygEYkJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1960/36763","googleCitationCount":94,"googleAuthor":"A Lattanzi","doi":"10.1182/blood-2017-10-811505","elsevierAuthor":"Antoniani C.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"62","altmetricAuthors":["Chiara Antoniani","Vasco Meneghini","Annalisa Lattanzi","Tristan Felix","Oriana Romano","Elisa Magrin","Leslie Weber","Giulia Pavani","Sara El Hoss","Ryo Kurita","Yukio Nakamura","Thomas J. Cradick","Ante S. Lundberg","Matthew Porteus","Mario Amendola","Wassim El Nemer","Marina Cavazzana","Fulvio Mavilio","Annarita Miccio"],"twitterCount":52,"altmetricId":34111933},{"title":"SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes","googleId":"Zb9xzJWGEzsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/26/2838/36597","googleCitationCount":92,"googleAuthor":"","doi":"10.1182/blood-2017-04-778423","elsevierAuthor":"Gogishvili T.","publicationName":"Blood","elsevierCoverDate":"2017-12-28","elsevierCoverDisplayDate":"28 December 2017","elsevierCitationCount":"65","altmetricAuthors":["Tea Gogishvili","Sophia Danhof","Sabrina Prommersberger","Julian Rydzek","Martin Schreder","Christian Brede","Hermann Einsele","Michael Hudecek"],"twitterCount":84,"altmetricId":28289675},{"title":"Gemtuzumab ozogamicin for acute myeloid leukemia","googleId":"Vmdf4whq_7UJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/22/2373/36556","googleCitationCount":98,"googleAuthor":"FR Appelbaum","doi":"10.1182/blood-2017-09-797712","elsevierAuthor":"Appelbaum F.R.","publicationName":"Blood","elsevierCoverDate":"2017-11-30","elsevierCoverDisplayDate":"30 November 2017","elsevierCitationCount":"68","altmetricAuthors":["Frederick R. Appelbaum","Irwin D. Bernstein"],"twitterCount":26,"altmetricId":27472900},{"title":"Classification systems for chronic graft-versus-host disease","googleId":"3ZGcqknCS6MJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/1/30/35839","googleCitationCount":140,"googleAuthor":"SJ Lee","doi":"10.1182/blood-2016-07-686642","elsevierAuthor":"Lee S.","publicationName":"Blood","elsevierCoverDate":"2017-01-05","elsevierCoverDisplayDate":"5 January 2017","elsevierCitationCount":"81","altmetricAuthors":["Stephanie J. Lee"],"twitterCount":22,"altmetricId":13426084},{"title":"High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","googleId":"O7nL5Yhl7dAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2060/36718","googleCitationCount":87,"googleAuthor":"RL King","doi":"10.1182/blood-2017-12-820605","elsevierAuthor":"Scott D.W.","publicationName":"Blood","elsevierCoverDate":"2018-05-03","elsevierCoverDisplayDate":"3 May 2018","elsevierCitationCount":"56","altmetricAuthors":["David W. Scott","Rebecca L. King","Annette M. Staiger","Susana Ben-Neriah","Aixiang Jiang","Heike Horn","Anja Mottok","Pedro Farinha","Graham W. Slack","Daisuke Ennishi","Norbert Schmitz","Michael Pfreundschuh","Grzegorz S. Nowakowski","Brad S. Kahl","Joseph M. Connors","Randy D. Gascoyne","German Ott","William R. Macon","Andreas Rosenwald"],"twitterCount":41,"altmetricId":33638088},{"title":"CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells","googleId":"O8T4qdxuI5AJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/311/38326","googleCitationCount":94,"googleAuthor":"AK Sewell","doi":"10.1182/blood-2017-05-787598","elsevierAuthor":"Legut M.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"72","altmetricAuthors":["Mateusz Legut","Garry Dolton","Afsar Ali Mian","Oliver G. Ottmann","Andrew K. Sewell"],"twitterCount":77,"altmetricId":28662108},{"title":"Myeloid neoplasms with eosinophilia","googleId":"TG28vyrqYfIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/6/704/36333","googleCitationCount":138,"googleAuthor":"","doi":"10.1182/blood-2016-10-695973","elsevierAuthor":"Reiter A.","publicationName":"Blood","elsevierCoverDate":"2017-02-09","elsevierCoverDisplayDate":"9 February 2017","elsevierCitationCount":"95","altmetricAuthors":["Andreas Reiter","Jason Gotlib"],"twitterCount":25,"altmetricId":15106652},{"title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","googleId":"LaDodVtRNS4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/9/1104/36991","googleCitationCount":101,"googleAuthor":"M Pai","doi":"10.1182/blood-2017-04-778993","elsevierAuthor":"Warkentin T.E.","publicationName":"Blood","elsevierCoverDate":"2017-08-31","elsevierCoverDisplayDate":"31 August 2017","elsevierCitationCount":"58","altmetricAuthors":["Theodore E. Warkentin","Menaka Pai","Lori-Ann Linkins"],"twitterCount":134,"altmetricId":21306356},{"title":"Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations","googleId":"I8vVW1leuNcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1225/39628","googleCitationCount":74,"googleAuthor":"E Sharma","doi":"10.1182/blood-2018-04-843771","elsevierAuthor":"Pellagatti A.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"55","altmetricAuthors":["Andrea Pellagatti","Richard N. Armstrong","Violetta Steeples","Eshita Sharma","Emmanouela Repapi","Shalini Singh","Andrea Sanchi","Aleksandar Radujkovic","Patrick Horn","Hamid Dolatshad","Swagata Roy","John Broxholme","Helen Lockstone","Stephen Taylor","Aristoteles Giagounidis","Paresh Vyas","Anna Schuh","Angela Hamblin","Elli Papaemmanuil","Sally Killick","Luca Malcovati","Marco L. Hennrich","Anne-Claude Gavin","Anthony D. Ho","Thomas Luft","Eva Hellström-Lindberg","Mario Cazzola","Christopher W. J. Smith","Stephen Smith","Jacqueline Boultwood"],"twitterCount":21,"altmetricId":44003382},{"title":"Coagulation factor XII in thrombosis and inflammation","googleId":"VnujRBMUezYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1903/36747","googleCitationCount":78,"googleAuthor":"C Maas","doi":"10.1182/blood-2017-04-569111","elsevierAuthor":"Maas C.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"52","altmetricAuthors":["Coen Maas","Thomas Renné"],"twitterCount":16,"altmetricId":33748424},{"title":"Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse","googleId":"9pXXCiHMCHgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2639/39577","googleCitationCount":80,"googleAuthor":"","doi":"10.1182/blood-2018-07-861641","elsevierAuthor":"Moskowitz C.H.","publicationName":"Blood","elsevierCoverDate":"2018-12-20","elsevierCoverDisplayDate":"20 December 2018","elsevierCitationCount":"54","altmetricAuthors":["Craig H. Moskowitz","Jan Walewski","Auayporn Nademanee","Tamas Masszi","Edward Agura","Jerzy Holowiecki","Muneer H. Abidi","Andy I. Chen","Patrick Stiff","Simonetta Viviani","Veronika Bachanova","Anna Sureda","Teresa McClendon","Connie Lee","Julie Lisano","John Sweetenham"],"twitterCount":48,"altmetricId":49004837},{"title":"Genetic predisposition to hematologic malignancies: management and surveillance","googleId":"bCzxpgduvvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/424/37108","googleCitationCount":97,"googleAuthor":"","doi":"10.1182/blood-2017-02-735290","elsevierAuthor":"Godley L.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"65","altmetricAuthors":["Lucy A. Godley","Akiko Shimamura"],"twitterCount":21,"altmetricId":20956424},{"title":"Immune regulatory cell infusion for graft-versus-host disease prevention and therapy","googleId":"gZnCmbwA9CYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2651/37155","googleCitationCount":76,"googleAuthor":"BR Blazar","doi":"10.1182/blood-2017-11-785865","elsevierAuthor":"Blazar B.R.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"55","altmetricAuthors":["Bruce R. Blazar","Kelli P. A. MacDonald","Geoffrey R. Hill"],"twitterCount":17,"altmetricId":40865185},{"title":"Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML","googleId":"UUmN-mj-7WsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/598/39411","googleCitationCount":75,"googleAuthor":"","doi":"10.1182/blood-2018-01-821629","elsevierAuthor":"Cortes J.E.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"63","altmetricAuthors":["Jorge E. Cortes","Martin S. Tallman","Gary J. Schiller","Denise Trone","Guy Gammon","Stuart L. Goldberg","Alexander E. Perl","Jean-Pierre Marie","Giovanni Martinelli","Hagop M. Kantarjian","Mark J. Levis"],"twitterCount":9,"altmetricId":43396346},{"title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","googleId":"Nr_yEjV6wVAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/19/2055/36693","googleCitationCount":95,"googleAuthor":"","doi":"10.1182/blood-2017-06-788026","elsevierAuthor":"Scully M.","publicationName":"Blood","elsevierCoverDate":"2017-11-09","elsevierCoverDisplayDate":"9 November 2017","elsevierCitationCount":"73","altmetricAuthors":["Marie Scully","Paul Knöbl","Karim Kentouche","Lawrence Rice","Jerzy Windyga","Reinhard Schneppenheim","Johanna A. Kremer Hovinga","Michiko Kajiwara","Yoshihiro Fujimura","Caterina Maggiore","Jennifer Doralt","Christopher Hibbard","Leah Martell","Bruce Ewenstein"],"twitterCount":23,"altmetricId":25266766},{"title":"Venetoclax and obinutuzumab in chronic lymphocytic leukemia","googleId":"beUCTvr3V5kJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/19/2702/36147","googleCitationCount":105,"googleAuthor":"O Al-Sawaf","doi":"10.1182/blood-2017-01-761973","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2017-07-13","elsevierCoverDisplayDate":"13 July 2017","elsevierCitationCount":"0","altmetricAuthors":["Kirsten Fischer","Othman Al-Sawaf","Anna-Maria Fink","Mark Dixon","Jasmin Bahlo","Simon Warburton","Thomas J. Kipps","Robert Weinkove","Sue Robinson","Till Seiler","Stephen Opat","Carolyn Owen","Javier López","Kathryn Humphrey","Rod Humerickhouse","Eugen Tausch","Lukas Frenzel","Barbara Eichhorst","Clemens-M. Wendtner","Stephan Stilgenbauer","Anton W. Langerak","Jacque J. M. van Dongen","Sebastian Böttcher","Matthias Ritgen","Valentin Goede","Mehrdad Mobasher","Michael Hallek"],"twitterCount":16,"altmetricId":18019782},{"title":"Axicabtagene ciloleucel in the real world: outcomes and predictors of response, resistance and toxicity","googleId":"3mLEDeWxv7EJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/92/266121","googleCitationCount":64,"googleAuthor":"J Ritz","doi":"10.1182/blood-2018-99-117199","elsevierCitationCount":0,"altmetricAuthors":["Caron A. Jacobson","Bradley Hunter","Philippe Armand","Yusuke Kamihara","Jerome Ritz","Scott J Rodig","Kyle Wright","Mikel Lipschitz","Robert A. Redd","Marcela V. Maus","Yi-Bin Chen","Jeremy S. Abramson","Justin Kline","Jonathon B. Cohen","Joseph Maakaron","Samantha Jaglowski","Stephen D. Smith","David G. Maloney","Ajay K. Gopal","Matthew J. Frigault","Utkarsh H. Acharya"],"twitterCount":0,"altmetricId":76617394},{"title":"Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML","googleId":"5kmc4FrHYb4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/23/2469/36739","googleCitationCount":91,"googleAuthor":"AH Wei","doi":"10.1182/blood-2017-08-784066","elsevierAuthor":"Wei A.H.","publicationName":"Blood","elsevierCoverDate":"2017-12-07","elsevierCoverDisplayDate":"7 December 2017","elsevierCitationCount":"77","altmetricAuthors":["Andrew H. Wei","Ing S. Tiong"],"twitterCount":43,"altmetricId":27671146},{"title":"Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type","googleId":"j4-S_OhYCI4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2528/36945","googleCitationCount":81,"googleAuthor":"","doi":"10.1182/blood-2017-12-791418","elsevierAuthor":"Yamaguchi M.","publicationName":"Blood","elsevierCoverDate":"2018-06-07","elsevierCoverDisplayDate":"7 June 2018","elsevierCitationCount":"51","altmetricAuthors":["Motoko Yamaguchi","Ritsuro Suzuki","Masahiko Oguchi"],"twitterCount":33,"altmetricId":35091284},{"title":"How I treat autoimmune hemolytic anemia","googleId":"8QZolMI1SqcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/22/2971/36045","googleCitationCount":98,"googleAuthor":"RS Go","doi":"10.1182/blood-2016-11-693689","elsevierAuthor":"Go R.","publicationName":"Blood","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"61","altmetricAuthors":["Ronald S. Go","Jeffrey L. Winters","Neil E. Kay"],"twitterCount":67,"altmetricId":18336202},{"title":"Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia","googleId":"PqfArGry4TYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/15/1568/39320","googleCitationCount":70,"googleAuthor":"FT Awan","doi":"10.1182/blood-2018-05-853564","elsevierAuthor":"Rogers K.","publicationName":"Blood","elsevierCoverDate":"2018-10-11","elsevierCoverDisplayDate":"11 October 2018","elsevierCitationCount":"65","altmetricAuthors":["Kerry A. Rogers","Ying Huang","Amy S. Ruppert","Farrukh T. Awan","Nyla A. Heerema","Corinne Hoffman","Gerard Lozanski","Kami J. Maddocks","Mollie E. Moran","Mark A. Reid","Margaret Lucas","Jennifer A. Woyach","W. Thomas Whitlow","Jeffrey A. Jones","John C. Byrd"],"twitterCount":29,"altmetricId":46563337},{"title":"Pathophysiology of thrombotic thrombocytopenic purpura","googleId":"5spDYvJOGEUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/10/1181/36350","googleCitationCount":94,"googleAuthor":"","doi":"10.1182/blood-2017-04-636431","elsevierAuthor":"Sadler J.","publicationName":"Blood","elsevierCoverDate":"2017-09-07","elsevierCoverDisplayDate":"7 September 2017","elsevierCitationCount":"74","altmetricAuthors":["J. Evan Sadler"],"twitterCount":52,"altmetricId":23389769},{"title":"PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells","googleId":"cxA89f1TdOwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1095/39390","googleCitationCount":75,"googleAuthor":"AJ Silver","doi":"10.1182/blood-2018-05-850339","elsevierAuthor":"Kahn J.D.","publicationName":"Blood","elsevierCoverDate":"2018-09-13","elsevierCoverDisplayDate":"13 September 2018","elsevierCitationCount":"56","altmetricAuthors":["Josephine D. Kahn","Peter G. Miller","Alexander J. Silver","Rob S. Sellar","Shruti Bhatt","Christopher Gibson","Marie McConkey","Dylan Adams","Brenton Mar","Philipp Mertins","Shaunt Fereshetian","Karsten Krug","Haoling Zhu","Anthony Letai","Steven A. Carr","John Doench","Siddhartha Jaiswal","Benjamin L. Ebert"],"twitterCount":24,"altmetricId":44313579},{"title":"Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab","googleId":"SPd0qc1gMBIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1275/36003","googleCitationCount":128,"googleAuthor":"Y Abaza","doi":"10.1182/blood-2016-09-736686","elsevierAuthor":"Abaza Y.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"100","altmetricAuthors":["Yasmin Abaza","Hagop Kantarjian","Guillermo Garcia-Manero","Elihu Estey","Gautam Borthakur","Elias Jabbour","Stefan Faderl","Susan O’Brien","William Wierda","Sherry Pierce","Mark Brandt","Deborah McCue","Rajyalakshmi Luthra","Keyur Patel","Steven Kornblau","Tapan Kadia","Naval Daver","Courtney DiNardo","Nitin Jain","Srdan Verstovsek","Alessandra Ferrajoli","Michael Andreeff","Marina Konopleva","Zeev Estrov","Maria Foudray","David McCue","Jorge Cortes","Farhad Ravandi"],"twitterCount":28,"altmetricId":15246912},{"title":"Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking","googleId":"k__LF6XF_4YJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/1/100/35801","googleCitationCount":127,"googleAuthor":"M Goebeler","doi":"10.1182/blood-2016-05-718395","elsevierAuthor":"Braig F.","publicationName":"Blood","elsevierCoverDate":"2017-01-05","elsevierCoverDisplayDate":"5 January 2017","elsevierCitationCount":"93","altmetricAuthors":["Friederike Braig","Anna Brandt","Mariele Goebeler","Hans-Peter Tony","Anna-Katharina Kurze","Peter Nollau","Thomas Bumm","Sebastian Böttcher","Ralf C. Bargou","Mascha Binder"],"twitterCount":9,"altmetricId":13074753},{"title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1–infected T cells","googleId":"rfj6dbCsuUYJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/9/1071/36572","googleCitationCount":97,"googleAuthor":"","doi":"10.1182/blood-2016-09-692574","elsevierAuthor":"Watanabe T.","publicationName":"Blood","elsevierCoverDate":"2017-03-02","elsevierCoverDisplayDate":"2 March 2017","elsevierCitationCount":"73","altmetricAuthors":["Toshiki Watanabe"],"twitterCount":10,"altmetricId":15796613},{"title":"Biology and treatment of Richter syndrome","googleId":"n62INAq8hboJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2761/37138","googleCitationCount":69,"googleAuthor":"D Rossi","doi":"10.1182/blood-2018-01-791376","elsevierAuthor":"Rossi D.","publicationName":"Blood","elsevierCoverDate":"2018-06-21","elsevierCoverDisplayDate":"21 June 2018","elsevierCitationCount":"49","altmetricAuthors":["Davide Rossi","Valeria Spina","Gianluca Gaidano"],"twitterCount":45,"altmetricId":39307768},{"title":"Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia","googleId":"pcc3QziIM2UJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2395/35979","googleCitationCount":96,"googleAuthor":"SK Tasian","doi":"10.1182/blood-2016-08-736041","elsevierAuthor":"Tasian S.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"80","altmetricAuthors":["Sarah K. Tasian","Saad S. Kenderian","Feng Shen","Marco Ruella","Olga Shestova","Miroslaw Kozlowski","Yong Li","April Schrank-Hacker","Jennifer J. D. Morrissette","Martin Carroll","Carl H. June","Stephan A. Grupp","Saar Gill"],"twitterCount":20,"altmetricId":16863023},{"title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","googleId":"XQB7BY9H-m0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2454/37093","googleCitationCount":74,"googleAuthor":"E Ladewig","doi":"10.1182/blood-2017-11-814913","elsevierAuthor":"Tiacci E.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"51","altmetricAuthors":["Enrico Tiacci","Erik Ladewig","Gianluca Schiavoni","Alex Penson","Elisabetta Fortini","Valentina Pettirossi","Yuchun Wang","Ariele Rosseto","Alessandra Venanzi","Sofija Vlasevska","Roberta Pacini","Simonetta Piattoni","Alessia Tabarrini","Alessandra Pucciarini","Barbara Bigerna","Alessia Santi","Alessandro M. Gianni","Simonetta Viviani","Antonello Cabras","Stefano Ascani","Barbara Crescenzi","Cristina Mecucci","Laura Pasqualucci","Raul Rabadan","Brunangelo Falini"],"twitterCount":22,"altmetricId":36988123},{"title":"Genetics of diffuse large B-cell lymphoma","googleId":"XCAQhp-8WZEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2307/37115","googleCitationCount":73,"googleAuthor":"L Pasqualucci","doi":"10.1182/blood-2017-11-764332","elsevierAuthor":"Pasqualucci L.","publicationName":"Blood","elsevierCoverDate":"2018-05-24","elsevierCoverDisplayDate":"24 May 2018","elsevierCitationCount":"53","altmetricAuthors":["Laura Pasqualucci","Riccardo Dalla-Favera"],"twitterCount":39,"altmetricId":37947213},{"title":"Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor","googleId":"qRfWJj-a2Q8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/2/257/36083","googleCitationCount":126,"googleAuthor":"LY Lee","doi":"10.1182/blood-2016-10-745133","elsevierAuthor":"Lee L.","publicationName":"Blood","elsevierCoverDate":"2017-01-12","elsevierCoverDisplayDate":"12 January 2017","elsevierCitationCount":"91","altmetricAuthors":["Lauren Y. Lee","Daniela Hernandez","Trivikram Rajkhowa","Samuel C. Smith","Jayant Ranganathan Raman","Bao Nguyen","Donald Small","Mark Levis"],"twitterCount":4,"altmetricId":15422541},{"title":"Mechanisms of platelet clearance and translation to improve platelet storage","googleId":"tTXYey4l7NMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1512/36658","googleCitationCount":74,"googleAuthor":"ME Quach","doi":"10.1182/blood-2017-08-743229","elsevierAuthor":"Edward Quach M.","publicationName":"Blood","elsevierCoverDate":"2018-04-05","elsevierCoverDisplayDate":"5 April 2018","elsevierCitationCount":"56","altmetricAuthors":["M. Edward Quach","Wenchun Chen","Renhao Li"],"twitterCount":35,"altmetricId":33797178},{"title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","googleId":"EgIMzMtOdogJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1737/39507","googleCitationCount":68,"googleAuthor":"E Haddad","doi":"10.1182/blood-2018-03-840702","elsevierAuthor":"Haddad E.","publicationName":"Blood","elsevierCoverDate":"2018-10-25","elsevierCoverDisplayDate":"25 October 2018","elsevierCitationCount":"57","altmetricAuthors":["Elie Haddad","Brent R. Logan","Linda M. Griffith","Rebecca H. Buckley","Roberta E. Parrott","Susan E. Prockop","Trudy N. Small","Jessica Chaisson","Christopher C. Dvorak","Megan Murnane","Neena Kapoor","Hisham Abdel-Azim","Imelda C. Hanson","Caridad Martinez","Jack J. H. Bleesing","Sharat Chandra","Angela R. Smith","Matthew E. Cavanaugh","Soma Jyonouchi","Kathleen E. Sullivan","Lauri Burroughs","Suzanne Skoda-Smith","Ann E. Haight","Audrey G. Tumlin","Troy C. Quigg","Candace Taylor","Blachy J. Dávila Saldaña","Michael D. Keller","Christine M. Seroogy","Kenneth B. Desantes","Aleksandra Petrovic","Jennifer W. Leiding","David C. Shyr","Hélène Decaluwe","Pierre Teira","Alfred P. Gillio","Alan P. Knutsen","Theodore B. Moore","Morris Kletzel","John A. Craddock","Victor Aquino","Jeffrey H. Davis","Lolie C. Yu","Geoffrey D. E. Cuvelier","Jeffrey J. Bednarski","Frederick D. Goldman","Elizabeth M. Kang","Evan Shereck","Matthew H. Porteus","James A. Connelly","Thomas A. Fleisher","Harry L. Malech","William T. Shearer","Paul Szabolcs","Monica S. Thakar","Mark T. Vander Lugt","Jennifer Heimall","Ziyan Yin","Michael A. Pulsipher","Sung-Yun Pai","Donald B. Kohn","Jennifer M. Puck","Morton J. Cowan","Richard J. O'Reilly","Luigi D. Notarangelo"],"twitterCount":13,"altmetricId":47198911},{"title":"Hepcidin agonists as therapeutic tools","googleId":"1jxdJ4rHkEYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1790/36820","googleCitationCount":69,"googleAuthor":"C Casu","doi":"10.1182/blood-2017-11-737411","elsevierAuthor":"Casu C.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"44","altmetricAuthors":["Carla Casu","Elizabeta Nemeth","Stefano Rivella"],"twitterCount":9,"altmetricId":34286137},{"title":"A MALT lymphoma prognostic index","googleId":"V-aS-JNbw9sJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/12/1409/36508","googleCitationCount":85,"googleAuthor":"C Thieblemont","doi":"10.1182/blood-2017-03-771915","elsevierAuthor":"Thieblemont C.","publicationName":"Blood","elsevierCoverDate":"2017-09-21","elsevierCoverDisplayDate":"21 September 2017","elsevierCitationCount":"58","altmetricAuthors":["Catherine Thieblemont","Luciano Cascione","Annarita Conconi","Barbara Kiesewetter","Markus Raderer","Gianluca Gaidano","Maurizio Martelli","Daniele Laszlo","Bertrand Coiffier","Armando Lopez Guillermo","Valter Torri","Franco Cavalli","Peter W. Johnson","Emanuele Zucca"],"twitterCount":26,"altmetricId":22252413},{"title":"Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma","googleId":"D6Sw2tiUZp8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/777/39453","googleCitationCount":68,"googleAuthor":"","doi":"10.1182/blood-2018-04-839217","elsevierAuthor":"Chow V.A.","publicationName":"Blood","elsevierCoverDate":"2018-08-23","elsevierCoverDisplayDate":"23 August 2018","elsevierCitationCount":"53","altmetricAuthors":["Victor A. Chow","Mazyar Shadman","Ajay K. Gopal"],"twitterCount":45,"altmetricId":43896090},{"title":"Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN","googleId":"coVaQ-RJTvIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/13/1514/36551","googleCitationCount":89,"googleAuthor":"NJ Short","doi":"10.1182/blood-2017-06-788497","elsevierAuthor":"Jabbour E.","publicationName":"Blood","elsevierCoverDate":"2017-09-28","elsevierCoverDisplayDate":"28 September 2017","elsevierCitationCount":"63","altmetricAuthors":["Elias Jabbour","Nicholas J. Short","Guillermo Montalban-Bravo","Xuelin Huang","Carlos Bueso-Ramos","Wei Qiao","Hui Yang","Chong Zhao","Tapan Kadia","Gautam Borthakur","Naveen Pemmaraju","Koji Sasaki","Zeev Estrov","Jorge Cortes","Farhad Ravandi","Yesid Alvarado","Rami Komrokji","Mikkael A. Sekeres","David P. Steensma","Amy DeZern","Gail Roboz","Hagop Kantarjian","Guillermo Garcia-Manero"],"twitterCount":46,"altmetricId":23396045},{"title":"A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis","googleId":"CPgNlcVH0e4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/597/36786","googleCitationCount":90,"googleAuthor":"","doi":"10.1182/blood-2017-03-771220","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2020-03-26","elsevierCoverDisplayDate":"26 March 2020","elsevierCitationCount":"0","altmetricAuthors":["Vaishali Sanchorawala","Giovanni Palladini","Vishal Kukreti","Jeffrey A. Zonder","Adam D. Cohen","David C. Seldin","Angela Dispenzieri","Arnaud Jaccard","Stefan O. Schönland","Deborah Berg","Huyuan Yang","Neeraj Gupta","Ai-Min Hui","Raymond L. Comenzo","Giampaolo Merlini"],"twitterCount":31,"altmetricId":20636069},{"title":"Phase 3 randomized study of daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) in patients with newly …","googleId":"mvR9xDUoV18J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/LBA-2/375112","googleCitationCount":66,"googleAuthor":"T Plesner","doi":"10.1182/blood-2018-120737","elsevierAuthor":"Zanwar S.","publicationName":"Current Hematologic Malignancy Reports","elsevierCoverDate":"2019-04-15","elsevierCoverDisplayDate":"15 April 2019","elsevierCitationCount":"3","altmetricAuthors":["Thierry Facon","Shaji K. Kumar","Torben Plesner","Robert Z. Orlowski","Philippe Moreau","Nizar Bahlis","Supratik Basu","Hareth Nahi","Cyrille Hulin","Hang Quach","Hartmut Goldschmidt","Michael O'Dwyer","Aurore Perrot","Christopher P. Venner","Katja Weisel","Joseph R. Mace","Tahamtan Ahmadi","Christopher Chiu","Jianping Wang","Rian Van Rampelbergh","Clarissa M. Uhlar","Rachel Kobos","Ming Qi","Saad Z. Usmani"],"twitterCount":1,"altmetricId":54506660},{"title":"How I treat double-hit lymphoma","googleId":"HjVjTbx1xooJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/590/36799","googleCitationCount":84,"googleAuthor":"","doi":"10.1182/blood-2017-04-737320","elsevierAuthor":"Friedberg J.W.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"52","altmetricAuthors":["Jonathan W. Friedberg"],"twitterCount":105,"altmetricId":20932896},{"title":"PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy","googleId":"f3pazvX_S8UJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2186/36420","googleCitationCount":90,"googleAuthor":"","doi":"10.1182/blood-2016-09-741629","elsevierAuthor":"Asano T.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"75","altmetricAuthors":["Takeru Asano","Yusuke Meguri","Takanori Yoshioka","Yuriko Kishi","Miki Iwamoto","Makoto Nakamura","Yasuhisa Sando","Hideo Yagita","John Koreth","Haesook T. Kim","Edwin P. Alyea","Philippe Armand","Corey S. Cutler","Vincent T. Ho","Joseph H. Antin","Robert J. Soiffer","Yoshinobu Maeda","Mitsune Tanimoto","Jerome Ritz","Ken-ichi Matsuoka"],"twitterCount":24,"altmetricId":16042642},{"title":"The Medalist trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or …","googleId":"jido8SlaCjoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1/262479","googleCitationCount":62,"googleAuthor":"GJ Mufti","doi":"10.1182/blood-2018-99-110805","elsevierCitationCount":0,"altmetricAuthors":["Pierre Fenaux","Uwe Platzbecker","Ghulam J. Mufti","Guillermo Garcia-Manero","Rena Buckstein","Valeria Santini","María Díez-Campelo","Carlo Finelli","Mario Cazzola","Osman Ilhan","Mikkael A. Sekeres","José F. Falantes","Beatriz Arrizabalaga","Flavia Salvi","Valentina Giai","Paresh Vyas","David Bowen","Dominik Selleslag","Amy E. DeZern","Joseph G. Jurcic","Ulrich Germing","Katharina S. Götze","Bruno Quesnel","Odile Beyne-Rauzy","Thomas Cluzeau","Maria Teresa Voso","Dominiek Mazure","Edo Vellenga","Peter L Greenberg","Eva Hellström-Lindberg","Amer M. Zeidan","Abderrahmane Laadem","Aziz Benzohra","Jennie Zhang","Anita Rampersad","Peter G. Linde","Matthew L. Sherman","Rami S. Komrokji","Alan F. List"],"twitterCount":0,"altmetricId":53740712},{"title":"Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide","googleId":"Mu5B_czUTfIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/17/1889/36509","googleCitationCount":85,"googleAuthor":"AJ Mead","doi":"10.1182/blood-2017-05-785790","elsevierAuthor":"Harrison C.N.","publicationName":"Blood","elsevierCoverDate":"2017-10-26","elsevierCoverDisplayDate":"26 October 2017","elsevierCitationCount":"62","altmetricAuthors":["Claire N. Harrison","Adam J. Mead","Anesh Panchal","Sonia Fox","Christina Yap","Emmanouela Gbandi","Aimee Houlton","Samah Alimam","Joanne Ewing","Marion Wood","Frederick Chen","Jason Coppell","Nicki Panoskaltsis","Steven Knapper","Sahra Ali","Angela Hamblin","Robyn Scherber","Amylou C. Dueck","Nicholas C. P. Cross","Ruben Mesa","Mary Frances McMullin"],"twitterCount":32,"altmetricId":23551462},{"title":"Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia","googleId":"cW6MbPVcwSEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/995/39172","googleCitationCount":75,"googleAuthor":"R Aplenc","doi":"10.1182/blood-2017-07-794214","elsevierAuthor":"Bride K.L.","publicationName":"Blood","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"58","altmetricAuthors":["Karen L. Bride","Tiffaney L. Vincent","Soo-Yeon Im","Richard Aplenc","David M. Barrett","William L. Carroll","Robin Carson","Yunfeng Dai","Meenakshi Devidas","Kimberly P. Dunsmore","Tori Fuller","Tina Glisovic-Aplenc","Terzah M. Horton","Stephen P. Hunger","Mignon L. Loh","Shannon L. Maude","Elizabeth A. Raetz","Stuart S. Winter","Stephan A. Grupp","Michelle L. Hermiston","Brent L. Wood","David T. Teachey"],"twitterCount":52,"altmetricId":31343170},{"title":"Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy","googleId":"wivty1wFMcsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/6/699/36794","googleCitationCount":84,"googleAuthor":"","doi":"10.1182/blood-2017-02-763086","elsevierAuthor":"Prokocimer M.","publicationName":"Blood","elsevierCoverDate":"2017-08-10","elsevierCoverDisplayDate":"10 August 2017","elsevierCitationCount":"58","altmetricAuthors":["Miron Prokocimer","Alina Molchadsky","Varda Rotter"],"twitterCount":22,"altmetricId":21024502},{"title":"Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice","googleId":"TQZ-dpKfXagJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/4/405/36190","googleCitationCount":113,"googleAuthor":"S Canali","doi":"10.1182/blood-2016-06-721571","elsevierAuthor":"Canali S.","publicationName":"Blood","elsevierCoverDate":"2017-01-26","elsevierCoverDisplayDate":"26 January 2017","elsevierCitationCount":"91","altmetricAuthors":["Susanna Canali","Kimberly B. Zumbrennen-Bullough","Amanda B. Core","Chia-Yu Wang","Manfred Nairz","Richard Bouley","Filip K. Swirski","Jodie L. Babitt"],"twitterCount":3,"altmetricId":14089890},{"title":"Preliminary results of prophylactic tocilizumab after axicabtageneciloleucel (axi-cel; KTE-C19) treatment for patients with refractory, aggressive non-Hodgkin …","googleId":"xzNNahH9jgUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1547/79746","googleCitationCount":79,"googleAuthor":"FL Locke","doi":"10.1182/blood.V130.Suppl_1.1547.1547","elsevierCitationCount":0,"altmetricAuthors":["Locke, Frederick L.","Neelapu, Sattva S.","Bartlett, Nancy L.","Lekakis, Lazaros J.","Jacobson, Caron A.","Braunschweig, Ira","Oluwole, Olalekan O.","Siddiqi, Tanya","Lin, Yi","Timmerman, John M","Reagan, Patrick M.","Bot, Adrian","Rossi, John M.","Sherman, Marika","Navale, Lynn","Jiang, Yizhou","Aycock, Jeff S.","Elias, Meg","Wiezorek, Jeffrey S.","Go, William Y.","Miklos, David B."],"twitterCount":0,"altmetricId":79335748},{"title":"GATA factor mutations in hematologic disease","googleId":"-DHU_4tFCjAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2103/36433","googleCitationCount":87,"googleAuthor":"","doi":"10.1182/blood-2016-09-687889","elsevierAuthor":"Crispino J.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"58","altmetricAuthors":["John D. Crispino","Marshall S. Horwitz"],"twitterCount":6,"altmetricId":18852730},{"title":"Splenectomy for immune thrombocytopenia: down but not out","googleId":"S3Cvy7ruGEMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1172/36453","googleCitationCount":76,"googleAuthor":"S Chaturvedi","doi":"10.1182/blood-2017-09-742353","elsevierAuthor":"Chaturvedi S.","publicationName":"Blood","elsevierCoverDate":"2018-03-15","elsevierCoverDisplayDate":"15 March 2018","elsevierCitationCount":"46","altmetricAuthors":["Shruti Chaturvedi","Donald M. Arnold","Keith R. McCrae"],"twitterCount":74,"altmetricId":31246028},{"title":"Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients","googleId":"rOPcNqhun6AJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/24/2610/36869","googleCitationCount":77,"googleAuthor":"NJ Bahlis","doi":"10.1182/blood-2017-06-791228","elsevierAuthor":"Avet-Loiseau H.","publicationName":"Blood","elsevierCoverDate":"2017-12-14","elsevierCoverDisplayDate":"14 December 2017","elsevierCitationCount":"51","altmetricAuthors":["Hervé Avet-Loiseau","Nizar J. Bahlis","Wee-Joo Chng","Tamas Masszi","Luisa Viterbo","Ludek Pour","Peter Ganly","Antonio Palumbo","Michele Cavo","Christian Langer","Andrzej Pluta","Arnon Nagler","Shaji Kumar","Dina Ben-Yehuda","S. Vincent Rajkumar","Jesus San-Miguel","Deborah Berg","Jianchang Lin","Helgi van de Velde","Dixie-Lee Esseltine","Alessandra di Bacco","Philippe Moreau","Paul G. Richardson"],"twitterCount":62,"altmetricId":27721120},{"title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","googleId":"kZ6Byc6aM-gJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2846/37158","googleCitationCount":70,"googleAuthor":"AS Renteria","doi":"10.1182/blood-2018-01-822957","elsevierAuthor":"Major-Monfried H.","publicationName":"Blood","elsevierCoverDate":"2018-06-21","elsevierCoverDisplayDate":"21 June 2018","elsevierCitationCount":"48","altmetricAuthors":["Hannah Major-Monfried","Anne S. Renteria","Attaphol Pawarode","Pavan Reddy","Francis Ayuk","Ernst Holler","Yvonne A. Efebera","William J. Hogan","Matthias Wölfl","Muna Qayed","Elizabeth O. Hexner","Kitsada Wudhikarn","Rainer Ordemann","Rachel Young","Jay Shah","Matthew J. Hartwell","Mohammed S. Chaudhry","Mina Aziz","Aaron Etra","Gregory A. Yanik","Nicolaus Kröger","Daniela Weber","Yi-Bin Chen","Ryotaro Nakamura","Wolf Rösler","Carrie L. Kitko","Andrew C. Harris","Michael Pulsipher","Ran Reshef","Steven Kowalyk","George Morales","Ivan Torres","Umut Özbek","James L. M. Ferrara","John E. Levine"],"twitterCount":26,"altmetricId":34388183},{"title":"Durable clinical responses in heavily pretreated patients with relapsed/refractory multiple myeloma: updated results from a multicenter study of bb2121 anti-Bcma …","googleId":"woSmchPMw4gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/740/83633","googleCitationCount":84,"googleAuthor":"D Siegel","doi":"10.1182/blood.V130.Suppl_1.740.740","elsevierCitationCount":0,"altmetricAuthors":["Berdeja, Jesus G.","Lin, Yi","Raje, Noopur","Munshi, Nikhil","Siegel, David","Liedtke, Michaela","Jagannath, Sundar","Maus, Marcela V.","Turka, Ashley","Lam, Lyh Ping","Hege, Kristen","Morgan, Richard A.","Quigley, Michael Travis","Kochenderfer, James N."],"twitterCount":0,"altmetricId":99635120},{"title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","googleId":"jRbN5WW2f1gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/89/39281","googleCitationCount":79,"googleAuthor":"OS Eckstein","doi":"10.1182/blood-2017-11-814244","elsevierAuthor":"Chinn I.K.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"57","altmetricAuthors":["Ivan K. Chinn","Olive S. Eckstein","Erin C. Peckham-Gregory","Baruch R. Goldberg","Lisa R. Forbes","Sarah K. Nicholas","Emily M. Mace","Tiphanie P. Vogel","Harshal A. Abhyankar","Maria I. Diaz","Helen E. Heslop","Robert A. Krance","Caridad A. Martinez","Trung C. Nguyen","Dalia A. Bashir","Jordana R. Goldman","Asbjørg Stray-Pedersen","Luis A. Pedroza","M. Cecilia Poli","Juan C. Aldave-Becerra","Sean A. McGhee","Waleed Al-Herz","Aghiad Chamdin","Zeynep H. Coban-Akdemir","Shalini N. Jhangiani","Donna M. Muzny","Tram N. Cao","Diana N. Hong","Richard A. Gibbs","James R. Lupski","Jordan S. Orange","Kenneth L. McClain","Carl E. Allen"],"twitterCount":17,"altmetricId":36758419},{"title":"Inflammation, von Willebrand factor, and ADAMTS13","googleId":"ommquQR-iZAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120320796","googleCitationCount":59,"googleAuthor":"","doi":"10.1182/blood-2018-02-769000","elsevierAuthor":"Chen J.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"47","altmetricAuthors":["Junmei Chen","Dominic W. Chung"],"twitterCount":13,"altmetricId":43500568},{"title":"The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease","googleId":"D-SdaI49pbMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/927/36334","googleCitationCount":111,"googleAuthor":"A Staffas","doi":"10.1182/blood-2016-09-691394","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"0","altmetricAuthors":["Anna Staffas","Marina Burgos da Silva","Marcel R. M. van den Brink"],"twitterCount":51,"altmetricId":14632591},{"title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","googleId":"A8jyJboyg2YJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2183/6537","googleCitationCount":70,"googleAuthor":"EJ van Beers","doi":"10.1182/blood-2017-10-810796","elsevierAuthor":"Grace R.F.","publicationName":"Blood","elsevierCoverDate":"2018-05-17","elsevierCoverDisplayDate":"17 May 2018","elsevierCitationCount":"42","altmetricAuthors":["Rachael F. Grace","Paola Bianchi","Eduard J. van Beers","Stefan W. Eber","Bertil Glader","Hassan M. Yaish","Jenny M. Despotovic","Jennifer A. Rothman","Mukta Sharma","Melissa M. McNaull","Elisa Fermo","Kimberly Lezon-Geyda","D. Holmes Morton","Ellis J. Neufeld","Satheesh Chonat","Nina Kollmar","Christine M. Knoll","Kevin Kuo","Janet L. Kwiatkowski","Dagmar Pospíšilová","Yves D. Pastore","Alexis A. Thompson","Peter E. Newburger","Yaddanapudi Ravindranath","Winfred C. Wang","Marcin W. Wlodarski","Heng Wang","Susanne Holzhauer","Vicky R. Breakey","Joachim Kunz","Sujit Sheth","Melissa J. Rose","Heather A. Bradeen","Nolan Neu","Dongjing Guo","Hasan Al-Sayegh","Wendy B. London","Patrick G. Gallagher","Alberto Zanella","Wilma Barcellini"],"twitterCount":37,"altmetricId":34478601},{"title":"Clinical responses and pharmacokinetics of MCARH171, a human-derived Bcma targeted CAR T cell therapy in relapsed/refractory multiple myeloma: final results of a …","googleId":"5hpGuIy02UsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/959/266042","googleCitationCount":56,"googleAuthor":"S Mailankody","doi":"10.1182/blood-2018-99-119717","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma","googleId":"IDTlT-s1iDMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2016/39480","googleCitationCount":55,"googleAuthor":"L Cerchietti","doi":"10.1182/blood-2018-07-859769","elsevierAuthor":"Ruan J.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"35","altmetricAuthors":["Jia Ruan","Peter Martin","Paul Christos","Leandro Cerchietti","Wayne Tam","Bijal Shah","Stephen J. Schuster","Amelyn Rodriguez","David Hyman","Maria Nieves Calvo-Vidal","Sonali M. Smith","Jakub Svoboda","Richard R. Furman","Morton Coleman","John P. Leonard"],"twitterCount":45,"altmetricId":47666430},{"title":"Safety and persistence of WT1-specific T-cell receptor gene− transduced lymphocytes in patients with AML and MDS","googleId":"WX6rhSoXBhMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/18/1985/36534","googleCitationCount":79,"googleAuthor":"","doi":"10.1182/blood-2017-06-791202","elsevierAuthor":"Tawara I.","publicationName":"Blood","elsevierCoverDate":"2017-11-02","elsevierCoverDisplayDate":"2 November 2017","elsevierCitationCount":"59","altmetricAuthors":["Isao Tawara","Shinichi Kageyama","Yoshihiro Miyahara","Hiroshi Fujiwara","Tetsuya Nishida","Yoshiki Akatsuka","Hiroaki Ikeda","Kazushi Tanimoto","Seitaro Terakura","Makoto Murata","Yoko Inaguma","Masahiro Masuya","Naoki Inoue","Tomohide Kidokoro","Sachiko Okamoto","Daisuke Tomura","Hideto Chono","Ikuei Nukaya","Junichi Mineno","Tomoki Naoe","Nobuhiko Emi","Masaki Yasukawa","Naoyuki Katayama","Hiroshi Shiku"],"twitterCount":14,"altmetricId":24664656},{"title":"A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia","googleId":"arE2_PKMvkAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/387/38494","googleCitationCount":72,"googleAuthor":"AT Fathi","doi":"10.1182/blood-2017-06-789800","elsevierAuthor":"Stein E.M.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"60","altmetricAuthors":["Eytan M. Stein","Roland B. Walter","Harry P. Erba","Amir T. Fathi","Anjali S. Advani","Jeffrey E. Lancet","Farhad Ravandi","Tibor Kovacsovics","Daniel J. DeAngelo","Dale Bixby","Stefan Faderl","Anand P. Jillella","Phoenix A. Ho","Megan M. O’Meara","Baiteng Zhao","Charles Biddle-Snead","Anthony S. Stein"],"twitterCount":12,"altmetricId":29995682},{"title":"A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice","googleId":"wiGjepcqZqoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/e1/37145","googleCitationCount":69,"googleAuthor":"JS Dahlin","doi":"10.1182/blood-2017-12-821413","elsevierAuthor":"Dahlin J.","publicationName":"Blood","elsevierCoverDate":"2018-05-24","elsevierCoverDisplayDate":"24 May 2018","elsevierCitationCount":"38","altmetricAuthors":["Joakim S. Dahlin","Fiona K. Hamey","Blanca Pijuan-Sala","Mairi Shepherd","Winnie W. Y. Lau","Sonia Nestorowa","Caleb Weinreb","Samuel Wolock","Rebecca Hannah","Evangelia Diamanti","David G. Kent","Berthold Göttgens","Nicola K. Wilson"],"twitterCount":59,"altmetricId":34963460},{"title":"Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura","googleId":"TF80EpG6xzUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2143/39510","googleCitationCount":60,"googleAuthor":"","doi":"10.1182/blood-2018-04-840090","elsevierAuthor":"Jestin M.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"40","altmetricAuthors":["Matthieu Jestin","Ygal Benhamou","An-Sofie Schelpe","Elien Roose","François Provôt","Lionel Galicier","Miguel Hié","Claire Presne","Pascale Poullin","Alain Wynckel","Samir Saheb","Christophe Deligny","Aude Servais","Stéphane Girault","Yahsou Delmas","Tarik Kanouni","Alexandre Lautrette","Dominique Chauveau","Christiane Mousson","Pierre Perez","Jean-Michel Halimi","Anne Charvet-Rumpler","Mohamed Hamidou","Pascal Cathébras","Karen Vanhoorelbeke","Agnès Veyradier","Paul Coppo"],"twitterCount":58,"altmetricId":48143723},{"title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","googleId":"ujbScnkP0nsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2283/37126","googleCitationCount":58,"googleAuthor":"","doi":"10.1182/blood-2017-10-764373","elsevierAuthor":"Puente X.","publicationName":"Blood","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"2018","elsevierCitationCount":"36","altmetricAuthors":["Xose S. Puente","Pedro Jares","Elias Campo"],"twitterCount":24,"altmetricId":38888723},{"title":"Chronic immune response dysregulation in MDS pathogenesis","googleId":"XjiJpFqKXRoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/15/1553/39326","googleCitationCount":58,"googleAuthor":"L Barreyro","doi":"10.1182/blood-2018-03-784116","elsevierAuthor":"Barreyro L.","publicationName":"Blood","elsevierCoverDate":"2018-10-11","elsevierCoverDisplayDate":"11 October 2018","elsevierCitationCount":"40","altmetricAuthors":["Laura Barreyro","Timothy M. Chlon","Daniel T. Starczynowski"],"twitterCount":44,"altmetricId":46725730},{"title":"Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements","googleId":"mUOHwiYVBAcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/3/280/36006","googleCitationCount":103,"googleAuthor":"NA Johnson","doi":"10.1182/blood-2016-02-636316","elsevierAuthor":"Sesques P.","publicationName":"Blood","elsevierCoverDate":"2017-01-19","elsevierCoverDisplayDate":"19 January 2017","elsevierCitationCount":"77","altmetricAuthors":["Pierre Sesques","Nathalie A. Johnson"],"twitterCount":26,"altmetricId":13452155},{"title":"Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease","googleId":"N5--ku4I-FcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/948/39426","googleCitationCount":56,"googleAuthor":"DT Yeung","doi":"10.1182/blood-2018-02-832253","elsevierAuthor":"Branford S.","publicationName":"Blood","elsevierCoverDate":"2018-08-30","elsevierCoverDisplayDate":"30 August 2018","elsevierCitationCount":"41","altmetricAuthors":["Susan Branford","Paul Wang","David T. Yeung","Daniel Thomson","Adrian Purins","Carol Wadham","Nur Hezrin Shahrin","Justine E. Marum","Nathalie Nataren","Wendy T. Parker","Joel Geoghegan","Jinghua Feng","Naranie Shanmuganathan","Martin C. Mueller","Christian Dietz","Doris Stangl","Zoe Donaldson","Haley Altamura","Jasmina Georgievski","Jodi Braley","Anna Brown","Christopher Hahn","Ieuan Walker","Soo-Hyun Kim","Soo-Young Choi","Sa-Hee Park","Dong-Wook Kim","Deborah L. White","Agnes S. M. Yong","David M. Ross","Hamish S. Scott","Andreas W. Schreiber","Timothy P. Hughes"],"twitterCount":14,"altmetricId":44534783},{"title":"Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies","googleId":"7_me1GrDGL0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/328/38363","googleCitationCount":72,"googleAuthor":"S Kurtenbach","doi":"10.1182/blood-2017-06-789669","elsevierAuthor":"Yang H.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"60","altmetricAuthors":["Hui Yang","Stefan Kurtenbach","Ying Guo","Ines Lohse","Michael A. Durante","Jianping Li","Zhaomin Li","Hassan Al-Ali","Lingxiao Li","Zizhen Chen","Matthew G. Field","Peng Zhang","Shi Chen","Shohei Yamamoto","Zhuo Li","Yuan Zhou","Stephen D. Nimer","J. William Harbour","Claes Wahlestedt","Mingjiang Xu","Feng-Chun Yang"],"twitterCount":6,"altmetricId":32070218},{"title":"BCL-2 inhibition in AML: an unexpected bonus?","googleId":"d-qm0buyEHAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/1007/39300","googleCitationCount":59,"googleAuthor":"A Letai","doi":"10.1182/blood-2018-03-828269","elsevierAuthor":"Konopleva M.","publicationName":"Blood","elsevierCoverDate":"2018-09-06","elsevierCoverDisplayDate":"6 September 2018","elsevierCitationCount":"39","altmetricAuthors":["Marina Konopleva","Anthony Letai"],"twitterCount":38,"altmetricId":47110839},{"title":"The rise of apoptosis: targeting apoptosis in hematologic malignancies","googleId":"EmLsgQSGCDkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1248/39612","googleCitationCount":51,"googleAuthor":"","doi":"10.1182/blood-2018-02-791350","elsevierAuthor":"Valentin R.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"46","altmetricAuthors":["Rebecca Valentin","Stephanie Grabow","Matthew S. Davids"],"twitterCount":14,"altmetricId":45184222},{"title":"AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis","googleId":"iUpIXx1ajJcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/632/36808","googleCitationCount":78,"googleAuthor":"","doi":"10.1182/blood-2017-02-767475","elsevierAuthor":"Dittrich T.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"63","altmetricAuthors":["Tobias Dittrich","Tilmann Bochtler","Christoph Kimmich","Natalia Becker","Anna Jauch","Hartmut Goldschmidt","Anthony D. Ho","Ute Hegenbart","Stefan O. Schönland"],"twitterCount":22,"altmetricId":20667488},{"title":"An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma","googleId":"5KiIvmIKHrIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/7/746/39305","googleCitationCount":68,"googleAuthor":"","doi":"10.1182/blood-2017-05-781351","elsevierAuthor":"Lee L.","publicationName":"Blood","elsevierCoverDate":"2018-02-15","elsevierCoverDisplayDate":"15 February 2018","elsevierCitationCount":"53","altmetricAuthors":["Lydia Lee","Benjamin Draper","Neil Chaplin","Brian Philip","Melody Chin","Daria Galas-Filipowicz","Shimobi Onuoha","Simon Thomas","Vania Baldan","Reyisa Bughda","Paul Maciocia","Eva Kokalaki","Margarida P. Neves","Dominic Patel","Manuel Rodriguez-Justo","James Francis","Kwee Yong","Martin Pule"],"twitterCount":48,"altmetricId":31026612},{"title":"Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact","googleId":"r1EKb0TmoBIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/20/2760/36119","googleCitationCount":76,"googleAuthor":"","doi":"10.1182/blood-2016-11-747022","elsevierAuthor":"Ennishi D.","publicationName":"Blood","elsevierCoverDate":"2017-05-18","elsevierCoverDisplayDate":"18 May 2017","elsevierCitationCount":"59","altmetricAuthors":["Daisuke Ennishi","Anja Mottok","Susana Ben-Neriah","Hennady P. Shulha","Pedro Farinha","Fong Chun Chan","Barbara Meissner","Merrill Boyle","Christoffer Hother","Robert Kridel","Daniel Lai","Saeed Saberi","Ali Bashashati","Sohrab P. Shah","Ryan D. Morin","Marco A. Marra","Kerry J. Savage","Laurie H. Sehn","Christian Steidl","Joseph M. Connors","Randy D. Gascoyne","David W. Scott"],"twitterCount":44,"altmetricId":18203078},{"title":"Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation","googleId":"BvaC95LppWIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2083/36382","googleCitationCount":74,"googleAuthor":"R Avellino","doi":"10.1182/blood-2016-09-687822","elsevierAuthor":"Avellino R.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"50","altmetricAuthors":["Roberto Avellino","Ruud Delwel"],"twitterCount":10,"altmetricId":18818456},{"title":"Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non–transferrin-bound iron","googleId":"UYEKx8pgnDAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/245/36928","googleCitationCount":75,"googleAuthor":"J Arezes","doi":"10.1182/blood-2017-03-772715","elsevierAuthor":"Stefanova D.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"56","altmetricAuthors":["Deborah Stefanova","Antoan Raychev","Joao Arezes","Piotr Ruchala","Victoria Gabayan","Mikael Skurnik","Barbara J. Dillon","Marcus A. Horwitz","Tomas Ganz","Yonca Bulut","Elizabeta Nemeth"],"twitterCount":15,"altmetricId":19846323},{"title":"Double autologous stem cell transplantation significantly prolongs progression-free survival and overall survival in comparison with single autotransplantation in …","googleId":"RswXyWqq4wsJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/401/72564","googleCitationCount":71,"googleAuthor":"M Cavo","doi":"10.1182/blood.V130.Suppl_1.401.401","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps","googleId":"ZNsYhIwfj7QJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/1021/36344","googleCitationCount":96,"googleAuthor":"DF Noubouossie","doi":"10.1182/blood-2016-06-722298","elsevierAuthor":"Noubouossie D.","publicationName":"Blood","elsevierCoverDate":"2017-02-23","elsevierCoverDisplayDate":"23 February 2017","elsevierCitationCount":"75","altmetricAuthors":["Denis F. Noubouossie","Matthew F. Whelihan","Yuan-Bin Yu","Erica Sparkenbaugh","Rafal Pawlinski","Dougald M. Monroe","Nigel S. Key"],"twitterCount":5,"altmetricId":16834025},{"title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","googleId":"gIYucgIUGU8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/16/2316/35932","googleCitationCount":76,"googleAuthor":"JA Hill","doi":"10.1182/blood-2016-10-748426","elsevierAuthor":"Hill J.A.","publicationName":"Blood","elsevierCoverDate":"2017-04-20","elsevierCoverDisplayDate":"20 April 2017","elsevierCitationCount":"61","altmetricAuthors":["Joshua A. Hill","Bryan T. Mayer","Hu Xie","Wendy M. Leisenring","Meei-Li Huang","Terry Stevens-Ayers","Filippo Milano","Colleen Delaney","Mohamed L. Sorror","Brenda M. Sandmaier","Garrett Nichols","Danielle M. Zerr","Keith R. Jerome","Joshua T. Schiffer","Michael Boeckh"],"twitterCount":14,"altmetricId":16797822},{"title":"Efficacy and updated safety analysis of a safety Run-in cohort from Griffin, a phase 2 randomized study of Daratumumab (DarA), bortezomib (V), lenalidomide (R), and …","googleId":"ZH75Pkbn6WcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/151/272998","googleCitationCount":51,"googleAuthor":"","doi":"10.1182/blood-2018-151","elsevierCitationCount":0,"altmetricAuthors":["Peter M. Voorhees","Cesar Rodriguez","Brandi Reeves","Nitya Nathwani","Luciano J Costa","Yana Lutska","Daniela Hoehn","Huiling Pei","Jon Ukropec","Ming Qi","Thomas Lin","Paul Richardson"],"twitterCount":0,"altmetricId":61620921},{"title":"An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia","googleId":"8tTrycBR22YJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/609/36176","googleCitationCount":102,"googleAuthor":"S Sukumaran","doi":"10.1182/blood-2016-08-735365","elsevierAuthor":"Leong S.R.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"73","altmetricAuthors":["Steven R. Leong","Siddharth Sukumaran","Maria Hristopoulos","Klara Totpal","Shannon Stainton","Elizabeth Lu","Alfred Wong","Lucinda Tam","Robert Newman","Brian R. Vuillemenot","Diego Ellerman","Chen Gu","Mary Mathieu","Mark S. Dennis","Allen Nguyen","Bing Zheng","Crystal Zhang","Genee Lee","Yu-Waye Chu","Rodney A. Prell","Kedan Lin","Steven T. Laing","Andrew G. Polson"],"twitterCount":32,"altmetricId":14422412},{"title":"Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma","googleId":"wrFUIUHlazMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/4/473/36199","googleCitationCount":100,"googleAuthor":"M Matlock","doi":"10.1182/blood-2016-07-729954","elsevierAuthor":"Krysiak K.","publicationName":"Blood","elsevierCoverDate":"2017-01-26","elsevierCoverDisplayDate":"26 January 2017","elsevierCitationCount":"68","altmetricAuthors":["Kilannin Krysiak","Felicia Gomez","Brian S. White","Matthew Matlock","Christopher A. Miller","Lee Trani","Catrina C. Fronick","Robert S. Fulton","Friederike Kreisel","Amanda F. Cashen","Kenneth R. Carson","Melissa M. Berrien-Elliott","Nancy L. Bartlett","Malachi Griffith","Obi L. Griffith","Todd A. Fehniger"],"twitterCount":29,"altmetricId":13609595},{"title":"Clinical and pathological characteristics of HIV-and HHV-8–negative Castleman disease","googleId":"xWFhSNGBXFUJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1658/36127","googleCitationCount":95,"googleAuthor":"","doi":"10.1182/blood-2016-11-748855","elsevierAuthor":"Yu L.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"62","altmetricAuthors":["Li Yu","Meifeng Tu","Jorge Cortes","Zijun Y. Xu-Monette","Roberto N. Miranda","Jun Zhang","Robert Z. Orlowski","Sattva Neelapu","Prajwal C. Boddu","Mary A. Akosile","Thomas S. Uldrick","Robert Yarchoan","L. Jeffrey Medeiros","Yong Li","David C. Fajgenbaum","Ken H. Young"],"twitterCount":5,"altmetricId":15590760},{"title":"Remissions of acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm following treatment with CD123-specific CAR T cells: a first-in-human clinical …","googleId":"1NYmCEp70YsJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/811/83447","googleCitationCount":68,"googleAuthor":"JY Song","doi":"10.1182/blood.V130.Suppl_1.811.811","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ivosidenib or enasidenib combined with induction and consolidation chemotherapy in patients with newly diagnosed AML with an IDH1 or IDH2 mutation is safe …","googleId":"xO7cZs-egXkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/560/263325","googleCitationCount":52,"googleAuthor":"AT Fathi","doi":"10.1182/blood-2018-99-110449","elsevierAuthor":"Becker J.S.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":["Eytan M. Stein","Courtney D. DiNardo","Amir T. Fathi","Alice S. Mims","Keith W. Pratz","Michael R. Savona","Anthony S. Stein","Richard M. Stone","Eric S. Winer","Christopher S. Seet","Hartmut Döhner","Daniel A Pollyea","James K McCloskey","Olatoyosi Odenike","Bob Lowenberg","Gert J. Ossenkoppele","Prapti A. Patel","Mikhail Roshal","Frederik Lersch","Salah Nabhan","Sung Choe","Hongfang Wang","Lei Hua","Caroline Almon","Michael Cooper","Martin S. Tallman"],"twitterCount":0,"altmetricId":54505497},{"title":"DNA damage responses and p53 in the aging process","googleId":"F6sZVUf9x_8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120325064","googleCitationCount":73,"googleAuthor":"B Schumacher","doi":"10.1182/blood-2017-07-746396","elsevierAuthor":"Ou H.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"41","altmetricAuthors":["Hui-Ling Ou","Björn Schumacher"],"twitterCount":14,"altmetricId":28989813},{"title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","googleId":"--i6pGVeK68J","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2773/37156","googleCitationCount":59,"googleAuthor":"K Yazdanbakhsh","doi":"10.1182/blood-2018-02-785964","elsevierAuthor":"Pirenne F.","publicationName":"Blood","elsevierCoverDate":"2018-06-21","elsevierCoverDisplayDate":"21 June 2018","elsevierCitationCount":"38","altmetricAuthors":["France Pirenne","Karina Yazdanbakhsh"],"twitterCount":42,"altmetricId":40688955},{"title":"Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma","googleId":"02d2ndeRITEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2305/39525","googleCitationCount":55,"googleAuthor":"F Lemonnier","doi":"10.1182/blood-2018-04-840538","elsevierAuthor":"Lemonnier F.","publicationName":"Blood","elsevierCoverDate":"2018-11-22","elsevierCoverDisplayDate":"22 November 2018","elsevierCitationCount":"38","altmetricAuthors":["François Lemonnier","Jehan Dupuis","Pierre Sujobert","Olivier Tournillhac","Morgane Cheminant","Clémentine Sarkozy","Laura Pelletier","Ambroise Marçais","Cyrielle Robe","Virginie Fataccioli","Corinne Haioun","Olivier Hermine","Philippe Gaulard","Richard Delarue"],"twitterCount":49,"altmetricId":49161064},{"title":"The MYC oncogene is a global regulator of the immune response","googleId":"oPV94PRqKt4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2007/36721","googleCitationCount":61,"googleAuthor":"V Baylot","doi":"10.1182/blood-2017-11-742577","elsevierAuthor":"Casey S.","publicationName":"Blood","elsevierCoverDate":"2018-05-03","elsevierCoverDisplayDate":"3 May 2018","elsevierCitationCount":"43","altmetricAuthors":["Stephanie C. Casey","Virginie Baylot","Dean W. Felsher"],"twitterCount":31,"altmetricId":34080096},{"title":"EPCR expression marks UM171-expanded CD34+ cord blood stem cells","googleId":"FbprXvQFpAMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3344/107629","googleCitationCount":72,"googleAuthor":"I Fares","doi":"10.1182/blood-2016-11-750729","elsevierAuthor":"Fares I.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"55","altmetricAuthors":["Iman Fares","Jalila Chagraoui","Bernhard Lehnertz","Tara MacRae","Nadine Mayotte","Elisa Tomellini","Léo Aubert","Philippe P. Roux","Guy Sauvageau"],"twitterCount":3,"altmetricId":18861806},{"title":"Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia","googleId":"qY3rs9fONO4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/8/855/104417","googleCitationCount":66,"googleAuthor":"D Siegel","doi":"10.1182/blood-2017-08-797886","elsevierAuthor":"Chen C.","publicationName":"Blood","elsevierCoverDate":"2018-02-22","elsevierCoverDisplayDate":"22 February 2018","elsevierCitationCount":"50","altmetricAuthors":["Christine Chen","David Siegel","Martin Gutierrez","Meagan Jacoby","Craig C. Hofmeister","Nashat Gabrail","Rachid Baz","Morten Mau-Sorensen","Jesus G. Berdeja","Michael Savona","Lynn Savoie","Suzanne Trudel","Nuchanan Areethamsirikul","T. J. Unger","Tami Rashal","Tim Hanke","Michael Kauffman","Sharon Shacham","Donna Reece"],"twitterCount":21,"altmetricId":30048651},{"title":"A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia","googleId":"4LOBGToPCkcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2249/39554","googleCitationCount":50,"googleAuthor":"","doi":"10.1182/blood-2018-06-860593","elsevierAuthor":"Chen L.S.","publicationName":"Blood","elsevierCoverDate":"2018-11-22","elsevierCoverDisplayDate":"22 November 2018","elsevierCitationCount":"39","altmetricAuthors":["Lisa S. Chen","Prithviraj Bose","Nichole D. Cruz","Yongying Jiang","Qi Wu","Philip A. Thompson","Shuju Feng","Michael H. Kroll","Wei Qiao","Xuelin Huang","Nitin Jain","William G. Wierda","Michael J. Keating","Varsha Gandhi"],"twitterCount":29,"altmetricId":48901013},{"title":"Initial results from a phase 1 clinical study of bb21217, a next-generation anti Bcma CAR T therapy","googleId":"P1qDII-0hKAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/488/262309","googleCitationCount":55,"googleAuthor":"DS Siegel","doi":"10.1182/blood-2018-99-116953","elsevierCitationCount":0,"altmetricAuthors":["Nina Shah","Melissa Alsina","David S Siegel","Sundar Jagannath","Deepu Madduri","Jonathan L Kaufman","Ashley Turka","Lyh Ping Lam","Monica Massaro","Kristen Hege","Fabio Petrocca","Jesus G. Berdeja","Noopur Raje"],"twitterCount":0,"altmetricId":55319133},{"title":"The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications","googleId":"EGw_UWNVDH8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1617/36115","googleCitationCount":73,"googleAuthor":"H Medyouf","doi":"10.1182/blood-2016-11-696070","elsevierAuthor":"Medyouf H.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"56","altmetricAuthors":["Hind Medyouf"],"twitterCount":12,"altmetricId":16115960},{"title":"A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy","googleId":"gtwqc_ytA6EJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/49/39283","googleCitationCount":60,"googleAuthor":"E Bachy","doi":"10.1182/blood-2017-11-816405","elsevierAuthor":"Bachy E.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"42","altmetricAuthors":["Emmanuel Bachy","Matthew J. Maurer","Thomas M. Habermann","Bénédicte Gelas-Dore","Delphine Maucort-Boulch","Jane A. Estell","Eric Van den Neste","Réda Bouabdallah","Emmanuel Gyan","Andrew L. Feldman","Joan Bargay","Alain Delmer","Susan L. Slager","Maria Gomes da Silva","Olivier Fitoussi","David Belada","Hervé Maisonneuve","Tanin Intragumtornchai","Stephen M. Ansell","Thierry Lamy","Peggy Dartigues","Brian K. Link","John F. Seymour","James R. Cerhan","Gilles Salles"],"twitterCount":59,"altmetricId":37947206},{"title":"R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma","googleId":"0vKIyZ7BFA0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/2/174/37014","googleCitationCount":66,"googleAuthor":"P Soubeyran","doi":"10.1182/blood-2017-07-793984","elsevierAuthor":"Lamy T.","publicationName":"Blood","elsevierCoverDate":"2018-01-11","elsevierCoverDisplayDate":"11 January 2018","elsevierCitationCount":"54","altmetricAuthors":["Thierry Lamy","Gandhi Damaj","Pierre Soubeyran","Emmanuel Gyan","Guillaume Cartron","Krimo Bouabdallah","Rémy Gressin","Jérôme Cornillon","Anne Banos","Katell Le Du","Mohamed Benchalal","Marie-Pierre Moles","Steven Le Gouill","Joel Fleury","Pascal Godmer","Hervé Maisonneuve","Eric Deconinck","Roch Houot","Kamel Laribi","Jean Pierre Marolleau","Olivier Tournilhac","Bernard Branger","Anne Devillers","Jean Philippe Vuillez","Thierry Fest","Philippe Colombat","Valérie Costes","Vanessa Szablewski","Marie C. Béné","Vincent Delwail"],"twitterCount":75,"altmetricId":27854239},{"title":"Ferritin is secreted via 2 distinct nonclassical vesicular pathways","googleId":"xUJ4nPwYt8AJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/342/38393","googleCitationCount":64,"googleAuthor":"M Truman-Rosentsvit","doi":"10.1182/blood-2017-02-768580","elsevierAuthor":"Truman-Rosentsvit M.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"52","altmetricAuthors":["Marianna Truman-Rosentsvit","Dina Berenbaum","Lior Spektor","Lyora A. Cohen","Shirly Belizowsky-Moshe","Lena Lifshitz","Jing Ma","Wei Li","Ellina Kesselman","Inbal Abutbul-Ionita","Dganit Danino","Lucia Gutierrez","Huihui Li","Kuanyu Li","Huifang Lou","Maria Regoni","Maura Poli","Fabian Glaser","Tracey A. Rouault","Esther G. Meyron-Holtz"],"twitterCount":12,"altmetricId":28384638},{"title":"Updated analysis of the efficacy and safety of tisagenlecleucel in pediatric and young adult patients with relapsed/refractory (r/r) acute lymphoblastic leukemia","googleId":"_ri9Xp1qMvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/895/266293","googleCitationCount":53,"googleAuthor":"SA Grupp","doi":"10.1182/blood-2018-99-112599","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Novel approaches to hemophilia therapy: successes and challenges","googleId":"iWwiAbD7ShYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2251/36664","googleCitationCount":65,"googleAuthor":"BJ Samelson-Jones","doi":"10.1182/blood-2017-08-742312","elsevierAuthor":"Zhang F.","publicationName":"Human Gene Therapy","elsevierCoverDate":"2020-04-01","elsevierCoverDisplayDate":"April 2020","elsevierCitationCount":"1","altmetricAuthors":["Valder R. Arruda","Bhavya S. Doshi","Benjamin J. Samelson-Jones"],"twitterCount":30,"altmetricId":27566234},{"title":"MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts","googleId":"05iJJ7eesBgJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/11/1290/36448","googleCitationCount":67,"googleAuthor":"RM O'Connell","doi":"10.1182/blood-2016-10-697698","elsevierAuthor":"Wallace J.","publicationName":"Blood","elsevierCoverDate":"2017-09-14","elsevierCoverDisplayDate":"14 September 2017","elsevierCitationCount":"57","altmetricAuthors":["Jared A. Wallace","Ryan M. O’Connell"],"twitterCount":13,"altmetricId":22804000},{"title":"Apixaban, dalteparin, in active cancer associated venous thromboembolism, the ADAM VTE trial","googleId":"jjuVZLuxupEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/421/275722","googleCitationCount":55,"googleAuthor":"","doi":"10.1182/blood-2018-99-118808","elsevierAuthor":"Trujillo Santos A.J.","publicationName":"Revista Clinica Espanola","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0","altmetricAuthors":["Robert D. McBane","Waldemar E. Wysokinski","Jennifer Le-Rademacher","Aneel A. Ashrani","Alfonso J Tafur","Krishna Gundabolu","Juliana Perez-Botero","Usha Perepu","Daniel M. Anderson","Charles Kuzma","Roberto leon Ferre","Stanislav Henkin","Charles Lenz","Charles Loprinzi"],"twitterCount":2,"altmetricId":57888327},{"title":"Immunoassay for human serum erythroferrone","googleId":"TETijAx8GHwJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/10/1243/36345","googleCitationCount":70,"googleAuthor":"T Ganz","doi":"10.1182/blood-2017-04-777987","elsevierAuthor":"Ganz T.","publicationName":"Blood","elsevierCoverDate":"2017-09-07","elsevierCoverDisplayDate":"7 September 2017","elsevierCitationCount":"52","altmetricAuthors":["Tomas Ganz","Grace Jung","Arash Naeim","Yelena Ginzburg","Zahra Pakbaz","Patrick B. Walter","Léon Kautz","Elizabeta Nemeth"],"twitterCount":5,"altmetricId":25209429},{"title":"Phase 1b/2 combination study of APR-246 and azacitidine (AZA) in patients with TP53 mutant myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)","googleId":"SZABTb60FXcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3091/263862","googleCitationCount":55,"googleAuthor":"DP Steensma","doi":"10.1182/blood-2018-99-119990","elsevierAuthor":"Adès L.","publicationName":"HemaSphere","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"1 June 2019","elsevierCitationCount":"0","altmetricAuthors":["David A Sallman","Amy E. DeZern","David P. Steensma","Kendra L. Sweet","Thomas Cluzeau","Mikkael A. Sekeres","Guillermo Garcia-Manero","Gail J. Roboz","Amy F McLemore","Kathy L McGraw","John Puskas","Ling Zhang","Chirag K Bhagat","Jiqiang Yao","Najla Al Ali","Eric Padron","Roger Tell","Jeffrey E. Lancet","Pierre Fenaux","Alan F. List","Rami S. Komrokji"],"twitterCount":0,"altmetricId":92878594},{"title":"Activated protein C, protease activated receptor 1, and neuroprotection","googleId":"6dJ8Uy-5SFAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/159/39239","googleCitationCount":50,"googleAuthor":"JH Griffin","doi":"10.1182/blood-2018-02-769026","elsevierAuthor":"Griffin J.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"34","altmetricAuthors":["John H. Griffin","Berislav V. Zlokovic","Laurent O. Mosnier"],"twitterCount":3,"altmetricId":45087861},{"title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","googleId":"kzhyPbSDIpEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2344/36657","googleCitationCount":65,"googleAuthor":"S Aguila","doi":"10.1182/blood-2017-05-786699","elsevierAuthor":"Lavin M.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"51","altmetricAuthors":["Michelle Lavin","Sonia Aguila","Sonja Schneppenheim","Niall Dalton","Kenneth L. Jones","Jamie M. O’Sullivan","Niamh M. O’Connell","Kevin Ryan","Barry White","Mary Byrne","Marie Rafferty","Mairead M. Doyle","Margaret Nolan","Roger J. S. Preston","Ulrich Budde","Paula James","Jorge Di Paola","James S. O’Donnell"],"twitterCount":34,"altmetricId":25432645},{"title":"Phase 1/2 study of venetoclax with low-dose cytarabine in treatment-naive, elderly patients with acute myeloid leukemia unfit for intensive chemotherapy: 1-year …","googleId":"E4JNWjcrHn4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/890/83379","googleCitationCount":64,"googleAuthor":"A Wei","doi":"10.1182/blood.V130.Suppl_1.890.890","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia","googleId":"E-cbmfRtsNIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/2/177/36096","googleCitationCount":88,"googleAuthor":"SK Tasian","doi":"10.1182/blood-2016-05-707653","elsevierAuthor":"Tasian S.K.","publicationName":"Blood","elsevierCoverDate":"2017-01-12","elsevierCoverDisplayDate":"12 January 2017","elsevierCitationCount":"68","altmetricAuthors":["Sarah K. Tasian","David T. Teachey","Yong Li","Feng Shen","Richard C. Harvey","I-Ming Chen","Theresa Ryan","Tiffaney L. Vincent","Cheryl L. Willman","Alexander E. Perl","Stephen P. Hunger","Mignon L. Loh","Martin Carroll","Stephan A. Grupp"],"twitterCount":0,"altmetricId":57819297},{"title":"SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia","googleId":"nSvMx4S9ZYkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/24/2631/36872","googleCitationCount":61,"googleAuthor":"BG Mar","doi":"10.1182/blood-2017-03-775569","elsevierAuthor":"Mar B.G.","publicationName":"Blood","elsevierCoverDate":"2017-12-14","elsevierCoverDisplayDate":"14 December 2017","elsevierCitationCount":"47","altmetricAuthors":["Brenton G. Mar","S. Haihua Chu","Josephine D. Kahn","Andrei V. Krivtsov","Richard Koche","Cecilia A. Castellano","Jacob L. Kotlier","Rebecca L. Zon","Marie E. McConkey","Jonathan Chabon","Ryan Chappell","Peter V. Grauman","James J. Hsieh","Scott A. Armstrong","Benjamin L. Ebert"],"twitterCount":31,"altmetricId":30618465},{"title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","googleId":"Ua1-5xIne8IJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1538/35953","googleCitationCount":70,"googleAuthor":"D Winkelhorst","doi":"10.1182/blood-2016-10-739656","elsevierAuthor":"Winkelhorst D.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"42","altmetricAuthors":["Dian Winkelhorst","Michael F. Murphy","Andreas Greinacher","Nadine Shehata","Taman Bakchoul","Edwin Massey","Jillian Baker","Lani Lieberman","Susano Tanael","Heather Hume","Donald M. Arnold","Shoma Baidya","Gerald Bertrand","James Bussel","Mette Kjaer","Cécile Kaplan","Jens Kjeldsen-Kragh","Dick Oepkes","Greg Ryan"],"twitterCount":19,"altmetricId":15903557},{"title":"Runx transcription factors in the development and function of the definitive hematopoietic system","googleId":"Tme9pTKAkskJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2061/36387","googleCitationCount":70,"googleAuthor":"","doi":"10.1182/blood-2016-12-689109","elsevierAuthor":"De Bruijn M.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"40","altmetricAuthors":["Marella de Bruijn","Elaine Dzierzak"],"twitterCount":5,"altmetricId":18802048},{"title":"Ibrutinib blocks Btk-dependent NF-ĸB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis","googleId":"Gkm_C7Jg-EAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1985/39605","googleCitationCount":51,"googleAuthor":"T Colley","doi":"10.1182/blood-2017-12-823393","elsevierAuthor":"Bercusson A.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"39","altmetricAuthors":["Amelia Bercusson","Thomas Colley","Anand Shah","Adilia Warris","Darius Armstrong-James"],"twitterCount":84,"altmetricId":45210526},{"title":"SCL/TAL1: a multifaceted regulator from blood development to disease","googleId":"pxFfMq-p5-gJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2051/36413","googleCitationCount":67,"googleAuthor":"MS Kristiansen","doi":"10.1182/blood-2016-12-754051","elsevierAuthor":"Porcher C.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"39","altmetricAuthors":["Catherine Porcher","Hedia Chagraoui","Maiken S. Kristiansen"],"twitterCount":6,"altmetricId":16579522},{"title":"von Willebrand factor regulation of blood vessel formation","googleId":"tbNZu4TdwGkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/132/39222","googleCitationCount":54,"googleAuthor":"","doi":"10.1182/blood-2018-01-769018","elsevierAuthor":"Maaland A.F.","publicationName":"PLoS ONE","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":["Anna M. Randi","Koval E. Smith","Giancarlo Castaman"],"twitterCount":12,"altmetricId":43364516},{"title":"Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group","googleId":"mcoWZ4HCsXcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/815/39461","googleCitationCount":46,"googleAuthor":"","doi":"10.1182/blood-2018-04-841676","elsevierAuthor":"Roberts K.G.","publicationName":"Blood","elsevierCoverDate":"2018-08-23","elsevierCoverDisplayDate":"23 August 2018","elsevierCitationCount":"31","altmetricAuthors":["Kathryn G. Roberts","Shalini C. Reshmi","Richard C. Harvey","I-Ming Chen","Kinnari Patel","Eileen Stonerock","Heather Jenkins","Yunfeng Dai","Marc Valentine","Zhaohui Gu","Yaqi Zhao","Jinghui Zhang","Debbie Payne-Turner","Meenakshi Devidas","Nyla A. Heerema","Andrew J. Carroll","Elizabeth A. Raetz","Michael J. Borowitz","Brent L. Wood","Leonard A. Mattano","Kelly W. Maloney","William L. Carroll","Mignon L. Loh","Cheryl L. Willman","Julie M. Gastier-Foster","Charles G. Mullighan","Stephen P. Hunger"],"twitterCount":25,"altmetricId":44995352},{"title":"Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome","googleId":"HJfq3KjWJ-MJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1557/35898","googleCitationCount":86,"googleAuthor":"S Dhanraj","doi":"10.1182/blood-2016-08-735431","elsevierAuthor":"Dhanraj S.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"56","altmetricAuthors":["Santhosh Dhanraj","Anna Matveev","Hongbing Li","Supanun Lauhasurayotin","Lawrence Jardine","Michaela Cada","Bozana Zlateska","Chetankumar S. Tailor","Joseph Zhou","Roberto Mendoza-Londono","Ajoy Vincent","Peter R. Durie","Stephen W. Scherer","Johanna M. Rommens","Elise Heon","Yigal Dror"],"twitterCount":8,"altmetricId":15527708},{"title":"How I treat CLL patients with ibrutinib","googleId":"t877E0PQEGwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120325234","googleCitationCount":63,"googleAuthor":"","doi":"10.1182/blood-2017-08-764712","elsevierAuthor":"Brown J.R.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"40","altmetricAuthors":["Jennifer R. Brown"],"twitterCount":73,"altmetricId":30643049},{"title":"How I treat chronic myelomonocytic leukemia","googleId":"m1XH1J5II1gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/2/126/36728","googleCitationCount":66,"googleAuthor":"","doi":"10.1182/blood-2017-04-736421","elsevierAuthor":"Solary E.","publicationName":"Blood","elsevierCoverDate":"2017-07-13","elsevierCoverDisplayDate":"13 July 2017","elsevierCitationCount":"51","altmetricAuthors":["Eric Solary","Raphael Itzykson"],"twitterCount":78,"altmetricId":20768767},{"title":"Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy","googleId":"nfUW7kEEPR8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/22/2980/36039","googleCitationCount":67,"googleAuthor":"RD Lopes","doi":"10.1182/blood-2016-08-731638","elsevierAuthor":"Lopes R.D.","publicationName":"Blood","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"50","altmetricAuthors":["Renato D. Lopes","Patrícia O. Guimarães","Bradley J. Kolls","Daniel M. Wojdyla","Cheryl D. Bushnell","Michael Hanna","J. Donald Easton","Laine Thomas","Lars Wallentin","Sana M. Al-Khatib","Claes Held","Pedro Gabriel Melo de Barros e Silva","John H. Alexander","Christopher B. Granger","Hans-Christoph Diener"],"twitterCount":19,"altmetricId":18255171},{"title":"Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death","googleId":"si8_Kjo9a1YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2183/39501","googleCitationCount":49,"googleAuthor":"T Tokunaga","doi":"10.1182/blood-2018-04-842260","elsevierAuthor":"Ueki S.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"40","altmetricAuthors":["Shigeharu Ueki","Takahiro Tokunaga","Rossana C. N. Melo","Hidekazu Saito","Kohei Honda","Mineyo Fukuchi","Yasunori Konno","Masahide Takeda","Yohei Yamamoto","Makoto Hirokawa","Shigeharu Fujieda","Lisa A. Spencer","Peter F. Weller"],"twitterCount":4,"altmetricId":47258660},{"title":"RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice","googleId":"MnSBZ7tDYKMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/935/39421","googleCitationCount":51,"googleAuthor":"JC Aster","doi":"10.1182/blood-2017-11-818617","elsevierAuthor":"Ng S.","publicationName":"Blood","elsevierCoverDate":"2018-08-30","elsevierCoverDisplayDate":"30 August 2018","elsevierCitationCount":"32","altmetricAuthors":["Samuel Y. Ng","Leon Brown","Kristen Stevenson","Tiffany deSouza","Jon C. Aster","Abner Louissaint","David M. Weinstock"],"twitterCount":6,"altmetricId":41912407},{"title":"How I manage monoclonal gammopathy of undetermined significance","googleId":"nRC6XZPFTEcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/2/163/37011","googleCitationCount":59,"googleAuthor":"RS Go","doi":"10.1182/blood-2017-09-807560","elsevierAuthor":"Go R.","publicationName":"Blood","elsevierCoverDate":"2018-01-11","elsevierCoverDisplayDate":"11 January 2018","elsevierCitationCount":"35","altmetricAuthors":["Ronald S. Go","S. Vincent Rajkumar"],"twitterCount":263,"altmetricId":29627700},{"title":"Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma","googleId":"B7StvKe_mycJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1768/35817","googleCitationCount":66,"googleAuthor":"N Beeharry","doi":"10.1182/blood-2016-09-736892","elsevierAuthor":"Gayle S.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"55","altmetricAuthors":["Sophia Gayle","Sean Landrette","Neil Beeharry","Chris Conrad","Marylens Hernandez","Paul Beckett","Shawn M. Ferguson","Talya Mandelkern","Meiling Zheng","Tian Xu","Jonathan Rothberg","Henri Lichenstein"],"twitterCount":14,"altmetricId":15665838},{"title":"Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome","googleId":"lAOJAE0-cAsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/625/36788","googleCitationCount":64,"googleAuthor":"P Milani","doi":"10.1182/blood-2017-02-767467","elsevierAuthor":"Milani P.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"58","altmetricAuthors":["Paolo Milani","Marco Basset","Francesca Russo","Andrea Foli","Giampaolo Merlini","Giovanni Palladini"],"twitterCount":24,"altmetricId":20646847},{"title":"Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML","googleId":"lI_pzqyYez4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2384/35973","googleCitationCount":68,"googleAuthor":"R Warfvinge","doi":"10.1182/blood-2016-07-728873","elsevierAuthor":"Warfvinge R.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"53","altmetricAuthors":["Rebecca Warfvinge","Linda Geironson","Mikael N. E. Sommarin","Stefan Lang","Christine Karlsson","Teona Roschupkina","Leif Stenke","Jesper Stentoft","Ulla Olsson-Strömberg","Henrik Hjorth-Hansen","Satu Mustjoki","Shamit Soneji","Johan Richter","Göran Karlsson"],"twitterCount":9,"altmetricId":15815361},{"title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","googleId":"B7aoy4S9wDsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1430/36633","googleCitationCount":56,"googleAuthor":"","doi":"10.1182/blood-2017-06-789552","elsevierAuthor":"Girard-Guyonvarc’h C.","publicationName":"Blood","elsevierCoverDate":"2018-03-29","elsevierCoverDisplayDate":"29 March 2018","elsevierCitationCount":"40","altmetricAuthors":["Charlotte Girard-Guyonvarc’h","Jennifer Palomo","Praxedis Martin","Emiliana Rodriguez","Sabina Troccaz","Gaby Palmer","Cem Gabay"],"twitterCount":7,"altmetricId":31370501},{"title":"Platelets kill circulating parasites of all major Plasmodium species in human malaria","googleId":"A1wTz1arp1wJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1332/39622","googleCitationCount":44,"googleAuthor":"S Kho","doi":"10.1182/blood-2018-05-849307","elsevierAuthor":"Kho S.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"27","altmetricAuthors":["Steven Kho","Bridget E. Barber","Edison Johar","Benediktus Andries","Jeanne R. Poespoprodjo","Enny Kenangalem","Kim A. Piera","Anna Ehmann","Ric N. Price","Timothy William","Tonia Woodberry","Simon Foote","Gabriela Minigo","Tsin W. Yeo","Matthew J. Grigg","Nicholas M. Anstey","Brendan J. McMorran"],"twitterCount":57,"altmetricId":45295882},{"title":"Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia","googleId":"7Pl-VShWYB8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1617/36676","googleCitationCount":53,"googleAuthor":"A Lequeux","doi":"10.1182/blood-2017-06-792267","elsevierAuthor":"Wierz M.","publicationName":"Blood","elsevierCoverDate":"2018-04-05","elsevierCoverDisplayDate":"5 April 2018","elsevierCitationCount":"42","altmetricAuthors":["Marina Wierz","Sandrine Pierson","Léa Guyonnet","Elodie Viry","Audrey Lequeux","Anaïs Oudin","Simone P. Niclou","Markus Ollert","Guy Berchem","Bassam Janji","Coralie Guérin","Jerome Paggetti","Etienne Moussay"],"twitterCount":7,"altmetricId":35736130},{"title":"Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL","googleId":"XsBKRqX8tgQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/310/36915","googleCitationCount":64,"googleAuthor":"","doi":"10.1182/blood-2016-12-758599","elsevierAuthor":"Erdmann T.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"50","altmetricAuthors":["Tabea Erdmann","Pavel Klener","James T. Lynch","Michael Grau","Petra Vočková","Jan Molinsky","Diana Tuskova","Kevin Hudson","Urszula M. Polanska","Michael Grondine","Michele Mayo","Beiying Dai","Matthias Pfeifer","Kristian Erdmann","Daniela Schwammbach","Myroslav Zapukhlyak","Annette M. Staiger","German Ott","Wolfgang E. Berdel","Barry R. Davies","Francisco Cruzalegui","Marek Trneny","Peter Lenz","Simon T. Barry","Georg Lenz"],"twitterCount":5,"altmetricId":16457550},{"title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy","googleId":"FTIak2Y2QVcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1437/35927","googleCitationCount":83,"googleAuthor":"F Petitprez","doi":"10.1182/blood-2016-08-737163","elsevierAuthor":"Chauvet S.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"63","altmetricAuthors":["Sophie Chauvet","Véronique Frémeaux-Bacchi","Florent Petitprez","Alexandre Karras","Laurent Daniel","Stéphane Burtey","Gabriel Choukroun","Yahsou Delmas","Dominique Guerrot","Arnaud François","Moglie Le Quintrec","Vincent Javaugue","David Ribes","Laurence Vrigneaud","Bertrand Arnulf","Jean Michel Goujon","Pierre Ronco","Guy Touchard","Frank Bridoux"],"twitterCount":41,"altmetricId":15390741},{"title":"Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy","googleId":"f5XLfaQ0LgcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/22/3037/36042","googleCitationCount":66,"googleAuthor":"","doi":"10.1182/blood-2016-12-757740","elsevierAuthor":"Gopal A.K.","publicationName":"Blood","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"51","altmetricAuthors":["Ajay K. Gopal","Brad S. Kahl","Christopher R. Flowers","Peter Martin","Stephen M. Ansell","Esteban Abella-Dominicis","Brian Koh","Wei Ye","Paul M. Barr","Gilles A. Salles","Jonathan W. Friedberg"],"twitterCount":23,"altmetricId":17892565},{"title":"How I treat myeloma with new agents","googleId":"DAR0O_g85BcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/13/1507/36520","googleCitationCount":57,"googleAuthor":"P Moreau","doi":"10.1182/blood-2017-05-743203","elsevierAuthor":"Moreau P.","publicationName":"Blood","elsevierCoverDate":"2017-09-28","elsevierCoverDisplayDate":"28 September 2017","elsevierCitationCount":"40","altmetricAuthors":["Philippe Moreau"],"twitterCount":55,"altmetricId":22662445},{"title":"Checkpoint inhibitors augment CD19-directed chimeric antigen receptor (CAR) T cell therapy in relapsed B-cell acute lymphoblastic leukemia","googleId":"_kjEX5gTdZUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/556/263334","googleCitationCount":44,"googleAuthor":"AE Seif","doi":"10.1182/blood-2018-99-112572","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","googleId":"njZF8tP4sZUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2323/107704","googleCitationCount":37,"googleAuthor":"DC Fajgenbaum","doi":"10.1182/blood-2018-05-848671","elsevierAuthor":"Fajgenbaum D.C.","publicationName":"Blood","elsevierCoverDate":"2018-11-29","elsevierCoverDisplayDate":"29 November 2018","elsevierCitationCount":"18","altmetricAuthors":["David C. Fajgenbaum"],"twitterCount":21,"altmetricId":52141090},{"title":"Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry","googleId":"VdvsM8Mb2j8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/10/1209/36348","googleCitationCount":59,"googleAuthor":"H Ariffin","doi":"10.1182/blood-2017-05-782383","elsevierAuthor":"Moriyama T.","publicationName":"Blood","elsevierCoverDate":"2017-09-07","elsevierCoverDisplayDate":"7 September 2017","elsevierCitationCount":"50","altmetricAuthors":["Takaya Moriyama","Yung-Li Yang","Rina Nishii","Hany Ariffin","Chengcheng Liu","Ting-Nien Lin","Wenjian Yang","Dong-Tsamn Lin","Chih-Hsiang Yu","Shirley Kham","Ching-Hon Pui","William E. Evans","Sima Jeha","Mary V. Relling","Allen Eng-Juh Yeoh","Jun J. Yang"],"twitterCount":8,"altmetricId":21402118},{"title":"Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial","googleId":"noFGATS8fiwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1456/36613","googleCitationCount":53,"googleAuthor":"","doi":"10.1182/blood-2017-07-795476","elsevierAuthor":"Cottereau A.S.","publicationName":"Blood","elsevierCoverDate":"2018-03-29","elsevierCoverDisplayDate":"29 March 2018","elsevierCitationCount":"41","altmetricAuthors":["Anne-Ségolène Cottereau","Annibale Versari","Annika Loft","Olivier Casasnovas","Monica Bellei","Romain Ricci","Stéphane Bardet","Antonio Castagnoli","Pauline Brice","John Raemaekers","Bénédicte Deau","Catherine Fortpied","Tiana Raveloarivahy","Emelie Van Zele","Loic Chartier","Thierry Vander Borght","Massimo Federico","Martin Hutchings","Umberto Ricardi","Marc Andre","Michel Meignan"],"twitterCount":30,"altmetricId":32954470},{"title":"Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2","googleId":"vLB1lGLJgU0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/24/2682/36885","googleCitationCount":63,"googleAuthor":"H Hashem","doi":"10.1182/blood-2017-07-798660","elsevierAuthor":"Hashem H.","publicationName":"Blood","elsevierCoverDate":"2017-12-14","elsevierCoverDisplayDate":"14 December 2017","elsevierCitationCount":"52","altmetricAuthors":["Hasan Hashem","Ashish R. Kumar","Ingo Müller","Florian Babor","Robbert Bredius","Jignesh Dalal","Amy P. Hsu","Steven M. Holland","Dennis D. Hickstein","Stephen Jolles","Robert Krance","Ghadir Sasa","Mervi Taskinen","Minna Koskenvuo","Janna Saarela","Joris van Montfrans","Keith Wilson","Barbara Bosch","Leen Moens","Michael Hershfield","Isabelle Meyts"],"twitterCount":11,"altmetricId":26990728},{"title":"HAVEN 2 updated analysis: multicenter, open-label, phase 3 study to evaluate efficacy, safety and pharmacokinetics of subcutaneous administration of emicizumab …","googleId":"YgtEAYakuxUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/85/83407","googleCitationCount":55,"googleAuthor":"RF Sidonio","doi":"10.1182/blood.V130.Suppl_1.85.85","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Carfilzomib-lenalidomide-dexamethasone (KRd) induction-autologous transplant (ASCT)-Krd consolidation vs KRd 12 cycles vs carfilzomib-cyclophosphamide …","googleId":"5j5CuC1DoGMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/121/262862","googleCitationCount":47,"googleAuthor":"","doi":"10.1182/blood-2018-99-112093","elsevierAuthor":"Alsina M.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2021-02-01","elsevierCoverDisplayDate":"1 February 2021","elsevierCitationCount":"0","altmetricAuthors":["Francesca Gay","Chiara Cerrato","Delia Rota Scalabrini","Monica Galli","Angelo Belotti","Elena Zamagni","Antonio Ledda","Mariella Grasso","Emanuele Angelucci","Anna Marina Liberati","Patrizia Tosi","Francesco Pisani","Stefano Spada","Ombretta Annibali","Anna Baraldi","Paola Omedé","Piero Galieni","Rita Rizzi","Norbert Pescosta","Sonia Ronconi","Donatella Vincelli","Anna Maria Cafro","Massimo Offidani","Antonio Palumbo","Pellegrino Musto","Michele Cavo","Mario Boccadoro"],"twitterCount":0,"altmetricId":54506661},{"title":"Autophagy, a key mechanism of oncogenesis and resistance in leukemia","googleId":"iNSgY1z5xdsJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/547/36143","googleCitationCount":76,"googleAuthor":"","doi":"10.1182/blood-2016-07-692707","elsevierAuthor":"Auberger P.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"57","altmetricAuthors":["Patrick Auberger","Alexandre Puissant"],"twitterCount":7,"altmetricId":16094895},{"title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","googleId":"Vk8iu0oWM4gJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/9/1095/36554","googleCitationCount":78,"googleAuthor":"","doi":"10.1182/blood-2016-09-692541","elsevierAuthor":"Lunning M.","publicationName":"Blood","elsevierCoverDate":"2017-03-02","elsevierCoverDisplayDate":"2 March 2017","elsevierCitationCount":"48","altmetricAuthors":["Matthew A. Lunning","Julie M. Vose"],"twitterCount":29,"altmetricId":15722683},{"title":"Long term follow-up of the PRIMA study: half of patients receiving rituximab maintenance remain progression free at 10 years","googleId":"NMZxwu42tR4J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/486/72473","googleCitationCount":55,"googleAuthor":"GA Salles","doi":"10.1182/blood.V130.Suppl_1.486.486","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Safety and efficacy of B-cell maturation antigen (BCMA)-specific chimeric antigen receptor T cells (CART-BCMA) with cyclophosphamide conditioning for refractory …","googleId":"YOCxW7phMx4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/505/80932","googleCitationCount":58,"googleAuthor":"AL Garfall","doi":"10.1182/blood.V130.Suppl_1.505.505","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","googleId":"vmSQFnrYEZcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2475/37076","googleCitationCount":46,"googleAuthor":"CU Rank","doi":"10.1182/blood-2018-01-827949","elsevierAuthor":"Rank C.U.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"36","altmetricAuthors":["Cecilie Utke Rank","Nina Toft","Ruta Tuckuviene","Kathrine Grell","Ove Juul Nielsen","Thomas Leth Frandsen","Hanne Vibeke Hansen Marquart","Birgitte Klug Albertsen","Ulf Tedgård","Helene Hallböök","Ellen Ruud","Kirsten Brunsvig Jarvis","Petter Quist-Paulsen","Pasi Huttunen","Ulla Wartiovaara-Kautto","Ólafur Gísli Jónsson","Sonata Saulyte Trakymiene","Laimonas Griškevičius","Kadri Saks","Mari Punab","Kjeld Schmiegelow"],"twitterCount":9,"altmetricId":37692612},{"title":"High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis","googleId":"80vMapDqEMIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/8/1007/36950","googleCitationCount":58,"googleAuthor":"","doi":"10.1182/blood-2017-01-761718","elsevierAuthor":"Bonometti A.","publicationName":"Journal of Cutaneous Pathology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":["Matthias Papo","Eli L. Diamond","Fleur Cohen-Aubart","Jean-François Emile","Damien Roos-Weil","Nishant Gupta","Benjamin H. Durham","Neval Ozkaya","Ahmet Dogan","Gary A. Ulaner","Raajit Rampal","Jean-Emmanuel Kahn","Thomas Sené","Frédéric Charlotte","Baptiste Hervier","Caroline Besnard","Olivier A. Bernard","Catherine Settegrana","Nathalie Droin","Zofia Hélias-Rodzewicz","Zahir Amoura","Omar Abdel-Wahab","Julien Haroche"],"twitterCount":26,"altmetricId":21544935},{"title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","googleId":"MDX3-Jiby-8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1635/39368","googleCitationCount":41,"googleAuthor":"BS Hoppe","doi":"10.1182/blood-2018-03-837633","elsevierAuthor":"Moreno A.C.","publicationName":"Advances in Radiation Oncology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0","altmetricAuthors":["Bouthaina Shbib Dabaja","Bradford S. Hoppe","John P. Plastaras","Wayne Newhauser","Katerina Rosolova","Stella Flampouri","Radhe Mohan","N. George Mikhaeel","Youlia Kirova","Lena Specht","Joachim Yahalom"],"twitterCount":33,"altmetricId":46526053},{"title":"Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1","googleId":"XJaFxJkewl8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2896/36277","googleCitationCount":58,"googleAuthor":"","doi":"10.1182/blood-2016-09-742825","elsevierAuthor":"Sugimoto M.A.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"0","altmetricAuthors":["Michelle A. Sugimoto","Ana Luíza C. Ribeiro","Bruno R. C. Costa","Juliana P. Vago","Kátia M. Lima","Fernanda S. Carneiro","Mylena Maira O. Ortiz","Graziele Letícia N. Lima","Aline A. F. Carmo","Renata M. Rocha","Denise A. Perez","Alessandra C. Reis","Vanessa Pinho","Lindsey A. Miles","Cristiana C. Garcia","Mauro M. Teixeira","Lirlândia P. Sousa"],"twitterCount":8,"altmetricId":20545000},{"title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","googleId":"c-5-i-YpsxIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/554/37074","googleCitationCount":62,"googleAuthor":"","doi":"10.1182/blood-2016-12-755496","elsevierAuthor":"Pedersen M.B.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"39","altmetricAuthors":["Martin Bjerregård Pedersen","Stephen Jacques Hamilton-Dutoit","Knud Bendix","Rhett P. Ketterling","Patrick P. Bedroske","Ivy M. Luoma","Christopher A. Sattler","Rebecca L. Boddicker","N. Nora Bennani","Peter Nørgaard","Michael Boe Møller","Torben Steiniche","Francesco d’Amore","Andrew L. Feldman"],"twitterCount":8,"altmetricId":20276367},{"title":"Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation","googleId":"LZgDcnOzfOAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/970/36366","googleCitationCount":73,"googleAuthor":"H Schrezenmeier","doi":"10.1182/blood-2016-08-732800","elsevierAuthor":"Harder M.","publicationName":"Blood","elsevierCoverDate":"2017-02-23","elsevierCoverDisplayDate":"23 February 2017","elsevierCitationCount":"60","altmetricAuthors":["Markus J. Harder","Nadine Kuhn","Hubert Schrezenmeier","Britta Höchsmann","Inge von Zabern","Christof Weinstock","Thomas Simmet","Daniel Ricklin","John D. Lambris","Arne Skerra","Markus Anliker","Christoph Q. Schmidt"],"twitterCount":15,"altmetricId":15106665},{"title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","googleId":"D7un5yyaE1MJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/417/38488","googleCitationCount":57,"googleAuthor":"","doi":"10.1182/blood-2017-07-797019","elsevierAuthor":"Aukema S.M.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"45","altmetricAuthors":["Sietse M. Aukema","Eva Hoster","Andreas Rosenwald","Danielle Canoni","Marie-Hélène Delfau-Larue","Grzegorz Rymkiewicz","Christoph Thorns","Sylvia Hartmann","Hanneke Kluin-Nelemans","Olivier Hermine","Martin Dreyling","Wolfram Klapper"],"twitterCount":19,"altmetricId":29875378},{"title":"A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations","googleId":"axw4OM55jtwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/426/38537","googleCitationCount":48,"googleAuthor":"","doi":"10.1182/blood-2017-05-786657","elsevierAuthor":"Yamaura T.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"37","altmetricAuthors":["Takeshi Yamaura","Toshiyuki Nakatani","Ken Uda","Hayato Ogura","Wigyon Shin","Naoya Kurokawa","Koichi Saito","Norie Fujikawa","Tomomi Date","Masaru Takasaki","Daisuke Terada","Atsushi Hirai","Akimi Akashi","Fangli Chen","Yoshiya Adachi","Yuichi Ishikawa","Fumihiko Hayakawa","Shinji Hagiwara","Tomoki Naoe","Hitoshi Kiyoi"],"twitterCount":24,"altmetricId":29905522},{"title":"Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies","googleId":"XRf1Tk9ogcwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1438/105719","googleCitationCount":44,"googleAuthor":"CE Allen","doi":"10.1182/blood-2018-01-828277","elsevierAuthor":"Allen C.E.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"33","altmetricAuthors":["Carl E. Allen","Rebecca Marsh","Peter Dawson","Catherine M. Bollard","Shalini Shenoy","Philip Roehrs","Rabi Hanna","Lauri Burroughs","Leslie Kean","Julie-An Talano","Kirk R. Schultz","Sung-Yun Pai","K. Scott Baker","Jeffrey R. Andolina","Elizabeth O. Stenger","James Connelly","Alyssa Ramirez","Christopher Bryant","Mary Eapen","Michael A. Pulsipher"],"twitterCount":34,"altmetricId":44901175},{"title":"Radius: a phase 2 randomized trial investigating standard of care±midostaurin after allogeneic stem cell transplant in FLT3-ITD-mutated AML","googleId":"qm_5oLStC1sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/662/266179","googleCitationCount":41,"googleAuthor":"MM Patnaik","doi":"10.1182/blood-2018-99-113582","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Updated analysis of a phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B-cell maturation antigen, in …","googleId":"wUlaEowlA1IJ","googleLink":"https://cms.cws.net/content/beta.myelomasociety.org/files/2018ash/Wan-Hong%20Zhao%20-%20ASH%20presentation%20_Abstract%20955.pdf","googleCitationCount":40,"googleAuthor":""},{"title":"T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency","googleId":"WQc23I5TiIUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2362/107711","googleCitationCount":39,"googleAuthor":"I Brigida","doi":"10.1182/blood-2018-07-863431","elsevierAuthor":"Brigida I.","publicationName":"Blood","elsevierCoverDate":"2018-11-29","elsevierCoverDisplayDate":"29 November 2018","elsevierCitationCount":"26","altmetricAuthors":["Immacolata Brigida","Matteo Zoccolillo","Maria Pia Cicalese","Laurène Pfajfer","Federica Barzaghi","Serena Scala","Carmen Oleaga-Quintas","Jesus A. Álvarez-Álvarez","Lucia Sereni","Stefania Giannelli","Claudia Sartirana","Francesca Dionisio","Luca Pavesi","Marta Benavides-Nieto","Luca Basso-Ricci","Paola Capasso","Benedetta Mazzi","Jeremie Rosain","Nufar Marcus","Yu Nee Lee","Raz Somech","Massimo Degano","Giuseppe Raiola","Roberta Caorsi","Paolo Picco","Marcela Moncada Velez","Joelle Khourieh","Andrés Augusto Arias","Aziz Bousfiha","Thomas Issekutz","Andrew Issekutz","Bertrand Boisson","Kerry Dobbs","Anna Villa","Angelo Lombardo","Benedicte Neven","Despina Moshous","Jean-Laurent Casanova","José Luis Franco","Luigi D. Notarangelo","Cristina Scielzo","Stefano Volpi","Loïc Dupré","Jacinta Bustamante","Marco Gattorno","Alessandro Aiuti"],"twitterCount":8,"altmetricId":48933547},{"title":"Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade","googleId":"HRF1IfVXkFEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1675/39370","googleCitationCount":44,"googleAuthor":"SA Minnie","doi":"10.1182/blood-2018-01-825240","elsevierAuthor":"Minnie S.A.","publicationName":"Blood","elsevierCoverDate":"2019-11-21","elsevierCoverDisplayDate":"21 November 2019","elsevierCitationCount":"0","altmetricAuthors":["Simone A. Minnie","Rachel D. Kuns","Kate H. Gartlan","Ping Zhang","Andrew N. Wilkinson","Luke Samson","Camille Guillerey","Christian Engwerda","Kelli P. A. MacDonald","Mark J. Smyth","Kate A. Markey","Slavica Vuckovic","Geoffrey R. Hill"],"twitterCount":45,"altmetricId":47267765},{"title":"Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?","googleId":"VkMPmnC5LhsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/351/103892","googleCitationCount":42,"googleAuthor":"","doi":"10.1182/blood-2018-02-778530","elsevierAuthor":"Boissel N.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"26","altmetricAuthors":["Nicolas Boissel","André Baruchel"],"twitterCount":44,"altmetricId":45578200},{"title":"The potential role of γδ T cells after allogeneic HCT for leukemia","googleId":"JnYPV9ccOSQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1063/36406","googleCitationCount":47,"googleAuthor":"K Schilbach","doi":"10.1182/blood-2017-08-752162","elsevierAuthor":"Handgretinger R.","publicationName":"Blood","elsevierCoverDate":"2018-03-08","elsevierCoverDisplayDate":"8 March 2018","elsevierCitationCount":"35","altmetricAuthors":["Rupert Handgretinger","Karin Schilbach"],"twitterCount":17,"altmetricId":32130904},{"title":"Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia","googleId":"xbzOUeYRTgYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/289/38308","googleCitationCount":49,"googleAuthor":"A Petit","doi":"10.1182/blood-2017-04-778829","elsevierAuthor":"Petit A.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"40","altmetricAuthors":["Arnaud Petit","Amélie Trinquand","Sylvie Chevret","Paola Ballerini","Jean-Michel Cayuela","Nathalie Grardel","Aurore Touzart","Benoit Brethon","Hélène Lapillonne","Claudine Schmitt","Sandrine Thouvenin","Gerard Michel","Claude Preudhomme","Jean Soulier","Judith Landman-Parker","Guy Leverger","Elizabeth Macintyre","André Baruchel","Vahid Asnafi"],"twitterCount":21,"altmetricId":27710354},{"title":"How I treat breast implant–associated anaplastic large cell lymphoma","googleId":"YoSwGwY-R_gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1889/39611","googleCitationCount":37,"googleAuthor":"MW Clemens","doi":"10.1182/blood-2018-03-785972","elsevierAuthor":"Mehta-Shah N.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"28","altmetricAuthors":["Neha Mehta-Shah","Mark W. Clemens","Steven M. Horwitz"],"twitterCount":43,"altmetricId":48248197},{"title":"T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10","googleId":"zCCpPKwPzBIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/18/2557/36263","googleCitationCount":56,"googleAuthor":"R Kapur","doi":"10.1182/blood-2016-12-758185","elsevierAuthor":"Kapur R.","publicationName":"Blood","elsevierCoverDate":"2017-05-04","elsevierCoverDisplayDate":"4 May 2017","elsevierCitationCount":"47","altmetricAuthors":["Rick Kapur","Michael Kim","Rukhsana Aslam","Mark J. McVey","Arata Tabuchi","Alice Luo","Jonathan Liu","Yuan Li","Shanjeevan Shanmugabhavananthan","Edwin R. Speck","Anne Zufferey","George Yousef","Haibo Zhang","Matthew T. Rondina","Andrew S. Weyrich","Leendert Porcelijn","Wolfgang M. Kuebler","Arthur S. Slutsky","John W. Semple"],"twitterCount":10,"altmetricId":16514014},{"title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","googleId":"6r6DczkUJ-8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/408/38500","googleCitationCount":50,"googleAuthor":"CA Miller","doi":"10.1182/blood-2017-08-801985","elsevierAuthor":"Xia J.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"36","altmetricAuthors":["Jun Xia","Christopher A. Miller","Jack Baty","Amrita Ramesh","Matthew R. M. Jotte","Robert S. Fulton","Tiphanie P. Vogel","Megan A. Cooper","Kelly J. Walkovich","Vahagn Makaryan","Audrey A. Bolyard","Mary C. Dinauer","David B. Wilson","Adrianna Vlachos","Kasiani C. Myers","Robert J. Rothbaum","Alison A. Bertuch","David C. Dale","Akiko Shimamura","Laurence A. Boxer","Daniel C. Link"],"twitterCount":31,"altmetricId":28292021},{"title":"Autologous stem cell transplantation versus bortezomib-melphalan-prednisone for newly diagnosed multiple myeloma: second interim analysis of the phase 3 …","googleId":"0xf3rnUIDokJ","googleLink":"https://research.vumc.nl/en/publications/autologous-stem-cell-transplantation-versus-bortezomib-melphalan-","googleCitationCount":50,"googleAuthor":"M Cavo"},{"title":"Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition","googleId":"CFyBTvztbIAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1639/36848","googleCitationCount":44,"googleAuthor":"P Gallipoli","doi":"10.1182/blood-2017-12-820035","elsevierAuthor":"Gallipoli P.","publicationName":"Blood","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"29","altmetricAuthors":["Paolo Gallipoli","George Giotopoulos","Konstantinos Tzelepis","Ana S. H. Costa","Shabana Vohra","Paula Medina-Perez","Faisal Basheer","Ludovica Marando","Lorena Di Lisio","Joao M. L. Dias","Haiyang Yun","Daniel Sasca","Sarah J. Horton","George Vassiliou","Christian Frezza","Brian J. P. Huntly"],"twitterCount":15,"altmetricId":33550784},{"title":"Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond–like syndrome","googleId":"CcIfZAPzLKYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1318/39626","googleCitationCount":40,"googleAuthor":"","doi":"10.1182/blood-2017-12-820308","elsevierAuthor":"Bellanné-Chantelot C.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"28","altmetricAuthors":["Christine Bellanné-Chantelot","Barbara Schmaltz-Panneau","Caroline Marty","Odile Fenneteau","Isabelle Callebaut","Séverine Clauin","Aurélie Docet","Gandhi-Laurent Damaj","Thierry Leblanc","Isabelle Pellier","Cécile Stoven","Sylvie Souquere","Iléana Antony-Debré","Blandine Beaupain","Nathalie Aladjidi","Vincent Barlogis","Frédéric Bauduer","Philippe Bensaid","Odile Boespflug-Tanguy","Claire Berger","Yves Bertrand","Liana Carausu","Claire Fieschi","Claire Galambrun","Aline Schmidt","Hubert Journel","Françoise Mazingue","Brigitte Nelken","Thuan Chong Quah","Eric Oksenhendler","Marie Ouachée","Marlène Pasquet","Véronique Saada","Felipe Suarez","Gérard Pierron","William Vainchenker","Isabelle Plo","Jean Donadieu"],"twitterCount":16,"altmetricId":43908301},{"title":"Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse","googleId":"Jb-ASGzxXyoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/15/1604/39340","googleCitationCount":38,"googleAuthor":"TH Kim","doi":"10.1182/blood-2018-04-848028","elsevierAuthor":"Kim T.H.","publicationName":"Blood","elsevierCoverDate":"2018-10-11","elsevierCoverDisplayDate":"11 October 2018","elsevierCitationCount":"29","altmetricAuthors":["TaeHyung Kim","Joon Ho Moon","Jae-Sook Ahn","Yeo-Kyeoung Kim","Seung-Shin Lee","Seo-Yeon Ahn","Sung-Hoon Jung","Deok-Hwan Yang","Je-Jung Lee","Seung Hyun Choi","Ja-yeon Lee","Marc S. Tyndel","Myung-Geun Shin","Yoo Jin Lee","Sang Kyun Sohn","Seong-Kyu Park","Zhaolei Zhang","Hyeoung-Joon Kim","Dennis Dong Hwan Kim"],"twitterCount":31,"altmetricId":47873604},{"title":"Phase 1 study of CD19/CD22 bispecific chimeric antigen receptor (CAR) therapy in children and young adults with B cell acute lymphoblastic leukemia (ALL)","googleId":"LueD7KVBV28J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/898/266319","googleCitationCount":39,"googleAuthor":"","doi":"10.1182/blood-2018-99-117445","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies","googleId":"gFLEjuyGWg0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1654/36819","googleCitationCount":43,"googleAuthor":"C Steidl","doi":"10.1182/blood-2017-09-772632","elsevierAuthor":"Mottok A.","publicationName":"Blood","elsevierCoverDate":"2018-04-12","elsevierCoverDisplayDate":"12 April 2018","elsevierCitationCount":"27","altmetricAuthors":["Anja Mottok","Christian Steidl"],"twitterCount":43,"altmetricId":33873060},{"title":"Eltrombopag: a powerful chelator of cellular or extracellular iron (III) alone or combined with a second chelator","googleId":"t3ApJfKFFhAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/17/1923/36515","googleCitationCount":49,"googleAuthor":"E Vlachodimitropoulou","doi":"10.1182/blood-2016-10-740241","elsevierAuthor":"Vlachodimitropoulou E.","publicationName":"Blood","elsevierCoverDate":"2017-10-26","elsevierCoverDisplayDate":"26 October 2017","elsevierCitationCount":"42","altmetricAuthors":["Evangelia Vlachodimitropoulou","Yu-Lin Chen","Maciej Garbowski","Pimpisid Koonyosying","Bethan Psaila","Martha Sola-Visner","Nichola Cooper","Robert Hider","John Porter"],"twitterCount":22,"altmetricId":24802119},{"title":"How I treat first relapse of myeloma","googleId":"cCeQ-5AebrQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/8/963/36946","googleCitationCount":50,"googleAuthor":"","doi":"10.1182/blood-2017-03-726703","elsevierAuthor":"Harousseau J.","publicationName":"Blood","elsevierCoverDate":"2017-08-24","elsevierCoverDisplayDate":"24 August 2017","elsevierCitationCount":"38","altmetricAuthors":["Jean Luc Harousseau","Michel Attal"],"twitterCount":55,"altmetricId":21538452},{"title":"Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project","googleId":"NTdGreE-aDUJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2368/35949","googleCitationCount":54,"googleAuthor":"JM Soucie","doi":"10.1182/blood-2016-02-683169","elsevierAuthor":"Manco-Johnson M.J.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"58","altmetricAuthors":["Marilyn J. Manco-Johnson","J. Michael Soucie","Joan Cox Gill"],"twitterCount":15,"altmetricId":17154774},{"title":"Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells","googleId":"VtdI_FGO4_IJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/2/176/36706","googleCitationCount":56,"googleAuthor":"","doi":"10.1182/blood-2016-12-757377","elsevierAuthor":"Durham B.H.","publicationName":"Blood","elsevierCoverDate":"2017-07-13","elsevierCoverDisplayDate":"13 July 2017","elsevierCitationCount":"46","altmetricAuthors":["Benjamin H. Durham","Damien Roos-Weil","Claude Baillou","Fleur Cohen-Aubart","Akihide Yoshimi","Makoto Miyara","Matthias Papo","Zofia Hélias-Rodzewicz","Nathalie Terrones","Neval Ozkaya","Ahmet Dogan","Raajit Rampal","Fanny Urbain","Lucie Le Fèvre","Eli L. Diamond","Christopher Y. Park","Thomas Papo","Frédéric Charlotte","Guy Gorochov","Valérie Taly","Olivier A. Bernard","Zahir Amoura","Omar Abdel-Wahab","François M. Lemoine","Julien Haroche","Jean-François Emile"],"twitterCount":6,"altmetricId":20753984},{"title":"Apoptosis in megakaryocytes and platelets: the life and death of a lineage","googleId":"BFzxWxTmmmQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/6/605/39214","googleCitationCount":47,"googleAuthor":"K McArthur","doi":"10.1182/blood-2017-11-742684","elsevierAuthor":"McArthur K.","publicationName":"Blood","elsevierCoverDate":"2018-02-08","elsevierCoverDisplayDate":"8 February 2018","elsevierCitationCount":"31","altmetricAuthors":["Kate McArthur","Stephane Chappaz","Benjamin T. Kile"],"twitterCount":26,"altmetricId":32897946},{"title":"Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial","googleId":"8euDDpv54w8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/537/37109","googleCitationCount":53,"googleAuthor":"","doi":"10.1182/blood-2017-04-778175","elsevierAuthor":"Berentsen S.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"38","altmetricAuthors":["Sigbjørn Berentsen","Ulla Randen","Markku Oksman","Henrik Birgens","Tor Henrik Anderson Tvedt","Jakob Dalgaard","Eivind Galteland","Einar Haukås","Robert Brudevold","Jon Hjalmar Sørbø","Inger Anne Næss","Agnieszka Malecka","Geir E. Tjønnfjord"],"twitterCount":30,"altmetricId":20394335},{"title":"Immunogenicity of emicizumab in people with hemophilia A (PwHA): results from the HAVEN 1-4 studies","googleId":"DRGcpMg2eWwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/633/266374","googleCitationCount":37,"googleAuthor":"I Paz-Priel","doi":"10.1182/blood-2018-99-118492","elsevierAuthor":"Pierre F.","publicationName":"Swiss Medical Weekly","elsevierCoverDate":"2020-12-18","elsevierCoverDisplayDate":"18 December 2020","elsevierCitationCount":"0","altmetricAuthors":["Ido Paz-Priel","Tiffany Chang","Elina Asikanius","Sammy Chebon","Thomas Emrich","Elena Fernandez","Peter Kuebler","Christophe Schmitt"],"twitterCount":0,"altmetricId":100032991},{"title":"Biomarkers for posttransplantation outcomes","googleId":"JtXEAoXEfkMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2193/6540","googleCitationCount":41,"googleAuthor":"S Paczesny","doi":"10.1182/blood-2018-02-791509","elsevierAuthor":"Paczesny S.","publicationName":"Blood","elsevierCoverDate":"2018-05-17","elsevierCoverDisplayDate":"17 May 2018","elsevierCitationCount":"25","altmetricAuthors":["Sophie Paczesny"],"twitterCount":40,"altmetricId":35767976},{"title":"Preliminary data on safety, cellular kinetics and anti-leukemic activity of UCART19, an allogeneic anti-CD19 CAR T-cell product, in a pool of adult and pediatric …","googleId":"LhU-9iwzajgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/896/266300","googleCitationCount":45,"googleAuthor":"R Benjamin","doi":"10.1182/blood-2018-99-111356","elsevierCitationCount":0,"altmetricAuthors":["Reuben Benjamin","Charlotte Graham","Deborah Yallop","Agnieszka Jozwik","Oana Ciocarlie","Nitin Jain","Elias J. Jabbour","Marcela V. Maus","Matthiew Frigault","Nicolas Boissel","Jerome Larghero","Andre Baruchel","Mohamad Mohty","Barbara De Moerloose","Adrian Bloor","Noelle V. Frey","Amina Zinaï","Svetlana Balandraud","Anne Philippe","Sylvain Fouliard","Ludiane Gauthier","Jeanne Pauly","Cyril Konto","Candy Bermingham","Paul Veys","Waseem Qasim"],"twitterCount":0,"altmetricId":52535214},{"title":"Stem and progenitor cell alterations in myelodysplastic syndromes","googleId":"IxMoXxtdlhkJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1586/36080","googleCitationCount":52,"googleAuthor":"B Will","doi":"10.1182/blood-2016-10-696062","elsevierAuthor":"Shastri A.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"37","altmetricAuthors":["Aditi Shastri","Britta Will","Ulrich Steidl","Amit Verma"],"twitterCount":18,"altmetricId":16226328},{"title":"Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans","googleId":"8XCu70CZVPQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2605/37238","googleCitationCount":41,"googleAuthor":"H Deckmyn","doi":"10.1182/blood-2017-09-808808","elsevierAuthor":"Busygina K.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"34","altmetricAuthors":["Kristina Busygina","Janina Jamasbi","Till Seiler","Hans Deckmyn","Christian Weber","Richard Brandl","Reinhard Lorenz","Wolfgang Siess"],"twitterCount":38,"altmetricId":34652151},{"title":"Tonic B-cell receptor signaling in diffuse large B-cell lymphoma","googleId":"wLxBSwI2ccIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/8/995/36968","googleCitationCount":50,"googleAuthor":"O Havranek","doi":"10.1182/blood-2016-10-747303","elsevierAuthor":"Havranek O.","publicationName":"Blood","elsevierCoverDate":"2017-08-24","elsevierCoverDisplayDate":"24 August 2017","elsevierCitationCount":"34","altmetricAuthors":["Ondrej Havranek","Jingda Xu","Stefan Köhrer","Zhiqiang Wang","Lisa Becker","Justin M. Comer","Jared Henderson","Wencai Ma","John Man Chun Ma","Jason R. Westin","Dipanjan Ghosh","Nicholas Shinners","Luhong Sun","Allen F. Yi","Anusha R. Karri","Jan A. Burger","Tomasz Zal","R. Eric Davis"],"twitterCount":23,"altmetricId":21327528},{"title":"Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?","googleId":"sUcWlSOlHskJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120337691","googleCitationCount":66,"googleAuthor":"","doi":"10.1182/blood-2016-08-731885","elsevierAuthor":"Rosenblatt J.","publicationName":"Blood","elsevierCoverDate":"2017-01-19","elsevierCoverDisplayDate":"19 January 2017","elsevierCitationCount":"50","altmetricAuthors":["Jacalyn Rosenblatt","David Avigan"],"twitterCount":60,"altmetricId":14478908},{"title":"Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p. Q575E)","googleId":"LZSsqurMUgEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/12/1430/36502","googleCitationCount":54,"googleAuthor":"J Park","doi":"10.1182/blood-2017-02-768234","elsevierAuthor":"Park J.","publicationName":"Blood","elsevierCoverDate":"2017-09-21","elsevierCoverDisplayDate":"21 September 2017","elsevierCitationCount":"42","altmetricAuthors":["Joonhee Park","Jingyi Yang","Alexander T. Wenzel","Akshaya Ramachandran","Wung J. Lee","Jay C. Daniels","Juhyun Kim","Estela Martinez-Escala","Nduka Amankulor","Barbara Pro","Joan Guitart","Marc L. Mendillo","Jeffrey N. Savas","Titus J. Boggon","Jaehyuk Choi"],"twitterCount":16,"altmetricId":21858268},{"title":"PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke","googleId":"KQF_AwPlNNoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1163/36458","googleCitationCount":46,"googleAuthor":"RK Sinha","doi":"10.1182/blood-2017-10-810895","elsevierAuthor":"Sinha R.","publicationName":"Blood","elsevierCoverDate":"2018-03-15","elsevierCoverDisplayDate":"15 March 2018","elsevierCitationCount":"35","altmetricAuthors":["Ranjeet K. Sinha","Yaoming Wang","Zhen Zhao","Xiao Xu","Laurent Burnier","Naveen Gupta","José A. Fernández","Greg Martin","Sergey Kupriyanov","Laurent O. Mosnier","Berislav V. Zlokovic","John H. Griffin"],"twitterCount":4,"altmetricId":34417349},{"title":"First report of the Gimema LAL1811 phase II prospective study of the combination of steroids with ponatinib as frontline therapy of elderly or unfit patients with …","googleId":"AJI9QA7SsC4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/99/83577","googleCitationCount":49,"googleAuthor":"G Martinelli","doi":"10.1182/blood.V130.Suppl_1.99.99","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Anti-CD37 chimeric antigen receptor T cells are active against B-and T-cell lymphomas","googleId":"FTWQMkKA28YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1495/39349","googleCitationCount":35,"googleAuthor":"I Scarfò","doi":"10.1182/blood-2018-04-842708","elsevierAuthor":"Scarfò I.","publicationName":"Blood","elsevierCoverDate":"2018-12-06","elsevierCoverDisplayDate":"6 December 2018","elsevierCitationCount":"0","altmetricAuthors":["Irene Scarfò","Maria Ormhøj","Matthew J. Frigault","Ana P. Castano","Selena Lorrey","Amanda A. Bouffard","Alexandria van Scoyk","Scott J. Rodig","Alexandra J. Shay","Jon C. Aster","Frederic I. Preffer","David M. Weinstock","Marcela V. Maus"],"twitterCount":63,"altmetricId":46301250},{"title":"The interplay of leukemia cells and the bone marrow microenvironment","googleId":"SUsYnku1d8QJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1507/36671","googleCitationCount":39,"googleAuthor":"D Duarte","doi":"10.1182/blood-2017-12-784132","elsevierAuthor":"Duarte D.","publicationName":"Blood","elsevierCoverDate":"2018-04-05","elsevierCoverDisplayDate":"5 April 2018","elsevierCitationCount":"30","altmetricAuthors":["Delfim Duarte","Edwin D. Hawkins","Cristina Lo Celso"],"twitterCount":18,"altmetricId":33758937},{"title":"Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil","googleId":"rCEeOQ3YKg0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/9/39263","googleCitationCount":39,"googleAuthor":"C Herbaux","doi":"10.1182/blood-2018-02-811174","elsevierAuthor":"Herbaux C.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"28","altmetricAuthors":["Charles Herbaux","Reid Merryman","Steven Devine","Philippe Armand","Roch Houot","Franck Morschhauser","Bradley Haverkos"],"twitterCount":79,"altmetricId":40636330},{"title":"S100A9 induces differentiation of acute myeloid leukemia cells through TLR4","googleId":"ogZ9q2WaEPEJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/14/1980/35876","googleCitationCount":50,"googleAuthor":"","doi":"10.1182/blood-2016-09-738005","elsevierAuthor":"Laouedj M.","publicationName":"Blood","elsevierCoverDate":"2017-04-06","elsevierCoverDisplayDate":"6 April 2017","elsevierCitationCount":"37","altmetricAuthors":[],"twitterCount":0},{"title":"How I Treat Flt3-Mutated Aml","googleId":"EFJ0_p9XiQUJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/565/36161","googleCitationCount":64,"googleAuthor":"KW Pratz","doi":"10.1182/blood-2016-09-693648","elsevierAuthor":"Pratz K.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"44","altmetricAuthors":["Keith W. Pratz","Mark Levis"],"twitterCount":51,"altmetricId":13876009},{"title":"Emicizumab prophylaxis provides flexible and effective bleed control in children with hemophilia Α with inhibitors: results from the HAVEN 2 study","googleId":"lIpoBCsboeUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/632/266365","googleCitationCount":40,"googleAuthor":"RF Sidonio","doi":"10.1182/blood-2018-99-118153","elsevierAuthor":"Davydkin I.L.","publicationName":"Pediatriya - Zhurnal im G.N. Speranskogo","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July-August 2020","elsevierCitationCount":"0","altmetricAuthors":["Guy Young","Ri Liesner","Robert F. Sidonio","Johannes Oldenburg","Victor Jimenez-Yuste","Johnny Mahlangu","Rebecca Kruse-Jarres","Michael Wang","Tiffany Chang","Marianne Uguen","Michelle Doral","Christophe Schmitt","Gallia G. Levy","Midori Shima","Maria Elisa Mancuso"],"twitterCount":0,"altmetricId":57496320},{"title":"First-in-human CLL1-CD33 compound CAR T cell therapy induces complete remission in patients with refractory acute myeloid leukemia: update on phase 1 clinical …","googleId":"WnRGjeK8-NQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/901/266370","googleCitationCount":36,"googleAuthor":"K Chen","doi":"10.1182/blood-2018-99-110579","elsevierAuthor":"Agrawal V.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial","googleId":"23gBj5UpFs8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/10/1247/36360","googleCitationCount":50,"googleAuthor":"TH Hamza","doi":"10.1182/blood-2017-01-757930","elsevierAuthor":"Uhl L.","publicationName":"Blood","elsevierCoverDate":"2017-09-07","elsevierCoverDisplayDate":"7 September 2017","elsevierCitationCount":"35","altmetricAuthors":["Lynne Uhl","Susan F. Assmann","Taye H. Hamza","Ryan W. Harrison","Terry Gernsheimer","Sherrill J. Slichter"],"twitterCount":17,"altmetricId":23772307},{"title":"Cooperative PSGL-1 and CXCR2 signaling in neutrophils promotes deep vein thrombosis in mice","googleId":"8FYVg7Szz9wJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1426/105722","googleCitationCount":34,"googleAuthor":"T Yago","doi":"10.1182/blood-2018-05-850859","elsevierAuthor":"Yago T.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"28","altmetricAuthors":["Tadayuki Yago","Zhenghui Liu","Jasimuddin Ahamed","Rodger P. McEver"],"twitterCount":13,"altmetricId":45971772},{"title":"Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged≥ 60 years with HL","googleId":"HLvbvG3spycJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/26/2829/36593","googleCitationCount":47,"googleAuthor":"","doi":"10.1182/blood-2017-06-787200","elsevierAuthor":"Friedberg J.W.","publicationName":"Blood","elsevierCoverDate":"2017-12-28","elsevierCoverDisplayDate":"28 December 2017","elsevierCitationCount":"45","altmetricAuthors":["Jonathan W. Friedberg","Andres Forero-Torres","Rodolfo E. Bordoni","Vivian J. M. Cline","Dipti Patel Donnelly","Patrick J. Flynn","Gregg Olsen","Robert Chen","Abraham Fong","Yinghui Wang","Christopher A. Yasenchak"],"twitterCount":57,"altmetricId":27577164},{"title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","googleId":"jKepa1BxbtIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1386/105720","googleCitationCount":40,"googleAuthor":"RA Luchtel","doi":"10.1182/blood-2018-03-838524","elsevierAuthor":"Luchtel R.A.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"28","altmetricAuthors":["Rebecca A. Luchtel","Surendra Dasari","Naoki Oishi","Martin Bjerregård Pedersen","Guangzhen Hu","Karen L. Rech","Rhett P. Ketterling","Jagmohan Sidhu","Xueju Wang","Ryohei Katoh","Ahmet Dogan","N. Sertac Kip","Julie M. Cunningham","Zhifu Sun","Saurabh Baheti","Julie C. Porcher","Jonathan W. Said","Liuyan Jiang","Stephen Jacques Hamilton-Dutoit","Michael Boe Møller","Peter Nørgaard","N. Nora Bennani","Wee-Joo Chng","Gaofeng Huang","Brian K. Link","Fabio Facchetti","James R. Cerhan","Francesco d’Amore","Stephen M. Ansell","Andrew L. Feldman"],"twitterCount":15,"altmetricId":46632769},{"title":"α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","googleId":"yY0gxQ_mWssJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/12/1372/36620","googleCitationCount":40,"googleAuthor":"RJ Soiffer","doi":"10.1182/blood-2017-11-815746","elsevierAuthor":"Magenau J.M.","publicationName":"Blood","elsevierCoverDate":"2018-03-22","elsevierCoverDisplayDate":"22 March 2018","elsevierCitationCount":"35","altmetricAuthors":["John M. Magenau","Steven C. Goldstein","Dan Peltier","Robert J. Soiffer","Thomas Braun","Attaphol Pawarode","Mary M. Riwes","Maggi Kennel","Joseph H. Antin","Corey S. Cutler","Vincent T. Ho","Edwin P. Alyea","Brian L. Parkin","Gregory A. Yanik","Sung Won Choi","Eli C. Lewis","Charles A. Dinarello","John Koreth","Pavan Reddy"],"twitterCount":28,"altmetricId":32863672},{"title":"A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era","googleId":"FzDOzKm_zY0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/521/39398","googleCitationCount":36,"googleAuthor":"C Nichols","doi":"10.1182/blood-2018-02-830992","elsevierAuthor":"Robinson H.","publicationName":"Blood","elsevierCoverDate":"2018-08-02","elsevierCoverDisplayDate":"2 August 2018","elsevierCitationCount":"26","altmetricAuthors":["Hannah R. Robinson","Junpeng Qi","Erika M. Cook","Cydney Nichols","Eman L. Dadashian","Chingiz Underbayev","Sarah E. M. Herman","Nakhle S. Saba","Keyvan Keyvanfar","Clare Sun","Inhye E. Ahn","Sivasubramanian Baskar","Christoph Rader","Adrian Wiestner"],"twitterCount":21,"altmetricId":40915727},{"title":"Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with pembrolizumab in patients with relapsed or …","googleId":"vcgao4TmPVoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4198/275591","googleCitationCount":39,"googleAuthor":"J Svoboda","doi":"10.1182/blood-2018-99-119502","elsevierAuthor":"Hull C.M.","publicationName":"Expert Opinion on Biological Therapy","elsevierCoverDate":"2019-08-03","elsevierCoverDisplayDate":"3 August 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0},{"title":"Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies","googleId":"77s8QrXEtjoJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/1/88/35825","googleCitationCount":65,"googleAuthor":"","doi":"10.1182/blood-2016-08-731240","elsevierAuthor":"Deng C.","publicationName":"Blood","elsevierCoverDate":"2017-01-05","elsevierCoverDisplayDate":"5 January 2017","elsevierCitationCount":"54","altmetricAuthors":["Changchun Deng","Mark R. Lipstein","Luigi Scotto","Xavier O. Jirau Serrano","Michael A. Mangone","Shirong Li","Jeremie Vendome","Yun Hao","Xiaoming Xu","Shi-Xian Deng","Ronald B. Realubit","Nicholas P. Tatonetti","Charles Karan","Suzanne Lentzsch","David A. Fruman","Barry Honig","Donald W. Landry","Owen A. O’Connor"],"twitterCount":21,"altmetricId":13075072},{"title":"Posttransplant chimeric antigen receptor therapy","googleId":"HASw_Ici6q0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1045/36415","googleCitationCount":42,"googleAuthor":"","doi":"10.1182/blood-2017-08-752121","elsevierAuthor":"Smith M.","publicationName":"Blood","elsevierCoverDate":"2018-03-08","elsevierCoverDisplayDate":"8 March 2018","elsevierCitationCount":"25","altmetricAuthors":["Melody Smith","Johannes Zakrzewski","Scott James","Michel Sadelain"],"twitterCount":62,"altmetricId":32217550},{"title":"Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia","googleId":"a94fA7EiiaYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/2/205/36724","googleCitationCount":48,"googleAuthor":"O Niss","doi":"10.1182/blood-2017-02-767624","elsevierAuthor":"Niss O.","publicationName":"Blood","elsevierCoverDate":"2017-07-13","elsevierCoverDisplayDate":"13 July 2017","elsevierCitationCount":"38","altmetricAuthors":["Omar Niss","Robert Fleck","Fowe Makue","Tarek Alsaied","Payal Desai","Jeffrey A. Towbin","Punam Malik","Michael D. Taylor","Charles T. Quinn"],"twitterCount":7,"altmetricId":21907360},{"title":"High-throughput sequencing for noninvasive disease detection in hematologic malignancies","googleId":"-hnzR2hz-dQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/440/37099","googleCitationCount":47,"googleAuthor":"F Scherer","doi":"10.1182/blood-2017-03-735639","elsevierAuthor":"Scherer F.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"29","altmetricAuthors":["Florian Scherer","David M. Kurtz","Maximilian Diehn","Ash A. Alizadeh"],"twitterCount":22,"altmetricId":20953285},{"title":"Phase I experience with a bi-specific CAR targeting CD19 and CD22 in adults with B-cell malignancies","googleId":"Z31dG_pwEJsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/490/262047","googleCitationCount":35,"googleAuthor":"B Sahaf","doi":"10.1182/blood-2018-99-110142","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"None of the above: thrombotic microangiopathy beyond TTP and HUS","googleId":"5fWajFIINL4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120333577","googleCitationCount":51,"googleAuthor":"S Vasu","doi":"10.1182/blood-2016-11-743104","elsevierAuthor":"Masias C.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"37","altmetricAuthors":["Camila Masias","Sumithira Vasu","Spero R. Cataland"],"twitterCount":33,"altmetricId":19149394},{"title":"Tandom autologous transplantation and combined infusion of CD19 and Bcma-specific chimeric antigen receptor T cells for high risk MM: initial safety and efficacy …","googleId":"cTfz8bFAgCEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1009/262598","googleCitationCount":37,"googleAuthor":"","doi":"10.1182/blood-2018-99-117964","elsevierCitationCount":0,"altmetricAuthors":["Xiaolan Shi","Lingzhi Yan","Jingjing Shang","Su Qu","Liqing Kang","Jin Zhou","Song Jin","Weiqin Yao","Ying Yao","Shuang Yan","Yong Liu","Guanghua Chen","Ziling Zhu","Huirong Chang","Depei Wu","Lei Yu","ChengCheng Fu"],"twitterCount":0,"altmetricId":55319143},{"title":"A phase II study of nivolumab or ipilimumab with or without azacitidine for patients with myelodysplastic syndrome (MDS)","googleId":"iEOltpzFr0UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/465/262217","googleCitationCount":34,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood-2018-99-119424","elsevierAuthor":"Garcia-Manero G.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"2","altmetricAuthors":["Guillermo Garcia-Manero","Koji Sasaki","Guillermo Montalban-Bravo","Naval G. Daver","Elias J. Jabbour","Yesid Alvarado","Courtney D. DiNardo","Farhad Ravandi","Gautam Borthakur","Prithviraj Bose","Naveen Pemmaraju","Kiran Naqvi","Jorge E. Cortes","Tapan M. Kadia","Marina Y. Konopleva","Simona Colla","Hui Yang","Caitlin R. Rausch","Yvonne Gasior","Carlos E. Bueso-Ramos","Rashmi Kanagal-Shamanna","Keyur P. Patel","Hagop M. Kantarjian"],"twitterCount":0,"altmetricId":67696351},{"title":"Azacitidine with or without eltrombopag for first-line treatment of intermediate-or high-risk MDS with thrombocytopenia","googleId":"ThykdeYlS1oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2629/39573","googleCitationCount":32,"googleAuthor":"M Dickinson","doi":"10.1182/blood-2018-06-855221","elsevierAuthor":"Dickinson M.","publicationName":"Blood","elsevierCoverDate":"2018-12-20","elsevierCoverDisplayDate":"20 December 2018","elsevierCitationCount":"26","altmetricAuthors":["Michael Dickinson","Honar Cherif","Pierre Fenaux","Moshe Mittelman","Amit Verma","Maria Socorro O. Portella","Paul Burgess","Pedro Marques Ramos","Jeea Choi","Uwe Platzbecker"],"twitterCount":89,"altmetricId":49489224},{"title":"B-cell receptor–mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma","googleId":"K1rTTR4joRUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1805/39520","googleCitationCount":33,"googleAuthor":"J Zhang","doi":"10.1182/blood-2018-03-841015","elsevierAuthor":"Li L.","publicationName":"Blood","elsevierCoverDate":"2018-10-25","elsevierCoverDisplayDate":"25 October 2018","elsevierCitationCount":"26","altmetricAuthors":["Li","Jun Zhang","Juan Chen","Zijun Y. Xu-Monette","Yi Miao","Min Xiao","Ken H. Young","Sa Wang","L. Jeffrey Medeiros","Michael Wang","Richard J. Ford","Lan V. Pham"],"twitterCount":8,"altmetricId":48357220},{"title":"Numerous niches for hematopoietic stem cells remain empty during homeostasis","googleId":"cJgcdO-lZ0oJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2124/36379","googleCitationCount":49,"googleAuthor":"M Shimoto","doi":"10.1182/blood-2016-09-740563","elsevierAuthor":"Shimoto M.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"36","altmetricAuthors":["Manabu Shimoto","Tatsuki Sugiyama","Takashi Nagasawa"],"twitterCount":10,"altmetricId":15901995},{"title":"Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial","googleId":"DYtx97ZMFa0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/883/39413","googleCitationCount":37,"googleAuthor":"KMJ Heitink-Pollé","doi":"10.1182/blood-2018-02-830844","elsevierAuthor":"Heitink-Pollé K.M.J.","publicationName":"Blood","elsevierCoverDate":"2018-08-30","elsevierCoverDisplayDate":"30 August 2018","elsevierCitationCount":"23","altmetricAuthors":["Katja M. J. Heitink-Pollé","Cuno S. P. M. Uiterwaal","Leendert Porcelijn","Rienk Y. J. Tamminga","Frans J. Smiers","Nicole L. van Woerden","Judit Wesseling","Gestur Vidarsson","Annemieke G. Laarhoven","Masja de Haas","Marrie C. A. Bruin"],"twitterCount":25,"altmetricId":44179362},{"title":"Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition","googleId":"OEWavOeyFLYJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/2/e1/36101","googleCitationCount":61,"googleAuthor":"J Geiger","doi":"10.1182/blood-2016-05-714048","elsevierAuthor":"Beck F.","publicationName":"Blood","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"46","altmetricAuthors":["Florian Beck","Jörg Geiger","Stepan Gambaryan","Fiorella A. Solari","Margherita Dell’Aica","Stefan Loroch","Nadine J. Mattheij","Igor Mindukshev","Oliver Pötz","Kerstin Jurk","Julia M. Burkhart","Christian Fufezan","Johan W. M. Heemskerk","Ulrich Walter","René P. Zahedi","Albert Sickmann"],"twitterCount":3,"altmetricId":15460421},{"title":"Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma","googleId":"FQXP5x4BWp4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2552/36954","googleCitationCount":35,"googleAuthor":"","doi":"10.1182/blood-2017-07-794529","elsevierAuthor":"Higuchi H.","publicationName":"Blood","elsevierCoverDate":"2018-06-07","elsevierCoverDisplayDate":"7 June 2018","elsevierCitationCount":"28","altmetricAuthors":["Hiroshi Higuchi","Natsuko Yamakawa","Ken-Ichi Imadome","Takashi Yahata","Ryutaro Kotaki","Jun Ogata","Masatoshi Kakizaki","Koji Fujita","Jun Lu","Kazuaki Yokoyama","Kazuki Okuyama","Ai Sato","Masako Takamatsu","Natsumi Kurosaki","Syakira Mohamad Alba","Azran Azhim","Ryouichi Horie","Toshiki Watanabe","Toshio Kitamura","Kiyoshi Ando","Takao Kashiwagi","Toshimitsu Matsui","Akinao Okamoto","Hiroshi Handa","Masahiko Kuroda","Naoya Nakamura","Ai Kotani"],"twitterCount":11,"altmetricId":43446236},{"title":"Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial","googleId":"anMnUsW8uE8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/223/39261","googleCitationCount":37,"googleAuthor":"N van Geloven","doi":"10.1182/blood-2018-02-831289","elsevierAuthor":"van der Meer P.F.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"27","altmetricAuthors":["Pieter F. van der Meer","Paula F. Ypma","Nan van Geloven","Joost A. van Hilten","Rinie J. van Wordragen-Vlaswinkel","Okke Eissen","Jaap J. Zwaginga","Michael Trus","Erik A. M. Beckers","Peter te Boekhorst","Alan Tinmouth","Yulia Lin","Cyrus Hsia","David Lee","Philip J. Norris","Raymond P. Goodrich","Anneke Brand","Tor Hervig","Nancy M. Heddle","Johanna G. van der Bom","Jean-Louis H. Kerkhoffs"],"twitterCount":13,"altmetricId":42067617},{"title":"l-Glutamine for sickle cell anemia: more questions than answers","googleId":"QVMyKsIomcoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/689/39431","googleCitationCount":38,"googleAuthor":"CT Quinn","doi":"10.1182/blood-2018-03-834440","elsevierAuthor":"Quinn C.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"28","altmetricAuthors":["Charles T. Quinn"],"twitterCount":10,"altmetricId":44104298},{"title":"Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells","googleId":"8mdeSj9ROZwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/14/1927/35870","googleCitationCount":46,"googleAuthor":"M Jung","doi":"10.1182/blood-2016-08-734236","elsevierAuthor":"Schlums H.","publicationName":"Blood","elsevierCoverDate":"2017-04-06","elsevierCoverDisplayDate":"6 April 2017","elsevierCitationCount":"40","altmetricAuthors":["Heinrich Schlums","Moonjung Jung","Hongya Han","Jakob Theorell","Venetia Bigley","Samuel C. C. Chiang","David S. J. Allan","Jan K. Davidson-Moncada","Rachel E. Dickinson","Tim D. Holmes","Amy P. Hsu","Danielle Townsley","Thomas Winkler","Weixin Wang","Pål Aukrust","Ingvild Nordøy","Katherine R. Calvo","Steve M. Holland","Matthew Collin","Cynthia E. Dunbar","Yenan T. Bryceson"],"twitterCount":7,"altmetricId":18764157},{"title":"HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities","googleId":"Z-75W5dtAV4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/9/1089/36983","googleCitationCount":47,"googleAuthor":"BE Shaw","doi":"10.1182/blood-2017-03-742346","elsevierAuthor":"Fleischhauer K.","publicationName":"Blood","elsevierCoverDate":"2017-08-31","elsevierCoverDisplayDate":"31 August 2017","elsevierCitationCount":"30","altmetricAuthors":["Katharina Fleischhauer","Bronwen E. Shaw"],"twitterCount":19,"altmetricId":21451398},{"title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","googleId":"tQ0-bKrVRq4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/10/1259/36372","googleCitationCount":45,"googleAuthor":"N Luebbering","doi":"10.1182/blood-2017-05-782870","elsevierAuthor":"Gloude N.","publicationName":"Blood","elsevierCoverDate":"2017-09-07","elsevierCoverDisplayDate":"7 September 2017","elsevierCitationCount":"36","altmetricAuthors":["Nicholas J. Gloude","Pooja Khandelwal","Nathan Luebbering","Dana T. Lounder","Sonata Jodele","Matthew N. Alder","Adam Lane","Alyss Wilkey","Kelly E. Lake","Bridget Litts","Stella M. Davies"],"twitterCount":19,"altmetricId":21915581},{"title":"Daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM) …","googleId":"aUWGVKbk5dcJ","googleLink":"http://cms.cws.net/content/beta.myelomasociety.org/files/2017ash/Dimopoulos_POLLUX-ASH%202017.pdf","googleCitationCount":43,"googleAuthor":"MA Dimopoulos"},{"title":"Updated results from a phase 1 study of gilteritinib in combination with induction and consolidation chemotherapy in subjects with newly diagnosed acute myeloid …","googleId":"ea8c0UaLyKgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/564/263255","googleCitationCount":33,"googleAuthor":"KW Pratz","doi":"10.1182/blood-2018-99-110975","elsevierAuthor":"Hogan F.L.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia","googleId":"VmOXSMVzo9sJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/14/1620/107642","googleCitationCount":42,"googleAuthor":"","doi":"10.1182/blood-2017-02-749101","elsevierAuthor":"Wayne A.","publicationName":"Blood","elsevierCoverDate":"2017-10-05","elsevierCoverDisplayDate":"5 October 2017","elsevierCitationCount":"39","altmetricAuthors":["Alan S. Wayne","Nirali N. Shah","Deepa Bhojwani","Lewis B. Silverman","James A. Whitlock","Maryalice Stetler-Stevenson","Weili Sun","Meina Liang","Jie Yang","Robert J. Kreitman","Mark C. Lanasa","Ira Pastan"],"twitterCount":22,"altmetricId":23555381},{"title":"Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity","googleId":"fCBttAdjqpkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1293/39625","googleCitationCount":34,"googleAuthor":"QL Sievers","doi":"10.1182/blood-2018-01-821769","elsevierAuthor":"Sievers Q.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"29","altmetricAuthors":["Quinlan L. Sievers","Jessica A. Gasser","Glenn S. Cowley","Eric S. Fischer","Benjamin L. Ebert"],"twitterCount":8,"altmetricId":45814568},{"title":"Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome","googleId":"tuo2mbNEEgIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/974/39169","googleCitationCount":41,"googleAuthor":"JI Arostegui","doi":"10.1182/blood-2017-10-810366","elsevierAuthor":"Rowczenio D.M.","publicationName":"Blood","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"33","altmetricAuthors":["Dorota M. Rowczenio","Shelly Pathak","Juan I. Arostegui","Anna Mensa-Vilaro","Ebun Omoyinmi","Paul Brogan","Dan Lipsker","Thomas Scambler","Roger Owen","Hadija Trojer","Anna Baginska","Julian D. Gillmore","Ashutosh D. Wechalekar","Thirusha Lane","Rene Williams","Taryn Youngstein","Philip N. Hawkins","Sinisa Savic","Helen J. Lachmann"],"twitterCount":9,"altmetricId":31071656},{"title":"PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells","googleId":"qCD37zOzVj4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/18/2493/36276","googleCitationCount":50,"googleAuthor":"F Michelet","doi":"10.1182/blood-2016-10-747436","elsevierAuthor":"Naudin C.","publicationName":"Blood","elsevierCoverDate":"2017-05-04","elsevierCoverDisplayDate":"4 May 2017","elsevierCitationCount":"31","altmetricAuthors":["Cécile Naudin","Aurore Hattabi","Fabio Michelet","Ayda Miri-Nezhad","Aissa Benyoucef","Françoise Pflumio","François Guillonneau","Serge Fichelson","Isabelle Vigon","Isabelle Dusanter-Fourt","Evelyne Lauret"],"twitterCount":2,"altmetricId":16964844},{"title":"Venetoclax plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) improves outcomes in BCL2-positive first-line diffuse large B-cell …","googleId":"t0Wr4WBO9dIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/782/266037","googleCitationCount":31,"googleAuthor":"RE Gasiorowski","doi":"10.1182/blood-2018-99-118519","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Initial results of ibrutinib plus venetoclax in relapsed, refractory CLL (Bloodwise TAP CLARITY Study): high rates of overall response, complete remission and MRD …","googleId":"zh5RT_9l9UkJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/428/72735","googleCitationCount":44,"googleAuthor":"P Hillmen","doi":"10.1182/blood.V130.Suppl_1.428.428","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice","googleId":"nHSputFNqSIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/18/2547/36270","googleCitationCount":44,"googleAuthor":"AS Revenko","doi":"10.1182/blood-2016-11-753202","elsevierAuthor":"Chen Z.","publicationName":"Blood","elsevierCoverDate":"2017-05-04","elsevierCoverDisplayDate":"4 May 2017","elsevierCitationCount":"36","altmetricAuthors":["Zu-Lin Chen","Alexey S. Revenko","Pradeep Singh","A. Robert MacLeod","Erin H. Norris","Sidney Strickland"],"twitterCount":10,"altmetricId":16964312},{"title":"The combination of quizartinib with azacitidine or low dose cytarabine is highly active in patients (Pts) with FLT3-ITD mutated myeloid leukemias: interim report of a …","googleId":"G_UVAxRT8MYJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/723/83424","googleCitationCount":44,"googleAuthor":"M Swaminathan","doi":"10.1182/blood.V130.Suppl_1.723.723","elsevierCitationCount":0,"altmetricAuthors":["Swaminathan, Mahesh","Kantarjian, Hagop M.","Daver, Naval","Borthakur, Gautam","Ohanian, Maro","Kadia, Tapan","DiNardo, Courtney D.","Jain, Nitin","Estrov, Zeev","Ferrajoli, Alessandra","Garcia-Manero, Guillermo","Konopleva, Marina","Andreeff, Michael","Pemmaraju, Naveen","Jabbour, Elias J.","Wierda, William G","Ravandi, Farhad","Pinsoy, Maria Rhona","Cortes, Jorge E."],"twitterCount":0,"altmetricId":100277242},{"title":"Integrated molecular profiling of juvenile myelomonocytic leukemia","googleId":"WgHyEvdDhSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1576/36685","googleCitationCount":36,"googleAuthor":"Y Okuno","doi":"10.1182/blood-2017-07-798157","elsevierAuthor":"Murakami N.","publicationName":"Blood","elsevierCoverDate":"2018-04-05","elsevierCoverDisplayDate":"5 April 2018","elsevierCitationCount":"24","altmetricAuthors":["Norihiro Murakami","Yusuke Okuno","Kenichi Yoshida","Yuichi Shiraishi","Genta Nagae","Kyogo Suzuki","Atsushi Narita","Hirotoshi Sakaguchi","Nozomu Kawashima","Xinan Wang","Yinyan Xu","Kenichi Chiba","Hiroko Tanaka","Asahito Hama","Masashi Sanada","Masafumi Ito","Masashi Hirayama","Arata Watanabe","Toshihide Ueno","Seiji Kojima","Hiroyuki Aburatani","Hiroyuki Mano","Satoru Miyano","Seishi Ogawa","Yoshiyuki Takahashi","Hideki Muramatsu"],"twitterCount":5,"altmetricId":32989662},{"title":"Biology and management of primary effusion lymphoma","googleId":"_mhePIxC_58J","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1879/39604","googleCitationCount":30,"googleAuthor":"K Shimada","doi":"10.1182/blood-2018-03-791426","elsevierAuthor":"Shimada K.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"19","altmetricAuthors":["Kazuyuki Shimada","Fumihiko Hayakawa","Hitoshi Kiyoi"],"twitterCount":9,"altmetricId":47264323},{"title":"Lysophosphatidic acid converts monocytes into macrophages in both mice and humans","googleId":"E3GIsxHQTfkJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/9/1177/36569","googleCitationCount":54,"googleAuthor":"","doi":"10.1182/blood-2016-10-743757","elsevierAuthor":"Ray R.","publicationName":"Blood","elsevierCoverDate":"2017-03-02","elsevierCoverDisplayDate":"2 March 2017","elsevierCitationCount":"46","altmetricAuthors":["Rashmi Ray","Vivek Rai"],"twitterCount":4,"altmetricId":15391187},{"title":"Low dose of human scFv-derived BCMA-targeted CAR-T cells achieved fast response and high complete remission in patients with relapsed/refractory multiple …","googleId":"oNscQ-1PW3UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/960/266056","googleCitationCount":31,"googleAuthor":"J Jin","doi":"10.1182/blood-2018-99-113220","elsevierAuthor":"Borrello I.","publicationName":"Journal of Clinical Investigation","elsevierCoverDate":"2019-06-03","elsevierCoverDisplayDate":"3 June 2019","elsevierCitationCount":"4","altmetricAuthors":["Songfu Jiang","Jie Jin","Siguo Hao","Min Yang","Linjun Chen","Huaying Ruan","Jun Xiao","Wei Wang","Zonghai Li","Kang Yu"],"twitterCount":0,"altmetricId":55319140},{"title":"Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies","googleId":"G4K1W0E18rQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/525/104413","googleCitationCount":39,"googleAuthor":"P Milani","doi":"10.1182/blood-2017-04-780544","elsevierAuthor":"Palladini G.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"31","altmetricAuthors":["Giovanni Palladini","Paolo Milani","Andrea Foli","Marco Basset","Francesca Russo","Stefano Perlini","Giampaolo Merlini"],"twitterCount":25,"altmetricId":28455186},{"title":"Subcutaneous delivery of daratumumab in patients (pts) with relapsed or refractory multiple myeloma (RRMM): PAVO, an open-label, multicenter, dose escalation …","googleId":"yKvFHkHPq4gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/838/83272","googleCitationCount":41,"googleAuthor":"H Nahi","doi":"10.1182/blood.V130.Suppl_1.838.838","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia","googleId":"FlCKHjvrwv4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/1012/39182","googleCitationCount":38,"googleAuthor":"DK Ragan","doi":"10.1182/blood-2017-06-789842","elsevierAuthor":"Guilliams K.","publicationName":"Blood","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"27","altmetricAuthors":["Kristin P. Guilliams","Melanie E. Fields","Dustin K. Ragan","Cihat Eldeniz","Michael M. Binkley","Yasheng Chen","Liam S. Comiskey","Allan Doctor","Monica L. Hulbert","Joshua S. Shimony","Katie D. Vo","Robert C. McKinstry","Hongyu An","Jin-Moo Lee","Andria L. Ford"],"twitterCount":8,"altmetricId":30921110},{"title":"How I treat the postthrombotic syndrome","googleId":"il3xEJ3AcawJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2215/6532","googleCitationCount":35,"googleAuthor":"SR Kahn","doi":"10.1182/blood-2018-01-785956","elsevierAuthor":"Rabinovich A.","publicationName":"Blood","elsevierCoverDate":"2018-05-17","elsevierCoverDisplayDate":"17 May 2018","elsevierCitationCount":"29","altmetricAuthors":["Anat Rabinovich","Susan R. Kahn"],"twitterCount":25,"altmetricId":34389726},{"title":"Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow","googleId":"fijJKbBAG7YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1714/39362","googleCitationCount":33,"googleAuthor":"DK Ragan","doi":"10.1182/blood-2018-04-841247","elsevierAuthor":"Ford A.L.","publicationName":"Blood","elsevierCoverDate":"2018-10-18","elsevierCoverDisplayDate":"18 October 2018","elsevierCitationCount":"28","altmetricAuthors":["Andria L. Ford","Dustin K. Ragan","Slim Fellah","Michael M. Binkley","Melanie E. Fields","Kristin P. Guilliams","Hongyu An","Lori C. Jordan","Robert C. McKinstry","Jin-Moo Lee","Michael R. DeBaun"],"twitterCount":9,"altmetricId":47452995},{"title":"Safety and activity of the investigational Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) in patients with mantle cell lymphoma from a phase 2 trial","googleId":"helsX8t9eG8J","googleLink":"https://www.beigenemedical.com/CongressDocuments/Song%20BGB-3111%20206%20ASH%20Abstract%202018.pdf","googleCitationCount":29,"googleAuthor":""},{"title":"Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance","googleId":"AFcw2cVTrJYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/11/1234/36473","googleCitationCount":55,"googleAuthor":"S Bhattacharjee","doi":"10.1182/blood-2017-11-814665","elsevierAuthor":"Bhattacharjee S.","publicationName":"Blood","elsevierCoverDate":"2018-03-15","elsevierCoverDisplayDate":"15 March 2018","elsevierCitationCount":"36","altmetricAuthors":["Souvik Bhattacharjee","Isabelle Coppens","Alassane Mbengue","Niraja Suresh","Mehdi Ghorbal","Zdenek Slouka","Innocent Safeukui","Hsin-Yao Tang","David W. Speicher","Robert V. Stahelin","Narla Mohandas","Kasturi Haldar"],"twitterCount":8,"altmetricId":32441414},{"title":"BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism","googleId":"vrwrkUl93IcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2047/36740","googleCitationCount":35,"googleAuthor":"","doi":"10.1182/blood-2017-10-811752","elsevierAuthor":"Chen J.","publicationName":"Blood","elsevierCoverDate":"2018-05-03","elsevierCoverDisplayDate":"3 May 2018","elsevierCitationCount":"27","altmetricAuthors":["Jiaji G. Chen","Xia Liu","Manit Munshi","Lian Xu","Nicholas Tsakmaklis","Maria G. Demos","Amanda Kofides","Maria Luisa Guerrera","Gloria G. Chan","Christopher J. Patterson","Kirsten Meid","Joshua Gustine","Toni Dubeau","Patricia Severns","Jorge J. Castillo","Zachary R. Hunter","Jinhua Wang","Sara J. Buhrlage","Nathanael S. Gray","Steven P. Treon","Guang Yang"],"twitterCount":4,"altmetricId":34008465},{"title":"Novel therapeutics for hemophilia and other bleeding disorders","googleId":"G08sm5TEHCgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/23/39267","googleCitationCount":33,"googleAuthor":"MU Callaghan","doi":"10.1182/blood-2017-09-743385","elsevierAuthor":"Callaghan M.U.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"24","altmetricAuthors":["Michael U. Callaghan","Robert Sidonio","Steven W. Pipe"],"twitterCount":59,"altmetricId":41832464},{"title":"Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia","googleId":"TRS9nNjrCwwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/717/39444","googleCitationCount":34,"googleAuthor":"TW LeBlanc","doi":"10.1182/blood-2018-03-842575","elsevierAuthor":"LeBlanc T.W.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"30","altmetricAuthors":["Thomas W. LeBlanc","Pamela C. Egan","Adam J. Olszewski"],"twitterCount":88,"altmetricId":43013974},{"title":"BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation","googleId":"5HcjUrRK3yMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/489/37125","googleCitationCount":45,"googleAuthor":"","doi":"10.1182/blood-2016-12-759621","elsevierAuthor":"Tsuyama N.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"26","altmetricAuthors":["Naoko Tsuyama","Seiji Sakata","Satoko Baba","Yuko Mishima","Noriko Nishimura","Kyoko Ueda","Masahiro Yokoyama","Yasuhito Terui","Kiyohiko Hatake","Masanobu Kitagawa","Naoki Ishizuka","Naoto Tomita","Kengo Takeuchi"],"twitterCount":12,"altmetricId":20295229},{"title":"Imetelstat is effective treatment for patients with intermediate-2 or high-risk myelofibrosis who have relapsed on or are refractory to Janus kinase inhibitor therapy …","googleId":"mn3x7coI-YIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/685/266430","googleCitationCount":31,"googleAuthor":"M Cavo","doi":"10.1182/blood-2018-99-115163","elsevierAuthor":"Barraco D.","publicationName":"Drugs in Context","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":["John Mascarenhas","Rami S. Komrokji","Michele Cavo","Bruno Martino","Dietger Niederwieser","Andreas Reiter","Bart L Scott","Maria R. Baer","Ronald Hoffman","Olatoyosi Odenike","Jacqueline Bussolari","Eugene Zhu","Fei Huang","Esther Rose","Laurie Sherman","Souria Dougherty","Faye M. Feller","Jean-Jacques Kiladjian"],"twitterCount":0,"altmetricId":91239115},{"title":"SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells","googleId":"62TqIg3N58AJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/7/881/37002","googleCitationCount":40,"googleAuthor":"","doi":"10.1182/blood-2017-03-776070","elsevierAuthor":"Mortera-Blanco T.","publicationName":"Blood","elsevierCoverDate":"2017-08-17","elsevierCoverDisplayDate":"17 August 2017","elsevierCitationCount":"28","altmetricAuthors":["Teresa Mortera-Blanco","Marios Dimitriou","Petter S. Woll","Mohsen Karimi","Edda Elvarsdottir","Simona Conte","Magnus Tobiasson","Monika Jansson","Iyadh Douagi","Matahi Moarii","Leonie Saft","Elli Papaemmanuil","Sten Eirik W. Jacobsen","Eva Hellström-Lindberg"],"twitterCount":13,"altmetricId":21239778},{"title":"A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL","googleId":"JlZcDyXft8IJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/955/39171","googleCitationCount":42,"googleAuthor":"","doi":"10.1182/blood-2017-06-792333","elsevierAuthor":"Dimier N.","publicationName":"Blood","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"31","altmetricAuthors":["Natalie Dimier","Paul Delmar","Carol Ward","Rodica Morariu-Zamfir","Günter Fingerle-Rowson","Jasmin Bahlo","Kirsten Fischer","Barbara Eichhorst","Valentin Goede","Jacques J. M. van Dongen","Matthias Ritgen","Sebastian Böttcher","Anton W. Langerak","Michael Kneba","Michael Hallek"],"twitterCount":18,"altmetricId":30634567},{"title":"Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy","googleId":"eByKotZIJskJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2375/35964","googleCitationCount":45,"googleAuthor":"","doi":"10.1182/blood-2016-12-758409","elsevierAuthor":"Cox T.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"27","altmetricAuthors":["Timothy M. Cox","Guillermo Drelichman","Renata Cravo","Manisha Balwani","Thomas Andrew Burrow","Ana Maria Martins","Elena Lukina","Barry Rosenbloom","Ozlem Goker-Alpan","Nora Watman","Amal El-Beshlawy","Priya S. Kishnani","Maria Lucia Pedroso","Sebastiaan J. M. Gaemers","Regina Tayag","M. Judith Peterschmitt"],"twitterCount":8,"altmetricId":16345143},{"title":"Combined venetoclax and ibrutinib for patients with previously untreated high-risk CLL, and relapsed/refractory CLL: a phase II trial","googleId":"fWvIBLP-2wgJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/429/72836","googleCitationCount":42,"googleAuthor":"N Jain","doi":"10.1182/blood.V130.Suppl_1.429.429","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Platelets and von Willebrand factor in atherogenesis","googleId":"GoK--PZ2-hYJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/11/1415/35899","googleCitationCount":44,"googleAuthor":"","doi":"10.1182/blood-2016-07-692673","elsevierAuthor":"Wu M.D.","publicationName":"Blood","elsevierCoverDate":"2017-03-16","elsevierCoverDisplayDate":"16 March 2017","elsevierCitationCount":"28","altmetricAuthors":["Melinda D. Wu","Tamara M. Atkinson","Jonathan R. Lindner"],"twitterCount":8,"altmetricId":18019249},{"title":"Eculizumab cessation in atypical hemolytic uremic syndrome","googleId":"b8mzrZBl4aoJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/368/36895","googleCitationCount":46,"googleAuthor":"AR Moliterno","doi":"10.1182/blood-2017-02-770214","elsevierAuthor":"Merrill S.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"34","altmetricAuthors":["Samuel A. Merrill","Zachary D. Brittingham","Xuan Yuan","Alison R. Moliterno","C. John Sperati","Robert A. Brodsky"],"twitterCount":6,"altmetricId":20258677},{"title":"Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling","googleId":"sIwpWzkXU1UJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/6/759/36328","googleCitationCount":54,"googleAuthor":"JH Myklebust","doi":"10.1182/blood-2016-05-718494","elsevierAuthor":"Myklebust J.H.","publicationName":"Blood","elsevierCoverDate":"2017-02-09","elsevierCoverDisplayDate":"9 February 2017","elsevierCitationCount":"41","altmetricAuthors":["June H. Myklebust","Joshua Brody","Holbrook E. Kohrt","Arne Kolstad","Debra K. Czerwinski","Sébastien Wälchli","Michael R. Green","Gunhild Trøen","Knut Liestøl","Klaus Beiske","Roch Houot","Jan Delabie","Ash A. Alizadeh","Jonathan M. Irish","Ronald Levy"],"twitterCount":4,"altmetricId":15099346},{"title":"CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation","googleId":"_pOzuqYdsCcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/19/2092/36695","googleCitationCount":41,"googleAuthor":"R Grieshaber-Bouyer","doi":"10.1182/blood-2017-03-768507","elsevierAuthor":"Bai M.","publicationName":"Blood","elsevierCoverDate":"2017-11-09","elsevierCoverDisplayDate":"9 November 2017","elsevierCitationCount":"31","altmetricAuthors":["Ming Bai","Ricardo Grieshaber-Bouyer","Junxia Wang","Angela B. Schmider","Zachary S. Wilson","Liling Zeng","Olha Halyabar","Matthew D. Godin","Hung N. Nguyen","Anaïs Levescot","Pierre Cunin","Craig T. Lefort","Roy J. Soberman","Peter A. Nigrovic"],"twitterCount":5,"altmetricId":28662077},{"title":"ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies","googleId":"piiTH2hFrAMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1094/36428","googleCitationCount":36,"googleAuthor":"","doi":"10.1182/blood-2017-10-813493","elsevierAuthor":"Zammarchi F.","publicationName":"Blood","elsevierCoverDate":"2018-03-08","elsevierCoverDisplayDate":"8 March 2018","elsevierCitationCount":"34","altmetricAuthors":["Francesca Zammarchi","Simon Corbett","Lauren Adams","Peter C. Tyrer","Konstantinos Kiakos","Narinder Janghra","Teresa Marafioti","Charles E. Britten","Carin E. G. Havenith","Simon Chivers","Francois D’Hooge","David G. Williams","Arnaud Tiberghien","Philip W. Howard","John A. Hartley","Patrick H. van Berkel"],"twitterCount":6,"altmetricId":31543182},{"title":"Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with iDH1-mutant untreated AML: results from a phase 1 dose escalation …","googleId":"QyQ1vKyBB48J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/561/263448","googleCitationCount":30,"googleAuthor":"S de Botton","doi":"10.1182/blood-2018-99-110595","elsevierCitationCount":0,"altmetricAuthors":["Gail J. Roboz","Courtney D. DiNardo","Eytan M. Stein","Stephane de Botton","Alice S. Mims","Gabrielle T. Prince","Jessica K. Altman","Martha L. Arellano","William B. Donnellan","Harry P. Erba","Gabriel N. Mannis","Daniel A Pollyea","Anthony S. Stein","Geoffrey L. Uy","Justin M. Watts","Amir T. Fathi","Hagop M. Kantarjian","Martin S. Tallman","Sung Choe","David Dai","Bin Fan","Hongfang Wang","Vickie Zhang","Katharine E. Yen","Stephanie M. Kapsalis","Denice Hickman","Hua Liu","Samuel V. Agresta","Bin Wu","Eyal C. Attar","Richard M. Stone"],"twitterCount":0,"altmetricId":54505498},{"title":"First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia","googleId":"UdnQH6gacm0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/23/2499/36743","googleCitationCount":41,"googleAuthor":"","doi":"10.1182/blood-2017-05-785683","elsevierAuthor":"Boidol B.","publicationName":"Blood","elsevierCoverDate":"2017-12-07","elsevierCoverDisplayDate":"7 December 2017","elsevierCitationCount":"31","altmetricAuthors":["Bernd Boidol","Christoph Kornauth","Emiel van der Kouwe","Nicole Prutsch","Lukas Kazianka","Sinan Gültekin","Gregor Hoermann","Marius E. Mayerhoefer","Georg Hopfinger","Alexander Hauswirth","Michael Panny","Marie-Bernadette Aretin","Bernadette Hilgarth","Wolfgang R. Sperr","Peter Valent","Ingrid Simonitsch-Klupp","Richard Moriggl","Olaf Merkel","Lukas Kenner","Ulrich Jäger","Stefan Kubicek","Philipp B. Staber"],"twitterCount":32,"altmetricId":26679888},{"title":"New molecular and therapeutic insights into canine diffuse large B cell lymphoma elucidates the role of the dog as a model for human disease","googleId":"owYWPI1NfCgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4173/275835","googleCitationCount":27,"googleAuthor":"L Aresu","doi":"10.1182/blood-2018-99-112763","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma","googleId":"lsqD1uLFLZkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/9/1114/37003","googleCitationCount":39,"googleAuthor":"","doi":"10.1182/blood-2016-09-741983","elsevierAuthor":"Narita T.","publicationName":"Blood","elsevierCoverDate":"2017-08-31","elsevierCoverDisplayDate":"31 August 2017","elsevierCitationCount":"33","altmetricAuthors":["Tomoko Narita","Takashi Ishida","Asahi Ito","Ayako Masaki","Shiori Kinoshita","Susumu Suzuki","Hisashi Takino","Takashi Yoshida","Masaki Ri","Shigeru Kusumoto","Hirokazu Komatsu","Kazunori Imada","Yuetsu Tanaka","Akifumi Takaori-Kondo","Hiroshi Inagaki","Arne Scholz","Philip Lienau","Taruho Kuroda","Ryuzo Ueda","Shinsuke Iida"],"twitterCount":11,"altmetricId":21334018},{"title":"CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice","googleId":"_AP84RGfAKUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1535/39346","googleCitationCount":28,"googleAuthor":"EC Fink","doi":"10.1182/blood-2018-05-852798","elsevierAuthor":"Fink E.C.","publicationName":"Blood","elsevierCoverDate":"2018-10-04","elsevierCoverDisplayDate":"4 October 2018","elsevierCitationCount":"25","altmetricAuthors":["Emma C. Fink","Marie McConkey","Dylan N. Adams","Saurav D. Haldar","James A. Kennedy","Andrew A. Guirguis","Namrata D. Udeshi","D. R. Mani","Michelle Chen","Brian Liddicoat","Tanya Svinkina","Andrew T. Nguyen","Steven A. Carr","Benjamin L. Ebert"],"twitterCount":16,"altmetricId":45839651},{"title":"Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population","googleId":"Y3E3CTSBsFcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2882/36300","googleCitationCount":40,"googleAuthor":"N Hein","doi":"10.1182/blood-2016-05-718171","elsevierAuthor":"Hein N.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"31","altmetricAuthors":["Nadine Hein","Donald P. Cameron","Katherine M. Hannan","Nhu-Y N. Nguyen","Chun Yew Fong","Jirawas Sornkom","Meaghan Wall","Megan Pavy","Carleen Cullinane","Jeannine Diesch","Jennifer R. Devlin","Amee J. George","Elaine Sanij","Jaclyn Quin","Gretchen Poortinga","Inge Verbrugge","Adele Baker","Denis Drygin","Simon J. Harrison","James D. Rozario","Jason A. Powell","Stuart M. Pitson","Johannes Zuber","Ricky W. Johnstone","Mark A. Dawson","Mark A. Guthridge","Andrew Wei","Grant A. McArthur","Richard B. Pearson","Ross D. Hannan"],"twitterCount":13,"altmetricId":17419493},{"title":"Testing and monitoring direct oral anticoagulants","googleId":"NAdzjFqhir4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S000649712043023X","googleCitationCount":29,"googleAuthor":"","doi":"10.1182/blood-2018-04-791541","elsevierAuthor":"Connors J.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"18","altmetricAuthors":["Jean M. Connors"],"twitterCount":41,"altmetricId":48113798},{"title":"Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation","googleId":"OGpp5lgEGOIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/84/107724","googleCitationCount":39,"googleAuthor":"JP Reddy","doi":"10.1182/blood-2017-04-773838","elsevierAuthor":"Akhtari M.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"30","altmetricAuthors":["Mani Akhtari","Sarah A. Milgrom","Chelsea C. Pinnix","Jay P. Reddy","Wenli Dong","Grace L. Smith","Osama Mawlawi","Zeinab Abou Yehia","Jillian Gunther","Eleanor M. Osborne","Therese Y. Andraos","Christine F. Wogan","Eric Rohren","Naveen Garg","Hubert Chuang","Joseph D. Khoury","Yasuhiro Oki","Michelle Fanale","Bouthaina S. Dabaja"],"twitterCount":34,"altmetricId":27643834},{"title":"Targeting BCL-2 in B-cell lymphomas","googleId":"vC_7szGrMcUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/9/1081/36985","googleCitationCount":39,"googleAuthor":"","doi":"10.1182/blood-2017-04-737338","elsevierAuthor":"Davids M.","publicationName":"Blood","elsevierCoverDate":"2017-08-31","elsevierCoverDisplayDate":"31 August 2017","elsevierCitationCount":"35","altmetricAuthors":["Matthew S. Davids"],"twitterCount":26,"altmetricId":22224313},{"title":"Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML","googleId":"vQfFD9SN-TAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/12/1636/36097","googleCitationCount":50,"googleAuthor":"","doi":"10.1182/blood-2016-10-740613","elsevierAuthor":"Löwenberg B.","publicationName":"Blood","elsevierCoverDate":"2017-03-23","elsevierCoverDisplayDate":"23 March 2017","elsevierCitationCount":"44","altmetricAuthors":["Bob Löwenberg","Thomas Pabst","Johan Maertens","Yvette van Norden","Bart J. Biemond","Harry C. Schouten","Olivier Spertini","Edo Vellenga","Carlos Graux","Violaine Havelange","Georgine E. de Greef","Okke de Weerdt","Marie-Cecile J. C. Legdeur","Juergen Kuball","Marinus van Marwijk Kooy","Bjorn T. Gjertsen","Mojca Jongen-Lavrencic","Arjan A. van de Loosdrecht","Daniëlle van Lammeren-Venema","Beata Hodossy","Dimitri A. Breems","Yves Chalandon","Jakob Passweg","Peter J. M. Valk","Markus G. Manz","Gert J. Ossenkoppele"],"twitterCount":9,"altmetricId":15368030},{"title":"Sensing of the microbiota by NOD1 in mesenchymal stromal cells regulates murine hematopoiesis","googleId":"LkFX5_K8afkJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/2/171/36075","googleCitationCount":52,"googleAuthor":"N Bouladoux","doi":"10.1182/blood-2016-06-723742","elsevierAuthor":"Iwamura C.","publicationName":"Blood","elsevierCoverDate":"2017-01-12","elsevierCoverDisplayDate":"12 January 2017","elsevierCitationCount":"42","altmetricAuthors":["Chiaki Iwamura","Nicolas Bouladoux","Yasmine Belkaid","Alan Sher","Dragana Jankovic"],"twitterCount":6,"altmetricId":15526326},{"title":"GPIbα is required for platelet-mediated hepatic thrombopoietin generation","googleId":"nA5BgRDW1IUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/622/39439","googleCitationCount":32,"googleAuthor":"M Xu","doi":"10.1182/blood-2017-12-820779","elsevierAuthor":"Xu M.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"23","altmetricAuthors":["Miao Xu","June Li","Miguel Antonio Dias Neves","Guangheng Zhu","Naadiya Carrim","Ruoying Yu","Sahil Gupta","John Marshall","Ori Rotstein","Jun Peng","Ming Hou","Shinji Kunishima","Jerry Ware","Donald R. Branch","Alan H. Lazarus","Zaverio M. Ruggeri","John Freedman","Heyu Ni"],"twitterCount":16,"altmetricId":43065956},{"title":"Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML","googleId":"V0MMG-ubV0MJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/397/37087","googleCitationCount":43,"googleAuthor":"A Yoshimi","doi":"10.1182/blood-2017-01-763219","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2017-09-28","elsevierCoverDisplayDate":"28 September 2017","elsevierCitationCount":"0","altmetricAuthors":["Akihide Yoshimi","Maria E. Balasis","Alexis Vedder","Kira Feldman","Yan Ma","Hailing Zhang","Stanley Chun-Wei Lee","Christopher Letson","Sandrine Niyongere","Sydney X. Lu","Markus Ball","Justin Taylor","Qing Zhang","Yulong Zhao","Salma Youssef","Young Rock Chung","Xiao Jing Zhang","Benjamin H. Durham","Wendy Yang","Alan F. List","Mignon L. Loh","Virginia Klimek","Michael F. Berger","Elliot Stieglitz","Eric Padron","Omar Abdel-Wahab"],"twitterCount":15,"altmetricId":20781995},{"title":"IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and Aiolos","googleId":"CkbfT8ulTwMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2166/39517","googleCitationCount":27,"googleAuthor":"Y Liao","doi":"10.1182/blood-2018-05-850727","elsevierAuthor":"Fedele P.L.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"18","altmetricAuthors":["Pasquale L. Fedele","Simon N. Willis","Yang Liao","Michael S. Low","Jai Rautela","David H. Segal","Jia-Nan Gong","Nicholas D. Huntington","Wei Shi","David C. S. Huang","George Grigoriadis","Julie Tellier","Stephen L. Nutt"],"twitterCount":23,"altmetricId":48647581},{"title":"Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury","googleId":"yV8wVT8zox8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2001/36726","googleCitationCount":30,"googleAuthor":"J Zhang","doi":"10.1182/blood-2017-11-784108","elsevierAuthor":"Zhang J.","publicationName":"Blood","elsevierCoverDate":"2018-05-03","elsevierCoverDisplayDate":"3 May 2018","elsevierCitationCount":"20","altmetricAuthors":["Jianning Zhang","Fangyi Zhang","Jing-fei Dong"],"twitterCount":10,"altmetricId":40705769},{"title":"Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine","googleId":"6LwlEQBuVeIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/655/36810","googleCitationCount":39,"googleAuthor":"G Cheloni","doi":"10.1182/blood-2016-10-745588","elsevierAuthor":"Cheloni G.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"32","altmetricAuthors":["Giulia Cheloni","Michele Tanturli","Ignazia Tusa","Ngoc Ho DeSouza","Yi Shan","Antonella Gozzini","Fréderic Mazurier","Elisabetta Rovida","Shaoguang Li","Persio Dello Sbarba"],"twitterCount":13,"altmetricId":20817413},{"title":"Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress","googleId":"JiFKAR-1CIwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2078/39481","googleCitationCount":27,"googleAuthor":"DL Zhang","doi":"10.1182/blood-2018-04-842997","elsevierAuthor":"Zhang D.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"17","altmetricAuthors":["De-Liang Zhang","Manik C. Ghosh","Hayden Ollivierre","Yan Li","Tracey A. Rouault"],"twitterCount":1,"altmetricId":51124090},{"title":"Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease","googleId":"DNaMjLV68WoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/469/39396","googleCitationCount":30,"googleAuthor":"","doi":"10.1182/blood-2018-03-838235","elsevierAuthor":"Lenglet M.","publicationName":"Blood","elsevierCoverDate":"2018-08-02","elsevierCoverDisplayDate":"2 August 2018","elsevierCitationCount":"23","altmetricAuthors":["Marion Lenglet","Florence Robriquet","Klaus Schwarz","Carme Camps","Anne Couturier","David Hoogewijs","Alexandre Buffet","Samantha J. L. Knight","Sophie Gad","Sophie Couvé","Franck Chesnel","Mathilde Pacault","Pierre Lindenbaum","Sylvie Job","Solenne Dumont","Thomas Besnard","Marine Cornec","Helene Dreau","Melissa Pentony","Erika Kvikstad","Sophie Deveaux","Nelly Burnichon","Sophie Ferlicot","Mathias Vilaine","Jean-Michaël Mazzella","Fabrice Airaud","Céline Garrec","Laurence Heidet","Sabine Irtan","Elpis Mantadakis","Karim Bouchireb","Klaus-Michael Debatin","Richard Redon","Stéphane Bezieau","Brigitte Bressac-de Paillerets","Bin Tean Teh","François Girodon","Maria-Luigia Randi","Maria Caterina Putti","Vincent Bours","Richard Van Wijk","Joachim R. Göthert","Antonis Kattamis","Nicolas Janin","Celeste Bento","Jenny C. Taylor","Yannick Arlot-Bonnemains","Stéphane Richard","Anne-Paule Gimenez-Roqueplo","Holger Cario","Betty Gardie"],"twitterCount":17,"altmetricId":46220981},{"title":"Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor","googleId":"232u53Tu3IYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/643/36789","googleCitationCount":37,"googleAuthor":"F Seyfried","doi":"10.1182/blood-2017-03-769315","elsevierAuthor":"Münch V.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"27","altmetricAuthors":["Vera Münch","Luca Trentin","Julia Herzig","Salih Demir","Felix Seyfried","Johann M. Kraus","Hans A. Kestler","Rolf Köhler","Thomas F. E. Barth","Geertruy te Kronnie","Klaus-Michael Debatin","Lüder H. Meyer"],"twitterCount":26,"altmetricId":20641002},{"title":"How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","googleId":"deLDBAnDUK4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/4/448/36179","googleCitationCount":51,"googleAuthor":"","doi":"10.1182/blood-2016-08-693507","elsevierAuthor":"Williams K.","publicationName":"Blood","elsevierCoverDate":"2017-01-26","elsevierCoverDisplayDate":"26 January 2017","elsevierCitationCount":"36","altmetricAuthors":["Kirsten M. Williams"],"twitterCount":61,"altmetricId":13799564},{"title":"Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis","googleId":"vMoD3HAujB0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/15/1757/36375","googleCitationCount":40,"googleAuthor":"FR Rosendaal","doi":"10.1182/blood-2017-06-791756","elsevierAuthor":"Rosendaal F.R.","publicationName":"Blood","elsevierCoverDate":"2017-10-12","elsevierCoverDisplayDate":"12 October 2017","elsevierCitationCount":"26","altmetricAuthors":["Frits R. Rosendaal","Roberta Palla","Isabella Garagiola","Pier M. Mannucci","Flora Peyvandi"],"twitterCount":21,"altmetricId":23383673},{"title":"How I treat myelodysplastic syndromes of childhood","googleId":"R94NofwffiMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1406/36617","googleCitationCount":33,"googleAuthor":"","doi":"10.1182/blood-2017-09-765214","elsevierAuthor":"Locatelli F.","publicationName":"Blood","elsevierCoverDate":"2018-03-29","elsevierCoverDisplayDate":"29 March 2018","elsevierCitationCount":"20","altmetricAuthors":["Franco Locatelli","Brigitte Strahm"],"twitterCount":30,"altmetricId":32970424},{"title":"Deep and durable responses in patients (Pts) with relapsed/refractory multiple myeloma (MM) treated with monotherapy GSK2857916, an antibody drug conjugate …","googleId":"iaUMExlfWEcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/741/83640","googleCitationCount":38,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.741.741","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","googleId":"CfRhjWX1UB4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1871/39601","googleCitationCount":26,"googleAuthor":"D Gratzinger","doi":"10.1182/blood-2018-04-842559","elsevierAuthor":"Natkunam Y.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"16","altmetricAuthors":["Yasodha Natkunam","Dita Gratzinger","Amy Chadburn","John R. Goodlad","John K. C. Chan","Jonathan Said","Elaine S. Jaffe","Daphne de Jong"],"twitterCount":61,"altmetricId":46254250},{"title":"Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow","googleId":"0aQDkVcHMuIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/19/2101/36703","googleCitationCount":40,"googleAuthor":"T Wun","doi":"10.1182/blood-2017-05-783027","elsevierAuthor":"Morikis V.A.","publicationName":"Blood","elsevierCoverDate":"2017-11-09","elsevierCoverDisplayDate":"9 November 2017","elsevierCitationCount":"29","altmetricAuthors":["Vasilios A. Morikis","Shannon Chase","Ted Wun","Elliot L. Chaikof","John L. Magnani","Scott I. Simon"],"twitterCount":7,"altmetricId":23977455},{"title":"Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism","googleId":"BM8yydwQwAgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/19/2151/36908","googleCitationCount":35,"googleAuthor":"C Kearon","doi":"10.1182/blood-2017-09-805689","elsevierAuthor":"Kearon C.","publicationName":"Blood","elsevierCoverDate":"2018-05-10","elsevierCoverDisplayDate":"10 May 2018","elsevierCitationCount":"28","altmetricAuthors":["Clive Kearon","Sameer Parpia","Frederick A. Spencer","Trevor Baglin","Scott M. Stevens","Kenneth A. Bauer","Steven R. Lentz","Craig M. Kessler","James D. Douketis","Stephan Moll","Scott Kaatz","Sam Schulman","Jean M. Connors","Jeffrey S. Ginsberg","Luciana Spadafora","Vinai Bhagirath","Patricia C. Liaw","Jeffrey I. Weitz","Jim A. Julian"],"twitterCount":60,"altmetricId":33788012},{"title":"Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke","googleId":"GzPLT4P6LHcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/16/2280/35933","googleCitationCount":48,"googleAuthor":"F Simão","doi":"10.1182/blood-2016-09-740670","elsevierAuthor":"Simao F.","publicationName":"Blood","elsevierCoverDate":"2017-04-20","elsevierCoverDisplayDate":"20 April 2017","elsevierCitationCount":"46","altmetricAuthors":["Fabrício Simão","Tuna Ustunkaya","Allen C. Clermont","Edward P. Feener"],"twitterCount":7,"altmetricId":15877000},{"title":"Surgical experience in two multicenter, open-label phase 3 studies of emicizumab in persons with hemophilia A with inhibitors (HAVEN 1 and HAVEN 2)","googleId":"vF4Iw_ukxQoJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/89/83367","googleCitationCount":36,"googleAuthor":"MU Callaghan","doi":"10.1182/blood.V130.Suppl_1.89.89","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"How I treat the young patient with multiple myeloma","googleId":"CwMYah8XzpwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1114/39366","googleCitationCount":29,"googleAuthor":"","doi":"10.1182/blood-2017-05-693606","elsevierAuthor":"Gandolfi S.","publicationName":"Blood","elsevierCoverDate":"2018-09-13","elsevierCoverDisplayDate":"13 September 2018","elsevierCitationCount":"21","altmetricAuthors":["Sara Gandolfi","Claudia Paba Prada","Paul G. Richardson"],"twitterCount":56,"altmetricId":44425725},{"title":"An analysis of maintenance therapy and post-midostaurin outcomes in the international prospective randomized, placebo-controlled, double-blind trial (CALGB 10603 …","googleId":"yhA8wJ2JxcgJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/145/79622","googleCitationCount":39,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.145.145","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study","googleId":"C6332ChPG2kJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/16/2308/35914","googleCitationCount":42,"googleAuthor":"SM Davies","doi":"10.1182/blood-2016-09-743112","elsevierAuthor":"Mehta P.","publicationName":"Blood","elsevierCoverDate":"2017-04-20","elsevierCoverDisplayDate":"20 April 2017","elsevierCitationCount":"30","altmetricAuthors":["Parinda A. Mehta","Stella M. Davies","Thomas Leemhuis","Kasiani Myers","Nancy A. Kernan","Susan E. Prockop","Andromachi Scaradavou","Richard J. O’Reilly","David A. Williams","Leslie Lehmann","Eva Guinan","David Margolis","K. Scott Baker","Adam Lane","Farid Boulad"],"twitterCount":13,"altmetricId":16409196},{"title":"Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial","googleId":"HwvHxz4OvUEJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3304/107607","googleCitationCount":43,"googleAuthor":"JK Hitzler","doi":"10.1182/blood-2017-01-764324","elsevierAuthor":"Taub J.W.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"27","altmetricAuthors":["Jeffrey W. Taub","Jason N. Berman","Johann K. Hitzler","April D. Sorrell","Norman J. Lacayo","Kelley Mast","David Head","Susana Raimondi","Betsy Hirsch","Yubin Ge","Robert B. Gerbing","Yi-Cheng Wang","Todd A. Alonzo","Dario Campana","Elaine Coustan-Smith","Prasad Mathew","Alan S. Gamis"],"twitterCount":16,"altmetricId":18629186},{"title":"CD138 mediates selection of mature plasma cells by regulating their survival","googleId":"EfB3jtUMuvAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/20/2749/36120","googleCitationCount":44,"googleAuthor":"MJ McCarron","doi":"10.1182/blood-2017-01-761643","elsevierAuthor":"McCarron M.","publicationName":"Blood","elsevierCoverDate":"2017-05-18","elsevierCoverDisplayDate":"18 May 2017","elsevierCitationCount":"30","altmetricAuthors":["Mark J. McCarron","Pyong Woo Park","David R. Fooksman"],"twitterCount":12,"altmetricId":18588439},{"title":"A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL","googleId":"x1KKu6biHrwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1805/36828","googleCitationCount":33,"googleAuthor":"","doi":"10.1182/blood-2017-08-802561","elsevierAuthor":"Sauter C.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"25","altmetricAuthors":["Craig S. Sauter","Matthew J. Matasar","Heiko Schoder","Sean M. Devlin","Pamela Drullinsky","John Gerecitano","Anita Kumar","Ariela Noy","Maria L. Palomba","Carol S. Portlock","David J. Straus","Andrew D. Zelenetz","Susan J. McCall","Shoshana T. Miller","Amanda I. Courtien","Anas Younes","Craig H. Moskowitz"],"twitterCount":66,"altmetricId":32487643},{"title":"Hematopoietic transcription factor mutations: important players in inherited platelet defects","googleId":"3_A_IHEdj8YJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2873/36262","googleCitationCount":40,"googleAuthor":"AK Rao","doi":"10.1182/blood-2016-11-709881","elsevierAuthor":"Songdej N.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"26","altmetricAuthors":["Natthapol Songdej","A. Koneti Rao"],"twitterCount":15,"altmetricId":19156342},{"title":"Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks","googleId":"Kx3xsI7wD8oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120606875","googleCitationCount":60,"googleAuthor":"M Ponzoni","doi":"10.1182/blood-2017-04-737445","elsevierAuthor":"Ponzoni M.","publicationName":"Blood","elsevierCoverDate":"2018-10-11","elsevierCoverDisplayDate":"11 October 2018","elsevierCitationCount":"32","altmetricAuthors":["Maurilio Ponzoni","Elias Campo","Shigeo Nakamura"],"twitterCount":28,"altmetricId":46561391},{"title":"Racial and ethnic disparities in hematologic malignancies","googleId":"_zmzK62RalcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/15/1699/36381","googleCitationCount":40,"googleAuthor":"K Kirtane","doi":"10.1182/blood-2017-04-778225","elsevierAuthor":"Kirtane K.","publicationName":"Blood","elsevierCoverDate":"2017-10-12","elsevierCoverDisplayDate":"12 October 2017","elsevierCitationCount":"30","altmetricAuthors":["Kedar Kirtane","Stephanie J. Lee"],"twitterCount":16,"altmetricId":22205881},{"title":"A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis","googleId":"93aU_wpondMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1664/39361","googleCitationCount":31,"googleAuthor":"","doi":"10.1182/blood-2018-04-846626","elsevierAuthor":"Masarova L.","publicationName":"Blood","elsevierCoverDate":"2018-10-18","elsevierCoverDisplayDate":"18 October 2018","elsevierCitationCount":"23","altmetricAuthors":["Lucia Masarova","Srdan Verstovsek","Juliana E. Hidalgo-Lopez","Naveen Pemmaraju","Prithviraj Bose","Zeev Estrov","Elias J. Jabbour","Farhad Ravandi-Kashani","Koichi Takahashi","Jorge E. Cortes","Jing Ning","Maro Ohanian","Yesid Alvarado","Lingsha Zhou","Sherry Pierce","Romany Gergis","Keyur P. Patel","Rajyalakshmi Luthra","Tapan M. Kadia","Courtney D. DiNardo","Gautam Borthakur","Kapil Bhalla","Guillermo Garcia-Manero","Carlos E. Bueso-Ramos","Hagop M. Kantarjian","Naval Daver"],"twitterCount":64,"altmetricId":47779511},{"title":"Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions","googleId":"W8dbDZmP4LsJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2917/36285","googleCitationCount":40,"googleAuthor":"M Yang","doi":"10.1182/blood-2016-11-750133","elsevierAuthor":"Yang M.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"27","altmetricAuthors":["Moua Yang","Brian C. Cooley","Wei Li","Yiliang Chen","Jeannette Vasquez-Vivar","Na’il O. Scoggins","Scott J. Cameron","Craig N. Morrell","Roy L. Silverstein"],"twitterCount":3,"altmetricId":20523143},{"title":"A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens","googleId":"2vmbki8pkSMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1911/39623","googleCitationCount":26,"googleAuthor":"J Sun","doi":"10.1182/blood-2018-04-843763","elsevierAuthor":"Hu Z.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"23","altmetricAuthors":["Zhuting Hu","Annabelle J. Anandappa","Jing Sun","Jintaek Kim","Donna E. Leet","David J. Bozym","Christina Chen","Louise Williams","Sachet A. Shukla","Wandi Zhang","Diana Tabbaa","Scott Steelman","Oriol Olive","Kenneth J. Livak","Hiroyuki Kishi","Atsushi Muraguchi","Indira Guleria","Jonathan Stevens","William J. Lane","Ute E. Burkhardt","Edward F. Fritsch","Donna Neuberg","Patrick A. Ott","Derin B. Keskin","Nir Hacohen","Catherine J. Wu"],"twitterCount":28,"altmetricId":47165638},{"title":"Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas","googleId":"AHOc9XnvIqEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/245/39241","googleCitationCount":28,"googleAuthor":"","doi":"10.1182/blood-2018-01-791335","elsevierAuthor":"Schmitz N.","publicationName":"Blood","elsevierCoverDate":"2018-07-19","elsevierCoverDisplayDate":"19 July 2018","elsevierCitationCount":"19","altmetricAuthors":["Norbert Schmitz","Georg Lenz","Matthias Stelljes"],"twitterCount":67,"altmetricId":39420081},{"title":"Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?","googleId":"UCfnlwpF0rMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/7/859/36974","googleCitationCount":37,"googleAuthor":"F Lo-Coco","doi":"10.1182/blood-2017-03-737403","elsevierAuthor":"Efficace F.","publicationName":"Blood","elsevierCoverDate":"2017-08-17","elsevierCoverDisplayDate":"17 August 2017","elsevierCitationCount":"31","altmetricAuthors":["Fabio Efficace","Gianluca Gaidano","Francesco Lo-Coco"],"twitterCount":25,"altmetricId":21753909},{"title":"Increased risk of colon cancer and osteogenic sarcoma in Diamond-Blackfan anemia","googleId":"GAQ8U9xH3QIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2205/39487","googleCitationCount":27,"googleAuthor":"PS Rosenberg","doi":"10.1182/blood-2018-05-848937","elsevierAuthor":"Vlachos A.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"18","altmetricAuthors":["Adrianna Vlachos","Philip S. Rosenberg","Eva Atsidaftos","Jessica Kang","Kenan Onel","Ravi N. Sharaf","Blanche P. Alter","Jeffrey M. Lipton"],"twitterCount":4,"altmetricId":51304162},{"title":"Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma","googleId":"xnuqX9Y_keAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/303/263675","googleCitationCount":32,"googleAuthor":"G Morgan","doi":"10.1182/blood-2018-99-117026","elsevierCitationCount":0,"altmetricAuthors":["Luciano J Costa","Edward A. Stadtmauer","Gareth Morgan","Gregory Monohan","Tibor Kovacsovics","Nicholas Burwick","Andrzej Jakubowiak","Jonathan L Kaufman","Mehrdad Mobasher","Kevin J. Freise","Jeremy A. Ross","John Pesko","Wijith Munasinghe","Saketh Gudipati","Sarah Mudd","Orlando Bueno","Shaji K. Kumar"],"twitterCount":0,"altmetricId":54506682},{"title":"A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD","googleId":"4nfn7dJiEOYJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/643/36160","googleCitationCount":46,"googleAuthor":"","doi":"10.1182/blood-2016-09-738625","elsevierAuthor":"Socié G.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"33","altmetricAuthors":["Gérard Socié","Stéphane Vigouroux","Ibrahim Yakoub-Agha","Jacques-Olivier Bay","Sabine Fürst","Karin Bilger","Felipe Suarez","Mauricette Michallet","Dominique Bron","Philippe Gard","Zakaria Medeghri","Philippe Lehert","Chinglin Lai","Tim Corn","Jean-Paul Vernant"],"twitterCount":26,"altmetricId":14168955},{"title":"Aged murine hematopoietic stem cells drive aging-associated immune remodeling","googleId":"Ixaoobr1ScgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/565/39425","googleCitationCount":28,"googleAuthor":"M Mulaw","doi":"10.1182/blood-2018-02-831065","elsevierAuthor":"Leins H.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"22","altmetricAuthors":["Hanna Leins","Medhanie Mulaw","Karina Eiwen","Vadim Sakk","Ying Liang","Michael Denkinger","Hartmut Geiger","Reinhold Schirmbeck"],"twitterCount":9,"altmetricId":43671700},{"title":"Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92","googleId":"KjCET0i80S4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/1050/39327","googleCitationCount":28,"googleAuthor":"N Amodio","doi":"10.1182/blood-2018-03-836601","elsevierAuthor":"Morelli E.","publicationName":"Blood","elsevierCoverDate":"2018-09-06","elsevierCoverDisplayDate":"6 September 2018","elsevierCitationCount":"27","altmetricAuthors":["Eugenio Morelli","Lavinia Biamonte","Cinzia Federico","Nicola Amodio","Maria Teresa Di Martino","Maria Eugenia Gallo Cantafio","Martina Manzoni","Francesca Scionti","Mehmet Kemal Samur","Annamaria Gullà","Maria Angelica Stamato","Maria Rita Pitari","Daniele Caracciolo","Settimio Sesti","Niels M. Frandsen","Marco Rossi","Antonino Neri","Mariateresa Fulciniti","Nikhil C. Munshi","Pierosandro Tagliaferri","Pierfrancesco Tassone"],"twitterCount":12,"altmetricId":44904704},{"title":"How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa","googleId":"jggRYiqA4osJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/254/39246","googleCitationCount":28,"googleAuthor":"","doi":"10.1182/blood-2018-04-844472","elsevierAuthor":"Gopal S.","publicationName":"Blood","elsevierCoverDate":"2018-07-19","elsevierCoverDisplayDate":"19 July 2018","elsevierCitationCount":"15","altmetricAuthors":["Satish Gopal","Thomas G. Gross"],"twitterCount":36,"altmetricId":44719521},{"title":"Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab","googleId":"ZPNt14qapcwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2906/39156","googleCitationCount":29,"googleAuthor":"","doi":"10.1182/blood-2017-09-804658","elsevierAuthor":"Topp M.S.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"25","altmetricAuthors":["Max S. Topp","Zachary Zimmerman","Paul Cannell","Hervé Dombret","Johan Maertens","Anthony Stein","Janet Franklin","Qui Tran","Ze Cong","Andre C. Schuh"],"twitterCount":10,"altmetricId":44324972},{"title":"Durable remission achieved from Bcma-directed CAR-T therapy against relapsed or refractory multiple myeloma","googleId":"y2trD9t43E0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/956/266010","googleCitationCount":27,"googleAuthor":"Y Liu","doi":"10.1182/blood-2018-99-112786","elsevierCitationCount":0,"altmetricAuthors":["Yarong Liu","Zhi Chen","Hongliang Fang","Runhong Wei","Kang Yu","Songfu Jiang","Weijun Fu","Hua Jiang","Juan Du","Feng He","Ronglin Xie","Jing Chen","Baofeng Wei","Jin Tao","Pin Wang"],"twitterCount":0,"altmetricId":55319142},{"title":"Mutant isocitrate dehydrogenase (mIDH) inhibitors, enasidenib or ivosidenib, in combination with azacitidine (AZA): preliminary results of a phase 1b/2 study in …","googleId":"b_Bvx20Rg2oJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/639/83406","googleCitationCount":38,"googleAuthor":"AT Fathi","doi":"10.1182/blood.V130.Suppl_1.639.639","elsevierCitationCount":0,"altmetricAuthors":["DiNardo, Courtney D.","Stein, Anthony S.","Fathi, Amir T.","Montesinos, Pau","Odenike, Olatoyosi","Kantarjian, Hagop M.","Stone, Richard M.","Koralek, Daniel O.","Van Oostendorp, Jason","Gong, Jing","Gupta, Ira","Vyas, Paresh"],"twitterCount":0,"altmetricId":100277235},{"title":"Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis","googleId":"_eK8Fozbr-0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1568/36656","googleCitationCount":32,"googleAuthor":"E Kastritis","doi":"10.1182/blood-2017-12-819904","elsevierAuthor":"Kastritis E.","publicationName":"Blood","elsevierCoverDate":"2018-04-05","elsevierCoverDisplayDate":"5 April 2018","elsevierCitationCount":"25","altmetricAuthors":["Efstathios Kastritis","Ioannis Papassotiriou","Giampaolo Merlini","Paolo Milani","Evangelos Terpos","Marco Basset","Athanasios Akalestos","Francesca Russo","Erasmia Psimenou","Filia Apostolakou","Maria Roussou","Maria Gavriatopoulou","Evangelos Eleutherakis-Papaiakovou","Despina Fotiou","Dimitrios C. Ziogas","Elektra Papadopoulou","Constantinos Pamboucas","Meletios A. Dimopoulos","Giovanni Palladini"],"twitterCount":23,"altmetricId":32505344},{"title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment","googleId":"Tjxpz2U3oUEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/758/39432","googleCitationCount":29,"googleAuthor":"","doi":"10.1182/blood-2018-02-835991","elsevierAuthor":"Sakamoto Y.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"22","altmetricAuthors":["Yuma Sakamoto","Takashi Ishida","Ayako Masaki","Takayuki Murase","Kentaro Yonekura","Yukie Tashiro","Masahito Tokunaga","Atae Utsunomiya","Asahi Ito","Shigeru Kusumoto","Shinsuke Iida","Ryuzo Ueda","Hiroshi Inagaki"],"twitterCount":3,"altmetricId":46612304},{"title":"The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia","googleId":"6Md-9kRLuWQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/4/497/36192","googleCitationCount":46,"googleAuthor":"BG Mar","doi":"10.1182/blood-2016-05-714493","elsevierAuthor":"Li H.","publicationName":"Blood","elsevierCoverDate":"2017-01-26","elsevierCoverDisplayDate":"26 January 2017","elsevierCitationCount":"37","altmetricAuthors":["Hubo Li","Brenton G. Mar","Huadi Zhang","Rishi V. Puram","Francisca Vazquez","Barbara A. Weir","William C. Hahn","Benjamin Ebert","David Pellman"],"twitterCount":2,"altmetricId":13057662},{"title":"Long term follow-up after SCRI-CAR19v1 reveals late recurrences as well as a survival advantage to consolidation with HCT after CAR T cell induced remission","googleId":"ZIkjeQkTwVQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/967/266133","googleCitationCount":26,"googleAuthor":"","doi":"10.1182/blood-2018-99-115599","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells","googleId":"eszB14JriM4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/25/2762/36880","googleCitationCount":34,"googleAuthor":"Z Wu","doi":"10.1182/blood-2017-08-803353","elsevierAuthor":"Zhao X.","publicationName":"Blood","elsevierCoverDate":"2017-12-21","elsevierCoverDisplayDate":"21 December 2017","elsevierCitationCount":"26","altmetricAuthors":["Xin Zhao","Shouguo Gao","Zhijie Wu","Sachiko Kajigaya","Xingmin Feng","Qingguo Liu","Danielle M. Townsley","James Cooper","Jinguo Chen","Keyvan Keyvanfar","Maria del Pilar Fernandez Ibanez","Xujing Wang","Neal S. Young"],"twitterCount":18,"altmetricId":27550857},{"title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies","googleId":"tSvonoKGcVMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1507/39348","googleCitationCount":31,"googleAuthor":"UA Shah","doi":"10.1182/blood-2018-01-824607","elsevierAuthor":"Shah U.A.","publicationName":"Blood","elsevierCoverDate":"2018-10-04","elsevierCoverDisplayDate":"4 October 2018","elsevierCitationCount":"24","altmetricAuthors":["Urvi A. Shah","Elaine Y. Chung","Orsi Giricz","Kith Pradhan","Keisuke Kataoka","Shanisha Gordon-Mitchell","Tushar D. Bhagat","Yun Mai","Yongqiang Wei","Elise Ishida","Gaurav S. Choudhary","Ancy Joseph","Ronald Rice","Nadege Gitego","Crystall Parrish","Matthias Bartenstein","Swati Goel","Ioannis Mantzaris","Aditi Shastri","Olga Derman","Adam Binder","Kira Gritsman","Noah Kornblum","Ira Braunschweig","Chirag Bhagat","Jeff Hall","Armin Graber","Lee Ratner","Yanhua Wang","Seishi Ogawa","Amit Verma","B. Hilda Ye","Murali Janakiram"],"twitterCount":24,"altmetricId":46536250},{"title":"CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia","googleId":"FvFANpsg3iQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/837/39482","googleCitationCount":27,"googleAuthor":"B Yan","doi":"10.1182/blood-2017-11-814319","elsevierAuthor":"Luo H.","publicationName":"Blood","elsevierCoverDate":"2018-08-23","elsevierCoverDisplayDate":"23 August 2018","elsevierCitationCount":"22","altmetricAuthors":["Huacheng Luo","Fei Wang","Jie Zha","Haoli Li","Bowen Yan","Qinghua Du","Fengchun Yang","Amin Sobh","Christopher Vulpe","Leylah Drusbosky","Christopher Cogle","Iouri Chepelev","Bing Xu","Stephen D. Nimer","Jonathan Licht","Yi Qiu","Baoan Chen","Mingjiang Xu","Suming Huang"],"twitterCount":37,"altmetricId":41631094},{"title":"Treating relapsed/refractory (RR) AML with biodegradable anti-CD123 CAR modified T cells","googleId":"G1_4MrzAgqIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1359/116253","googleCitationCount":36,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.1359.1359","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!","googleId":"SxOFzLHSqkkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2722/39681","googleCitationCount":27,"googleAuthor":"M Dreyling","doi":"10.1182/blood-2017-08-737502","elsevierAuthor":"Dreyling M.","publicationName":"Blood","elsevierCoverDate":"2018-12-27","elsevierCoverDisplayDate":"27 December 2018","elsevierCitationCount":"16","altmetricAuthors":["Martin Dreyling","Wolfram Klapper","Simon Rule"],"twitterCount":40,"altmetricId":50665319},{"title":"B-cell targeting in chronic graft-versus-host disease","googleId":"7TzesTm6Ug0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/13/1399/36612","googleCitationCount":29,"googleAuthor":"R Zeiser","doi":"10.1182/blood-2017-11-784017","elsevierAuthor":"Zeiser R.","publicationName":"Blood","elsevierCoverDate":"2018-03-29","elsevierCoverDisplayDate":"29 March 2018","elsevierCitationCount":"22","altmetricAuthors":["Robert Zeiser","Stefanie Sarantopoulos","Bruce R. Blazar"],"twitterCount":33,"altmetricId":32875816},{"title":"Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma","googleId":"ZMs52WBgwW8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2555/39537","googleCitationCount":25,"googleAuthor":"","doi":"10.1182/blood-2018-07-863829","elsevierAuthor":"Garderet L.","publicationName":"Blood","elsevierCoverDate":"2018-12-13","elsevierCoverDisplayDate":"13 December 2018","elsevierCitationCount":"22","altmetricAuthors":["Laurent Garderet","Frederique Kuhnowski","Benoit Berge","Murielle Roussel","Martine Escoffre-Barbe","Ingrid Lafon","Thierry Facon","Xavier Leleu","Lionel Karlin","Aurore Perrot","Philippe Moreau","Gerald Marit","Anne-Marie Stoppa","Bruno Royer","Carine Chaleteix","Mourad Tiab","Carla Araujo","Pascal Lenain","Margaret Macro","Eric Voog","Lofti Benboubker","Olivier Allangba","Eric Jourdan","Frederique Orsini-Piocelle","Sabine Brechignac","Jean-Richard Eveillard","Karim Belhadj","Marc Wetterwald","Brigitte Pegourie","Arnaud Jaccard","Jean-Claude Eisenmann","Sylvie Glaisner","Mohamad Mohty","Cyrille Hulin","Herve Avet Loiseau","Claire Mathiot","Michel Attal"],"twitterCount":22,"altmetricId":49194395},{"title":"Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial","googleId":"Sgq1fJux6CoJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/25/3314/107626","googleCitationCount":40,"googleAuthor":"","doi":"10.1182/blood-2017-01-765057","elsevierAuthor":"Uffmann M.","publicationName":"Blood","elsevierCoverDate":"2017-06-22","elsevierCoverDisplayDate":"22 June 2017","elsevierCitationCount":"26","altmetricAuthors":["Madita Uffmann","Mareike Rasche","Martin Zimmermann","Christine von Neuhoff","Ursula Creutzig","Michael Dworzak","Lenie Scheffers","Henrik Hasle","C. Michel Zwaan","Dirk Reinhardt","Jan-Henning Klusmann"],"twitterCount":5,"altmetricId":18737220},{"title":"Venetoclax plus rituximab is superior to bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia-results from pre-planned …","googleId":"Xo_pf00FbT8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/LBA-2/83681","googleCitationCount":38,"googleAuthor":"TJ Kipps","doi":"10.1182/blood.V130.Suppl_1.LBA-2.LBA-2","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","googleId":"Xb6qYiWmEOwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2262/6534","googleCitationCount":30,"googleAuthor":"N Oishi","doi":"10.1182/blood-2018-01-830968","elsevierAuthor":"Sharma A.","publicationName":"Blood","elsevierCoverDate":"2018-05-17","elsevierCoverDisplayDate":"17 May 2018","elsevierCitationCount":"25","altmetricAuthors":["Ayush Sharma","Naoki Oishi","Rebecca L. Boddicker","Guangzhen Hu","Hailey K. Benson","Rhett P. Ketterling","Patricia T. Greipp","Darlene L. Knutson","Sara M. Kloft-Nelson","Rong He","Bruce W. Eckloff","Jin Jen","Asha A. Nair","Jaime I. Davila","Surendra Dasari","Konstantinos N. Lazaridis","N. Nora Bennani","Tsung-Teh Wu","Grzegorz S. Nowakowski","Joseph A. Murray","Andrew L. Feldman"],"twitterCount":4,"altmetricId":42372107},{"title":"The enigma of monosomy 7","googleId":"zqR6-y-6ovcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2891/39117","googleCitationCount":30,"googleAuthor":"H Honda","doi":"10.1182/blood-2017-12-822262","elsevierAuthor":"Inaba T.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"21","altmetricAuthors":["Toshiya Inaba","Hiroaki Honda","Hirotaka Matsui"],"twitterCount":28,"altmetricId":35364401},{"title":"The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment","googleId":"wmLEGvLFRP4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/1/82/35841","googleCitationCount":46,"googleAuthor":"E Muchtar","doi":"10.1182/blood-2016-06-721878","elsevierAuthor":"Muchtar E.","publicationName":"Blood","elsevierCoverDate":"2017-01-05","elsevierCoverDisplayDate":"5 January 2017","elsevierCitationCount":"33","altmetricAuthors":["Eli Muchtar","Dragan Jevremovic","Angela Dispenzieri","David Dingli","Francis K. Buadi","Martha Q. Lacy","Wilson Gonsalves","Suzanne R. Hayman","Prashant Kapoor","Nelson Leung","Stephen Russell","John A. Lust","Yi Lin","Ronald S. Go","Rajshekhar Chakraborty","Steven Zeldenrust","Shaji K. Kumar","Robert A. Kyle","S. Vincent Rajkumar","Morie A. Gertz"],"twitterCount":27,"altmetricId":12570323},{"title":"Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response","googleId":"O8UrLJwU0UMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/307/39262","googleCitationCount":29,"googleAuthor":"S Bhatia","doi":"10.1182/blood-2017-10-810986","elsevierAuthor":"Bhatia S.","publicationName":"Blood","elsevierCoverDate":"2018-07-19","elsevierCoverDisplayDate":"19 July 2018","elsevierCitationCount":"19","altmetricAuthors":["Sanil Bhatia","Daniela Diedrich","Benedikt Frieg","Heinz Ahlert","Stefan Stein","Bertan Bopp","Franziska Lang","Tao Zang","Tobias Kröger","Thomas Ernst","Gesine Kögler","Andreas Krieg","Steffen Lüdeke","Hana Kunkel","Ana J. Rodrigues Moita","Matthias U. Kassack","Viktoria Marquardt","Friederike V. Opitz","Marina Oldenburg","Marc Remke","Florian Babor","Manuel Grez","Andreas Hochhaus","Arndt Borkhardt","Georg Groth","Luitgard Nagel-Steger","Joachim Jose","Thomas Kurz","Holger Gohlke","Finn K. Hansen","Julia Hauer"],"twitterCount":11,"altmetricId":40684070},{"title":"The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis","googleId":"LkdQEGzqDCIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/19/2111/36909","googleCitationCount":31,"googleAuthor":"R Kramann","doi":"10.1182/blood-2018-02-834820","elsevierAuthor":"Kramann R.","publicationName":"Blood","elsevierCoverDate":"2018-05-10","elsevierCoverDisplayDate":"10 May 2018","elsevierCitationCount":"24","altmetricAuthors":["Rafael Kramann","Rebekka K. Schneider"],"twitterCount":17,"altmetricId":34786394},{"title":"Novel insights into the pathogenesis of T-cell lymphomas","googleId":"9nrVvWkYN9EJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2320/37107","googleCitationCount":26,"googleAuthor":"","doi":"10.1182/blood-2017-11-764357","elsevierAuthor":"Van Arnam J.","publicationName":"Blood","elsevierCoverDate":"2018-05-24","elsevierCoverDisplayDate":"24 May 2018","elsevierCitationCount":"20","altmetricAuthors":["John S. Van Arnam","Megan S. Lim","Kojo S. J. Elenitoba-Johnson"],"twitterCount":38,"altmetricId":38216298},{"title":"Emerging anticoagulant strategies","googleId":"bUUzw1F4-4kJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/2/147/36070","googleCitationCount":44,"googleAuthor":"PL Gross","doi":"10.1182/blood-2016-09-692996","elsevierAuthor":"Fredenburgh J.C.","publicationName":"Blood","elsevierCoverDate":"2017-01-12","elsevierCoverDisplayDate":"12 January 2017","elsevierCitationCount":"33","altmetricAuthors":["James C. Fredenburgh","Peter L. Gross","Jeffrey I. Weitz"],"twitterCount":12,"altmetricId":14822641},{"title":"Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment","googleId":"qAYTnf9iUssJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/735/39451","googleCitationCount":29,"googleAuthor":"S Kaur","doi":"10.1182/blood-2018-01-829663","elsevierAuthor":"Kaur S.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"20","altmetricAuthors":["Simranpreet Kaur","Liza J. Raggatt","Susan M. Millard","Andy C. Wu","Lena Batoon","Rebecca N. Jacobsen","Ingrid G. Winkler","Kelli P. MacDonald","Andrew C. Perkins","David A. Hume","Jean-Pierre Levesque","Allison R. Pettit"],"twitterCount":12,"altmetricId":44181690},{"title":"Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma","googleId":"Ks7OEX3LevkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2240/39544","googleCitationCount":28,"googleAuthor":"HW Tun","doi":"10.1182/blood-2018-02-835496","elsevierAuthor":"Tun H.","publicationName":"Blood","elsevierCoverDate":"2018-11-22","elsevierCoverDisplayDate":"22 November 2018","elsevierCitationCount":"20","altmetricAuthors":["Han W. Tun","Patrick B. Johnston","Lisa M. DeAngelis","Pamela J. Atherton","Levi D. Pederson","Patricia A. Koenig","Craig B. Reeder","Antonio M. Padula Omuro","David Schiff","Brian O’Neill","Jose Pulido","Kurt A. Jaeckle","Christian Grommes","Thomas E. Witzig"],"twitterCount":12,"altmetricId":48955421},{"title":"Minimal residual disease in multiple myeloma: final analysis of the IFM2009 trial","googleId":"JiXhy7vTPEkJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/435/72570","googleCitationCount":32,"googleAuthor":"P Moreau","doi":"10.1182/blood.V130.Suppl_1.435.435","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Lenalidomide maintenance significantly improves outcomes compared to observation irrespective of cytogenetic risk: results of the Myeloma XI trial","googleId":"_t4JDIpVRDAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/436/72685","googleCitationCount":33,"googleAuthor":"C Pawlyn","doi":"10.1182/blood.V130.Suppl_1.436.436","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Results of the myeloproliferative neoplasms-research consortium (MPN-RC) 112 randomized trial of pegylated interferon alfa-2a (PEG) versus hydroxyurea (HU) …","googleId":"UKPGMAEer3MJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/577/263247","googleCitationCount":26,"googleAuthor":"JT Prchal","doi":"10.1182/blood-2018-99-111946","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Can histologic transformation of follicular lymphoma be predicted and prevented?","googleId":"qeSYWb7UNVEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/258/36907","googleCitationCount":37,"googleAuthor":"R Kridel","doi":"10.1182/blood-2017-03-691345","elsevierAuthor":"Kridel R.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"26","altmetricAuthors":["Robert Kridel","Laurie H. Sehn","Randy D. Gascoyne"],"twitterCount":45,"altmetricId":18811331},{"title":"Safety and efficacy of emapalumab in pediatric patients with primary hemophagocytic lymphohistiocytosis","googleId":"wxIp7sWsdWMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/LBA-6/375116","googleCitationCount":24,"googleAuthor":"CE Allen","doi":"10.1182/blood-2018-120810","elsevierAuthor":"Chinello M.","publicationName":"Mediterranean Journal of Hematology and Infectious Diseases","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"A global, randomized, placebo-controlled, phase 3 study of ibrutinib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) in patients …","googleId":"iXivN_K2OUcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/784/266057","googleCitationCount":26,"googleAuthor":"P Johnson","doi":"10.1182/blood-2018-99-112988","elsevierAuthor":"Mondello P.","publicationName":"Hematological Oncology","elsevierCoverDate":"2019-10-01","elsevierCoverDisplayDate":"1 October 2019","elsevierCitationCount":"5","altmetricAuthors":[],"twitterCount":0},{"title":"Venetoclax with low-dose cytarabine induces rapid, deep, and durable responses in previously untreated older adults with AML ineligible for intensive chemotherapy","googleId":"-ofe-puQmBAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/284/263513","googleCitationCount":29,"googleAuthor":"A Wei","doi":"10.1182/blood-2018-99-118729","elsevierAuthor":"Juárez-Salcedo L.","publicationName":"Drugs in Context","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"12","altmetricAuthors":["Andrew Wei","Stephen A. Strickland","Jing-Zhou Hou","Walter Fiedler","Tara L Lin","Roland B. Walter","Anoop K Enjeti","Wan-Jen Hong","Brenda Chyla","Relja Popovic","Kaffa Fakouhi","Tu Xu","John Hayslip","Gail J. Roboz"],"twitterCount":1,"altmetricId":55317801},{"title":"Low relapse rate in younger patients≤ 60 years old with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) treated with crenolanib and cytarabine …","googleId":"TaY4a2mIeVoJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/566/115728","googleCitationCount":35,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.566.566","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"BAFF and CD4+ T cells are major survival factors for long-lived splenic plasma cells in a B-cell–depletion context","googleId":"HGfH18LebFAJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/14/1545/36669","googleCitationCount":32,"googleAuthor":"","doi":"10.1182/blood-2017-06-789578","elsevierAuthor":"Thai L.H.","publicationName":"Blood","elsevierCoverDate":"2018-04-05","elsevierCoverDisplayDate":"5 April 2018","elsevierCitationCount":"22","altmetricAuthors":["Lan-Huong Thai","Simon Le Gallou","Ailsa Robbins","Etienne Crickx","Tatiana Fadeev","Zhicheng Zhou","Nicolas Cagnard","Jérôme Mégret","Christine Bole","Jean-Claude Weill","Claude-Agnès Reynaud","Matthieu Mahévas"],"twitterCount":15,"altmetricId":32390512},{"title":"Phase 2 study of combination obinutuzumab, ibrutinib, and venetoclax in treatment-naive and relapsed/refractory chronic lymphocytic leukemia","googleId":"1eOgtV6-GlIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/693/266034","googleCitationCount":25,"googleAuthor":"FT Awan","doi":"10.1182/blood-2018-99-114169","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells","googleId":"VyYFGezvJtkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/3/321/39258","googleCitationCount":27,"googleAuthor":"A Paikari","doi":"10.1182/blood-2017-11-814335","elsevierAuthor":"Zhang Y.","publicationName":"Blood","elsevierCoverDate":"2018-07-19","elsevierCoverDisplayDate":"19 July 2018","elsevierCitationCount":"19","altmetricAuthors":["Yankai Zhang","Alireza Paikari","Pavel Sumazin","Carly C. Ginter Summarell","Jacy R. Crosby","Eric Boerwinkle","Mitchell J. Weiss","Vivien A. Sheehan"],"twitterCount":8,"altmetricId":43556694},{"title":"Combined infusion of CD19 and Bcma-specific chimeric antigen receptor T cells for RRMM: initial safety and efficacy report from a clinical pilot study","googleId":"lywfQAXTECIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/506/81040","googleCitationCount":32,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.506.506","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"How and when I do allogeneic transplant in CLL","googleId":"eYbaX4vBl6oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/31/39270","googleCitationCount":27,"googleAuthor":"JG Gribben","doi":"10.1182/blood-2018-01-785998","elsevierAuthor":"Gribben J.G.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"19","altmetricAuthors":["John G. Gribben"],"twitterCount":74,"altmetricId":41134473},{"title":"Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology","googleId":"rs0uMaOnvS4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/20/2771/36116","googleCitationCount":34,"googleAuthor":"","doi":"10.1182/blood-2016-11-749978","elsevierAuthor":"Hovorkova L.","publicationName":"Blood","elsevierCoverDate":"2017-05-18","elsevierCoverDisplayDate":"18 May 2017","elsevierCitationCount":"30","altmetricAuthors":["Lenka Hovorkova","Marketa Zaliova","Nicola C. Venn","Kirsten Bleckmann","Marie Trkova","Eliska Potuckova","Martina Vaskova","Jana Linhartova","Katerina Machova Polakova","Eva Fronkova","Walter Muskovic","Jodie E. Giles","Peter J. Shaw","Gunnar Cario","Rosemary Sutton","Jan Stary","Jan Trka","Jan Zuna"],"twitterCount":22,"altmetricId":18065768},{"title":"Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis","googleId":"zmiVieZmkvMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1878/35820","googleCitationCount":36,"googleAuthor":"","doi":"10.1182/blood-2016-11-749507","elsevierAuthor":"Geyer M.B.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"31","altmetricAuthors":["Mark B. Geyer","Meier Hsu","Sean M. Devlin","Martin S. Tallman","Dan Douer","Jae H. Park"],"twitterCount":16,"altmetricId":18305457},{"title":"Case series of potential Wernicke's encephalopathy in patients treated with Fedratinib","googleId":"a30xztsIFJYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4197/72746","googleCitationCount":31,"googleAuthor":"C Jamieson","doi":"10.1182/blood.V130.Suppl_1.4197.4197","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia","googleId":"Dk2viv9p50oJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1333/36009","googleCitationCount":35,"googleAuthor":"F Stölzel","doi":"10.1182/blood-2016-09-738161","elsevierAuthor":"Bochtler T.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"26","altmetricAuthors":["Tilmann Bochtler","Martin Granzow","Friedrich Stölzel","Christina Kunz","Brigitte Mohr","Mutlu Kartal-Kaess","Katrin Hinderhofer","Christoph E. Heilig","Michael Kramer","Christian Thiede","Volker Endris","Martina Kirchner","Albrecht Stenzinger","Axel Benner","Martin Bornhäuser","Gerhard Ehninger","Anthony D. Ho","Anna Jauch","Alwin Krämer"],"twitterCount":4,"altmetricId":16051327},{"title":"Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils","googleId":"8GHiyUdI824J","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/328/36939","googleCitationCount":34,"googleAuthor":"Z Khan","doi":"10.1182/blood-2016-11-752006","elsevierAuthor":"Khan Z.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"22","altmetricAuthors":["Zakir Khan","Xiao Z. Shen","Ellen A. Bernstein","Jorge F. Giani","Masahiro Eriguchi","Tuantuan V. Zhao","Romer A. Gonzalez-Villalobos","Sebastien Fuchs","George Y. Liu","Kenneth E. Bernstein"],"twitterCount":11,"altmetricId":20296503},{"title":"Thrombophilia risk is not increased in children after perinatal stroke","googleId":"y2ixQl9_XEwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/20/2793/36110","googleCitationCount":36,"googleAuthor":"A Mineyko","doi":"10.1182/blood-2016-11-750893","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"0","altmetricAuthors":["Colleen Curtis","Aleksandra Mineyko","Patricia Massicotte","Michael Leaker","Xiu Yan Jiang","Amalia Floer","Adam Kirton"],"twitterCount":24,"altmetricId":16964483},{"title":"Adeno-Associated Mediated Gene Transfer for Hemophilia B: 8 Year Follow up and Impact of Removing Empty Viral Particles on Safety and Efficacy of Gene Transfer","googleId":"QXe-Pye7VMgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/491/262157","googleCitationCount":23,"googleAuthor":"E Tuddenham","doi":"10.1182/blood-2018-99-118334","elsevierAuthor":"Cappella M.","publicationName":"Journal of Neuromuscular Diseases","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0","altmetricAuthors":["Amit C Nathwani","Ulrike Reiss","Edward Tuddenham","Pratima Chowdary","Jenny McIntosh","Anne Riddell","Jun Pie","Johnny N Mahlangu","Michael Recht","Yu-Min Shen","Kathleen G. Halka","Michael M Meagher","Arthur W. Nienhuis","Andrew M. Davidoff","Sarah Mangles","Chris L Morton","Zhou Junfang","Vlad Calin Radulescu"],"twitterCount":1,"altmetricId":52719411},{"title":"Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma","googleId":"X0vlhY3_GtwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2273/39538","googleCitationCount":25,"googleAuthor":"C Baues","doi":"10.1182/blood-2018-05-852129","elsevierAuthor":"Kobe C.","publicationName":"Blood","elsevierCoverDate":"2018-11-22","elsevierCoverDisplayDate":"22 November 2018","elsevierCitationCount":"18","altmetricAuthors":["Carsten Kobe","Helen Goergen","Christian Baues","Georg Kuhnert","Conrad-Amadeus Voltin","Josée Zijlstra","Otto Hoekstra","Jasmin Mettler","Alexander Drzezga","Andreas Engert","Peter Borchmann","Markus Dietlein"],"twitterCount":12,"altmetricId":47528647},{"title":"Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model","googleId":"xJnbEHWNea4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/22/2959/36063","googleCitationCount":32,"googleAuthor":"","doi":"10.1182/blood-2016-08-736454","elsevierAuthor":"Stoddart A.","publicationName":"Blood","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"24","altmetricAuthors":["Angela Stoddart","Jianghong Wang","Chunmei Hu","Anthony A. Fernald","Elizabeth M. Davis","Jason X. Cheng","Michelle M. Le Beau"],"twitterCount":9,"altmetricId":20761010},{"title":"Polycomb repressive complexes in hematological malignancies","googleId":"CzL4RJ_h9OYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/1/23/36222","googleCitationCount":35,"googleAuthor":"","doi":"10.1182/blood-2017-02-739490","elsevierAuthor":"Iwama A.","publicationName":"Blood","elsevierCoverDate":"2017-07-06","elsevierCoverDisplayDate":"6 July 2017","elsevierCitationCount":"28","altmetricAuthors":["Atsushi Iwama"],"twitterCount":2,"altmetricId":21617951},{"title":"PRM-151 in myelofibrosis: efficacy and safety in an open label extension study","googleId":"LEXJ3YcbZ3AJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/686/266439","googleCitationCount":24,"googleAuthor":"I Veletic","doi":"10.1182/blood-2018-99-115362","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis","googleId":"vhHwDpbsWI4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/9/1132/37008","googleCitationCount":31,"googleAuthor":"KR Machlus","doi":"10.1182/blood-2016-11-752840","elsevierAuthor":"Machlus K.","publicationName":"Blood","elsevierCoverDate":"2017-08-31","elsevierCoverDisplayDate":"31 August 2017","elsevierCitationCount":"26","altmetricAuthors":["Kellie R. Machlus","Stephen K. Wu","Prakrith Vijey","Thomas S. Soussou","Zhi-Jian Liu","Eran Shacham","T. J. Unger","Trinayan Kashyap","Boris Klebanov","Martha Sola-Visner","Marsha Crochiere","Joseph E. Italiano","Yosef Landesman"],"twitterCount":2,"altmetricId":24580617},{"title":"How I treat primary mediastinal B-cell lymphoma","googleId":"QIXcMrtGflkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/8/782/39454","googleCitationCount":26,"googleAuthor":"","doi":"10.1182/blood-2018-04-791566","elsevierAuthor":"Giulino-Roth L.","publicationName":"Blood","elsevierCoverDate":"2018-08-23","elsevierCoverDisplayDate":"23 August 2018","elsevierCitationCount":"19","altmetricAuthors":["Lisa Giulino-Roth"],"twitterCount":50,"altmetricId":44565186},{"title":"Critical influences on the pathogenesis of follicular lymphoma","googleId":"-8pS6i17hPwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2297/37112","googleCitationCount":27,"googleAuthor":"R Küppers","doi":"10.1182/blood-2017-11-764365","elsevierAuthor":"Küppers R.","publicationName":"Blood","elsevierCoverDate":"2018-05-24","elsevierCoverDisplayDate":"24 May 2018","elsevierCitationCount":"15","altmetricAuthors":["Ralf Küppers","Freda K. Stevenson"],"twitterCount":23,"altmetricId":38194025},{"title":"IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","googleId":"M-SMDHFIS1QJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/18/2507/36261","googleCitationCount":37,"googleAuthor":"S Pandey","doi":"10.1182/blood-2016-08-737239","elsevierAuthor":"Pandey S.","publicationName":"Blood","elsevierCoverDate":"2017-05-04","elsevierCoverDisplayDate":"4 May 2017","elsevierCitationCount":"29","altmetricAuthors":["Shubham Pandey","Frédéric Mourcin","Tony Marchand","Saba Nayar","Marion Guirriec","Céline Pangault","Céline Monvoisin","Patricia Amé-Thomas","Fabien Guilloton","Joelle Dulong","Mark Coles","Thierry Fest","Anja Mottok","Francesca Barone","Karin Tarte"],"twitterCount":6,"altmetricId":16809402},{"title":"Phase 1 study of Adct-301 (camidanlumab tesirine), a novel pyrrolobenzodiazepine-based antibody drug conjugate, in relapsed/refractory classical Hodgkin …","googleId":"jO5VB86pDTQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/928/266207","googleCitationCount":26,"googleAuthor":"M Hamadani","doi":"10.1182/blood-2018-99-118198","elsevierCitationCount":0,"altmetricAuthors":["Mehdi Hamadani","Graham P. Collins","Felipe Samaniego","Alexander I Spira","Andrew Davies","John Radford","Paolo Caimi","Tobias Menne","Joseph Boni","Hans Cruz","Jay Feingold","Shui He","Jens Wuerthner","Steven M. Horwitz"],"twitterCount":0,"altmetricId":100217119},{"title":"High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT","googleId":"Z-OPRzGVdasJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1345/39606","googleCitationCount":25,"googleAuthor":"DM Arnold","doi":"10.1182/blood-2018-04-847483","elsevierAuthor":"Warkentin T.E.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"19","altmetricAuthors":["Theodore E. Warkentin","Jo-Ann I. Sheppard","Lori-Ann Linkins","Donald M. Arnold","Ishac Nazy"],"twitterCount":5,"altmetricId":46089553},{"title":"The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis","googleId":"bYYdVUcoMiwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120319480","googleCitationCount":24,"googleAuthor":"SR Cataland","doi":"10.1182/blood-2018-02-791533","elsevierAuthor":"Masias C.","publicationName":"Blood","elsevierCoverDate":"2018-08-30","elsevierCoverDisplayDate":"30 August 2018","elsevierCitationCount":"16","altmetricAuthors":["Camila Masias","Spero R. Cataland"],"twitterCount":40,"altmetricId":45309195},{"title":"Obinutuzumab: what is there to learn from clinical trials?","googleId":"tnM2F4-UgZEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/5/581/36784","googleCitationCount":33,"googleAuthor":"","doi":"10.1182/blood-2017-03-771832","elsevierAuthor":"Cartron G.","publicationName":"Blood","elsevierCoverDate":"2017-08-03","elsevierCoverDisplayDate":"3 August 2017","elsevierCitationCount":"26","altmetricAuthors":["Guillaume Cartron","Hervé Watier"],"twitterCount":17,"altmetricId":20876958},{"title":"Slowed decay of mRNAs enhances platelet specific translation","googleId":"_r0fw1F9UhgJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/e38/35955","googleCitationCount":35,"googleAuthor":"EW Mills","doi":"10.1182/blood-2016-08-736108","elsevierAuthor":"Mills E.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"28","altmetricAuthors":["Eric W. Mills","Rachel Green","Nicholas T. Ingolia"],"twitterCount":6,"altmetricId":16543458},{"title":"Nivolumab for newly diagnosed advanced-stage classical Hodgkin lymphoma (cHL): results from the phase 2 Checkmate 205 Study","googleId":"ZxkkFyHA8LQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/651/83546","googleCitationCount":30,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.651.651","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy and safety of single-agent quizartinib (Q), a potent and selective FLT3 inhibitor (FLT3i), in patients (pts) with FLT3-internal tandem duplication (FLT3-ITD) …","googleId":"XV9mjEES24gJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/563/263148","googleCitationCount":23,"googleAuthor":"G Martinelli","doi":"10.1182/blood-2018-99-110439","elsevierAuthor":"Madanat Y.F.","publicationName":"Hematologic Malignancies","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"How I manage ibrutinib-refractory chronic lymphocytic leukemia","googleId":"f2NaKY6abQIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1270/36014","googleCitationCount":39,"googleAuthor":"","doi":"10.1182/blood-2016-09-693598","elsevierAuthor":"Woyach J.A.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"34","altmetricAuthors":["Jennifer A. Woyach"],"twitterCount":45,"altmetricId":15557455},{"title":"How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes","googleId":"m73mP-S0Xc8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/16/1657/39350","googleCitationCount":24,"googleAuthor":"DP Steensma","doi":"10.1182/blood-2018-06-860882","elsevierAuthor":"","publicationName":"Blood","elsevierCoverDate":"2018-11-29","elsevierCoverDisplayDate":"29 November 2018","elsevierCitationCount":"0","altmetricAuthors":["David P. Steensma"],"twitterCount":103,"altmetricId":47705529},{"title":"Ibrutinib plus venetoclax in relapsed/refractory CLL: results of the bloodwise TAP clarity study","googleId":"QQAMQDetDOAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/182/273012","googleCitationCount":27,"googleAuthor":"P Hillmen","doi":"10.1182/blood-2018-182","elsevierCitationCount":0,"altmetricAuthors":["Peter Hillmen","Andy Rawstron","Kristian Brock","Samuel Munoz Vicente","Francesca Yates","Rebecca Bishop","Donald Macdonald","Christopher Fegan","Alison McCaig","Anna Schuh","Andrew Pettitt","John G. Gribben","Piers E.M. Patten","Stephen Devereux","Adrian Bloor","Christopher P. Fox","Francesco Forconi","Talha Munir"],"twitterCount":1,"altmetricId":52299139},{"title":"Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study","googleId":"PVUgggStiD0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2449/37071","googleCitationCount":29,"googleAuthor":"S Luminari","doi":"10.1182/blood-2017-11-816298","elsevierAuthor":"Cottereau A.S.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"21","altmetricAuthors":["Anne Ségolène Cottereau","Annibale Versari","Stefano Luminari","Jehan Dupuis","Loïc Chartier","René-Olivier Casasnovas","Alina Berriolo-Riedinger","Massimo Menga","Corinne Haioun","Hervé Tilly","Vittoria Tarantino","Massimo Federico","Gilles Salles","Judith Trotman","Michel Meignan"],"twitterCount":31,"altmetricId":34645403},{"title":"TET2 deficiency leads to stem cell factor–dependent clonal expansion of dysfunctional erythroid progenitors","googleId":"P5qgNas7zkoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2406/107713","googleCitationCount":23,"googleAuthor":"X Qu","doi":"10.1182/blood-2018-05-853291","elsevierAuthor":"Qu X.","publicationName":"Blood","elsevierCoverDate":"2018-11-29","elsevierCoverDisplayDate":"29 November 2018","elsevierCitationCount":"16","altmetricAuthors":["Xiaoli Qu","Shijie Zhang","Shihui Wang","Yaomei Wang","Wei Li","Yumin Huang","Huizhi Zhao","Xiuyun Wu","Chao An","Xinhua Guo","John Hale","Jie Li","Christopher D. Hillyer","Narla Mohandas","Jing Liu","Karina Yazdanbakhsh","Francesca Vinchi","Lixiang Chen","Qiaozhen Kang","Xiuli An"],"twitterCount":11,"altmetricId":48934058},{"title":"SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice","googleId":"YJxhZy-vpgwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/9/911/39423","googleCitationCount":23,"googleAuthor":"","doi":"10.1182/blood-2018-02-831669","elsevierAuthor":"Hu M.","publicationName":"Blood","elsevierCoverDate":"2018-08-30","elsevierCoverDisplayDate":"30 August 2018","elsevierCitationCount":"21","altmetricAuthors":["Mengjia Hu","Hao Zeng","Shilei Chen","Yang Xu","Song Wang","Yong Tang","Xinmiao Wang","Changhong Du","Mingqiang Shen","Fang Chen","Mo Chen","Cheng Wang","Jining Gao","Fengchao Wang","Yongping Su","Junping Wang"],"twitterCount":11,"altmetricId":47300256},{"title":"BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years","googleId":"UL1Cz43UMaAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/4/456/36177","googleCitationCount":40,"googleAuthor":"M Gavriatopoulou","doi":"10.1182/blood-2016-09-742411","elsevierAuthor":"Gavriatopoulou M.","publicationName":"Blood","elsevierCoverDate":"2017-01-26","elsevierCoverDisplayDate":"26 January 2017","elsevierCitationCount":"34","altmetricAuthors":["Maria Gavriatopoulou","Ramón García-Sanz","Efstathios Kastritis","Pierre Morel","Marie-Christine Kyrtsonis","Eurydiki Michalis","Zafiris Kartasis","Xavier Leleu","Giovanni Palladini","Alessandra Tedeschi","Dimitra Gika","Giampaolo Merlini","Pieter Sonneveld","Meletios A. Dimopoulos"],"twitterCount":19,"altmetricId":13876000},{"title":"Phase 1 cohort expansion of flotetuzumab, a CD123× CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML)","googleId":"VJWyYwHaFfQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/764/266322","googleCitationCount":23,"googleAuthor":"GL Uy","doi":"10.1182/blood-2018-99-117085","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Evidence for superior efficacy and disease modification after three years of prospective randomized controlled treatment of polycythemia vera patients with …","googleId":"9GwtMS3HZXUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/579/263449","googleCitationCount":23,"googleAuthor":"","doi":"10.1182/blood-2018-99-118715","elsevierCitationCount":0,"altmetricAuthors":["Heinz Gisslinger","Christoph Klade","Pencho Georgiev","Dorota Krochmalczyk","Liana Gercheva-Kyuchukova","Miklos Egyed","Viktor Rossiev","Petr Dulicek","Arpad Illes","Halyna Pylypenko","Lylia Sivcheva","Jiri Mayer","Vera Yablokova","Kurt Krejcy","Barbara Grohmann-Izay","Hans Carl Hasselbalch","Robert Kralovics","Jean-Jacques Kiladjian"],"twitterCount":0,"altmetricId":52215808},{"title":"LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis","googleId":"IArPTxXwR30J","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/95/107705","googleCitationCount":30,"googleAuthor":"J Schwaller","doi":"10.1182/blood-2017-05-786962","elsevierAuthor":"El Ashkar S.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"23","altmetricAuthors":["Sara El Ashkar","Juerg Schwaller","Tim Pieters","Steven Goossens","Jonas Demeulemeester","Frauke Christ","Siska Van Belle","Sabine Juge","Nancy Boeckx","Alan Engelman","Pieter Van Vlierberghe","Zeger Debyser","Jan De Rijck"],"twitterCount":6,"altmetricId":28181565},{"title":"How I treat atypical chronic myeloid leukemia","googleId":"WzEre7UiWUEJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/7/838/36180","googleCitationCount":38,"googleAuthor":"","doi":"10.1182/blood-2016-08-693630","elsevierAuthor":"Gotlib J.","publicationName":"Blood","elsevierCoverDate":"2017-02-16","elsevierCoverDisplayDate":"16 February 2017","elsevierCitationCount":"25","altmetricAuthors":["Jason Gotlib"],"twitterCount":31,"altmetricId":14173213},{"title":"Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis","googleId":"G-h6YCUcuxAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/7/946/36986","googleCitationCount":29,"googleAuthor":"","doi":"10.1182/blood-2017-04-777722","elsevierAuthor":"Magina K.N.","publicationName":"Blood","elsevierCoverDate":"2017-08-17","elsevierCoverDisplayDate":"17 August 2017","elsevierCitationCount":"24","altmetricAuthors":["Kinkini N. Magina","Gudrun Pregartner","Armin Zebisch","Albert Wölfler","Peter Neumeister","Hildegard T. Greinix","Andrea Berghold","Heinz Sill"],"twitterCount":16,"altmetricId":21538453},{"title":"Complete responses in relapsed/refractory acute myeloid leukemia (AML) patients on a weekly dosing schedule of XmAb14045, a CD123 x CD3 T cell-engaging …","googleId":"xObuEcVh8DMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/763/266313","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2018-99-119786","elsevierAuthor":"Khanal N.","publicationName":"Clinical Pharmacology and Therapeutics","elsevierCoverDate":"2020-09-01","elsevierCoverDisplayDate":"1 September 2020","elsevierCitationCount":"2","altmetricAuthors":["Farhad Ravandi","Asad Bashey","James M. Foran","Wendy Stock","Raya Mawad","William Blum","M. Wayne Saville","Chelsea M. Johnson","K. Gary J. Vanasse","Thomas Ly","Hagop M. Kantarjian","Bhavana Bhatnagar","Koichi Takahashi","Alice S. Mims"],"twitterCount":0,"altmetricId":99651772},{"title":"Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis","googleId":"7qSO3jd37M4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2298/39522","googleCitationCount":20,"googleAuthor":"","doi":"10.1182/blood-2018-03-836783","elsevierAuthor":"Amin E.","publicationName":"Blood","elsevierCoverDate":"2018-11-22","elsevierCoverDisplayDate":"22 November 2018","elsevierCitationCount":"19","altmetricAuthors":["Elham E. Amin","Ingrid M. Bistervels","Karina Meijer","Lidwine W. Tick","Saskia Middeldorp","Guy Mostard","Marlène van de Poel","Erik H. Serné","Hans M. Otten","Edith M. Klappe","Manuela A. Joore","Hugo ten Cate","Marije ten Wolde","Arina J. ten Cate-Hoek"],"twitterCount":84,"altmetricId":48690656},{"title":"How I diagnose and treat venous thromboembolism in sickle cell disease","googleId":"qNajeWzMFLoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120606541","googleCitationCount":23,"googleAuthor":"AS Shet","doi":"10.1182/blood-2018-03-822593","elsevierAuthor":"Shet A.","publicationName":"Blood","elsevierCoverDate":"2018-10-25","elsevierCoverDisplayDate":"25 October 2018","elsevierCitationCount":"11","altmetricAuthors":["Arun S. Shet","Ted Wun"],"twitterCount":47,"altmetricId":41604831},{"title":"Increased risk of leukemia among sickle cell disease patients in California","googleId":"UhUg7ExDGr0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/13/1597/36516","googleCitationCount":29,"googleAuthor":"A Brunson","doi":"10.1182/blood-2017-05-783233","elsevierAuthor":"Brunson A.","publicationName":"Blood","elsevierCoverDate":"2017-09-28","elsevierCoverDisplayDate":"28 September 2017","elsevierCitationCount":"22","altmetricAuthors":["Ann Brunson","Theresa H. M. Keegan","Heejung Bang","Anjlee Mahajan","Susan Paulukonis","Ted Wun"],"twitterCount":13,"altmetricId":24485444},{"title":"Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia","googleId":"Lay77fT0D6UJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1876/35806","googleCitationCount":34,"googleAuthor":"S Perez","doi":"10.1182/blood-2016-10-748210","elsevierAuthor":"Ghia P.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"26","altmetricAuthors":["Paolo Ghia","Lydia Scarfò","Susan Perez","Kumudu Pathiraja","Martha Derosier","Karen Small","Christine McCrary Sisk","Nigel Patton"],"twitterCount":5,"altmetricId":16003527},{"title":"A phase 1/2 trial of investigational SPK-8011 in hemophilia A demonstrates durable expression and prevention of bleeds","googleId":"_5wv_m5RtkEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/487/262202","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2018-99-115495","elsevierAuthor":"Arruda V.R.","publicationName":"Mediterranean Journal of Hematology and Infectious Diseases","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia","googleId":"qydLLcx4EX0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/25/2750/36875","googleCitationCount":28,"googleAuthor":"","doi":"10.1182/blood-2017-05-784603","elsevierAuthor":"Serafin V.","publicationName":"Blood","elsevierCoverDate":"2017-12-21","elsevierCoverDisplayDate":"21 December 2017","elsevierCitationCount":"14","altmetricAuthors":["Valentina Serafin","Giorgia Capuzzo","Gloria Milani","Sonia Anna Minuzzo","Marica Pinazza","Roberta Bortolozzi","Silvia Bresolin","Elena Porcù","Chiara Frasson","Stefano Indraccolo","Giuseppe Basso","Benedetta Accordi"],"twitterCount":10,"altmetricId":30978258},{"title":"Clinical activity in a phase 1 study of Blu-285, a potent, highly-selective inhibitor of KIT D816V in advanced systemic mastocytosis (AdvSM)","googleId":"0UXqgSVihbkJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2/71272","googleCitationCount":29,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2.2","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL","googleId":"M4r_Ua6S2TUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/405/103901","googleCitationCount":23,"googleAuthor":"","doi":"10.1182/blood-2018-03-836528","elsevierAuthor":"Testi A.M.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"12","altmetricAuthors":["Anna Maria Testi","Andrea Pession","Daniela Diverio","David Grimwade","Brenda Gibson","Amilcar Cardoso de Azevedo","Lorena Moran","Guy Leverger","Sarah Elitzur","Henrik Hasle","Jutte van der Werff ten Bosch","Owen Smith","Marisa De Rosa","Alfonso Piciocchi","Francesco Lo Coco","Robin Foà","Franco Locatelli","Gertjan J. L. Kaspers"],"twitterCount":26,"altmetricId":42398243},{"title":"The disulfide isomerase ERp72 supports arterial thrombosis in mice","googleId":"j-RHiaru1F8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/6/817/36797","googleCitationCount":29,"googleAuthor":"Y Wu","doi":"10.1182/blood-2016-12-755587","elsevierAuthor":"Zhou J.","publicationName":"Blood","elsevierCoverDate":"2017-08-10","elsevierCoverDisplayDate":"10 August 2017","elsevierCitationCount":"25","altmetricAuthors":["Junsong Zhou","Yi Wu","Fengwu Chen","Lu Wang","Lubica Rauova","Vincent M. Hayes","Mortimer Poncz","Hong Li","Tong Liu","Junling Liu","David W. Essex"],"twitterCount":2,"altmetricId":23571699},{"title":"Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia","googleId":"IZN0p_u_0iMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/170/39232","googleCitationCount":24,"googleAuthor":"MK Hasan","doi":"10.1182/blood-2017-12-819383","elsevierAuthor":"Hasan K.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"19","altmetricAuthors":["Md Kamrul Hasan","Jian Yu","George F. Widhopf","Laura Z. Rassenti","Liguang Chen","Zhouxin Shen","Steven P. Briggs","Donna S. Neuberg","Thomas J. Kipps"],"twitterCount":4,"altmetricId":38778198},{"title":"Extravascular coagulation in hematopoietic stem and progenitor cell regulation","googleId":"8pbrGKQFMpwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/123/39213","googleCitationCount":21,"googleAuthor":"","doi":"10.1182/blood-2017-12-768986","elsevierAuthor":"Nguyen T.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"16","altmetricAuthors":["T. Son Nguyen","Tsvee Lapidot","Wolfram Ruf"],"twitterCount":7,"altmetricId":43371935},{"title":"Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma","googleId":"hHLqttqVh7AJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/2/179/39226","googleCitationCount":26,"googleAuthor":"L Milan","doi":"10.1182/blood-2018-01-826958","elsevierAuthor":"Ceriani L.","publicationName":"Blood","elsevierCoverDate":"2018-07-12","elsevierCoverDisplayDate":"12 July 2018","elsevierCitationCount":"17","altmetricAuthors":["Luca Ceriani","Lisa Milan","Maurizio Martelli","Andrés J. M. Ferreri","Luciano Cascione","Pier Luigi Zinzani","Alice Di Rocco","Annarita Conconi","Anastasios Stathis","Franco Cavalli","Monica Bellei","Kelly Cozens","Elena Porro","Luca Giovanella","Peter W. Johnson","Emanuele Zucca"],"twitterCount":30,"altmetricId":40659675},{"title":"How I treat the blast phase of Philadelphia chromosome–negative myeloproliferative neoplasms","googleId":"9zMudGvsxqsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2339/107700","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2018-03-785907","elsevierAuthor":"Odenike O.","publicationName":"Blood","elsevierCoverDate":"2018-11-29","elsevierCoverDisplayDate":"29 November 2018","elsevierCitationCount":"17","altmetricAuthors":["Olatoyosi Odenike"],"twitterCount":16,"altmetricId":49949104},{"title":"Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI","googleId":"6r2VN6r1iG8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/1008/36353","googleCitationCount":37,"googleAuthor":"P Agarwal","doi":"10.1182/blood-2016-05-714089","elsevierAuthor":"Agarwal P.","publicationName":"Blood","elsevierCoverDate":"2017-02-23","elsevierCoverDisplayDate":"23 February 2017","elsevierCitationCount":"26","altmetricAuthors":["Puneet Agarwal","Bin Zhang","Yinwei Ho","Amy Cook","Ling Li","Fady M. Mikhail","Youzhen Wang","Margaret E. McLaughlin","Ravi Bhatia"],"twitterCount":2,"altmetricId":16896387},{"title":"UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice","googleId":"ndRIy61Xj2MJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2564/39547","googleCitationCount":20,"googleAuthor":"S Hussain","doi":"10.1182/blood-2018-05-848515","elsevierAuthor":"Hussain S.","publicationName":"Blood","elsevierCoverDate":"2018-12-13","elsevierCoverDisplayDate":"13 December 2018","elsevierCitationCount":"14","altmetricAuthors":["Sajjad Hussain","Tibor Bedekovics","Qiuying Liu","Wenqian Hu","Haeseung Jeon","Sarah H. Johnson","George Vasmatzis","Danielle G. May","Kyle J. Roux","Paul J. Galardy"],"twitterCount":6,"altmetricId":48960785},{"title":"Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum","googleId":"WrQ7ZWDmW2gJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1111/36416","googleCitationCount":24,"googleAuthor":"","doi":"10.1182/blood-2017-08-802918","elsevierAuthor":"Zhang M.Y.","publicationName":"Blood","elsevierCoverDate":"2018-03-08","elsevierCoverDisplayDate":"8 March 2018","elsevierCitationCount":"12","altmetricAuthors":["Meng-Yao Zhang","Yang Zhang","Xiao-Dong Wu","Kun Zhang","Peng Lin","Hui-Jie Bian","Min-Min Qin","Wan Huang","Ding Wei","Zhao Zhang","Jiao Wu","Ruo Chen","Fei Feng","Bin Wang","Gang Nan","Ping Zhu","Zhi-Nan Chen"],"twitterCount":14,"altmetricId":32025456},{"title":"How I treat myelofibrosis after failure of JAK inhibitors","googleId":"xLRiUcvxIWUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S000649712032022X","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2018-02-785923","elsevierAuthor":"Pardanani A.","publicationName":"Blood","elsevierCoverDate":"2018-08-02","elsevierCoverDisplayDate":"2 August 2018","elsevierCitationCount":"12","altmetricAuthors":["Animesh Pardanani","Ayalew Tefferi"],"twitterCount":54,"altmetricId":43301917},{"title":"Tissue-type plasminogen activator regulates macrophage activation and innate immunity","googleId":"n9dWkbAmajQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/11/1364/36463","googleCitationCount":29,"googleAuthor":"E Mantuano","doi":"10.1182/blood-2017-04-780205","elsevierAuthor":"Mantuano E.","publicationName":"Blood","elsevierCoverDate":"2017-09-14","elsevierCoverDisplayDate":"14 September 2017","elsevierCitationCount":"22","altmetricAuthors":["Elisabetta Mantuano","Pardis Azmoon","Coralie Brifault","Michael A. Banki","Andrew S. Gilder","Wendy M. Campana","Steven L. Gonias"],"twitterCount":5,"altmetricId":21737075},{"title":"Blinatumomab in combination with immune checkpoint inhibitors of PD-1 and CTLA-4 in adult patients with relapsed/refractory (R/R) CD19 positive B-cell acute …","googleId":"RlFvahsCVfcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/557/262977","googleCitationCount":22,"googleAuthor":"J Webster","doi":"10.1182/blood-2018-99-111845","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Initial results of the phase 2 treatment naive cohort in a phase 1b/2 study of obinutuzumab, ibrutinib, and venetoclax in chronic lymphocytic leukemia","googleId":"rXNwtDNKOKAJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/431/72605","googleCitationCount":28,"googleAuthor":"FT Awan","doi":"10.1182/blood.V130.Suppl_1.431.431","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Daratumumab monotherapy for patients with intermediate or high-risk smoldering multiple myeloma (SMM): Centaurus, a randomized, open-label, multicenter phase 2 …","googleId":"jUvlwC6K6agJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/510/81019","googleCitationCount":31,"googleAuthor":"CC Hofmeister","doi":"10.1182/blood.V130.Suppl_1.510.510","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Vaccine therapy in hematologic malignancies","googleId":"5VL86YpymBcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/24/2640/37160","googleCitationCount":21,"googleAuthor":"","doi":"10.1182/blood-2017-11-785873","elsevierAuthor":"Avigan D.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"17","altmetricAuthors":["David Avigan","Jacalyn Rosenblatt"],"twitterCount":7,"altmetricId":43755625},{"title":"Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing","googleId":"9NeUiJECPSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2915/39188","googleCitationCount":28,"googleAuthor":"C Li","doi":"10.1182/blood-2018-03-838540","elsevierAuthor":"Li C.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"23","altmetricAuthors":["Chang Li","Nikoletta Psatha","Pavel Sova","Sucheol Gil","Hongjie Wang","Jiho Kim","Chandana Kulkarni","Cristina Valensisi","R. David Hawkins","George Stamatoyannopoulos","André Lieber"],"twitterCount":3,"altmetricId":42496809},{"title":"Curative strategy for high-risk smoldering myeloma (GEM-CESAR): carfilzomib, lenalidomide and dexamethasone (KRd) as induction followed by HDT-ASCT …","googleId":"JTZM0nvRy-gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/402/72665","googleCitationCount":31,"googleAuthor":"MV Mateos","doi":"10.1182/blood.V130.Suppl_1.402.402","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A phase 1 study with point-of-care manufacturing of dual targeted, tandem anti-CD19, anti-CD20 chimeric antigen receptor modified T (CAR-T) cells for relapsed …","googleId":"BwLp8lmC804J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4193/275540","googleCitationCount":22,"googleAuthor":"NN Shah","doi":"10.1182/blood-2018-99-110194","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"How I treat type 2B von Willebrand disease","googleId":"VTMR4hCcbEIJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/12/1292/36611","googleCitationCount":24,"googleAuthor":"","doi":"10.1182/blood-2017-06-742692","elsevierAuthor":"Kruse-Jarres R.","publicationName":"Blood","elsevierCoverDate":"2018-03-22","elsevierCoverDisplayDate":"22 March 2018","elsevierCitationCount":"18","altmetricAuthors":["Rebecca Kruse-Jarres","Jill M. Johnsen"],"twitterCount":31,"altmetricId":32408367},{"title":"Daratumumab, bortezomib, and dexamethasone (DVd) versus bortezomib and dexamethasone (Vd) in relapsed or refractory multiple myeloma (RRMM): updated …","googleId":"EXXk84CzKRcJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3145/80795","googleCitationCount":27,"googleAuthor":"MV Mateos","doi":"10.1182/blood.V130.Suppl_1.3145.3145","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival","googleId":"Uyik2sm60B8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2026/39485","googleCitationCount":23,"googleAuthor":"N Yusufova","doi":"10.1182/blood-2018-02-831438","elsevierAuthor":"Lu X.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"18","altmetricAuthors":["Xiaoqing Lu","Tharu M. Fernando","Chen Lossos","Nevin Yusufova","Fan Liu","Lorena Fontán","Matthew Durant","Huimin Geng","Jacob Melnick","Yuan Luo","Francisco Vega","Vincent Moy","Giorgio Inghirami","Stephen Nimer","Ari M. Melnick","Izidore S. Lossos"],"twitterCount":13,"altmetricId":46270109},{"title":"Ivosidenib or enasidenib combined with standard induction chemotherapy is well tolerated and active in patients with newly diagnosed AML with an IDH1 or IDH2 …","googleId":"oMDWR35utgQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/726/83457","googleCitationCount":28,"googleAuthor":"AS Mims","doi":"10.1182/blood.V130.Suppl_1.726.726","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ibrutinib+ obinutuzumab versus chlorambucil+ obinutuzumab as first-line treatment in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL …","googleId":"5Mf4iQKG2koJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/691/266013","googleCitationCount":22,"googleAuthor":"C Moreno","doi":"10.1182/blood-2018-99-111370","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Maintenance with 5-azacytidine for acute myeloid leukemia and myelodysplastic syndrome patients","googleId":"JczyQRBSej4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/971/266187","googleCitationCount":23,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood-2018-99-111582","elsevierCitationCount":0,"altmetricAuthors":["Betul Oran","Marcos de Lima","Guillermo Garcia-Manero","Peter F Thall","Ruitao Lin","Amin M. Alousi","Chitra Hosing","Partow Kebriaei","Uday Popat","Sergio Giralt","Sairah Ahmed","Elizabeth J. Shpall","Borje S Andersson","Qaiser Bashir","Stefan O. Ciurea","Katy Rezvani","Glenda Woodworth","Richard E Champlin"],"twitterCount":3,"altmetricId":58935801},{"title":"Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding","googleId":"-DQRW9_hKqQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/24/3210/36304","googleCitationCount":32,"googleAuthor":"","doi":"10.1182/blood-2016-12-758250","elsevierAuthor":"Belderbos M.","publicationName":"Journal of Experimental Medicine","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"1 January 2018","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Preliminary results from a phase Ib study evaluating BCL-2 inhibitor venetoclax in combination with MEK inhibitor cobimetinib or MDM2 inhibitor idasanutlin in patients …","googleId":"Tl9fp07TfbUJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/813/83471","googleCitationCount":27,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.813.813","elsevierCitationCount":0,"altmetricAuthors":["Daver, Naval","Pollyea, Daniel A.","Yee, Karen W.L.","Fenaux, Pierre","Brandwein, Joseph M.","Vey, Norbert","Martinelli, Giovanni","Kelly, Kevin R","Roboz, Gail J.","Garcia, Jacqueline S.","Pigneux, Arnaud","Kshirsagar, Smita","Dail, Monique","Wang, Jue","Mobasher, Mehrdad","Chen, Lin-Chi","Hong, Wan-Jen","Konopleva, Marina","Andreeff, Michael"],"twitterCount":0,"altmetricId":99631546},{"title":"Incidence and type of opportunistic infections during ibrutinib treatment at a single academic center","googleId":"32qy4YD6-X8J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/830/83667","googleCitationCount":26,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.830.830","elsevierAuthor":"Davis J.S.","publicationName":"Clinical Microbiology Reviews","elsevierCoverDate":"2020-07-01","elsevierCoverDisplayDate":"July 2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"CD30-chimeric antigen receptor (CAR) T cells for therapy of Hodgkin lymphoma (HL)","googleId":"QGR6LR8KrNwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/680/266379","googleCitationCount":21,"googleAuthor":"CA Ramos","doi":"10.1182/blood-2018-99-111202","elsevierCitationCount":0,"altmetricAuthors":["Carlos A. Ramos","Mrinalini Bilgi","Claudia P. Gerken","Olga Dakhova","Zhuyong Mei","Bambi J. Grilley","Adrian P. Gee","Cliona M. Rooney","Gianpietro Dotti","Barbara Savoldo","Helen E. Heslop","Malcolm K. Brenner"],"twitterCount":0,"altmetricId":52488348},{"title":"Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma","googleId":"u-5r3O-2e1cJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/7/771/39304","googleCitationCount":27,"googleAuthor":"","doi":"10.1182/blood-2017-09-805663","elsevierAuthor":"Kohnken R.","publicationName":"Blood","elsevierCoverDate":"2018-02-15","elsevierCoverDisplayDate":"15 February 2018","elsevierCitationCount":"21","altmetricAuthors":["Rebecca Kohnken","Jing Wen","Bethany Mundy-Bosse","Kathleen McConnell","Ashleigh Keiter","Leah Grinshpun","Alex Hartlage","Max Yano","Betina McNeil","Nitin Chakravarti","Basem William","James E. Bradner","Michael A. Caligiuri","Pierluigi Porcu","Anjali Mishra"],"twitterCount":4,"altmetricId":29736274},{"title":"Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice","googleId":"n6sfSD7GlP4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/563/104412","googleCitationCount":24,"googleAuthor":"","doi":"10.1182/blood-2017-08-801738","elsevierAuthor":"Zhou Y.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"24","altmetricAuthors":["Yuan Zhou","Wei Cai","Zilong Zhao","Tristan Hilton","Min Wang","Jason Yeon","Wei Liu","Fangyi Zhang","Fu-Dong Shi","Xiaoping Wu","Perumal Thiagarajan","Min Li","Jianning Zhang","Jing-fei Dong"],"twitterCount":3,"altmetricId":32526433},{"title":"Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): updated analysis of the keynote-170 phase 2 trial","googleId":"6VbGTaLrmsQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2833/80639","googleCitationCount":27,"googleAuthor":"PL Zinzani","doi":"10.1182/blood.V130.Suppl_1.2833.2833","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model","googleId":"Mt0R9I4pt4gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/2/146/36705","googleCitationCount":27,"googleAuthor":"DM Woods","doi":"10.1182/blood-2016-08-731505","elsevierAuthor":"Woods D.M.","publicationName":"Blood","elsevierCoverDate":"2017-07-13","elsevierCoverDisplayDate":"13 July 2017","elsevierCitationCount":"20","altmetricAuthors":["David M. Woods","Karrune V. Woan","Fengdong Cheng","Andressa L. Sodré","Dapeng Wang","Yongxia Wu","Zi Wang","Jie Chen","John Powers","Javier Pinilla-Ibarz","Yu","Ya Zhang","Xuefeng Wu","Xiaoyan Zheng","Jeffrey Weber","Wayne W. Hancock","Edward Seto","Alejandro Villagra","Xue-Zhong Yu","Eduardo M. Sotomayor"],"twitterCount":11,"altmetricId":20667606},{"title":"Promising activity of nelfinavir-Bortezomib-Dexamethasone in proteasome inhibitor–refractory multiple myeloma","googleId":"MmufFIq9YDoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2097/39455","googleCitationCount":19,"googleAuthor":"U Novak","doi":"10.1182/blood-2018-05-851170","elsevierAuthor":"Driessen C.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"15","altmetricAuthors":["Christoph Driessen","Rouven Müller","Urban Novak","Nathan Cantoni","Daniel Betticher","Nicolas Mach","Axel Rüfer","Ulrich Mey","Panagiotis Samaras","Karin Ribi","Lenka Besse","Andrej Besse","Catherine Berset","Stephanie Rondeau","Hanne Hawle","Felicitas Hitz","Thomas Pabst","Thilo Zander"],"twitterCount":12,"altmetricId":48705822},{"title":"BCR-ABL–specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors","googleId":"fCnRB9Yox0YJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/582/36170","googleCitationCount":34,"googleAuthor":"","doi":"10.1182/blood-2016-07-731091","elsevierAuthor":"Comoli P.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"23","altmetricAuthors":["Patrizia Comoli","Sabrina Basso","Giovanni Riva","Patrizia Barozzi","Ilaria Guido","Antonella Gurrado","Giuseppe Quartuccio","Laura Rubert","Ivana Lagreca","Daniela Vallerini","Fabio Forghieri","Monica Morselli","Paola Bresciani","Angela Cuoghi","Ambra Paolini","Elisabetta Colaci","Roberto Marasca","Antonio Cuneo","Lorenzo Iughetti","Tommaso Trenti","Franco Narni","Robin Foà","Marco Zecca","Mario Luppi","Leonardo Potenza"],"twitterCount":23,"altmetricId":14546137},{"title":"Differentiation-based model of hematopoietic stem cell functions and lineage pathways","googleId":"mmE0xYO9EGQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1106/39354","googleCitationCount":21,"googleAuthor":"T Höfer","doi":"10.1182/blood-2018-03-791517","elsevierAuthor":"Höfer T.","publicationName":"Blood","elsevierCoverDate":"2018-09-13","elsevierCoverDisplayDate":"13 September 2018","elsevierCitationCount":"12","altmetricAuthors":["Thomas Höfer","Hans-Reimer Rodewald"],"twitterCount":8,"altmetricId":45566186},{"title":"Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis","googleId":"y0SFdbUb-fgJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2161/36398","googleCitationCount":32,"googleAuthor":"EW Livingston","doi":"10.1182/blood-2016-08-734053","elsevierAuthor":"Sun J.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"26","altmetricAuthors":[],"twitterCount":0},{"title":"Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study","googleId":"i3F4eGeJH2gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/547/39375","googleCitationCount":23,"googleAuthor":"F Paoloni","doi":"10.1182/blood-2018-03-835413","elsevierAuthor":"Rossi G.","publicationName":"Blood","elsevierCoverDate":"2018-08-02","elsevierCoverDisplayDate":"2 August 2018","elsevierCitationCount":"15","altmetricAuthors":["Giuseppe Rossi","Doriana Gramegna","Francesca Paoloni","Bruno Fattizzo","Francesca Binda","Mariella D’Adda","Mirko Farina","Elisa Lucchini","Francesca Romana Mauro","Flavia Salvi","Monia Marchetti","Paola Fazi","Francesco Zaja","Wilma Barcellini"],"twitterCount":7,"altmetricId":46226234},{"title":"Safety, efficacy and MRD negativity of a combination of venetoclax and obinutuzumab in patients with previously untreated chronic lymphocytic leukemia-results from …","googleId":"JiHaJQatsAoJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/430/72939","googleCitationCount":27,"googleAuthor":"JG Gribben","doi":"10.1182/blood.V130.Suppl_1.430.430","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Hypoxia downregulates protein S expression","googleId":"zF_Q16ZlSs4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/452/103891","googleCitationCount":20,"googleAuthor":"VS Pilli","doi":"10.1182/blood-2018-04-841585","elsevierAuthor":"Pilli V.S.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"16","altmetricAuthors":["Vijaya S. Pilli","Arani Datta","Sadaf Afreen","Donna Catalano","Gyongyi Szabo","Rinku Majumder"],"twitterCount":6,"altmetricId":45783874},{"title":"Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients","googleId":"0wO_rVLI-dwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2143/36374","googleCitationCount":29,"googleAuthor":"D Pinato","doi":"10.1182/blood-2016-10-747477","elsevierAuthor":"Pria A.D.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"21","altmetricAuthors":["Alessia Dalla Pria","David Pinato","Jennifer Roe","Kikeri Naresh","Mark Nelson","Mark Bower"],"twitterCount":9,"altmetricId":16012428},{"title":"Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells","googleId":"brC3XBGBzq4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2670/39591","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2018-06-856203","elsevierAuthor":"Kabrani E.","publicationName":"Blood","elsevierCoverDate":"2018-12-20","elsevierCoverDisplayDate":"20 December 2018","elsevierCitationCount":"16","altmetricAuthors":["Eleni Kabrani","Van Trung Chu","Evangelia Tasouri","Thomas Sommermann","Kevin Baßler","Thomas Ulas","Thorsten Zenz","Lars Bullinger","Joachim L. Schultze","Klaus Rajewsky","Sandrine Sander"],"twitterCount":8,"altmetricId":49953909},{"title":"Treatment with combination of dabrafenib and trametinib in patients with recurrent/refractory BRAF V600E-mutated hairy cell leukemia (HCL)","googleId":"ZqdPa-OsnEkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/391/264975","googleCitationCount":19,"googleAuthor":"P Moreau","doi":"10.1182/blood-2018-99-113135","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"How I manage the toxicities of myeloma drugs","googleId":"bo7tal7qPwwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/17/2359/35945","googleCitationCount":28,"googleAuthor":"M Delforge","doi":"10.1182/blood-2017-01-725705","elsevierAuthor":"Delforge M.","publicationName":"Blood","elsevierCoverDate":"2017-04-27","elsevierCoverDisplayDate":"27 April 2017","elsevierCitationCount":"21","altmetricAuthors":["Michel Delforge","Heinz Ludwig"],"twitterCount":80,"altmetricId":17168331},{"title":"CK2β regulates thrombopoiesis and Ca2+-triggered platelet activation in arterial thrombosis","googleId":"aNX_W853PQIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/25/2774/36887","googleCitationCount":24,"googleAuthor":"","doi":"10.1182/blood-2017-05-784413","elsevierAuthor":"Münzer P.","publicationName":"Blood","elsevierCoverDate":"2017-12-21","elsevierCoverDisplayDate":"21 December 2017","elsevierCitationCount":"18","altmetricAuthors":["Patrick Münzer","Britta Walker-Allgaier","Sascha Geue","Friederike Langhauser","Eva Geuss","David Stegner","Katja Aurbach","Daniela Semeniak","Madhumita Chatterjee","Irene Gonzalez Menendez","Melanie Märklin","Leticia Quintanilla-Martinez","Helmut R. Salih","David W. Litchfield","Thierry Buchou","Christoph Kleinschnitz","Florian Lang","Bernhard Nieswandt","Irina Pleines","Harald Schulze","Meinrad Gawaz","Oliver Borst"],"twitterCount":4,"altmetricId":30772392},{"title":"Updated safety and efficacy of venetoclax with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","googleId":"dGNGeGxvYA0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2628/79868","googleCitationCount":27,"googleAuthor":"BA Jonas","doi":"10.1182/blood.V130.Suppl_1.2628.2628","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Sotatercept (ACE-011) alone and in combination with ruxolitinib in patients (pts) with myeloproliferative neoplasm (MPN)-associated myelofibrosis (MF) and anemia","googleId":"uyoBVFXNcB8J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/255/79927","googleCitationCount":25,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.255.255","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome: results …","googleId":"deyXuhRZYpMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1812/272936","googleCitationCount":20,"googleAuthor":"JM Watts","doi":"10.1182/blood-2018-99-111264","elsevierAuthor":"Fernández Delgado N.D.","publicationName":"Revista Cubana de Hematologia, Inmunologia y Hemoterapia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"First-in-human study of the EZH1/2 dual inhibitor DS-3201b in patients with relapsed or refractory non-Hodgkin lymphomas—preliminary results","googleId":"y7chqx8iSsEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4070/72772","googleCitationCount":26,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.4070.4070","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling","googleId":"Fwu4w0-G05cJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/6/674/39225","googleCitationCount":22,"googleAuthor":"E Liu","doi":"10.1182/blood-2017-02-768218","elsevierAuthor":"Rothmeier A.","publicationName":"Blood","elsevierCoverDate":"2018-02-08","elsevierCoverDisplayDate":"8 February 2018","elsevierCitationCount":"21","altmetricAuthors":["Andrea S. Rothmeier","Enbo Liu","Sagarika Chakrabarty","Jennifer Disse","Barbara M. Mueller","Henrik Østergaard","Wolfram Ruf"],"twitterCount":2,"altmetricId":30649608},{"title":"Donor-derived MDS/AML in families with germline GATA2 mutation","googleId":"-TwsK9OWwjoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1994/39608","googleCitationCount":19,"googleAuthor":"AP Hsu","doi":"10.1182/blood-2018-07-861070","elsevierAuthor":"Galera P.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"14","altmetricAuthors":["Pallavi Galera","Amy P. Hsu","Weixin Wang","Stephenie Droll","Rui Chen","Jason R. Schwartz","Jeffery M. Klco","Sally Arai","Luke Maese","Christa Zerbe","Mark J. Parta","Neal S. Young","Steven M. Holland","Dennis D. Hickstein","Katherine R. Calvo"],"twitterCount":20,"altmetricId":48702934},{"title":"An international registry of survivors with Hb Bart's hydrops fetalis syndrome","googleId":"OE64qzUUBYkJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1251/35989","googleCitationCount":32,"googleAuthor":"","doi":"10.1182/blood-2016-08-697110","elsevierAuthor":"Songdej D.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"18","altmetricAuthors":["Duantida Songdej","Christian Babbs","Douglas R. Higgs"],"twitterCount":6,"altmetricId":15332028},{"title":"Results of a phase 2, open-label study of idarubicin (I), cytarabine (A) and nivolumab (Nivo) in patients with newly diagnosed acute myeloid leukemia (AML) and high …","googleId":"-55YAA4vmJEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/905/266416","googleCitationCount":20,"googleAuthor":"R Assi","doi":"10.1182/blood-2018-99-116078","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding","googleId":"6UiyL2QOQeAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/e35/39549","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2018-02-831982","elsevierAuthor":"Baaten C.C.F.M.J.","publicationName":"Blood","elsevierCoverDate":"2018-12-13","elsevierCoverDisplayDate":"13 December 2018","elsevierCitationCount":"14","altmetricAuthors":["Constance C. F. M. J. Baaten","Stuart Meacham","Susanne M. de Witt","Marion A. H. Feijge","David J. Adams","Jan-Willem N. Akkerman","Judith M. E. M. Cosemans","Luigi Grassi","Steve Jupe","Myrto Kostadima","Nadine J. A. Mattheij","Martin H. Prins","Ramiro Ramirez-Solis","Oliver Soehnlein","Frauke Swieringa","Christian Weber","Jacqueline K. White","Willem H. Ouwehand","Johan W. M. Heemskerk"],"twitterCount":5,"altmetricId":49598109},{"title":"A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 …","googleId":"MvjCwiozu9sJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3229/263918","googleCitationCount":19,"googleAuthor":"","doi":"10.1182/blood-2018-99-110427","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease","googleId":"IytcZRQyDnQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/101/39273","googleCitationCount":20,"googleAuthor":"MD Chatfield","doi":"10.1182/blood-2018-02-830562","elsevierAuthor":"Sandhu K.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"15","altmetricAuthors":["Kam Sandhu","Kaledas Flintoff","Mark D. Chatfield","Jeannette L. Dixon","Louise E. Ramm","Grant A. Ramm","Lawrie W. Powell","V. Nathan Subramaniam","Daniel F. Wallace"],"twitterCount":8,"altmetricId":41277256},{"title":"Ivosidenib (AG-120) in mutant IDH1 AML and advanced hematologic malignancies: results of a phase 1 dose escalation and expansion study","googleId":"noXNh4hfngMJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/725/83443","googleCitationCount":25,"googleAuthor":"S De Botton","doi":"10.1182/blood.V130.Suppl_1.725.725","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis","googleId":"LuPAiPrxhdcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/934/36327","googleCitationCount":30,"googleAuthor":"","doi":"10.1182/blood-2016-09-728006","elsevierAuthor":"Skeith L.","publicationName":"Blood","elsevierCoverDate":"2017-02-23","elsevierCoverDisplayDate":"23 February 2017","elsevierCitationCount":"19","altmetricAuthors":["Leslie Skeith","Marc Carrier","Susan E. Robinson","Samah Alimam","Marc A. Rodger"],"twitterCount":35,"altmetricId":15220029},{"title":"Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition","googleId":"knvzpuNa-xIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/647/39443","googleCitationCount":18,"googleAuthor":"S Wu","doi":"10.1182/blood-2018-01-830901","elsevierAuthor":"Wu S.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"9","altmetricAuthors":["Sangwook Wu","Xuejie Chen","Da-Yun Jin","Darrel W. Stafford","Lee G. Pedersen","Jian-Ke Tie"],"twitterCount":3,"altmetricId":46328317},{"title":"Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy","googleId":"Gd8jISl7FPMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2466/37086","googleCitationCount":23,"googleAuthor":"W Yang","doi":"10.1182/blood-2017-11-815506","elsevierAuthor":"Nishii R.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"17","altmetricAuthors":["Rina Nishii","Takaya Moriyama","Laura J. Janke","Wenjian Yang","Chase C. Suiter","Ting-Nien Lin","Lie Li","Kentaro Kihira","Hidemi Toyoda","Ute Hofmann","Matthias Schwab","Masatoshi Takagi","Tomohiro Morio","Atsushi Manabe","Shirley Kham","Nan Jiang","Karen R. Rabin","Motohiro Kato","Katsuyoshi Koh","Allen Eng-Juh Yeoh","Hiroki Hori","Jun J. Yang"],"twitterCount":17,"altmetricId":34829737},{"title":"Inotuzumab ozogamicin in combination with bosutinib for patients with relapsed or refractory Ph+ ALL or CML in lymphoid blast phase","googleId":"OIOOB-bSbgEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/143/79401","googleCitationCount":23,"googleAuthor":"N Jain","doi":"10.1182/blood.V130.Suppl_1.143.143","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","googleId":"pDhun_bdzGwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2309/39535","googleCitationCount":17,"googleAuthor":"S Narumi","doi":"10.1182/blood-2017-05-787390","elsevierAuthor":"Nagata Y.","publicationName":"Blood","elsevierCoverDate":"2018-11-22","elsevierCoverDisplayDate":"22 November 2018","elsevierCitationCount":"12","altmetricAuthors":["Yasunobu Nagata","Satoshi Narumi","Yihong Guan","Bartlomiej P. Przychodzen","Cassandra M. Hirsch","Hideki Makishima","Hirohito Shima","Mai Aly","Victor Pastor","Teodora Kuzmanovic","Tomas Radivoyevitch","Vera Adema","Hassan Awada","Kenichi Yoshida","Samuel Li","Francesc Sole","Rabi Hanna","Babal K. Jha","Thomas LaFramboise","Seishi Ogawa","Mikkael A. Sekeres","Marcin W. Wlodarski","Jörg Cammenga","Jaroslaw P. Maciejewski"],"twitterCount":5,"altmetricId":49728897},{"title":"Interim results from a phase 1/2 clinical study of lentiglobin gene therapy for severe sickle cell disease","googleId":"hCWn1x2W0L8J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/527/81027","googleCitationCount":26,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.527.527","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Results from a phase II study of isatuximab as a single agent and in combination with dexamethasone in patients with relapsed/refractory multiple myeloma","googleId":"3rhp_nM3BoMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/155/272957","googleCitationCount":16,"googleAuthor":"MA Dimopoulos","doi":"10.1182/blood-2018-155","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk chronic lymphocytic leukemia (CLL)","googleId":"itzQOtNNn3sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/696/272996","googleCitationCount":20,"googleAuthor":"N Jain","doi":"10.1182/blood-2018-186","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Validation of POD24 as a robust early clinical endpoint of poor survival in follicular lymphoma: results from the Follicular Lymphoma Analysis of Surrogacy Hypothesis …","googleId":"famW1lH6PXEJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/412/72819","googleCitationCount":23,"googleAuthor":"J Dixon","doi":"10.1182/blood.V130.Suppl_1.412.412","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"FCR achieves long-term durable remissions in patients with IGHV-mutated CLL","googleId":"0C68S4YVuUsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2278/36650","googleCitationCount":23,"googleAuthor":"C Chai-Adisaksopha","doi":"10.1182/blood-2017-07-731588","elsevierAuthor":"Chai-Adisaksopha C.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"18","altmetricAuthors":["Chatree Chai-Adisaksopha","Jennifer R. Brown"],"twitterCount":29,"altmetricId":27423094},{"title":"Long-term follow-up of previously treated patients who received ibrutinib for symptomatic Waldenstrom's macroglobulinemia: update of pivotal clinical trial","googleId":"6CoPKUUOBf4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2766/80388","googleCitationCount":27,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2766.2766","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations","googleId":"BMHsjWu1wBsJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/7/879/36202","googleCitationCount":31,"googleAuthor":"CT Berger","doi":"10.1182/blood-2016-09-740217","elsevierAuthor":"Nordmann T.M.","publicationName":"Blood","elsevierCoverDate":"2017-02-16","elsevierCoverDisplayDate":"16 February 2017","elsevierCitationCount":"26","altmetricAuthors":["Thierry M. Nordmann","Freimut D. Juengling","Mike Recher","Christoph T. Berger","Daniel Kalbermatten","Andreas Wicki","Aino Paasinen-Sohns","Gieri Cathomas","Alexandar Tzankov","Thomas Daikeler"],"twitterCount":5,"altmetricId":14632588},{"title":"Acute hyperviscosity: syndromes and management","googleId":"8ub3jRMRTeEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120607212","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2018-06-846816","elsevierAuthor":"Gertz M.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"14","altmetricAuthors":["Morie A. Gertz"],"twitterCount":36,"altmetricId":46487402},{"title":"Cellubrevin/vesicle-associated membrane protein-3–mediated endocytosis and trafficking regulate platelet functions","googleId":"C9yyWrur4UwJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/26/2872/36595","googleCitationCount":23,"googleAuthor":"S Joshi","doi":"10.1182/blood-2017-02-768176","elsevierAuthor":"Banerjee M.","publicationName":"Blood","elsevierCoverDate":"2017-12-28","elsevierCoverDisplayDate":"28 December 2017","elsevierCitationCount":"16","altmetricAuthors":["Meenakshi Banerjee","Smita Joshi","Jinchao Zhang","Carole L. Moncman","Shilpi Yadav","Beth A. Bouchard","Brian Storrie","Sidney W. Whiteheart"],"twitterCount":7,"altmetricId":26379743},{"title":"Addition of polatuzumab vedotin to bendamustine and rituximab (BR) improves outcomes in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B …","googleId":"6KJV6ZOE0wIJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2821/80501","googleCitationCount":23,"googleAuthor":"AF Herrera","doi":"10.1182/blood.V130.Suppl_1.2821.2821","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Three-year follow up of the phase 3 pollux study of daratumumab plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) …","googleId":"wPAVL3UC_WIJ","googleLink":"http://eprints.whiterose.ac.uk/157106/2/Bahlis%20manuscript_FINAL.pdf","googleCitationCount":17,"googleAuthor":"N Bahlis"},{"title":"GNE variants causing autosomal recessive macrothrombocytopenia without associated muscle wasting","googleId":"Jpr5iLZSbmAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1851/39491","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2018-04-845545","elsevierAuthor":"Revel-Vilk S.","publicationName":"Blood","elsevierCoverDate":"2018-10-25","elsevierCoverDisplayDate":"25 October 2018","elsevierCitationCount":"10","altmetricAuthors":["Shoshana Revel-Vilk","Ela Shai","Ernest Turro","Nivin Jahshan","Esti Hi-Am","Galia Spectre","Hagit Daum","Yossef Kalish","Karina Althaus","Andreas Greinacher","Chaim Kaplinsky","Shai Izraeli","Rutendo Mapeta","Sri V. V. Deevi","Danuta Jarocha","Willem H. Ouwehand","Kate Downes","Mortimer Poncz","David Varon","Michele P. Lambert"],"twitterCount":6,"altmetricId":47670432},{"title":"Making HSCs in vitro: don't forget the hemogenic endothelium","googleId":"pjLkWCrH3WwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1372/105718","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood-2018-04-784140","elsevierAuthor":"Blaser B.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"12","altmetricAuthors":["Bradley W. Blaser","Leonard I. Zon"],"twitterCount":18,"altmetricId":46446721},{"title":"Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes","googleId":"O0YoltVGBo4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/501/39392","googleCitationCount":21,"googleAuthor":"SR Panch","doi":"10.1182/blood-2018-02-835330","elsevierAuthor":"Ciceri S.","publicationName":"Catalysts","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0","altmetricAuthors":["Sandhya R. Panch","Michael E. Bozik","Thomas Brown","Michelle Makiya","Calman Prussin","Donald G. Archibald","Gregory T. Hebrank","Mary Sullivan","Xiaoping Sun","Lauren Wetzler","JeanAnne Ware","Michael P. Fay","Cynthia E. Dunbar","Steven I. Dworetzky","Paneez Khoury","Irina Maric","Amy D. Klion"],"twitterCount":18,"altmetricId":40875518},{"title":"Subclonal TP53 copy number is associated with prognosis in multiple myeloma","googleId":"JliS6aqMpy8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/23/2465/39997","googleCitationCount":17,"googleAuthor":"AL Sherborne","doi":"10.1182/blood-2018-06-857250","elsevierAuthor":"Shah V.","publicationName":"Blood","elsevierCoverDate":"2018-12-06","elsevierCoverDisplayDate":"6 December 2018","elsevierCitationCount":"12","altmetricAuthors":["Vallari Shah","David C. Johnson","Amy L. Sherborne","Sidra Ellis","Frances M. Aldridge","Julie Howard-Reeves","Farzana Begum","Amy Price","Jack Kendall","Laura Chiecchio","Suvi Savola","Matthew W. Jenner","Mark T. Drayson","Roger G. Owen","Walter M. Gregory","Gareth J. Morgan","Faith E. Davies","Richard S. Houlston","Gordon Cook","David A. Cairns","Graham Jackson","Martin F. Kaiser"],"twitterCount":34,"altmetricId":50459066},{"title":"Anti-BCMA BiTE® AMG 701 potently induces specific T cell lysis of human multiple myeloma (MM) cells and immunomodulation in the bone marrow microenvironment","googleId":"freVGQqiJLMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/592/263439","googleCitationCount":19,"googleAuthor":"L Lin","doi":"10.1182/blood-2018-99-118425","elsevierAuthor":"Verkleij C.P.M.","publicationName":"Oncotarget","elsevierCoverDate":"2020-11-10","elsevierCoverDisplayDate":"10 November 2020","elsevierCitationCount":"0","altmetricAuthors":["Shih-Feng Cho","Liang Lin","Lijie Xing","Jiye Liu","Tengteng Yu","Kenneth Wen","Phillip Hsieh","Nikhil Munshi","Kenneth Anderson","Yu-Tzu Tai"],"twitterCount":0,"altmetricId":54506681},{"title":"Randomized trial of ibrutinib versus ibrutinib plus rituximab (Ib+ R) in patients with chronic lymphocytic leukemia (CLL)","googleId":"oBS_OKrnphIJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/427/72618","googleCitationCount":25,"googleAuthor":"JA Burger","doi":"10.1182/blood.V130.Suppl_1.427.427","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Daratumumab (DARA) in combination with carfilzomib, lenalidomide, and dexamethasone (KRd) in patients with newly diagnosed multiple myeloma (MMY1001) …","googleId":"HCvct5JAVwoJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3110/80532","googleCitationCount":22,"googleAuthor":"SZ Usmani","doi":"10.1182/blood.V130.Suppl_1.3110.3110","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia","googleId":"pTYf0_uf0hsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/22/2410/36564","googleCitationCount":21,"googleAuthor":"AW Daman","doi":"10.1182/blood-2017-04-777052","elsevierAuthor":"Oda S.","publicationName":"Blood","elsevierCoverDate":"2017-11-30","elsevierCoverDisplayDate":"30 November 2017","elsevierCitationCount":"17","altmetricAuthors":["Shannon K. Oda","Andrew W. Daman","Nicolas M. Garcia","Felecia Wagener","Thomas M. Schmitt","Xiaoxia Tan","Aude G. Chapuis","Philip D. Greenberg"],"twitterCount":4,"altmetricId":28497906},{"title":"Preliminary results from a phase I study of isatuximab (ISA) in combination with bortezomib, lenalidomide, dexamethasone (VRd), and in patients with newly …","googleId":"_Fam6pvhSz8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/595/263465","googleCitationCount":16,"googleAuthor":"EM Ocio","doi":"10.1182/blood-2018-99-111244","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma","googleId":"bVj8MZYdGKUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1486/39342","googleCitationCount":21,"googleAuthor":"G Salles","doi":"10.1182/blood-2018-05-853499","elsevierAuthor":"Morschhauser F.","publicationName":"Blood","elsevierCoverDate":"2018-10-04","elsevierCoverDisplayDate":"4 October 2018","elsevierCitationCount":"17","altmetricAuthors":["Franck Morschhauser","Gilles Salles","Steven Le Gouill","Herve Tilly","Catherine Thieblemont","Krimo Bouabdallah","Bettina Fabiani","Cédric Ménard","Karin Tarte","Guillaume Cartron","Roch Houot"],"twitterCount":41,"altmetricId":45907261},{"title":"Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment","googleId":"-Cvy5HlUL-AJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/21/2354/36660","googleCitationCount":24,"googleAuthor":"","doi":"10.1182/blood-2017-03-771857","elsevierAuthor":"Berthaut I.","publicationName":"Blood","elsevierCoverDate":"2017-11-23","elsevierCoverDisplayDate":"23 November 2017","elsevierCitationCount":"18","altmetricAuthors":["Isabelle Berthaut","Dora Bachir","Salma Kotti","Céline Chalas","Katia Stankovic","Florence Eustache","Célia Ravel","Anoosha Habibi","Sylvie Brailly-Tabard","Laurence Lévy-Dutel","Alexandre Bleibtreu","Tabassome Simon","Frédéric Galactéros","François Lionnet","Jacqueline Mandelbaum"],"twitterCount":3,"altmetricId":26728725},{"title":"Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations","googleId":"6HOn0MW1-sgJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2989/39100","googleCitationCount":23,"googleAuthor":"SO Ciurea","doi":"10.1182/blood-2018-02-832360","elsevierAuthor":"Ciurea S.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"17","altmetricAuthors":["Stefan O. Ciurea","Abhishek Chilkulwar","Rima M. Saliba","Julianne Chen","Gabriela Rondon","Keyur P. Patel","Haitham Khogeer","Abdul R. Shah","Brion V. Randolph","Jorge M. Ramos Perez","Uday Popat","Chitra M. Hosing","Qaiser Bashir","Rohtesh Mehta","Gheath Al-Atrash","Jin Im","Issa F. Khouri","Partow Kebriaei","Richard E. Champlin"],"twitterCount":15,"altmetricId":41814014},{"title":"Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in hematologic malignancies","googleId":"A_VCg3ivX1AJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4326/72822","googleCitationCount":24,"googleAuthor":"JC Byrd","doi":"10.1182/blood.V130.Suppl_1.4326.4326","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib","googleId":"Mx9Fvly816MJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2260/39546","googleCitationCount":21,"googleAuthor":"","doi":"10.1182/blood-2017-12-822569","elsevierAuthor":"De Weerdt I.","publicationName":"Blood","elsevierCoverDate":"2019-10-10","elsevierCoverDisplayDate":"10 October 2019","elsevierCitationCount":"0","altmetricAuthors":["Iris de Weerdt","Tom Hofland","Roeland Lameris","Sanne Endstra","Aldo Jongejan","Perry D. Moerland","Renee C. G. de Bruin","Ester B. M. Remmerswaal","Ineke J. M. ten Berge","Nora Liu","Mario van der Stelt","Laura M. Faber","Mark-David Levin","Eric Eldering","Sanne H. Tonino","Tanja D. de Gruijl","Hans J. van der Vliet","Arnon P. Kater"],"twitterCount":14,"altmetricId":48451202},{"title":"Safety, efficacy, pharmacokinetic (PK) and biomarker analyses of BCL2 inhibitor venetoclax (Ven) plus MDM2 inhibitor idasanutlin (idasa) in patients (pts) with …","googleId":"eZz5_s7yPEoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/767/266352","googleCitationCount":17,"googleAuthor":"BA Jonas","doi":"10.1182/blood-2018-99-116013","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"EBV/LMP-specific T cells maintain remissions of T-and B-cell EBV lymphomas after allogeneic bone marrow transplantation","googleId":"Csfq3rHDPXEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/22/2351/107706","googleCitationCount":18,"googleAuthor":"S Gottschalk","doi":"10.1182/blood-2018-07-863654","elsevierAuthor":"McLaughlin L.P.","publicationName":"Blood","elsevierCoverDate":"2018-11-29","elsevierCoverDisplayDate":"29 November 2018","elsevierCitationCount":"9","altmetricAuthors":["Lauren P. McLaughlin","Rayne Rouce","Stephen Gottschalk","Vicky Torrano","George Carrum","Meng-Fen Wu","Fahmida Hoq","Bambi Grilley","Andrea M. Marcogliese","Patrick J. Hanley","Adrian P. Gee","Malcolm K. Brenner","Cliona M. Rooney","Helen E. Heslop","Catherine M. Bollard"],"twitterCount":15,"altmetricId":48962155},{"title":"Rivaroxaban thromboprophylaxis in high-risk ambulatory cancer patients receiving systemic therapy: results of a randomized clinical trial (CASSINI)","googleId":"x7-S79ShjPYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/LBA-1/375115","googleCitationCount":19,"googleAuthor":"AA Khorana","doi":"10.1182/blood-2018-120738","elsevierAuthor":"Roopkumar J.","publicationName":"Cancer Treatment and Research","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"1","altmetricAuthors":["Alok A. Khorana","Gerald A. Soff","Ajay K. Kakkar","Saroj Vadhan-Raj","Hanno Riess","Ted Wun","Michael B. Streiff","David A. Garcia","Howard A. Liebman","Chandra Belani","Eileen M. O'Reilly","Jai N Patel","Habte A. Yimer","Peter Wildgoose","Paul Burton","Ujjwala Vijapurkar","Simrati Kaul","John Eikelboom","Robert D. McBane","Kenneth A. Bauer","Nicole M. Kuderer","Gary H. Lyman"],"twitterCount":1,"altmetricId":52080289},{"title":"Secreted mutant calreticulins as rogue cytokines trigger thrombopoietin receptor activation specifically in CALR mutated cells: perspectives for MPN therapy","googleId":"oa0c_9uTsBYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4/264991","googleCitationCount":20,"googleAuthor":"C Pecquet","doi":"10.1182/blood-2018-99-118348","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Origins of myelodysplastic syndromes after aplastic anemia","googleId":"D_DtrGYwCawJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/17/1953/36504","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2017-02-767731","elsevierAuthor":"Negoro E.","publicationName":"Blood","elsevierCoverDate":"2017-10-26","elsevierCoverDisplayDate":"26 October 2017","elsevierCitationCount":"17","altmetricAuthors":["Eiju Negoro","Yasunobu Nagata","Michael J. Clemente","Naoko Hosono","Wenyi Shen","Aziz Nazha","Tetsuichi Yoshizato","Cassandra Hirsch","Bartlomiej Przychodzen","Reda Z. Mahfouz","Teodora Kuzmanovic","Mikkael A. Sekeres","Hideki Makishima","Seishi Ogawa","Jaroslaw P. Maciejewski"],"twitterCount":27,"altmetricId":25166499},{"title":"HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies","googleId":"lYRjHogaUAsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/14/1628/107654","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2016-08-736066","elsevierAuthor":"Bobrowicz M.","publicationName":"Blood","elsevierCoverDate":"2017-10-05","elsevierCoverDisplayDate":"5 October 2017","elsevierCitationCount":"21","altmetricAuthors":["Malgorzata Bobrowicz","Michal Dwojak","Beata Pyrzynska","Joanna Stachura","Angelika Muchowicz","Elise Berthel","Nicole Dalla-Venezia","Mieszko Kozikowski","Marta Siernicka","Nina Miazek","Piotr Zapala","Antoni Domagala","Kamil Bojarczuk","Agata Malenda","Joanna Barankiewicz","Agnieszka Graczyk-Jarzynka","Agnieszka Zagozdzon","Magdalena Gabrysiak","Jean-Jacques Diaz","Marta Karp","Ewa Lech-Maranda","Malgorzata Firczuk","Krzysztof Giannopoulos","Dimitar G. Efremov","Luca Laurenti","Dunja Baatout","Lukas Frenzel","Agata Malinowska","Mikolaj Slabicki","Thorsten Zenz","Abdessamad Zerrouqi","Jakub Golab","Magdalena Winiarska"],"twitterCount":28,"altmetricId":24256021},{"title":"Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma","googleId":"8vRMSiXAG-UJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/561/36141","googleCitationCount":30,"googleAuthor":"CA Thompson","doi":"10.1182/blood-2016-08-685073","elsevierAuthor":"Cohen J.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"24","altmetricAuthors":["Jonathon B. Cohen","Madhusmita Behera","Carrie A. Thompson","Christopher R. Flowers"],"twitterCount":24,"altmetricId":14687267},{"title":"Tackling early morbidity and mortality in myeloma (TEAMM): assessing the benefit of antibiotic prophylaxis and its effect on healthcare associated infections in 977 …","googleId":"etk4iDfCSmIJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/903/83541","googleCitationCount":22,"googleAuthor":"T Planche","doi":"10.1182/blood.V130.Suppl_1.903.903","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective","googleId":"Wm6nA0mgYnsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/369/103906","googleCitationCount":19,"googleAuthor":"","doi":"10.1182/blood-2018-02-778480","elsevierAuthor":"Dunleavy K.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"14","altmetricAuthors":["Kieron Dunleavy","Thomas G. Gross"],"twitterCount":26,"altmetricId":43651147},{"title":"Preliminary results from a phase 1 study of gilteritinib in combination with induction and consolidation chemotherapy in subjects with newly diagnosed acute myeloid …","googleId":"iDZCNMCcflQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/722/83413","googleCitationCount":22,"googleAuthor":"K Pratz","doi":"10.1182/blood.V130.Suppl_1.722.722","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) for firstline treatment of patients with CLL with mutated IGHV and without TP53 aberrations","googleId":"X6AVqwAe0rMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/695/272866","googleCitationCount":18,"googleAuthor":"N Jain","doi":"10.1182/blood-2018-185","elsevierAuthor":"Bosch F.","publicationName":"Leukemia","elsevierCoverDate":"2020-02-01","elsevierCoverDisplayDate":"1 February 2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis","googleId":"ApMYf7W1lgYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/987/39324","googleCitationCount":20,"googleAuthor":"JE Cox","doi":"10.1182/blood-2018-01-829036","elsevierAuthor":"Burch J.","publicationName":"Blood","elsevierCoverDate":"2018-09-06","elsevierCoverDisplayDate":"6 September 2018","elsevierCitationCount":"12","altmetricAuthors":["Joseph S. Burch","Jason R. Marcero","John Alan Maschek","James E. Cox","Laurie K. Jackson","Amy E. Medlock","John D. Phillips","Harry A. Dailey"],"twitterCount":6,"altmetricId":47877425},{"title":"Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis","googleId":"9hb-8F21NxEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1265/39645","googleCitationCount":17,"googleAuthor":"E Pronier","doi":"10.1182/blood-2018-03-837468","elsevierAuthor":"Pronier E.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"7","altmetricAuthors":["Elodie Pronier","Robert L. Bowman","Jihae Ahn","Jacob Glass","Cyriac Kandoth","Tiffany R. Merlinsky","Justin T. Whitfield","Benjamin H. Durham","Antoine Gruet","Amritha Varshini Hanasoge Somasundara","Raajit Rampal","Ari Melnick","Richard P. Koche","Barry S. Taylor","Ross L. Levine"],"twitterCount":4,"altmetricId":46216628},{"title":"Safety of axicabtagene ciloleucel CD19 CAR T-cell therapy in elderly patients with relapsed or refractory large B-cell lymphoma","googleId":"DiAx05ICdSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/96/266049","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood-2018-99-120013","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?","googleId":"yyQ1h-uVXqoJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/23/3059/36036","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2016-05-672196","elsevierAuthor":"Le Gouill S.","publicationName":"Blood","elsevierCoverDate":"2017-06-08","elsevierCoverDisplayDate":"8 June 2017","elsevierCitationCount":"16","altmetricAuthors":["Steven Le Gouill","René-Olivier Casasnovas"],"twitterCount":12,"altmetricId":19191161},{"title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","googleId":"_4oyGnStLDEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2036/36738","googleCitationCount":19,"googleAuthor":"J Gunawardana","doi":"10.1182/blood-2017-09-808907","elsevierAuthor":"Vigano E.","publicationName":"Blood","elsevierCoverDate":"2018-05-03","elsevierCoverDisplayDate":"3 May 2018","elsevierCitationCount":"15","altmetricAuthors":["Elena Viganò","Jay Gunawardana","Anja Mottok","Tessa Van Tol","Katina Mak","Fong Chun Chan","Lauren Chong","Elizabeth Chavez","Bruce Woolcock","Katsuyoshi Takata","David Twa","Hennady P. Shulha","Adèle Telenius","Olga Kutovaya","Stacy S. Hung","Shannon Healy","Susana Ben-Neriah","Karen Leroy","Philippe Gaulard","Arjan Diepstra","Robert Kridel","Kerry J. Savage","Lisa Rimsza","Randy Gascoyne","Christian Steidl"],"twitterCount":16,"altmetricId":33493508},{"title":"Excellent outcome of young patients (18-60 years) with favourable-prognosis diffuse large B-cell lymphoma (DLBCL) treated with 4 cycles CHOP plus 6 applications of …","googleId":"Cx54HLu6sbgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/781/266032","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2018-99-112403","elsevierCitationCount":0,"altmetricAuthors":["Viola Poeschel","Gerhard Held","Marita Ziepert","Bettina Altmann","Mathias Witzens-Harig","Harald Holte","Lorenz Thurner","Andreas Viardot","Peter Borchmann","Lothar Kanz","Ulrich Keller","Christian Schmidt","Rolf Mahlberg","Bernd Metzner","Reinhard Marks","Heinz-Gert Hoeffkes","Konstantinos Christofyllakis","Josif Amam","Christian Berdel","Stephan Stilgenbauer","Norbert Schmitz","Lorenz Truemper","Niels Murawski","Markus Loeffler","Michael Pfreundschuh"],"twitterCount":0,"altmetricId":59501250},{"title":"A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium","googleId":"7W-C2C8t3zMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/10/1145/36403","googleCitationCount":19,"googleAuthor":"T Triche","doi":"10.1182/blood-2017-09-803809","elsevierAuthor":"Sun W.","publicationName":"Blood","elsevierCoverDate":"2018-03-08","elsevierCoverDisplayDate":"8 March 2018","elsevierCitationCount":"10","altmetricAuthors":["Weili Sun","Timothy Triche","Jemily Malvar","Paul Gaynon","Richard Sposto","Xiaojing Yang","Henrique Bittencourt","Andrew E. Place","Yoav Messinger","Chris Fraser","Luciano Dalla-Pozza","Bodour Salhia","Peter Jones","Alan S. Wayne","Lia Gore","Todd M. Cooper","Gangning Liang"],"twitterCount":19,"altmetricId":31892615},{"title":"Final analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with relapsed or refractory AL amyloidosis","googleId":"6Vq0buVaTCAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/509/80897","googleCitationCount":24,"googleAuthor":"MY Mapara","doi":"10.1182/blood.V130.Suppl_1.509.509","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model","googleId":"xgtX7yOoAb8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/21/2286/39548","googleCitationCount":14,"googleAuthor":"S Altamura","doi":"10.1182/blood-2018-05-852277","elsevierAuthor":"Artuso I.","publicationName":"Blood","elsevierCoverDate":"2019-07-04","elsevierCoverDisplayDate":"4 July 2019","elsevierCitationCount":"0","altmetricAuthors":["Irene Artuso","Maria Rosa Lidonnici","Sandro Altamura","Giacomo Mandelli","Mariateresa Pettinato","Martina U. Muckenthaler","Laura Silvestri","Giuliana Ferrari","Clara Camaschella","Antonella Nai"],"twitterCount":4,"altmetricId":51564609},{"title":"Interim analysis of phase II study of venetoclax with 10-day decitabine (DEC10-VEN) in acute myeloid leukemia and myelodysplastic syndrome","googleId":"gIKdyO00dosJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/286/263731","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2018-99-113749","elsevierCitationCount":0,"altmetricAuthors":["Abhishek Maiti","Courtney D. DiNardo","Jorge E. Cortes","Gautam Borthakur","Naveen Pemmaraju","Christopher B. Benton","Tapan M. Kadia","Koichi Takahashi","Kiran Naqvi","Farhad Ravandi","Yesid Alvarado","Nicholas J Short","Naval G. Daver","Koji Sasaki","Maro N. Ohanian","Guillermo Garcia-Manero","Philip A. Thompson","Steven M. Kornblau","Lucia Masarova","Nitin Jain","Elias J. Jabbour","Michael Andreeff","Rita Maduike","Julio A Guerrero","Qi Zhang","Antonio Cavazos","Helen Ma","Caitlin R. Rausch","Carol A. Bivins","Kenneth Vaughan","Sherry A. Pierce","Jing Ning","Wei Qiao","John S. Welch","Hagop M. Kantarjian","Marina Y. Konopleva"],"twitterCount":0,"altmetricId":55317799},{"title":"Hematopoiesis and the bacterial microbiome","googleId":"8_0MceyG8FQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/559/39408","googleCitationCount":18,"googleAuthor":"MT Baldridge","doi":"10.1182/blood-2018-02-832519","elsevierAuthor":"Yan H.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"13","altmetricAuthors":["Hannah Yan","Megan T. Baldridge","Katherine Y. King"],"twitterCount":37,"altmetricId":43236983},{"title":"Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models","googleId":"ZcUcrSXf5BAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/18/2526/36271","googleCitationCount":21,"googleAuthor":"","doi":"10.1182/blood-2017-01-763581","elsevierAuthor":"Dourado K.","publicationName":"Blood","elsevierCoverDate":"2017-05-04","elsevierCoverDisplayDate":"4 May 2017","elsevierCitationCount":"17","altmetricAuthors":["Keina M. C. Dourado","June Baik","Vanessa K. P. Oliveira","Miriam Beltrame","Ami Yamamoto","Charles P. Theuer","Camila A. V. Figueiredo","Michael R. Verneris","Rita C. R. Perlingeiro"],"twitterCount":8,"altmetricId":20024490},{"title":"Results of the pivotal STORM study (part 2) in penta-refractory multiple myeloma (MM): deep and durable responses with oral selinexor plus low dose dexamethasone …","googleId":"yJupHEn8MBIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/598/263468","googleCitationCount":17,"googleAuthor":"MA Dimopoulos","doi":"10.1182/blood-2018-99-116663","elsevierCitationCount":0,"altmetricAuthors":["Ajai Chari","Dan T. Vogl","Meletios A Dimopoulos","Ajay K Nooka","Carol Ann Huff","Philippe Moreau","Craig E. Cole","Joshua Richter","David Dingli","Ravi Vij","Sascha A Tuchman","Marc S Raab","Katja Weisel","Michel Delforge","David Kaminetzky","Robert Frank Cornell","A Keith Stewart","James Hoffman","Kelly N. Godby","Terri L Parker","Moshe Levy","Martin Schreder","Nathalie Meuleman","Laurent Frenzel","Mohamad Mohty","Choquet Sylvain","Andrew J. Yee","Maria Gavriatopoulou","Luciano J Costa","Jatin J. Shah","Carla Picklesimer","Jean-Richard Saint-Martin","Lingling Li","Michael G. Kauffman","Sharon Shacham","Paul Richardson","Sundar Jagannath"],"twitterCount":1,"altmetricId":54506673},{"title":"Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia","googleId":"QoeWNAQgkJMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/20/2205/6533","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2017-12-822908","elsevierAuthor":"Blumberg R.","publicationName":"Blood","elsevierCoverDate":"2018-05-17","elsevierCoverDisplayDate":"17 May 2018","elsevierCitationCount":"15","altmetricAuthors":["Richard S. Blumberg","David Lillicrap"],"twitterCount":8,"altmetricId":35044999},{"title":"High complete response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: results of an open-label, phase II study","googleId":"BC-EmC-GCBcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/414/72599","googleCitationCount":21,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.414.414","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Impact of next-generation flow (NGF) minimal residual disease (MRD) monitoring in multiple myeloma (MM): results from the Pethema/GEM2012 trial","googleId":"rrecnPT3TwgJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/905/83562","googleCitationCount":20,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.905.905","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma","googleId":"VkibMNw2NREJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1308/36029","googleCitationCount":28,"googleAuthor":"F Cottini","doi":"10.1182/blood-2016-09-738500","elsevierAuthor":"Hideshima T.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"15","altmetricAuthors":["Teru Hideshima","Francesca Cottini","Yoshihisa Nozawa","Hyuk-Soo Seo","Hiroto Ohguchi","Mehmet K. Samur","Diana Cirstea","Naoya Mimura","Yoshikazu Iwasawa","Paul G. Richardson","Nikhil C. Munshi","Dharminder Chauhan","Walter Massefski","Teruhiro Utsugi","Sirano Dhe-Paganon","Kenneth C. Anderson"],"twitterCount":12,"altmetricId":15446056},{"title":"Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study","googleId":"p2vhau-RH4QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120319868","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2018-01-829630","elsevierAuthor":"De Latour R.P.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"21","altmetricAuthors":["Regis Peffault de Latour","Sylvie Chevret","Charlotte Jubert","Anne Sirvent","Claire Galambrun","Annalisa Ruggeri","Virginie Gandemer","Jérôme Cornillon","Fanny Rialland","Jean-Hugues Dalle","Edouard Forcade","Benedicte Bruno","Catherine Paillard","Pierre S. Rorlich","Alexandra Salmon","Sabine Fürst","Flore Sicre de Fontbrune","Marie Therese Rubio","Jacques-Olivier Bay","Mohamad Mohty","Jerome Larghero","Eliane Gluckman","Gerard Socié"],"twitterCount":32,"altmetricId":41462652},{"title":"Universal SLAMF7-specific CAR T-cells as treatment for multiple myeloma","googleId":"broE9WU-_bkJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/502/81052","googleCitationCount":21,"googleAuthor":"R Mathur","doi":"10.1182/blood.V130.Suppl_1.502.502","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Balancing risk and benefit in early-stage classical Hodgkin lymphoma","googleId":"W6F4YfnpBksJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1666/36825","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2017-10-772665","elsevierAuthor":"Bröckelmann P.","publicationName":"Blood","elsevierCoverDate":"2018-04-12","elsevierCoverDisplayDate":"12 April 2018","elsevierCitationCount":"13","altmetricAuthors":["Paul J. Bröckelmann","Stephanie Sasse","Andreas Engert"],"twitterCount":34,"altmetricId":33918270},{"title":"Standardization of 18F-FDG PET/CT according to Deauville criteria for MRD evaluation in newly diagnosed transplant eligible multiple myeloma patients: joined …","googleId":"PN0fpfYUP20J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/257/264029","googleCitationCount":16,"googleAuthor":"L Dozza","doi":"10.1182/blood-2018-99-111321","elsevierAuthor":"Paschali A.","publicationName":"European Journal of Nuclear Medicine and Molecular Imaging","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Evaluation of sustained minimal residual disease (MRD) negativity in relapsed/refractory multiple myeloma (RRMM) patients (Pts) treated with daratumumab in …","googleId":"2NIu09rrPM8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3272/264829","googleCitationCount":16,"googleAuthor":"JF San-Miguel","doi":"10.1182/blood-2018-99-113177","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function","googleId":"8PAPwVL-8X0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/21/2335/37150","googleCitationCount":18,"googleAuthor":"JH Rowe","doi":"10.1182/blood-2018-02-835561","elsevierAuthor":"Rowe J.H.","publicationName":"Blood","elsevierCoverDate":"2018-05-24","elsevierCoverDisplayDate":"24 May 2018","elsevierCitationCount":"13","altmetricAuthors":["Jared H. Rowe","Ottavia M. Delmonte","Sevgi Keles","Brian D. Stadinski","Adam K. Dobbs","Lauren A. Henderson","Yasuhiro Yamazaki","Luis M. Allende","Francisco A. Bonilla","Luis I. Gonzalez-Granado","Seyma Celikbilek Celik","Sukru N. Guner","Hasan Kapakli","Christina Yee","Sung-Yun Pai","Eric S. Huseby","Ismail Reisli","Jose R. Regueiro","Luigi D. Notarangelo"],"twitterCount":7,"altmetricId":37095680},{"title":"Risk of hepatitis B virus reactivation in patients treated with ibrutinib","googleId":"ROt8KNrR17gJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1987/36751","googleCitationCount":23,"googleAuthor":"K Chen","doi":"10.1182/blood-2018-01-826495","elsevierAuthor":"Hammond S.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"14","altmetricAuthors":["Sarah P. Hammond","Kaiwen Chen","Alisha Pandit","Matthew S. Davids","Nicolas C. Issa","Francisco M. Marty"],"twitterCount":39,"altmetricId":33821176},{"title":"CD20-Tcb (RG6026), a Novel 2: 1 Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's …","googleId":"0Ch-1tUN-DMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/226/261591","googleCitationCount":19,"googleAuthor":"M Hutchings","doi":"10.1182/blood-2018-99-110207","elsevierAuthor":"Cremasco F.","publicationName":"PLoS ONE","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients","googleId":"3ycGxuOrkLAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/24/2608/39539","googleCitationCount":16,"googleAuthor":"R Sklavenitis-Pistofidis","doi":"10.1182/blood-2018-07-863241","elsevierAuthor":"Sklavenitis-Pistofidis R.","publicationName":"Blood","elsevierCoverDate":"2018-12-13","elsevierCoverDisplayDate":"13 December 2018","elsevierCitationCount":"13","altmetricAuthors":["Romanos Sklavenitis-Pistofidis","Marzia Capelletti","Chia-Jen Liu","Mairead Reidy","Oksana Zavidij","Daisy Huynh","Patrick Henrick","Alexandra Savell","Kaitlen Reyes","Bradley Rivotto","Mark Bustoros","Adriana Perilla-Glen","Lorenzo Trippa","Jorge J. Castillo","Steven P. Treon","Irene M. Ghobrial"],"twitterCount":31,"altmetricId":50426728},{"title":"The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation","googleId":"9ms_RlAVRaQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/11/1336/36444","googleCitationCount":22,"googleAuthor":"DC Moreira","doi":"10.1182/blood-2016-12-758458","elsevierAuthor":"Mizukawa B.","publicationName":"Blood","elsevierCoverDate":"2017-09-14","elsevierCoverDisplayDate":"14 September 2017","elsevierCitationCount":"15","altmetricAuthors":["Benjamin Mizukawa","Eric O’Brien","Daniel C. Moreira","Mark Wunderlich","Cindy L. Hochstetler","Xin Duan","Wei Liu","Emily Orr","H. Leighton Grimes","James C. Mulloy","Yi Zheng"],"twitterCount":5,"altmetricId":25280017},{"title":"A phase II study of the hyper-CVAD regimen in sequential combination with blinatumomab as frontline therapy for adults with B-cell acute lymphoblastic leukemia (B …","googleId":"YmIcwypsNtcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/32/263589","googleCitationCount":17,"googleAuthor":"NJ Short","doi":"10.1182/blood-2018-99-117470","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia","googleId":"CjsQMKxVsEcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/1/35/36236","googleCitationCount":22,"googleAuthor":"","doi":"10.1182/blood-2017-03-771238","elsevierAuthor":"Del Padre M.","publicationName":"Blood","elsevierCoverDate":"2017-07-06","elsevierCoverDisplayDate":"6 July 2017","elsevierCitationCount":"17","altmetricAuthors":["Martina Del Padre","Laura Todi","Milica Mitrevski","Ramona Marrapodi","Stefania Colantuono","Massimo Fiorilli","Milvia Casato","Marcella Visentini"],"twitterCount":4,"altmetricId":20757214},{"title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria …","googleId":"CivyX6QAIe8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2314/261691","googleCitationCount":15,"googleAuthor":"P Deschatelets","doi":"10.1182/blood-2018-99-110827","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Interim results from Fight-203, a phase 2, open-label, multicenter study evaluating the efficacy and safety of pemigatinib (INCB054828) in patients with myeloid …","googleId":"LO72d8w_aBsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/690/266005","googleCitationCount":15,"googleAuthor":"A Rambaldi","doi":"10.1182/blood-2018-99-110388","elsevierCitationCount":0,"altmetricAuthors":["Srdan Verstovsek","Alessandro M. Vannucchi","Alessandro Rambaldi","Jason R. Gotlib","Adam J. Mead","Andreas Hochhaus","Jean-Jacques Kiladjian","Juan Carlos Hernandez Boluda","Ekaterine Asatiani","Christine Lihou","Huiling Zhen","Andreas Reiter"],"twitterCount":0,"altmetricId":99866291},{"title":"14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling","googleId":"6yNnbHXs6IEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2436/37082","googleCitationCount":16,"googleAuthor":"Y Chen","doi":"10.1182/blood-2017-09-742650","elsevierAuthor":"Chen Y.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"10","altmetricAuthors":["Yunfeng Chen","Zaverio M. Ruggeri","Xiaoping Du"],"twitterCount":2,"altmetricId":43282493},{"title":"Multicenter prospective phase II study of venetoclax in patients with previously treated Waldenstrom macroglobulinemia","googleId":"RafapmwfW_QJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2888/263549","googleCitationCount":15,"googleAuthor":"JJ Castillo","doi":"10.1182/blood-2018-99-112325","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Polatuzumab vedotin (Pola) plus bendamustine (B) with rituximab (R) or obinutuzumab (G) in Relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) …","googleId":"brWxstncHM0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1683/272963","googleCitationCount":18,"googleAuthor":"AF Herrera","doi":"10.1182/blood-2018-99-118551","elsevierCitationCount":0,"altmetricAuthors":["Laurie H Sehn","Alex F. Herrera","Matthew J Matasar","Manali Kamdar","Sarit Assouline","Mark Hertzberg","Tae Min Kim","Won-Seog Kim","Andrew McMillan","Muhit Özcan","Jamie M Hirata","Elicia Penuel","Ji Cheng","Grace Ku","Christopher R Flowers"],"twitterCount":0,"altmetricId":72205013},{"title":"Sequential combination of low-intensity chemotherapy (mini-hyper-CVD) plus inotuzumab ozogamicin with or without blinatumomab in patients with relapsed …","googleId":"znUqApkxJukJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/553/263018","googleCitationCount":16,"googleAuthor":"K Sasaki","doi":"10.1182/blood-2018-99-115162","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Acalabrutinib in treatment-naive (TN) chronic lymphocytic leukemia (CLL): updated results from the phase 1/2 ACE-CL-001 study","googleId":"qDM7bvia93wJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/692/266024","googleCitationCount":14,"googleAuthor":"JC Byrd","doi":"10.1182/blood-2018-99-110451","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Tissue tolerance: a distinct concept to control acute GVHD severity","googleId":"DcNFxVE_cnQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1747/35833","googleCitationCount":24,"googleAuthor":"P Reddy","doi":"10.1182/blood-2016-09-740431","elsevierAuthor":"Wu S.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"17","altmetricAuthors":["Shin-Rong Wu","Pavan Reddy"],"twitterCount":13,"altmetricId":16144765},{"title":"The believe trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept in adult beta-thalassemia patients who require regular red …","googleId":"Cl4HHHQJ5b4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/163/272861","googleCitationCount":18,"googleAuthor":"MD Cappellini","doi":"10.1182/blood-2018-163","elsevierCitationCount":0,"altmetricAuthors":["Maria Domenica Cappellini","Vip Viprakasit","Ali Taher","Pencho Georgiev","Kevin H. M. Kuo","Thomas D. Coates","Ersi Voskaridou","Hong Keng Liew","Idit Pazgal-Kobrowski","Gianluca Forni","Silverio Perrotta","Abderrahim Khelif","Ashutosh Lal","Antonis Kattamis","Efthymia Vlachaki","Raffaella Origa","Yesim Aydinok","Mohamed Bejaoui","P. Joy Ho","Lee Ping Chew","Ping Chong Bee","Soo Min Lim","Meng-Yao Lu","Adisak Tantiworawit","Penka Ganeva","Liana Gercheva","Farrukh Shah","Ellis J. Neufeld","Abderrahmane Laadem","Jeevan K. Shetty","Jun Zou","Dimana Miteva","Tatiana Zinger","Peter G. Linde","Matthew L. Sherman","Olivier Hermine","John Porter","Antonio Piga"],"twitterCount":0,"altmetricId":52855200},{"title":"Nilotinib (Tasigna®) and low intensity chemotherapy for first-line treatment of elderly patients with BCR-ABL1-positive acute lymphoblastic leukemia: final results of a …","googleId":"zqT4CvBa0AYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/31/263951","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood-2018-99-114552","elsevierAuthor":"Chew S.","publicationName":"Hematologic Malignancies","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Overall survival (OS) of patients with relapsed/refractory multiple myeloma (RRMM) treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus …","googleId":"_oOWFxh2kJcJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/743/83661","googleCitationCount":22,"googleAuthor":"D Siegel","doi":"10.1182/blood.V130.Suppl_1.743.743","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Insight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies","googleId":"3jTCTFopp8oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/10/999/39303","googleCitationCount":14,"googleAuthor":"CC Oakes","doi":"10.1182/blood-2018-02-692970","elsevierAuthor":"Oakes C.","publicationName":"Blood","elsevierCoverDate":"2018-09-06","elsevierCoverDisplayDate":"6 September 2018","elsevierCitationCount":"10","altmetricAuthors":["Christopher C. Oakes","Jose I. Martin-Subero"],"twitterCount":16,"altmetricId":45514757},{"title":"Long-term follow-up of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma","googleId":"r7CkeVtsvSEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2876/263920","googleCitationCount":18,"googleAuthor":"M Wang","doi":"10.1182/blood-2018-99-110327","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation","googleId":"uxtpRKWn6TEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2967/39148","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2017-10-809822","elsevierAuthor":"Miggelbrink A.M.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"14","altmetricAuthors":["Alexandra M. Miggelbrink","Brent R. Logan","Rebecca H. Buckley","Roberta E. Parrott","Christopher C. Dvorak","Neena Kapoor","Hisham Abdel-Azim","Susan E. Prockop","David Shyr","Hélène Decaluwe","Imelda C. Hanson","Alfred Gillio","Blachy J. Dávila Saldaña","Hermann Eibel","Gregory Hopkins","Jolan E. Walter","Jennifer S. Whangbo","Donald B. Kohn","Jennifer M. Puck","Morton J. Cowan","Linda M. Griffith","Elie Haddad","Richard J. O’Reilly","Luigi D. Notarangelo","Sung-Yun Pai"],"twitterCount":5,"altmetricId":40867775},{"title":"LCL161, an oral Smac mimetic/IAP antagonist for patients with myelofibrosis (MF): novel translational findings among long-term responders in a phase 2 clinical trial","googleId":"v0rmMtvrEmAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/687/265961","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood-2018-99-119753","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Potency and selectivity of BTK inhibitors in clinical development for B-cell malignancies","googleId":"rSzJx5pw0acJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1871/273136","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood-2018-99-109973","elsevierAuthor":"Badillo M.","publicationName":"Clinical Journal of Oncology Nursing","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"August 2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"REGN5458, a bispecific BCMAxCD3 T cell engaging antibody, demonstrates robust in vitro and in vivo anti-tumor efficacy in multiple myeloma models, comparable to …","googleId":"A3r635WvPgwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1944/261532","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood-2018-99-112500","elsevierCitationCount":0,"altmetricAuthors":["David J Dilillo","Kara Olson","Katja Mohrs","T. Craig Meagher","Kevin Bray","Olga Sineshchekova","Thomas Startz","Marc Retter","Stephen Godin","Frank Delfino","John Lin","Eric Smith","Olin Gavin Thurston","Jessica R. Kirshner"],"twitterCount":1,"altmetricId":67123247},{"title":"Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome","googleId":"GbuSvKYDh68J","googleLink":"https://ashpublications.org/blood/article-abstract/129/21/2928/36266","googleCitationCount":23,"googleAuthor":"","doi":"10.1182/blood-2016-11-745638","elsevierAuthor":"Hoenig M.","publicationName":"Blood","elsevierCoverDate":"2017-05-25","elsevierCoverDisplayDate":"25 May 2017","elsevierCitationCount":"20","altmetricAuthors":["Manfred Hoenig","Chantal Lagresle-Peyrou","Ulrich Pannicke","Luigi D. Notarangelo","Fulvio Porta","Andrew R. Gennery","Mary Slatter","Morton J. Cowan","Polina Stepensky","Hamoud Al-Mousa","Daifulah Al-Zahrani","Sung-Yun Pai","Waleed Al Herz","Hubert B. Gaspar","Paul Veys","Koichi Oshima","Kohsuke Imai","Hiromasa Yabe","Lenora M. Noroski","Nico M. Wulffraat","Karl-Walter Sykora","Pere Soler-Palacin","Hideki Muramatsu","Mariam Al Hilali","Despina Moshous","Klaus-Michael Debatin","Catharina Schuetz","Eva-Maria Jacobsen","Ansgar S. Schulz","Klaus Schwarz","Alain Fischer","Wilhelm Friedrich","Marina Cavazzana"],"twitterCount":6,"altmetricId":18084000},{"title":"Anti-CCR4 monoclonal antibody, mogamulizumab, demonstrates significant improvement in PFS compared to vorinostat in patients with previously treated cutaneous …","googleId":"7dibSzRC2MsJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/817/83520","googleCitationCount":19,"googleAuthor":"M Bagot","doi":"10.1182/blood.V130.Suppl_1.817.817","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Transplant strategies in relapsed/refractory Hodgkin lymphoma","googleId":"hInpw9IGJhQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1689/36839","googleCitationCount":16,"googleAuthor":"GL Shah","doi":"10.1182/blood-2017-09-772673","elsevierAuthor":"Shah G.","publicationName":"Blood","elsevierCoverDate":"2018-04-12","elsevierCoverDisplayDate":"12 April 2018","elsevierCitationCount":"13","altmetricAuthors":["Gunjan L. Shah","Craig H. Moskowitz"],"twitterCount":24,"altmetricId":33975955},{"title":"Optimizing therapy in advanced-stage Hodgkin lymphoma","googleId":"qV_qrNM-HqEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1679/36837","googleCitationCount":16,"googleAuthor":"PWM Johnson","doi":"10.1182/blood-2017-09-772640","elsevierAuthor":"Lim S.H.","publicationName":"Blood","elsevierCoverDate":"2018-04-12","elsevierCoverDisplayDate":"12 April 2018","elsevierCitationCount":"11","altmetricAuthors":["Sean H. Lim","Peter W. M. Johnson"],"twitterCount":13,"altmetricId":34208653},{"title":"Heterodimerization of TPO and IFNγ impairs human hematopoietic stem/progenitor cell signaling and survival in chronic inflammation","googleId":"AaH6XqoX0dUJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/4/72032","googleCitationCount":23,"googleAuthor":"LJ Alvarado","doi":"10.1182/blood.V130.Suppl_1.4.4","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis","googleId":"_mQmIzU5C6cJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2088/39466","googleCitationCount":14,"googleAuthor":"A Worth","doi":"10.1182/blood-2018-01-827485","elsevierAuthor":"Lucchini G.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"11","altmetricAuthors":["Giovanna Lucchini","Rebecca Marsh","Kimberly Gilmour","Austen Worth","Zohreh Nademi","Anupama Rao","Claire Booth","Persis Amrolia","Juliana Silva","Robert Chiesa","Robert Wynn","Kai Lehmberg","Itziar Astigarraga","Tayfun Güngör","Jan Stary","Despina Moshous","Marianne Ifversen","Daniel Zinn","Michael Jordan","Ashish Kumar","Takahiro Yasumi","Paul Veys","Kanchan Rao"],"twitterCount":11,"altmetricId":46487424},{"title":"Incidence of differentiation syndrome with ivosidenib (IVO) and enasidenib (ENA) for treatment of patients with relapsed or refractory (R/R) isocitrate dehydrogenase …","googleId":"Ox4IN6QpWdMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/288/263959","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2018-99-117426","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome","googleId":"XtCxpQ9FlxwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/19/2173/36901","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood-2017-07-795385","elsevierAuthor":"Ohwada C.","publicationName":"Blood","elsevierCoverDate":"2018-05-10","elsevierCoverDisplayDate":"10 May 2018","elsevierCitationCount":"10","altmetricAuthors":["Chikako Ohwada","Emiko Sakaida","Chika Kawajiri-Manako","Yuhei Nagao","Nagisa Oshima-Hasegawa","Emi Togasaki","Tomoya Muto","Shokichi Tsukamoto","Shio Mitsukawa","Yusuke Takeda","Naoya Mimura","Masahiro Takeuchi","Naomi Shimizu","Sonoko Misawa","Tohru Iseki","Satoshi Kuwabara","Chiaki Nakaseko"],"twitterCount":13,"altmetricId":35008456},{"title":"Bortezomib, lenalidomide and dexamethasone (VRD-GEM) as induction therapy prior autologous stem cell transplantation (ASCT) in multiple myeloma (MM): results …","googleId":"-fgCRXNUYdsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2017/71490","googleCitationCount":19,"googleAuthor":"A Oriol","doi":"10.1182/blood.V130.Suppl_1.2017.2017","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ruxopeg, a multi-center Bayesian phase 1/2 adaptive randomized trial of the combination of ruxolitinib and pegylated interferon alpha 2a in patients with …","googleId":"n3gvQXDZuxcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/581/263204","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood-2018-99-110785","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib","googleId":"ZVkMvQNRiSUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/14/1676/107637","googleCitationCount":19,"googleAuthor":"AR Mato","doi":"10.1182/blood-2017-05-786988","elsevierAuthor":"Winter A.M.","publicationName":"Blood","elsevierCoverDate":"2017-10-05","elsevierCoverDisplayDate":"5 October 2017","elsevierCitationCount":"16","altmetricAuthors":["Allison M. Winter","Daniel J. Landsburg","Anthony R. Mato","Krista Isaac","Francisco J. Hernandez-Ilizaliturri","Nishitha Reddy","Stephen Smith","Mazyar Shadman","Mitchell R. Smith","Paolo Caimi","Deepa Jagadeesh","Brian T. Hill"],"twitterCount":38,"altmetricId":23579055},{"title":"Ibrutinib is highly active as first line therapy in symptomatic Waldenstrom's macroglobulinemia","googleId":"IW4tUboBRGUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2767/80399","googleCitationCount":23,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2767.2767","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Treatment strategies for adolescent and young adult patients with acute myeloid leukemia","googleId":"WU1OlMhS9F4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/362/103887","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2017-12-778472","elsevierAuthor":"O’Dwyer K.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"11","altmetricAuthors":["Kristen O’Dwyer","David R. Freyer","John T. Horan"],"twitterCount":23,"altmetricId":45578623},{"title":"A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference","googleId":"h7f_JjLAfKMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/670/39417","googleCitationCount":16,"googleAuthor":"MAV Willrich","doi":"10.1182/blood-2018-05-848986","elsevierAuthor":"Mills J.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"10","altmetricAuthors":["John R. Mills","Mindy C. Kohlhagen","Maria A. V. Willrich","Taxiarchis Kourelis","Angela Dispenzieri","David L. Murray"],"twitterCount":25,"altmetricId":43628899},{"title":"Histone acetyltransferase activity of MOF is required for adult but not early fetal hematopoiesis in mice","googleId":"Sekh6vL0W4sJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/1/48/35846","googleCitationCount":23,"googleAuthor":"","doi":"10.1182/blood-2016-05-714568","elsevierAuthor":"Valerio D.G.","publicationName":"Blood","elsevierCoverDate":"2017-01-05","elsevierCoverDisplayDate":"5 January 2017","elsevierCitationCount":"18","altmetricAuthors":[],"twitterCount":0},{"title":"Combination of enasidenib and venetoclax shows superior anti-leukemic activity against IDH2 mutated AML in patient-derived xenograft models","googleId":"daFVuIHxVgwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/562/263035","googleCitationCount":13,"googleAuthor":"D Sharon","doi":"10.1182/blood-2018-99-119688","elsevierAuthor":"Becker J.S.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"A prospective phase II of daratumumab in previously-treated systemic light-chain (AL) amyloidosis","googleId":"Trwn0Yq1s8UJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/508/81242","googleCitationCount":20,"googleAuthor":"A Perrot","doi":"10.1182/blood.V130.Suppl_1.508.508","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"The combination of duvelisib, a PI3K-δ, γ inhibitor, and romidepsin is highly active in relapsed/refractory peripheral T-cell lymphoma with low rates of transaminitis …","googleId":"cinRKp0T6tkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/683/266410","googleCitationCount":13,"googleAuthor":"SM Horwitz","doi":"10.1182/blood-2018-99-115241","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients","googleId":"mm93Z6AFK50J","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2179/39502","googleCitationCount":16,"googleAuthor":"V Balatti","doi":"10.1182/blood-2018-04-845115","elsevierAuthor":"Balatti V.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"13","altmetricAuthors":["Veronica Balatti","Luisa Tomasello","Laura Z. Rassenti","Dario Veneziano","Giovanni Nigita","Huan-You Wang","John A. Thorson","Thomas J. Kipps","Yuri Pekarsky","Carlo M. Croce"],"twitterCount":23,"altmetricId":48806585},{"title":"Phase 3 randomized study of daratumumab plus bortezomib, melphalan, and prednisone (D-VMP) versus bortezomib, melphalan, and prednisone (VMP) in newly …","googleId":"xMcWzeHCk2EJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/LBA-4/83700","googleCitationCount":19,"googleAuthor":"MV Mateos","doi":"10.1182/blood.V130.Suppl_1.LBA-4.LBA-4","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Early disease progression predicts poorer survival in patients with follicular lymphoma (FL) in the GALLIUM study","googleId":"92f7ncS6eckJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1490/79591","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.1490.1490","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Combining brentuximab vedotin with DHAP as salvage treatment in relapsed/refractory Hodgkin lymphoma: the phase II HOVON/LLPC transplant BRaVE study","googleId":"PT8007jpvigJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2923/263955","googleCitationCount":13,"googleAuthor":"JM Zijlstra","doi":"10.1182/blood-2018-99-112235","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase I/II study of pembrolizumab for progressive diffuse large B cell lymphoma after anti-CD19 directed chimeric antigen receptor modified T cell therapy","googleId":"zeS8Ux_el0sJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/4121/72839","googleCitationCount":17,"googleAuthor":"J Svoboda","doi":"10.1182/blood.V130.Suppl_1.4121.4121","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A phase I study of GSK525762, a selective bromodomain (BRD) and extra terminal protein (BET) inhibitor: results from part 1 of phase I/II open label single agent study …","googleId":"WX7yNtLebA4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1377/116449","googleCitationCount":22,"googleAuthor":"BJP Huntly","doi":"10.1182/blood.V130.Suppl_1.1377.1377","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis","googleId":"xi4Nul3sAMEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1413/105721","googleCitationCount":15,"googleAuthor":"P Gopalasingam","doi":"10.1182/blood-2017-10-802975","elsevierAuthor":"Geer M.J.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"11","altmetricAuthors":["Mitchell J. Geer","Johanna P. van Geffen","Piraveen Gopalasingam","Timo Vögtle","Christopher W. Smith","Silke Heising","Marijke J. E. Kuijpers","Bibian M. E. Tullemans","Gavin E. Jarvis","Johannes A. Eble","Mark Jeeves","Michael Overduin","Johan W. M. Heemskerk","Alexandra Mazharian","Yotis A. Senis"],"twitterCount":13,"altmetricId":43606116},{"title":"A phase 2 study of ruxolitinib with chemotherapy in children with Philadelphia chromosome-like acute lymphoblastic leukemia (INCB18424-269/AALL1521): dose …","googleId":"YYjfG3Icdm0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/555/263236","googleCitationCount":13,"googleAuthor":"SK Tasian","doi":"10.1182/blood-2018-99-110221","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice","googleId":"pRQIW9KXb9YJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1974/36765","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2017-06-789321","elsevierAuthor":"Wu Y.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"11","altmetricAuthors":["Yongxia Wu","Steven Schutt","Katelyn Paz","Mengmeng Zhang","Ryan P. Flynn","David Bastian","M. Hanief Sofi","Hung Nguyen","Min Dai","Chen Liu","Ying-Jun Chang","Bruce R. Blazar","Xue-Zhong Yu"],"twitterCount":6,"altmetricId":34262414},{"title":"Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients","googleId":"xcmQSPThWYEJ","googleLink":"https://www.viridiantherapeutics.com/publications/2017/12/Phase-1-Study-of-the-Safety-and-Efficacy-of-MRG-106-a-Synthetic-Inhibitor-of-microRNA-155-in-CTCL-Patients.pdf","googleCitationCount":17,"googleAuthor":""},{"title":"BIVV001: the first investigational factor VIII therapy to break through the VWF ceiling in hemophilia A, with potential for extended protection for one week or longer","googleId":"tUeyQ6jDXsUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/636/266400","googleCitationCount":14,"googleAuthor":"A Shapiro","doi":"10.1182/blood-2018-99-113575","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?","googleId":"zYcgVd99zsIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2619/39564","googleCitationCount":14,"googleAuthor":"SJ Cameron","doi":"10.1182/blood-2017-08-743237","elsevierAuthor":"Cameron S.","publicationName":"Blood","elsevierCoverDate":"2018-12-20","elsevierCoverDisplayDate":"20 December 2018","elsevierCitationCount":"6","altmetricAuthors":["Scott J. Cameron","Hannah M. Russell","A. Phillip Owens"],"twitterCount":17,"altmetricId":52967726},{"title":"Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial","googleId":"nTKsMZn8jkEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1452/105712","googleCitationCount":17,"googleAuthor":"N Russell","doi":"10.1182/blood-2018-05-851824","elsevierAuthor":"Russell N.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"15","altmetricAuthors":["Nigel Russell","Alan Burnett","Robert Hills","Sophie Betteridge","Mike Dennis","Jelena Jovanovic","Richard Dillon","David Grimwade"],"twitterCount":14,"altmetricId":46594731},{"title":"Atezolizumab in combination with daratumumab with or without lenalidomide or pomalidomide: a phase Ib study in patients with multiple myeloma","googleId":"CLEDhu4VQXIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/597/263467","googleCitationCount":12,"googleAuthor":"R Vij","doi":"10.1182/blood-2018-99-114960","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Duration of Deep Molecular Response Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia-Results …","googleId":"Y2cgh76ILh8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/313/80751","googleCitationCount":18,"googleAuthor":"J Richter","doi":"10.1182/blood.V130.Suppl_1.313.313","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Interim results from a phase 1 study of ADCT-301 (camidanlumab tesirine) show promising activity of a novel pyrrolobenzodiazepine-based antibody drug conjugate …","googleId":"GkquuG69-XkJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1510/79833","googleCitationCount":18,"googleAuthor":"SM Horwitz","doi":"10.1182/blood.V130.Suppl_1.1510.1510","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients","googleId":"y2JNLRyCfCIJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/19/2624/36163","googleCitationCount":19,"googleAuthor":"AR Cooper","doi":"10.1182/blood-2016-12-756734","elsevierAuthor":"Cooper A.","publicationName":"Blood","elsevierCoverDate":"2017-05-11","elsevierCoverDisplayDate":"11 May 2017","elsevierCitationCount":"16","altmetricAuthors":["Aaron R. Cooper","Georgia R. Lill","Kit Shaw","Denise A. Carbonaro-Sarracino","Alejandra Davila","Robert Sokolic","Fabio Candotti","Matteo Pellegrini","Donald B. Kohn"],"twitterCount":6,"altmetricId":18259363},{"title":"A single direct intratumoral injection of TTI-621 (SIRPαFc) induces antitumor activity in patients with relapsed/refractory mycosis fungoides and Sézary syndrome …","googleId":"jq2XFLkRcDoJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4076/72833","googleCitationCount":18,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.4076.4076","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Safety, efficacy, and biomarkers of response to azacitidine (AZA) with nivolumab (Nivo) and AZA with nivo and ipilimumab (Ipi) in relapsed/refractory acute myeloid …","googleId":"NUQSgWrYtJkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/906/266423","googleCitationCount":15,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood-2018-99-120157","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?","googleId":"owciG3ZdawAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/4/376/103907","googleCitationCount":14,"googleAuthor":"ML Metzger","doi":"10.1182/blood-2018-01-778548","elsevierAuthor":"Flerlage J.","publicationName":"Blood","elsevierCoverDate":"2018-07-26","elsevierCoverDisplayDate":"26 July 2018","elsevierCitationCount":"10","altmetricAuthors":["Jamie E. Flerlage","Monika L. Metzger","Nickhill Bhakta"],"twitterCount":13,"altmetricId":45579756},{"title":"TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma","googleId":"mucfRRYM7AUJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/25/2789/37161","googleCitationCount":16,"googleAuthor":"M Słabicki","doi":"10.1182/blood-2017-09-806679","elsevierAuthor":"Jethwa A.","publicationName":"Blood","elsevierCoverDate":"2018-06-21","elsevierCoverDisplayDate":"21 June 2018","elsevierCitationCount":"11","altmetricAuthors":["Alexander Jethwa","Mikołaj Słabicki","Jennifer Hüllein","Marius Jentzsch","Vineet Dalal","Sophie Rabe","Lena Wagner","Tatjana Walther","Wolfram Klapper","Hanibal Bohnenberger","Mandy Rettel","Junyan Lu","Arne H. Smits","Frank Stein","Mikhail M. Savitski","Wolfgang Huber","Yael Aylon","Moshe Oren","Thorsten Zenz"],"twitterCount":10,"altmetricId":37386781},{"title":"Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?","googleId":"k7oXXKEJ1fQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/17/39265","googleCitationCount":15,"googleAuthor":"A Carbone","doi":"10.1182/blood-2018-02-833806","elsevierAuthor":"Carbone A.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"13","altmetricAuthors":["Antonino Carbone","Annunziata Gloghini","Carmelo Carlo-Stella"],"twitterCount":30,"altmetricId":41454785},{"title":"Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma","googleId":"PS4DC4dQGDsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2744/39690","googleCitationCount":11,"googleAuthor":"L Thurner","doi":"10.1182/blood-2018-03-836932","elsevierAuthor":"Thurner L.","publicationName":"Blood","elsevierCoverDate":"2018-12-27","elsevierCoverDisplayDate":"27 December 2018","elsevierCitationCount":"8","altmetricAuthors":["Lorenz Thurner","Klaus-Dieter Preuss","Moritz Bewarder","Maria Kemele","Natalie Fadle","Evi Regitz","Sarah Altmeyer","Claudia Schormann","Viola Poeschel","Marita Ziepert","Silke Walter","Patrick Roth","Michael Weller","Monika Szczepanowski","Wolfram Klapper","Camelia Monoranu","Andreas Rosenwald","Peter Möller","Sylvia Hartmann","Martin-Leo Hansmann","Andreas Mackensen","Henning Schäfer","Elisabeth Schorb","Gerald Illerhaus","Rolf Buslei","Rainer Maria Bohle","Stephan Stilgenbauer","Yoo-Jin Kim","Michael Pfreundschuh"],"twitterCount":17,"altmetricId":48916819},{"title":"GO-8: preliminary results of a phase I/II dose escalation trial of gene therapy for haemophilia a using a novel human factor VIII variant","googleId":"_8Bx7vZhE50J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/489/262419","googleCitationCount":14,"googleAuthor":"E Tuddenham","doi":"10.1182/blood-2018-99-118256","elsevierAuthor":"Arruda V.R.","publicationName":"Mediterranean Journal of Hematology and Infectious Diseases","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Phase 2 trial of ixazomib, lenalidomide, dexamethasone and daratumumab in patients with newly diagnosed multiple myeloma","googleId":"QUaentiAaFsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/304/263787","googleCitationCount":12,"googleAuthor":"E Muchtar","doi":"10.1182/blood-2018-99-111065","elsevierCitationCount":0,"altmetricAuthors":["Shaji K. Kumar","Prashant Kapoor","Betsy Laplant","Eli Muchtar","Francis K. Buadi","Wilson I Gonsalves","David Dingli","Ronald S. Go","Rahma Warsame","Taxiarchis Kourelis","John A. Lust","Martha Q. Lacy","Angela Dispenzieri","Suzanne R. Hayman","Yi Hwa","Amie Fonder","Miriam Hobbs","Nelson Leung","S. Vincent Rajkumar","Morie A. Gertz","Eric Wolfe"],"twitterCount":0,"altmetricId":100116515},{"title":"Results of the randomized, double-blind, placebo-controlled, phase 3 Hercules study of caplacizumab in patients with acquired thrombotic thrombocytopenic purpura","googleId":"rsS0aVbbBTMJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/LBA-1/83673","googleCitationCount":21,"googleAuthor":"SR Cataland","doi":"10.1182/blood.V130.Suppl_1.LBA-1.LBA-1","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Daratumumab in combination with pomalidomide and dexamethasone for relapsed and/or refractory multiple myeloma (RRMM) patients with≥ 2 prior lines of therapy …","googleId":"uecWcve-X3IJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1824/79552","googleCitationCount":16,"googleAuthor":"BM Weiss","doi":"10.1182/blood.V130.Suppl_1.1824.1824","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation","googleId":"v0rS3llUdZMJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/2/191/37024","googleCitationCount":19,"googleAuthor":"H Bai","doi":"10.1182/blood-2017-04-780379","elsevierAuthor":"Li Y.","publicationName":"Blood","elsevierCoverDate":"2018-01-11","elsevierCoverDisplayDate":"11 January 2018","elsevierCitationCount":"8","altmetricAuthors":["Yueying Li","Chen Jin","Hao Bai","Yongxing Gao","Shu Sun","Lei Chen","Lei Qin","Paul P. Liu","Linzhao Cheng","Qian-Fei Wang"],"twitterCount":10,"altmetricId":28454767},{"title":"Perioperative anticoagulant use for surgery evaluation (PAUSE) study: a perioperative management plan for patients with atrial fibrillation who are receiving a direct …","googleId":"OksSQFUvy5cJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/LBA-5/375113","googleCitationCount":13,"googleAuthor":"J Douketis","doi":"10.1182/blood-2018-120770","elsevierCitationCount":0,"altmetricAuthors":["James Douketis","Alex C. Spyropoulos","Joanne M Duncan","Marc Carrier","Gregoire Le Gal","Alfonso J Tafur","Thomas Vanassche","Peter Verhamme","Sudeep P Shivakumar","Peter L. Gross","Agnes Yuet Ying Lee","Erik Yeo","Susan Solymoss","Jeannine Kassis","Genevieve Le Templier","Stephen Kowalski","Mark Blostein","Vinay Shah","Elizabeth MacKay","Cynthia M. Wu","Nathan Clark","Shannon M. Bates","Fred Spencer","Eleni Arnaoutoglou","Michiel Coppens","Donald M. Arnold","Joseph A Caprini","Na Li","Karen Moffat","Syed Summer","Sam Schulman"],"twitterCount":1,"altmetricId":52975699},{"title":"Generation of a half-life extended anti-CD19 BiTE® antibody construct compatible with once-weekly dosing for treatment of CD19-positive malignancies","googleId":"RFQokmDOLtIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2815/80433","googleCitationCount":20,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2815.2815","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses","googleId":"PJsPl7KKMYQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/1/131/107701","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood-2017-02-768762","elsevierAuthor":"Gillissen M.","publicationName":"Blood","elsevierCoverDate":"2018-01-04","elsevierCoverDisplayDate":"4 January 2018","elsevierCitationCount":"9","altmetricAuthors":["Marijn A. Gillissen","Martijn Kedde","Greta de Jong","Gemma Moiset","Etsuko Yasuda","Sophie E. Levie","Arjen Q. Bakker","Yvonne B. Claassen","Koen Wagner","Martino Böhne","Paul J. Hensbergen","Dave Speijer","Pauline M. van Helden","Tim Beaumont","Hergen Spits","Mette D. Hazenberg"],"twitterCount":52,"altmetricId":27850242},{"title":"Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma","googleId":"10JkLZC9TSAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/804/266281","googleCitationCount":14,"googleAuthor":"M Bustoros","doi":"10.1182/blood-2018-99-117871","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma","googleId":"RBJR55rBLl0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/6/577/39433","googleCitationCount":16,"googleAuthor":"A Patil","doi":"10.1182/blood-2018-01-828418","elsevierAuthor":"Patil A.","publicationName":"Blood","elsevierCoverDate":"2018-08-09","elsevierCoverDisplayDate":"9 August 2018","elsevierCitationCount":"12","altmetricAuthors":["Ajinkya Patil","Mark Manzano","Eva Gottwein"],"twitterCount":9,"altmetricId":44261479},{"title":"A personalized prediction model to risk stratify patients with myelodysplastic syndromes","googleId":"FGPgsPlLeLkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/793/266156","googleCitationCount":15,"googleAuthor":"A Nazha","doi":"10.1182/blood-2018-99-114774","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"FNDC3B is another novel partner fused to RARA in the t (3; 17)(q26; q21) variant of acute promyelocytic leukemia","googleId":"mZXbMvDmDs4J","googleLink":"https://ashpublications.org/blood/article-abstract/129/19/2705/36168","googleCitationCount":19,"googleAuthor":"","doi":"10.1182/blood-2017-02-767707","elsevierAuthor":"Cheng C.K.","publicationName":"Blood","elsevierCoverDate":"2017-05-11","elsevierCoverDisplayDate":"11 May 2017","elsevierCitationCount":"14","altmetricAuthors":["Chi Keung Cheng","Angela Z. Wang","Terry H. Y. Wong","Thomas S. K. Wan","Joyce S. Cheung","Radha Raghupathy","Natalie P. H. Chan","Margaret H. L. Ng"],"twitterCount":2,"altmetricId":17776146},{"title":"Two-year follow-up of keynote-087 study: pembrolizumab monotherapy in relapsed/refractory classic hodgkin lymphoma","googleId":"7Io1FAdfiM4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2900/263697","googleCitationCount":13,"googleAuthor":"PL Zinzani","doi":"10.1182/blood-2018-99-117045","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Randomized phase 2 trial of lirilumab (anti-KIR monoclonal antibody, mAb) as maintenance treatment in elderly patients (pts) with acute myeloid leukemia (AML) …","googleId":"AmhgHGo9bhsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/889/83356","googleCitationCount":16,"googleAuthor":"C Recher","doi":"10.1182/blood.V130.Suppl_1.889.889","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A phase I/Ib study of nivolumab for relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation (alloHCT)","googleId":"C_uDzMCqSssJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/705/266170","googleCitationCount":12,"googleAuthor":"HT Kim","doi":"10.1182/blood-2018-99-117671","elsevierAuthor":"Thummalapalli R.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Silica particles contribute to the procoagulant activity of DNA and polyphosphate isolated using commercial kits","googleId":"XJeDJkIP14QJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/1/88/36216","googleCitationCount":18,"googleAuthor":"JH Morrissey","doi":"10.1182/blood-2017-03-772848","elsevierAuthor":"Smith S.","publicationName":"Blood","elsevierCoverDate":"2017-07-06","elsevierCoverDisplayDate":"6 July 2017","elsevierCitationCount":"14","altmetricAuthors":["Stephanie A. Smith","Catherine J. Baker","Joshua M. Gajsiewicz","James H. Morrissey"],"twitterCount":9,"altmetricId":21561991},{"title":"Update on a phase II study of ixazomib with lenalidomide as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma","googleId":"w9XAWCxqXgQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/437/72787","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.437.437","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Assessment of maintenance rituximab after first-line bendamustine-rituximab in patients with follicular lymphoma: an analysis from the BRIGHT trial","googleId":"a3ImEJAJ3zQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/484/72278","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.484.484","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T cell vector leads to a high objective response rate in …","googleId":"fxDfG4dMKKoJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/742/83650","googleCitationCount":16,"googleAuthor":"S Mailankody","doi":"10.1182/blood.V130.Suppl_1.742.742","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress","googleId":"ulgNQmWFbnwJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/8/1031/36957","googleCitationCount":19,"googleAuthor":"A Pantaleo","doi":"10.1182/blood-2016-11-748053","elsevierAuthor":"Pantaleo A.","publicationName":"Blood","elsevierCoverDate":"2017-08-24","elsevierCoverDisplayDate":"24 August 2017","elsevierCitationCount":"14","altmetricAuthors":["Antonella Pantaleo","Kristina R. Kesely","Maria Carmina Pau","Ioannis Tsamesidis","Evelin Schwarzer","Oleksii A. Skorokhod","Huynh D. Chien","Marta Ponzi","Lucia Bertuccini","Philip S. Low","Francesco M. Turrini"],"twitterCount":7,"altmetricId":21261763},{"title":"How I treat the older adult with sickle cell disease","googleId":"yRYxtAzZ4T0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1750/39513","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood-2018-03-818161","elsevierAuthor":"Thein S.L.","publicationName":"Blood","elsevierCoverDate":"2018-10-25","elsevierCoverDisplayDate":"25 October 2018","elsevierCitationCount":"7","altmetricAuthors":["Swee Lay Thein","Jo Howard"],"twitterCount":24,"altmetricId":48263040},{"title":"Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia","googleId":"MjFi3l9Q0NcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1855/35845","googleCitationCount":21,"googleAuthor":"","doi":"10.1182/blood-2016-09-739334","elsevierAuthor":"Cao M.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"16","altmetricAuthors":["Muhua Cao","Tao Li","Zhangxiu He","Lixiu Wang","Xiaoyan Yang","Yan Kou","Lili Zou","Xue Dong","Valerie A. Novakovic","Yayan Bi","Junjie Kou","Bo Yu","Shaohong Fang","Jinghua Wang","Jin Zhou","Jialan Shi"],"twitterCount":6,"altmetricId":15241293},{"title":"CA180-372: An international collaborative phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly diagnosed Philadelphia chromosome positive …","googleId":"pWF_xZzJ3zQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/98/83454","googleCitationCount":15,"googleAuthor":"M Devidas","doi":"10.1182/blood.V130.Suppl_1.98.98","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Preliminary results of UCART19, an allogeneic anti-CD19 CAR T-cell product, in a first-in-human trial (CALM) in adult patients with CD19+ relapsed/refractory B-cell …","googleId":"ekYJjfW9UUMJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/887/83335","googleCitationCount":16,"googleAuthor":"C Graham","doi":"10.1182/blood.V130.Suppl_1.887.887","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Emicizumab subcutaneous dosing every 4 weeks for the management of hemophilia A: preliminary data from the pharmacokinetic run-in cohort of a multicenter, open …","googleId":"-Slgy2WQisgJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/86/83527","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.86.86","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Rapid MRD-negative responses in patients with relapsed/refractory CLL treated with Liso-Cel, a CD19-directed CAR T-cell product: preliminary results from transcend …","googleId":"6vGQKnKuMnYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/300/263833","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood-2018-99-110462","elsevierAuthor":"Cortés-Hernández A.","publicationName":"Methods in Molecular Biology","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Enasidenib monotherapy is effective and well-tolerated in patients with previously untreated mutant-IDH2 (m IDH2) acute myeloid leukemia (AML)","googleId":"HIsR0dYlZ58J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/638/83396","googleCitationCount":18,"googleAuthor":"S De Botton","doi":"10.1182/blood.V130.Suppl_1.638.638","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A single intravenous infusion of FLT180a results in factor IX activity levels of more than 40% and has the potential to provide a functional cure for patients with …","googleId":"94bgMk5b6PUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/631/266354","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood-2018-99-118050","elsevierAuthor":"Arruda V.R.","publicationName":"Mediterranean Journal of Hematology and Infectious Diseases","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":["Pratima Chowdary","Susie Shapiro","Andrew M. Davidoff","Ulrike Reiss","Rebecca Alade","Geoff Brooks","Allison Dane","Jenny McIntosh","Gerard Short","Edward Tuddenham","Amit C Nathwani"],"twitterCount":1,"altmetricId":51603716},{"title":"Inhibition of C3 with APL-2 results in normalisation of markers of intravascular and extravascular hemolysis in patients with autoimmune hemolytic anemia (AIHA)","googleId":"mpAG1zrcRBQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3623/264815","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2018-99-119468","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Dasatinib discontinuation in patients (pts) with chronic-phase chronic myeloid leukemia (CML-CP) and stable deep molecular response (DASFREE)","googleId":"oGHoa_xzp3MJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/314/80808","googleCitationCount":17,"googleAuthor":"JV García Gutiérrez","doi":"10.1182/blood.V130.Suppl_1.314.314","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"CD207+ CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis","googleId":"1iDQgRBwsewJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/17/1898/36511","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood-2017-05-782730","elsevierAuthor":"Silva E.A.C.","publicationName":"Blood","elsevierCoverDate":"2017-10-26","elsevierCoverDisplayDate":"26 October 2017","elsevierCitationCount":"11","altmetricAuthors":["Eugenio Antonio Carrera Silva","Wanda Nowak","Licina Tessone","Cinthia Mariel Olexen","Juan Manuel Ortiz Wilczyñski","Ivana Gisele Estecho","Graciela Elena","Andrea Emilse Errasti","Diego Alfredo Rosso"],"twitterCount":5,"altmetricId":24477442},{"title":"A phase 2 study of actinium-225 (225Ac)-lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy","googleId":"ZOoe1aJfiloJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2638/79974","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2638.2638","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Carfilzomib, pomalidomide and dexamethasone (KPd) in patients with multiple myeloma refractory to bortezomib and lenalidomide. the EMN011 trial","googleId":"mU7cN3GAjtYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/801/266248","googleCitationCount":11,"googleAuthor":"M Cavo","doi":"10.1182/blood-2018-99-114029","elsevierCitationCount":0,"altmetricAuthors":["Pieter Sonneveld","Sonja Zweegman","Michele Cavo","Kazem Nasserinejad","Rosella Troia","Ludek Pour","Sandra Croockewit","Paolo Corradini","Francesca Patriarca","Kalung Wu","Jolanda Droogendijk","Annemiek Broyl","Monique C Minnema","Bruno Costa","Karim Saad Iskander","Mario Boccadoro"],"twitterCount":0,"altmetricId":56863455},{"title":"Open label phase I study of single agent oral RG7388 (idasanutlin) in patients with polycythemia vera and essential thrombocythemia","googleId":"JitPY_PTT7sJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/254/80241","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.254.254","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Nrf2 regulates CD4+ T cell–induced acute graft-versus-host disease in mice","googleId":"ZTvhVQW5_1UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/26/2763/39706","googleCitationCount":9,"googleAuthor":"JJ Tsai","doi":"10.1182/blood-2017-10-812941","elsevierAuthor":"Tsai J.J.","publicationName":"Blood","elsevierCoverDate":"2018-12-27","elsevierCoverDisplayDate":"27 December 2018","elsevierCitationCount":"9","altmetricAuthors":["Jennifer J. Tsai","Enrico Velardi","Yusuke Shono","Kimon V. Argyropoulos","Amanda M. Holland","Odette M. Smith","Nury L. Yim","Uttam K. Rao","Fabiana M. Kreines","Sophie R. Lieberman","Lauren F. Young","Amina Lazrak","Salma Youssef","Ya-Yuan Fu","Chen Liu","Cecilia Lezcano","George F. Murphy","Il-Kang Na","Robert R. Jenq","Alan M. Hanash","Jarrod A. Dudakov","Marcel R. M. van den Brink"],"twitterCount":5,"altmetricId":53383915},{"title":"MURANO trial establishes feasibility of time-limited venetoclax-rituximab (VenR) combination therapy in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)","googleId":"a99hjAGxnDQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/184/273230","googleCitationCount":12,"googleAuthor":"TJ Kipps","doi":"10.1182/blood-2018-184","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"PET-guided treatment of early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase 3 trial HD16 by the German Hodgkin Study …","googleId":"FDiotPHI7DwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/925/266183","googleCitationCount":12,"googleAuthor":"C Baues","doi":"10.1182/blood-2018-99-114519","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Current results of lentiglobin gene therapy in patients with severe sickle cell disease treated under a refined protocol in the phase 1 Hgb-206 study","googleId":"QBFcVIfFXyoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1026/262786","googleCitationCount":17,"googleAuthor":"MY Mapara","doi":"10.1182/blood-2018-99-113480","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice","googleId":"lK7LC6s6JM8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2188/39514","googleCitationCount":12,"googleAuthor":"V Radojcic","doi":"10.1182/blood-2018-03-841155","elsevierAuthor":"Radojcic V.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"9","altmetricAuthors":["Vedran Radojcic","Katelyn Paz","Jooho Chung","Jing Du","Eric T. Perkey","Ryan Flynn","Sanja Ivcevic","Michael Zaiken","Ann Friedman","Minhong Yan","Maria A. Pletneva","Stefanie Sarantopoulos","Christian W. Siebel","Bruce R. Blazar","Ivan Maillard"],"twitterCount":14,"altmetricId":47677648},{"title":"Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT","googleId":"TpqvARLzxKcJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1846/36850","googleCitationCount":17,"googleAuthor":"","doi":"10.1182/blood-2017-09-805879","elsevierAuthor":"Berger G.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"11","altmetricAuthors":["Gerbrig Berger","Leonie I. Kroeze","Theresia N. Koorenhof-Scheele","Aniek O. de Graaf","Kenichi Yoshida","Hiroo Ueno","Yuichi Shiraishi","Satoru Miyano","Eva van den Berg","Hein Schepers","Bert A. van der Reijden","Seishi Ogawa","Edo Vellenga","Joop H. Jansen"],"twitterCount":17,"altmetricId":31436534},{"title":"Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis","googleId":"LPD9fDnan4MJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/23/2541/36947","googleCitationCount":15,"googleAuthor":"G Kleinstern","doi":"10.1182/blood-2017-11-814608","elsevierAuthor":"Kleinstern G.","publicationName":"Blood","elsevierCoverDate":"2018-06-07","elsevierCoverDisplayDate":"7 June 2018","elsevierCitationCount":"10","altmetricAuthors":["Geffen Kleinstern","Nicola J. Camp","Lynn R. Goldin","Celine M. Vachon","Claire M. Vajdic","Silvia de Sanjose","J. Brice Weinberg","Yolanda Benavente","Delphine Casabonne","Mark Liebow","Alexandra Nieters","Henrik Hjalgrim","Mads Melbye","Bengt Glimelius","Hans-Olov Adami","Paolo Boffetta","Paul Brennan","Marc Maynadie","James McKay","Pier Luigi Cocco","Tait D. Shanafelt","Timothy G. Call","Aaron D. Norman","Curtis Hanson","Dennis Robinson","Kari G. Chaffee","Angela R. Brooks-Wilson","Alain Monnereau","Jacqueline Clavel","Martha Glenn","Karen Curtin","Lucia Conde","Paige M. Bracci","Lindsay M. Morton","Wendy Cozen","Richard K. Severson","Stephen J. Chanock","John J. Spinelli","James B. Johnston","Nathaniel Rothman","Christine F. Skibola","Jose F. Leis","Neil E. Kay","Karin E. Smedby","Sonja I. Berndt","James R. Cerhan","Neil Caporaso","Susan L. Slager"],"twitterCount":13,"altmetricId":38300857},{"title":"PD-1 blockade with pembrolizumab in relapsed low grade non-Hodgkin lymphoma","googleId":"YdLqT6pr0yUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4055/72601","googleCitationCount":15,"googleAuthor":"W Ding","doi":"10.1182/blood.V130.Suppl_1.4055.4055","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"NKG2D-CAR transduced primary natural killer cells efficiently target multiple myeloma cells","googleId":"jDhXCG6zXfwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/590/263209","googleCitationCount":11,"googleAuthor":"A Leivas","doi":"10.1182/blood-2018-99-114522","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy and toxicity of JCAR014 in combination with durvalumab for the treatment of patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma","googleId":"JFaUGZniZT8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1680/272925","googleCitationCount":11,"googleAuthor":"J Gauthier","doi":"10.1182/blood-2018-99-116745","elsevierCitationCount":0,"altmetricAuthors":["Alexandre V. Hirayama","Jordan Gauthier","Kevin A. Hay","Alyssa Sheih","Sindhu Cherian","Xueyan Chen","Barbara S. Pender","Reed M. Hawkins","Aesha Vakil","Rachel N. Steinmetz","Tinh-Doan Phi","Aude G. Chapuis","Brian G. Till","Hans-Peter Kiem","Mazyar Shadman","Ryan D. Cassaday","Utkarsh H. Acharya","Stanley R. Riddell","David G. Maloney","Cameron J. Turtle"],"twitterCount":0,"altmetricId":70733218},{"title":"The addition of sorafenib to standard AML treatment results in a substantial reduction in relapse risk and improved survival. Updated results from long-term follow-up …","googleId":"I2NAQH9Uu90J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/721/83399","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.721.721","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Molecular responses after switching from a standard-dose twice-daily nilotinib regimen to a reduced-dose once-daily schedule in patients with chronic myeloid …","googleId":"ThDfFrQ99JYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/318/114734","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.318.318","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Risk-adapted therapy in adults with Burkitt lymphoma: results of NCI 9177, a multicenter prospective phase II study of DA-EPOCH-R","googleId":"7zLGBRufPyYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/188/71362","googleCitationCount":15,"googleAuthor":"JS Abramson","doi":"10.1182/blood.V130.Suppl_1.188.188","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Enhancer dysfunction in leukemia","googleId":"51ZzqdKmHQQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120322965","googleCitationCount":14,"googleAuthor":"AS Bhagwat","doi":"10.1182/blood-2017-11-737379","elsevierAuthor":"Bhagwat A.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"10","altmetricAuthors":["Anand S. Bhagwat","Bin Lu","Christopher R. Vakoc"],"twitterCount":16,"altmetricId":32989664},{"title":"Every 2 weeks or every 4 weeks subcutaneous injection of emicizumab in pediatric patients with severe hemophilia a without inhibitors: a multi-center, open-label …","googleId":"VEE02vNsHhAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1186/262605","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-115792","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"HDP101, a novel B-cell maturation antigen (BCMA)-targeted antibody conjugated to α-Amanitin, is active against myeloma with preferential efficacy against pre …","googleId":"oPId81kBba8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/593/263463","googleCitationCount":11,"googleAuthor":"RK Singh","doi":"10.1182/blood-2018-99-118412","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy and tolerability of ixazomib, daratumumab and low dose dexamethasone (IDd) in unfit and frail newly diagnosed multiple myeloma (NDMM) patients; first …","googleId":"mwOxW1aYTeAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/596/263466","googleCitationCount":12,"googleAuthor":"MD Levin","doi":"10.1182/blood-2018-99-114668","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Salvage autologous transplant and lenalidomide maintenance versus continuous lenalidomide/dexamethasone for relapsed multiple myeloma: results of the …","googleId":"QMtm3iHGIlkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/253/264089","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2018-99-111203","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA","googleId":"TYV8t0f2LVAJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/6/723/36306","googleCitationCount":22,"googleAuthor":"AA Thompson","doi":"10.1182/blood-2016-07-727719","elsevierAuthor":"Liem R.I.","publicationName":"Blood","elsevierCoverDate":"2017-02-09","elsevierCoverDisplayDate":"9 February 2017","elsevierCitationCount":"14","altmetricAuthors":["Robert I. Liem","Cheeling Chan","Thanh-Huyen T. Vu","Myriam Fornage","Alexis A. Thompson","Kiang Liu","Mercedes R. Carnethon"],"twitterCount":3,"altmetricId":16360463},{"title":"Murine pre–B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor","googleId":"ah8S6RV1IlwJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/18/1899/39617","googleCitationCount":11,"googleAuthor":"H Qin","doi":"10.1182/blood-2017-12-815548","elsevierAuthor":"Qin H.","publicationName":"Blood","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"5","altmetricAuthors":["Haiying Qin","Kazusa Ishii","Sang Nguyen","Paul P. Su","Chad R. Burk","Bong-Hyun Kim","Brynn B. Duncan","Samikasha Tarun","Nirali N. Shah","M. Eric Kohler","Terry J. Fry"],"twitterCount":7,"altmetricId":48684492},{"title":"Long-term efficacy and safety of recombinant interferon alpha-2 vs. hydroxyurea in polycythemia vera: preliminary results from the three-year analysis of the daliah trial …","googleId":"MZu9Z18lXn0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/580/263094","googleCitationCount":11,"googleAuthor":"DL Hansen","doi":"10.1182/blood-2018-99-111255","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"101HEMB01 is a phase 1/2 open-label, single ascending dose-finding trial of DTX101 (AAVrh10FIX) in patients with moderate/severe hemophilia B that demonstrated …","googleId":"KBJhsGvjf0QJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3331/114571","googleCitationCount":16,"googleAuthor":"S Pipe","doi":"10.1182/blood.V130.Suppl_1.3331.3331","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Maintaining perioperative hemostasis in patients with severe hemophilia A and inhibitors receiving emicizumab prophylaxis","googleId":"WH4E2FUxSJYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/635/266393","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-115089","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Molecular patterns of response and outcome in the chemotherapy and venetoclax in elderly AML trial (CAVEAT study)","googleId":"fPaBmYjO4A0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/333/264495","googleCitationCount":13,"googleAuthor":"AH Wei","doi":"10.1182/blood-2018-99-114243","elsevierAuthor":"Juárez-Salcedo L.","publicationName":"Drugs in Context","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0},{"title":"Preclinical evaluation of MEDI2228, a BCMA-targeting pyrrolobenzodiazepine-linked antibody drug conjugate for the treatment of multiple myeloma","googleId":"SwXZ-D_9HmwJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3153/114444","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.3153.3153","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Clinical responses to CAR. CD30-T cells in patients with CD30+ lymphomas relapsed after multiple treatments including brentuximab vedotin","googleId":"tXv_yMc7RBkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/681/266391","googleCitationCount":13,"googleAuthor":"SI Park","doi":"10.1182/blood-2018-99-113534","elsevierCitationCount":0,"altmetricAuthors":["Natalie S Grover","Steven I Park","Anastasia Ivanova","Paul Eldridge","Kathryn McKay","Catherine Joyce Arago Cheng","Spencer Laing","Deborah Covington","John West","S. Elizabeth Sharf","J. Kaitlin Morrison","Shaw Scott","Erin Crecelius","Desirae Shelley","Maurice Alexander","Faith Brianne Buchanan","Emily Herrick Kassam","Megan McElfresh","Alicia R Pinto","Angela Denise Spruill","Ashley Zanter","Kimberly Wehner","Christopher Dittus","Thomas C. Shea","Gianpietro Dotti","Jonathan S Serody","Anne Beaven","Barbara Savoldo"],"twitterCount":0,"altmetricId":52488161},{"title":"GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis","googleId":"x20LPNpI3roJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/7/908/37004","googleCitationCount":16,"googleAuthor":"M Suzuki","doi":"10.1182/blood-2016-12-756767","elsevierAuthor":"Katayama S.","publicationName":"Blood","elsevierCoverDate":"2017-08-17","elsevierCoverDisplayDate":"17 August 2017","elsevierCitationCount":"11","altmetricAuthors":["Saori Katayama","Mikiko Suzuki","Ayaka Yamaoka","Nadine Keleku-Lukwete","Fumiki Katsuoka","Akihito Otsuki","Shigeo Kure","James Douglas Engel","Masayuki Yamamoto"],"twitterCount":8,"altmetricId":24226031},{"title":"Phase 1 study of the IDH1m inhibitor FT-2102 as a single agent in patients with IDH1m acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)","googleId":"W6xLTTwqKL8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1453/272864","googleCitationCount":12,"googleAuthor":"J Watts","doi":"10.1182/blood-2018-99-114263","elsevierAuthor":"Becker J.S.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature","googleId":"QAq67cSz3a0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/20/2154/39511","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-05-849893","elsevierAuthor":"Chapman M.A.","publicationName":"Blood","elsevierCoverDate":"2018-11-15","elsevierCoverDisplayDate":"15 November 2018","elsevierCitationCount":"7","altmetricAuthors":["Michael A. Chapman","Jonathan Sive","John Ambrose","Claire Roddie","Nicholas Counsell","Anna Lach","Mahnaz Abbasian","Rakesh Popat","Jamie D. Cavenagh","Heather Oakervee","Matthew J. Streetly","Stephen Schey","Mickey Koh","Fenella Willis","Andres E. Virchis","Josephine Crowe","Michael F. Quinn","Gordon Cook","Charles R. Crawley","Guy Pratt","Mark Cook","Nivette Braganza","Toyin Adedayo","Paul Smith","Laura Clifton-Hadley","Roger G. Owen","Pieter Sonneveld","Jonathan J. Keats","Javier Herrero","Kwee Yong"],"twitterCount":22,"altmetricId":47857799},{"title":"OP-106 Horizon—melflufen therapy for RRMM patients refractory to daratumumab and/or pomalidomide; updated results and first report on PFS","googleId":"BswtMgWUK-AJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/600/266001","googleCitationCount":11,"googleAuthor":"E Ocio","doi":"10.1182/blood-2018-99-113095","elsevierCitationCount":0,"altmetricAuthors":["Paul Richardson","Enrique Ocio","Albert Oriol","Alessandra Larocca","Paula Rodriguez Otero","Jan Moreb","Joan Bladé","Hani Hassoun","Michele Cavo","Adrián Alegre","Amitabha Mazumder","Christopher Maisel","Agne Paner","Nashat Gabrail","Jeffrey A Zonder","Dharminder Chauhan","Johan Harmenberg","Sara Thuresson","Hanan Zubair","Maria-Victoria Mateos"],"twitterCount":0,"altmetricId":52535213},{"title":"Targeted therapy for fusion-driven high-risk acute leukemia","googleId":"ve2U1XlBe3QJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1241/39602","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-04-784157","elsevierAuthor":"Pikman Y.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"7","altmetricAuthors":["Yana Pikman","Kimberly Stegmaier"],"twitterCount":3,"altmetricId":48747257},{"title":"A mutation of the human EPHB2 gene leads to a major platelet functional defect","googleId":"N2xWvsFF7sMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2067/39483","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-04-845644","elsevierAuthor":"Berrou E.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"7","altmetricAuthors":["Eliane Berrou","Christelle Soukaseum","Rémi Favier","Frédéric Adam","Ziane Elaib","Alexandre Kauskot","Jean-Claude Bordet","Paola Ballerini","Stephane Loyau","Miao Feng","Karine Dias","Abbas Muheidli","Stephane Girault","Alan T. Nurden","Ernest Turro","Willem H. Ouwehand","Cécile V. Denis","Martine Jandrot-Perrus","Jean-Philippe Rosa","Paquita Nurden","Marijke Bryckaert"],"twitterCount":13,"altmetricId":48352793},{"title":"Updated safety and activity of the investigational bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) in patients with mantle cell lymphoma","googleId":"4zW3Ot9NmZsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1592/272930","googleCitationCount":10,"googleAuthor":"CS Tam","doi":"10.1182/blood-2018-99-117224","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Placental therapy: an insight to their biological and therapeutic properties","googleId":"p3va-Uuk-QgJ","googleLink":"https://www.researchgate.net/profile/Dmytro_Klokol2/publication/322873736_Placental_therapy_An_insight_to_their_biological_and_therapeutic_properties/links/5c90afaaa6fdcc38175cf47e/Placental-therapy-An-insight-to-their-biological-and-therapeutic-properties.pdf","googleCitationCount":16,"googleAuthor":"D Klokol"},{"title":"Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated results from the phase 1/2 ACE-CL-001 study","googleId":"2JC83FCbWQAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/498/81070","googleCitationCount":17,"googleAuthor":"JC Byrd","doi":"10.1182/blood.V130.Suppl_1.498.498","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group","googleId":"mlGOjHSD5_oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/14/1519/39338","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2018-02-836437","elsevierAuthor":"Eichenauer D.","publicationName":"Blood","elsevierCoverDate":"2018-10-04","elsevierCoverDisplayDate":"4 October 2018","elsevierCitationCount":"10","altmetricAuthors":["Dennis A. Eichenauer","Annette Plütschow","Lena Schröder","Michael Fuchs","Boris Böll","Bastian von Tresckow","Volker Diehl","Peter Borchmann","Andreas Engert"],"twitterCount":21,"altmetricId":45934140},{"title":"Venous thromboembolism in cancer patients receiving immunotherapy","googleId":"tfyh3eeMgrEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2510/264382","googleCitationCount":10,"googleAuthor":"AS Kim","doi":"10.1182/blood-2018-99-116439","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"The search for new antithrombotic mechanisms and therapies that may spare hemostasis","googleId":"Xa468UTcwKYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120322746","googleCitationCount":14,"googleAuthor":"Y Wang","doi":"10.1182/blood-2017-10-784074","elsevierAuthor":"Plow E.F.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"11","altmetricAuthors":["Edward F. Plow","Yunmei Wang","Daniel I. Simon"],"twitterCount":12,"altmetricId":39381469},{"title":"A phase 1b study investigating the combination of the tetravalent bispecific NK cell engager AFM13 and pembrolizumab in patients with relapsed/refractory Hodgkin …","googleId":"Z7DtFtSCMs0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1620/273257","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-99-118506","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ropeginterferon alfa-2b induces high rates of clinical, hematological and molecular responses in polycythemia vera: two-year results from the first prospective …","googleId":"qvOe-pEKOXoJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/320/114497","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.320.320","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Adct-301 (camidanlumab tesirine), a novel pyrrolobenzodiazepine-based CD25-targeting antibody drug conjugate, in a phase 1 study of relapsed/refractory non …","googleId":"G-DOMMLlJDUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1658/273195","googleCitationCount":13,"googleAuthor":"GP Collins","doi":"10.1182/blood-2018-99-115986","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Results from REACH1, a single-arm phase 2 study of ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease","googleId":"0TlOLJPsrbMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/601/266011","googleCitationCount":10,"googleAuthor":"NN Shah","doi":"10.1182/blood-2018-99-116342","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Activation of PPARγ by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia","googleId":"ITu_TezOVlQJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1802/35835","googleCitationCount":17,"googleAuthor":"DB Tukaramrao","doi":"10.1182/blood-2016-08-736405","elsevierAuthor":"Finch E.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"15","altmetricAuthors":[],"twitterCount":0},{"title":"Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t (15; 17)(q22; q12)/PML-RARA","googleId":"y1oXBTRqL1EJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/8/935/104414","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood-2017-09-807370","elsevierAuthor":"Yao L.","publicationName":"Blood","elsevierCoverDate":"2018-02-22","elsevierCoverDisplayDate":"22 February 2018","elsevierCitationCount":"11","altmetricAuthors":["Li Yao","Lijun Wen","Nana Wang","Tianhui Liu","Yang Xu","Changgeng Ruan","Depei Wu","Suning Chen"],"twitterCount":3,"altmetricId":30463715},{"title":"RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML","googleId":"gwLZ6apD-osJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2485/37075","googleCitationCount":11,"googleAuthor":"DGJ Cucchi","doi":"10.1182/blood-2017-12-819508","elsevierAuthor":"Cucchi D.G.J.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"9","altmetricAuthors":["David G. J. Cucchi","Barbara Denys","Gertjan J. L. Kaspers","Jeroen J. W. M. Janssen","Gert J. Ossenkoppele","Valérie de Haas","C. Michel Zwaan","Marry M. van den Heuvel-Eibrink","Jan Philippé","Tamás Csikós","Zinia Kwidama","Barbara de Moerloose","Eveline S. J. M. de Bont","Birgit I. Lissenberg-Witte","Sonja Zweegman","Femke Verwer","Karl Vandepoele","Gerrit Jan Schuurhuis","Edwin Sonneveld","Jacqueline Cloos"],"twitterCount":10,"altmetricId":38072824},{"title":"Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma","googleId":"iKMQZdYD9i0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/152/79460","googleCitationCount":15,"googleAuthor":"CS Tam","doi":"10.1182/blood.V130.Suppl_1.152.152","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL","googleId":"ODa-XKRFbsYJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/4/421/38492","googleCitationCount":14,"googleAuthor":"E Leroy","doi":"10.1182/blood-2017-07-797597","elsevierAuthor":"Degryse S.","publicationName":"Blood","elsevierCoverDate":"2018-01-25","elsevierCoverDisplayDate":"25 January 2018","elsevierCitationCount":"9","altmetricAuthors":["Sandrine Degryse","Simon Bornschein","Charles E. de Bock","Emilie Leroy","Marlies Vanden Bempt","Sofie Demeyer","Kris Jacobs","Ellen Geerdens","Olga Gielen","Jean Soulier","Christine J. Harrison","Stefan N. Constantinescu","Jan Cools"],"twitterCount":15,"altmetricId":29671531},{"title":"EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice","googleId":"M_R8j2TFWJsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/23/2516/36778","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood-2017-07-796821","elsevierAuthor":"Fish K.","publicationName":"Blood","elsevierCoverDate":"2017-12-07","elsevierCoverDisplayDate":"7 December 2017","elsevierCitationCount":"7","altmetricAuthors":["Kamonwan Fish","Richard P. Sora","Samantha J. Schaller","Richard Longnecker","Masato Ikeda"],"twitterCount":2,"altmetricId":27969962},{"title":"Preclinical characterization of AMG 424, a novel humanized T cell-recruiting bispecific anti-CD3/CD38 antibody","googleId":"Eu6YCWhM7QAJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/500/80847","googleCitationCount":15,"googleAuthor":"M Balazs","doi":"10.1182/blood.V130.Suppl_1.500.500","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Thrombotic events in patients with myeloma treated with immunomodulatory drugs; results of the myeloma XI study","googleId":"PGfElRWd7E8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/553/115718","googleCitationCount":15,"googleAuthor":"MW Jenner","doi":"10.1182/blood.V130.Suppl_1.553.553","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Avapritinib, a potent and selective inhibitor of KIT D816V, improves symptoms of advanced systemic mastocytosis (AdvSM): analyses of patient reported outcomes …","googleId":"a7rYALnXA9QJ","googleLink":"https://ashpublications.org/blood/article/132/Suppl_1/351/264522","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-112017","elsevierCitationCount":0,"altmetricAuthors":["Jason R. Gotlib","Deepti Radia","Daniel J. DeAngelo","Prithviraj Bose","Mark W Drummond","Elizabeth O. Hexner","William A Robinson","Maureen G. Conlan","Ronny G. Oren","Hongliang Shi","Michael W. Deininger"],"twitterCount":0,"altmetricId":84159459},{"title":"Safety and efficacy of atezolizumab in combination with obinutuzumab and bendamustine in patients with previously untreated follicular lymphoma: an interim analysis","googleId":"qwFY55Lc7G0J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/481/72427","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.481.481","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase 1 first-in-human trial of AMV564, a bivalent bispecific (2x2) CD33/CD3 T-cell Engager, in patients with relapsed/refractory acute myeloid leukemia (AML)","googleId":"yIs_-YSAF7UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1455/272888","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-99-111529","elsevierCitationCount":0,"altmetricAuthors":["Peter Westervelt","Gail J. Roboz","Jorge E. Cortes","Hagop M. Kantarjian","Sangmin Lee","Michael P. Rettig","Tae H. Han","Jeanmarie Guenot","Eric J. Feldman","John F. DiPersio"],"twitterCount":0,"altmetricId":100350913},{"title":"Novel CD19/CD22 bicistronic chimeric antigen receptors outperform single or bivalent cars in eradicating CD19+ CD22+, CD19-, and CD22-pre-B leukemia","googleId":"3kc9jtqyRREJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/810/83439","googleCitationCount":16,"googleAuthor":"H Qin","doi":"10.1182/blood.V130.Suppl_1.810.810","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Neutrophils, NETs, and immunothrombosis","googleId":"gQWrQE0ji3sJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/13/1360/105710","googleCitationCount":11,"googleAuthor":"SP Grover","doi":"10.1182/blood-2018-08-868067","elsevierAuthor":"Grover S.","publicationName":"Blood","elsevierCoverDate":"2018-09-27","elsevierCoverDisplayDate":"27 September 2018","elsevierCitationCount":"6","altmetricAuthors":["Steven P. Grover","Nigel Mackman"],"twitterCount":10,"altmetricId":49100409},{"title":"Addition of crenolanib to induction chemotherapy overcomes the poor prognostic impact of co-occurring driver mutations in patients with newly diagnosed FLT3 …","googleId":"lBiqiewRKFwJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1436/262951","googleCitationCount":10,"googleAuthor":"AD Goldberg","doi":"10.1182/blood-2018-99-117016","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Apixaban is safe and effective in morbidly obese patients: a retrospective analysis of 390 patients with BMI≥ 40","googleId":"YQYYocBykkUJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1105/116251","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.1105.1105","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation","googleId":"Gx1w-Nw9ProJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120327476","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood-2017-04-551606","elsevierAuthor":"Alvarnas J.","publicationName":"Blood","elsevierCoverDate":"2017-11-02","elsevierCoverDisplayDate":"2 November 2017","elsevierCitationCount":"12","altmetricAuthors":["Joseph C. Alvarnas","John A. Zaia","Stephen J. Forman"],"twitterCount":44,"altmetricId":25669589},{"title":"AUGMENT: A phase III randomized study of lenalidomide plus rituximab (R2) vs rituximab/placebo in patients with relapsed/refractory indolent non-Hodgkin …","googleId":"741PclHY6gYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/445/275452","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2018-99-110861","elsevierCitationCount":0,"altmetricAuthors":["John P. Leonard","Marek Trněný","Koji Izutsu","Nathan H. Fowler","Xiaonan Hong","Jun Zhu","Huilai Zhang","Fritz Offner","Adriana Scheliga","Grzegorz S. Nowakowski","Antonio Pinto","Francesca Re","Laura Maria Fogliatto","Phillip Scheinberg","Ian W. Flinn","Cláudia Moreira","David Liu","Stacey Kalambakas","Pierre Fustier","Chengqing Wu","John G. Gribben"],"twitterCount":0,"altmetricId":56327416},{"title":"Phase II, multiple-dose study of anti-FcRn antibody, rozanolixizumab (UCB7665), in patients with primary immune thrombocytopenia: interim analysis","googleId":"LQCPNi7_kxAJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/15/79700","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.15.15","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Normal plasma IgG inhibits HIT antibody–mediated platelet activation: implications for therapeutic plasma exchange","googleId":"nbimHebxNb0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/6/703/39216","googleCitationCount":13,"googleAuthor":"CG Jones","doi":"10.1182/blood-2017-08-803031","elsevierAuthor":"Jones C.","publicationName":"Blood","elsevierCoverDate":"2018-02-08","elsevierCoverDisplayDate":"8 February 2018","elsevierCitationCount":"10","altmetricAuthors":["Curtis G. Jones","Shannon M. Pechauer","Brian R. Curtis","Daniel W. Bougie","Richard H. Aster","Anand Padmanabhan"],"twitterCount":5,"altmetricId":30672999},{"title":"Integrated analysis of randomized controlled trials evaluating bortezomib+ lenalidomide+ dexamethasone or bortezomib+ thalidomide+ dexamethasone induction in …","googleId":"RXI4Tp3D0uUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3245/264523","googleCitationCount":12,"googleAuthor":"A Oriol","doi":"10.1182/blood-2018-99-112659","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"The addition of midostaurin to standard chemotherapy decreases cumulative incidence of relapse (CIR) in the international prospective randomized, placebo …","googleId":"v50bpSVZ3-UJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2580/80286","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2580.2580","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"FLT3-ITD activation mediates resistance to the BCL-2 selective antagonist, venetoclax, in FLT3-ITD mutant AML models","googleId":"dMUyN3Dv8lQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1348/116131","googleCitationCount":15,"googleAuthor":"RS Mali","doi":"10.1182/blood.V130.Suppl_1.1348.1348","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development","googleId":"4LA84_E6yS0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/12/1279/39659","googleCitationCount":8,"googleAuthor":"Q Wang","doi":"10.1182/blood-2018-02-835850","elsevierAuthor":"Wang Q.","publicationName":"Blood","elsevierCoverDate":"2018-09-20","elsevierCoverDisplayDate":"20 September 2018","elsevierCitationCount":"2","altmetricAuthors":["Qing Wang","Ran Yan","Nancy Pinnell","Anna C. McCarter","Yeonjoo Oh","Yiran Liu","Cher Sha","Noah F. Garber","Yitong Chen","Qingqing Wu","Chia-Jui Ku","Ivy Tran","Amparo Serna Alarcon","Rork Kuick","James Douglas Engel","Ivan Maillard","Tomasz Cierpicki","Mark Y. Chiang"],"twitterCount":1,"altmetricId":46494442},{"title":"Nivolumab for relapsed or refractory classical Hodgkin lymphoma (cHL) after autologous hematopoietic cell transplantation (auto-HCT): extended follow-up of the …","googleId":"PFtnjbORk6cJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2897/263642","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-112067","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Flipping the switch: initial results of genetic targeting of the fetal to adult globin switch in sickle cell patients","googleId":"RlmiBO8I6SYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1023/262755","googleCitationCount":12,"googleAuthor":"C Brendel","doi":"10.1182/blood-2018-99-116733","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Improvement in global longitudinal strain (GLS) correlates with NT-Probnp response in patients with cardiac amyloidosis treated on a Phase 1b study of anti-amyloid …","googleId":"J4_y0D1zHwMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/958/266030","googleCitationCount":10,"googleAuthor":"MS Maurer","doi":"10.1182/blood-2018-99-118464","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis","googleId":"3aaUsNH9HSUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/17/1842/39486","googleCitationCount":10,"googleAuthor":"CK Ward-Caviness","doi":"10.1182/blood-2018-02-831347","elsevierAuthor":"Ward-Caviness C.K.","publicationName":"Blood","elsevierCoverDate":"2019-07-11","elsevierCoverDisplayDate":"11 July 2019","elsevierCitationCount":"0","altmetricAuthors":["Cavin K. Ward-Caviness","Jennifer E. Huffman","Karl Everett","Marine Germain","Jenny van Dongen","W. David Hill","Min A. Jhun","Jennifer A. Brody","Mohsen Ghanbari","Lei Du","Nicholas S. Roetker","Paul S. de Vries","Melanie Waldenberger","Christian Gieger","Petra Wolf","Holger Prokisch","Wolfgang Koenig","Christopher J. O’Donnell","Daniel Levy","Chunyu Liu","Vinh Truong","Philip S. Wells","David-Alexandre Trégouët","Weihong Tang","Alanna C. Morrison","Eric Boerwinkle","Kerri L. Wiggins","Barbara McKnight","Xiuqing Guo","Bruce M. Psaty","Nona Sotoodehnia","Dorret I. Boomsma","Gonneke Willemsen","Lannie Ligthart","Ian J. Deary","Wei Zhao","Erin B. Ware","Sharon L. R. Kardia","Joyce B. J. Van Meurs","Andre G. Uitterlinden","Oscar H. Franco","Per Eriksson","Anders Franco-Cereceda","James S. Pankow","Andrew D. Johnson","France Gagnon","Pierre-Emmanuel Morange","Eco J. C. de Geus","John M. Starr","Jennifer A. Smith","Abbas Dehghan","Hanna M. Björck","Nicholas L. Smith","Annette Peters"],"twitterCount":24,"altmetricId":45530559},{"title":"Combination treatment with 5F9 and azacitidine enhances phagocytic elimination of acute myeloid leukemia","googleId":"lxwK1I_N8r8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2729/264326","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-120170","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Aged CAR T cells exhibit enhanced cytotoxicity and effector function but shorter persistence and less memory-like phenotypes","googleId":"CnW_ETMm29oJ","googleLink":"https://isoplexis.com/wp-content/uploads/2019/01/ASH-2018-Moffitt-Poster.pdf","googleCitationCount":10,"googleAuthor":"G Li"},{"title":"Phase 2 study of combination of cytarabine, idarubicin, and nivolumab for initial therapy of patients with newly diagnosed acute myeloid leukemia","googleId":"5FdryFPgDPsJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/815/83499","googleCitationCount":13,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood.V130.Suppl_1.815.815","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"CAR T cell therapy targeting G protein-coupled receptor class c group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma","googleId":"qUkitJ__fBYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/589/263087","googleCitationCount":9,"googleAuthor":"M Staehr","doi":"10.1182/blood-2018-99-110471","elsevierCitationCount":0,"altmetricAuthors":["Eric L. Smith","Kimberly Harrington","Mette Staehr","Reed Masakayan","Jon Jones","Thomas Long","Majid Ghoddusi","Terence J Purdon","Trevor Do","Xiuyan Wang","Minh Pham","Jessica M Brown","Elizabeth Peguero","Carlos Fernández De Larrea","Pei Wang","Hong Liu","Yiyang Xu","Sarah Garrett","Steven Almo","Isabelle Riviere","Cheng Liu","Blythe Duke Sather","Renier J. Brentjens"],"twitterCount":0,"altmetricId":81132916},{"title":"A phase I study with an expansion cohort of the combinations of ipilimumab, nivolumab and brentuximab vedotin in patients with relapsed/refractory Hodgkin …","googleId":"69CJ-Uli9e8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/679/266357","googleCitationCount":17,"googleAuthor":"F Hong","doi":"10.1182/blood-2018-99-115390","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Tislelizumab (BGB-A317) for relapsed/refractory classical Hodgkin lymphoma: preliminary efficacy and safety results from a phase 2 study","googleId":"hQk0ihAuAPkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/682/266402","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-117848","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Brentuximab vedotin plus doxorubicin, vinblastine, dacarbazine (A+ AVD) as frontline therapy demonstrates superior modified progression-free survival versus ABVD …","googleId":"jjCWT3Eo9FYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/6/115772","googleCitationCount":14,"googleAuthor":"W Jurczak","doi":"10.1182/blood.V130.Suppl_1.6.6","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Remissions in relapse/refractory acute myeloid leukemia patients following treatment with NKG2D CAR-T therapy without a prior preconditioning chemotherapy","googleId":"qo6OmL0cHbYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/902/266381","googleCitationCount":10,"googleAuthor":"X Poire","doi":"10.1182/blood-2018-99-111326","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies","googleId":"ftBXyBKY53oJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/3/297/36918","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood-2016-12-756585","elsevierAuthor":"Al Sayed M.","publicationName":"Blood","elsevierCoverDate":"2017-07-20","elsevierCoverDisplayDate":"20 July 2017","elsevierCitationCount":"13","altmetricAuthors":["Mohamad F. Al Sayed","Carla A. Ruckstuhl","Tamara Hilmenyuk","Christina Claus","Jean-Pierre Bourquin","Beat C. Bornhauser","Ramin Radpour","Carsten Riether","Adrian F. Ochsenbein"],"twitterCount":18,"altmetricId":20104840},{"title":"CX3CR1-dependent endothelial margination modulates Ly6Chigh monocyte systemic deployment upon inflammation in mice","googleId":"jjlWcAXjvh0J","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1296/36008","googleCitationCount":18,"googleAuthor":"P Hamon","doi":"10.1182/blood-2016-08-732164","elsevierAuthor":"Hamon P.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"16","altmetricAuthors":["Pauline Hamon","Pierre-Louis Loyher","Camille Baudesson de Chanville","Fabrice Licata","Christophe Combadière","Alexandre Boissonnas"],"twitterCount":2,"altmetricId":17171233},{"title":"Baseline PET-derived metabolic tumor volume metrics predict progression-free and overall survival in DLBCL after first-line treatment: results from the phase 3 GOYA …","googleId":"4cewsxJw2nAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/824/83594","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.824.824","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Preliminary results from an ongoing phase 1/2 study of INCB057643, a bromodomain and extraterminal (BET) protein inhibitor, in patients (pts) with advanced …","googleId":"WPVPNqdefasJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4048/72957","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.4048.4048","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Prediction of CAR T-related toxicities in R/R DLBCL patients treated with axicabtagene ciloleucel using point of care cytokine measurements","googleId":"sY_yD3XOBeQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/95/266432","googleCitationCount":10,"googleAuthor":"FL Locke","doi":"10.1182/blood-2018-99-116539","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Synergistic activity of IDH1 inhibitor Bay-1436032 with azacitidine in IDH1 mutant acute myeloid leukemia","googleId":"OEc4rYFDk-cJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1352/116180","googleCitationCount":12,"googleAuthor":"R Gabdoulline","doi":"10.1182/blood.V130.Suppl_1.1352.1352","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Lentiglobin gene therapy for patients with transfusion-dependent β-thalassemia (TDT): results from the phase 3 Northstar-2 and Northstar-3 studies","googleId":"ktsQmXV7sIUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1025/262776","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood-2018-99-112667","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy","googleId":"XRtwoSMqbrMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/10/1397/36017","googleCitationCount":18,"googleAuthor":"EJ Duncavage","doi":"10.1182/blood-2016-10-745273","elsevierAuthor":"Duncavage E.J.","publicationName":"Blood","elsevierCoverDate":"2017-03-09","elsevierCoverDisplayDate":"9 March 2017","elsevierCitationCount":"15","altmetricAuthors":["Eric J. Duncavage","Geoffrey L. Uy","Allegra A. Petti","Christopher A. Miller","Yi-Shan Lee","Bevan Tandon","Feng Gao","Catrina C. Fronick","Michelle O’Laughlin","Robert S. Fulton","Richard K. Wilson","Meagan A. Jacoby","Amanda F. Cashen","Lukas D. Wartman","Matthew J. Walter","Peter Westervelt","Daniel C. Link","John F. DiPersio","Timothy J. Ley","John S. Welch"],"twitterCount":1,"altmetricId":17168712},{"title":"PD-L1 blockade with atezolizumab in higher-risk myelodysplastic syndrome: an initial safety and efficacy analysis","googleId":"lqgTw1N9dY4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/466/262333","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-99-118577","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Lyra: a phase 2 study of daratumumab (Dara) plus cyclophosphamide, bortezomib, and dexamethasone (Cybord) in newly diagnosed and relapsed patients (Pts) with …","googleId":"nu7_nycvyOYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/152/273100","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-152","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Low levels of neurologic toxicity with retained anti-lymphoma activity in a phase I clinical trial of T cells expressing a novel anti-CD19 CAR","googleId":"nHnMtK7iKK4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/697/266071","googleCitationCount":9,"googleAuthor":"","doi":"10.1182/blood-2018-99-113731","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease","googleId":"i3r-5XOzJ30J","googleLink":"https://ashpublications.org/blood/article-abstract/131/18/2074/36730","googleCitationCount":11,"googleAuthor":"S Takahashi","doi":"10.1182/blood-2017-06-792614","elsevierAuthor":"Takahashi S.","publicationName":"Blood","elsevierCoverDate":"2018-05-03","elsevierCoverDisplayDate":"3 May 2018","elsevierCitationCount":"9","altmetricAuthors":["Shuichiro Takahashi","Daigo Hashimoto","Eiko Hayase","Reiki Ogasawara","Hiroyuki Ohigashi","Takahide Ara","Emi Yokoyama","Ko Ebata","Satomi Matsuoka","Geoffrey R. Hill","Junichi Sugita","Masahiro Onozawa","Takanori Teshima"],"twitterCount":24,"altmetricId":32227977},{"title":"Obinutuzumab-based immunochemotherapy prolongs progression-free survival and time to next anti-lymphoma treatment in patients with previously untreated …","googleId":"EdD7MRTxN6YJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1597/272983","googleCitationCount":12,"googleAuthor":"D Cunningham","doi":"10.1182/blood-2018-99-115167","elsevierCitationCount":0,"altmetricAuthors":["William Townsend","Christian Buske","Guillaume Cartron","David Cunningham","Martin JS Dyer","John G. Gribben","Georg Hess","Takayuki Ishikawa","Ulrich Keller","Michael Kneba","Ram Malladi","Jeffrey D Neidhart","Chiara Rusconi","Jun Zhu","Olivier Catalani","Andrea Knapp","Harald Zeuner","Michael Herold","Wolfgang Hiddemann","Robert Marcus"],"twitterCount":1,"altmetricId":54002151},{"title":"T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor with a CD28 costimulatory moiety cause remissions of poor …","googleId":"V_hvik81N70J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/524/81176","googleCitationCount":13,"googleAuthor":"M Wang","doi":"10.1182/blood.V130.Suppl_1.524.524","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Four versus two years of rituximab maintenance (R-maintenance) following bendamustine plus rituximab (BR): initial results of a prospective, randomized multicenter …","googleId":"Zw4THW0iO68J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/483/72172","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.483.483","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Early response data for pediatric patients with non-Hodgkin lymphoma treated with CD19 chimeric antigen receptor (CAR) T-cells","googleId":"x_log1i6cKgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2957/263812","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-113744","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Durable remissions with humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in CAR-naive and CAR-exposed children and young adults with …","googleId":"twYkEMQVNBkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1319/116300","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.1319.1319","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity","googleId":"OfHeQaJe_eoJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/8/991/36351","googleCitationCount":17,"googleAuthor":"S Sebastian","doi":"10.1182/blood-2016-09-738872","elsevierAuthor":"Sebastian S.","publicationName":"Blood","elsevierCoverDate":"2017-02-23","elsevierCoverDisplayDate":"23 February 2017","elsevierCitationCount":"15","altmetricAuthors":["Sinto Sebastian","Yuan X. Zhu","Esteban Braggio","Chang-Xin Shi","Sonali C. Panchabhai","Scott A. Van Wier","Greg J. Ahmann","Marta Chesi","P. Leif Bergsagel","A. Keith Stewart","Rafael Fonseca"],"twitterCount":36,"altmetricId":15104849},{"title":"Patient data supports the rationale of low dose cyclophosphamide to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage …","googleId":"6GNZyszddg0J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/121/116003","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.121.121","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma","googleId":"9iX4W2h852oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2040/39473","googleCitationCount":13,"googleAuthor":"A Sud","doi":"10.1182/blood-2018-06-855296","elsevierAuthor":"Sud A.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"8","altmetricAuthors":["Amit Sud","Hauke Thomsen","Giulia Orlando","Asta Försti","Philip J. Law","Peter Broderick","Rosie Cooke","Fadi Hariri","Tomi Pastinen","Douglas F. Easton","Paul D. P. Pharoah","Alison M. Dunning","Julian Peto","Federico Canzian","Rosalind Eeles","ZSofia Kote-Jarai","Kenneth Muir","Nora Pashayan","Daniele Campa","Per Hoffmann","Markus M. Nöthen","Karl-Heinz Jöckel","Elke Pogge von Strandmann","Anthony J. Swerdlow","Andreas Engert","Nick Orr","Kari Hemminki","Richard S. Houlston"],"twitterCount":19,"altmetricId":47933943},{"title":"Safety and tolerability of daratumumab in patients with relapsed light chain (AL) amyloidosis: preliminary results of a phase II study","googleId":"KeFQYxRQjI4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/507/81135","googleCitationCount":17,"googleAuthor":"JM Sloan","doi":"10.1182/blood.V130.Suppl_1.507.507","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Results of inter-B-NHL Ritux 2010-phase II study of DA-EPOCH-R for children and adolescents with primary mediastinal large B-cell lymphoma (PMLBL) on behalf of …","googleId":"v_LnSO3xa4IJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/4124/72864","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.4124.4124","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Association of circulating transcriptomic profiles with mortality in sickle cell disease","googleId":"bUrripQFDVcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/22/3009/36050","googleCitationCount":15,"googleAuthor":"AA Desai","doi":"10.1182/blood-2016-11-752279","elsevierAuthor":"Desai A.A.","publicationName":"Blood","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"9","altmetricAuthors":["Ankit A. Desai","Zhengdeng Lei","Neil Bahroos","Mark Maienschein-Cline","Santosh L. Saraf","Xu Zhang","Binal N. Shah","Seyed M. Nouraie","Taimur Abbasi","Amit R. Patel","Roberto M. Lang","Yves Lussier","Joe G. N. Garcia","Victor R. Gordeuk","Roberto F. Machado"],"twitterCount":10,"altmetricId":18496673},{"title":"Phase 1/1b study of the stapled peptide ALRN-6924, a dual inhibitor of MDMX and MDM2, as monotherapy or in combination with cytarabine for the treatment of …","googleId":"zKJl4T6mf8IJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4066/265250","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-99-118780","elsevierAuthor":"Sabat-Pospiech D.","publicationName":"Biochemical Society Transactions","elsevierCoverDate":"2019-09-10","elsevierCoverDisplayDate":"10 September 2019","elsevierCitationCount":"2","altmetricAuthors":[],"twitterCount":0},{"title":"Incidence of thromboembolic events is increased in a retrospective analysis of a large cold agglutinin disease (CAD) cohort","googleId":"ULqEWIvOV4YJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/928/83326","googleCitationCount":14,"googleAuthor":"M Mullins","doi":"10.1182/blood.V130.Suppl_1.928.928","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"FT-2102, an IDH1m inhibitor, in combination with azacitidine in patients with acute myeloid leukemia (AML) or myelodysplastic ayndrome (MDS): results from a phase …","googleId":"llMwJKjYD98J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1452/272851","googleCitationCount":11,"googleAuthor":"J Watts","doi":"10.1182/blood-2018-99-114126","elsevierAuthor":"Becker J.S.","publicationName":"Current Cancer Drug Targets","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"PTPN11 mutations confer unique metabolic properties and increase resistance to venetoclax and azacitidine in acute myelogenous leukemia","googleId":"YAgfKAm1z_gJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/909/265985","googleCitationCount":9,"googleAuthor":"","doi":"10.1182/blood-2018-99-119806","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Target antigen downregulation and other mechanisms of failure after axicabtagene ciloleucel (CAR19) therapy","googleId":"AcfX9_BTc3wJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4656/262290","googleCitationCount":8,"googleAuthor":"B Sahaf","doi":"10.1182/blood-2018-99-120206","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Carfilzomib-lenalidomide-dexamethasone versus bortezomib-lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma: results from the …","googleId":"r0BciICOgG8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%A01/799/266209","googleCitationCount":9,"googleAuthor":"DS Siegel","doi":"10.1182/blood-2018-99-112289","elsevierCitationCount":0,"altmetricAuthors":["Ola Landgren","David S Siegel","Daniel Auclair","Ajai Chari","Michael Boedigheimer","Tim Welliver","Khalid Mezzi","Karim Iskander","Andrzej Jakubowiak"],"twitterCount":2,"altmetricId":54506664},{"title":"Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis","googleId":"8vUXBDchCFgJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/6/829/36800","googleCitationCount":16,"googleAuthor":"O Leiva","doi":"10.1182/blood-2017-04-777417","elsevierAuthor":"Abbonante V.","publicationName":"Blood","elsevierCoverDate":"2017-08-10","elsevierCoverDisplayDate":"10 August 2017","elsevierCitationCount":"9","altmetricAuthors":["Vittorio Abbonante","Vipul Chitalia","Vittorio Rosti","Orly Leiva","Shinobu Matsuura","Alessandra Balduini","Katya Ravid"],"twitterCount":1,"altmetricId":23571695},{"title":"Initial report of the beat AML umbrella study for previously untreated AML: evidence of feasibility and early success in molecularly driven phase 1 and 2 studies","googleId":"y4DV5_yKI5oJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/559/263190","googleCitationCount":10,"googleAuthor":"AS Mims","doi":"10.1182/blood-2018-99-118494","elsevierCitationCount":0,"altmetricAuthors":["Amy Burd","Ross L. Levine","Abigail Shoben","Alice S. Mims","Uma Borate","Eytan M. Stein","Prapti A. Patel","Maria R. Baer","Wendy Stock","Michael W. Deininger","Amy S. Ruppert","Nyla A. Heerema","Jo-Anne Vergilio","TIm Brennan","Christine Vietz","Molly Vittorio","Leonard Rosenberg","Sonja Marcus","Mona Stefanos","Brian J. Druker","John C. Byrd"],"twitterCount":0,"altmetricId":54505495},{"title":"Consensus grading of cytokine release syndrome (CRS) in adult patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL) treated with …","googleId":"uW0hmU_dkrAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4190/275507","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-99-113052","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Argx-110 targeting CD70, in combination with azacitidine, shows favorable safety profile and promising anti-leukemia activity in newly diagnosed AML patients in an …","googleId":"7tpT9tK-1DcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2680/264264","googleCitationCount":9,"googleAuthor":"C Riether","doi":"10.1182/blood-2018-99-118302","elsevierAuthor":"Madanat Y.F.","publicationName":"Hematologic Malignancies","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Multiple Myeloma in Russia (First Results of the Registration Trial)","googleId":"kSQufOpiu4gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/5408/115763","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.5408.5408","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Uproleselan (GMI-1271), an e-selectin antagonist, improves the efficacy and safety of chemotherapy in relapsed/refractory (r/r) and newly diagnosed older patients …","googleId":"HvbDJXnOwKUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/331/264778","googleCitationCount":9,"googleAuthor":"BA Jonas","doi":"10.1182/blood-2018-99-114286","elsevierAuthor":"Cardoso B.A.","publicationName":"Advances in Experimental Medicine and Biology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Single cell resolution profiling defines the innate and adaptive immune repertoires modulated by daratumumab and IMiDs treatment in multiple myeloma (MM)","googleId":"6NSGCZDHOlkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/123/116220","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.123.123","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Lenalidomide maintenance therapy post-autologous stem cell transplant: a healthcare cost-impact analysis in Europe","googleId":"UZxEMsYRleIJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3405/114434","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.3405.3405","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Older patients (pts) with previously untreated classical Hodgkin lymphoma (cHL): a detailed analysis from the phase 3 ECHELON-1 study","googleId":"5F7jRYWqd54J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1618/273225","googleCitationCount":10,"googleAuthor":"AM Evens","doi":"10.1182/blood-2018-99-112178","elsevierCitationCount":0,"altmetricAuthors":["Andrew M. Evens","Joseph M. Connors","Anas Younes","Stephen M. Ansell","Won Seog Kim","John Radford","Tatyana A. Feldman","Joseph Tuscano","Kerry J Savage","Yasuhiro Oki","Andrew P. Grigg","Christopher Pocock","Monika Dlugosz-Danecka","Keenan Fenton","Gerald Engley","Rachael Liu","Harry Miao","Hina Jolin","Ashish Gautam","Andrea Gallamini"],"twitterCount":2,"altmetricId":61991308},{"title":"Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123× CD3 bispecific DART® molecule, in patients with relapsed/refractory acute …","googleId":"0lep1rK61hcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/444/275837","googleCitationCount":9,"googleAuthor":"S Rutella","doi":"10.1182/blood-2018-99-111539","elsevierAuthor":"Sivaccumar J.","publicationName":"Current Medicinal Chemistry","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"2021","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Extracellular galectins as controllers of cytokines in hematological cancer","googleId":"0LTsz10Tic8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/5/484/39380","googleCitationCount":8,"googleAuthor":"M Gordon-Alonso","doi":"10.1182/blood-2018-04-846014","elsevierAuthor":"Gordon-Alonso M.","publicationName":"Blood","elsevierCoverDate":"2018-08-02","elsevierCoverDisplayDate":"2 August 2018","elsevierCitationCount":"5","altmetricAuthors":["Monica Gordon-Alonso","Annika M. Bruger","Pierre van der Bruggen"],"twitterCount":7,"altmetricId":43473697},{"title":"Hif-1α and Hif-2α regulate hemogenic endothelium and hematopoietic stem cell formation in zebrafish","googleId":"mncXKe6gsxEJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/9/963/39200","googleCitationCount":10,"googleAuthor":"C Gerri","doi":"10.1182/blood-2017-07-797795","elsevierAuthor":"Gerri C.","publicationName":"Blood","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"7","altmetricAuthors":["Claudia Gerri","Michele Marass","Andrea Rossi","Didier Y. R. Stainier"],"twitterCount":15,"altmetricId":31795276},{"title":"Minimal residual disease response at end of induction and during maintenance correlates with updated outcome in the phase III GALLIUM study of obinutuzumab-or …","googleId":"PWcRRarpvWcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/396/265038","googleCitationCount":10,"googleAuthor":"C Pott","doi":"10.1182/blood-2018-99-115930","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Disease and patient characteristics, patterns of care, toxicities, and outcomes of chronic lymphocytic leukemia (CLL) patients treated with venetoclax: a multicenter …","googleId":"DCn4U8BhRt4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4315/72677","googleCitationCount":12,"googleAuthor":"AR Mato","doi":"10.1182/blood.V130.Suppl_1.4315.4315","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Imetelstat treatment leads to durable transfusion independence (TI) in RBC transfusion-dependent (TD), non-del (5q) lower risk MDS relapsed/refractory to …","googleId":"Ms6LHzfU3JsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/463/261993","googleCitationCount":8,"googleAuthor":"DP Steensma","doi":"10.1182/blood-2018-99-114877","elsevierCitationCount":0,"altmetricAuthors":["David P. Steensma","Uwe Platzbecker","Koen Van Eygen","Azra Raza","Valeria Santini","Ulrich Germing","Patricia Font","Irina Samarina","Maria Díez-Campelo","Sylvain Thepot","Edo Vellenga","Mrinal M. Patnaik","Jun Ho Jang","Jacqueline Bussolari","Laurie Sherman","Libo Sun","Helen Varsos","Esther Rose","Pierre Fenaux"],"twitterCount":0,"altmetricId":70668552},{"title":"Outcome of patients with myelofibrosis after ruxolitinib failure: role of disease status and treatment strategies in 214 patients","googleId":"BhQVIvhs2boJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4277/275515","googleCitationCount":8,"googleAuthor":"EM Elli","doi":"10.1182/blood-2018-99-116289","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"T cell costimulation blockade with abatacept nearly eliminates early severe acute graft versus host disease after HLA-mismatched (7/8 HLA matched) unrelated donor …","googleId":"PHMF2dk4gXAJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/212/71222","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.212.212","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"ALLO-715, an allogeneic BCMA CAR T therapy possessing an off-switch for the treatment of multiple myeloma","googleId":"3-BR2I8PqvgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/591/263328","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-119227","elsevierCitationCount":0,"altmetricAuthors":["Cesar Sommer","Bijan Boldajipour","Julien Valton","Roman Galetto","Trevor Bentley","Janette Sutton","Yajin Ni","Mark Leonard","Thomas Van Blarcom","Julianne Smith","Javier Chaparro-Riggers","Barbra Sasu"],"twitterCount":0,"altmetricId":64683353},{"title":"Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia","googleId":"tZS6yDoDYJoJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/26/2929/39170","googleCitationCount":10,"googleAuthor":"F Seyfried","doi":"10.1182/blood-2017-10-813576","elsevierAuthor":"Wang F.","publicationName":"Blood","elsevierCoverDate":"2018-06-28","elsevierCoverDisplayDate":"28 June 2018","elsevierCitationCount":"7","altmetricAuthors":["Fan Wang","Salih Demir","Franziska Gehringer","Clarissa D. Osswald","Felix Seyfried","Stefanie Enzenmüller","Sarah M. Eckhoff","Thomas Maier","Karlheinz Holzmann","Klaus-Michael Debatin","Thomas Wirth","Lüder H. Meyer","Alexey Ushmorov"],"twitterCount":3,"altmetricId":44260700},{"title":"Pembrolizumab in patients with relapsed or refractory primary mediastinal large B-cell lymphoma (PMBCL): data from the Keynote-013 and Keynote-170 studies","googleId":"5obI6J35-eMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/228/261811","googleCitationCount":11,"googleAuthor":"SJ Rodig","doi":"10.1182/blood-2018-99-110220","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Prognostic impact of NPM1/FLT3-ITD genotypes from randomized patients with acute myeloid leukemia (AML) treated within the international ratify study","googleId":"hG3PQQ6ktZQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/467/72288","googleCitationCount":13,"googleAuthor":"C Thiede","doi":"10.1182/blood.V130.Suppl_1.467.467","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy and safety of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma in the phase 2 ACE-LY-004 study","googleId":"HDyFyQ-wwE4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/155/79780","googleCitationCount":13,"googleAuthor":"M Wang","doi":"10.1182/blood.V130.Suppl_1.155.155","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Clinical outcomes up to 3 years following Lentiglobin gene therapy for transfusion-dependent β-thalassemia in the Northstar Hgb-204 study","googleId":"IlCtUracjzEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/360/71822","googleCitationCount":14,"googleAuthor":"AA Thompson","doi":"10.1182/blood.V130.Suppl_1.360.360","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia","googleId":"NMaiKSuy7R4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1298/262849","googleCitationCount":7,"googleAuthor":"A Contejean","doi":"10.1182/blood-2018-99-113359","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy and safety of ibrutinib (IBR) after venetoclax (VEN) treatment in IBR-naïve patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): follow …","googleId":"hm7fjr35BGgJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/5548/263219","googleCitationCount":10,"googleAuthor":"R Greil","doi":"10.1182/blood-2018-99-118148","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) versus bortezomib and dexamethasone (Vd) in first relapse patients: two-year update of …","googleId":"qV3J0WDioFcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3270/264807","googleCitationCount":10,"googleAuthor":"MV Mateos","doi":"10.1182/blood-2018-99-112554","elsevierCitationCount":0,"altmetricAuthors":["Maria-Victoria Mateos","Pieter Sonneveld","Vania T. M. Hungria","Ajay K Nooka","Jane Estell","Wolney G Barreto","Paolo Corradini","Chang-Ki Min","Eva Medvedova","Katja Weisel","Christopher Chiu","Jordan M. Schecter","Himal Amin","Xiang Qin","Ming Qi","Andrew Spencer"],"twitterCount":0,"altmetricId":63101833},{"title":"A retrospective review of tocilizumab for the management of blinatumomab (a bispecific T cell engager)-induced cytokine release syndrome (CRS)","googleId":"JSDs6kdF42UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/5211/265497","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-117353","elsevierAuthor":"Conde-Royo D.","publicationName":"Drugs in Context","elsevierCoverDate":"2020-10-14","elsevierCoverDisplayDate":"14 October 2020","elsevierCitationCount":"0","altmetricAuthors":["Jessica Choudhry","Mandy Parson","Jacqueline Wright"],"twitterCount":0,"altmetricId":100350887},{"title":"Daratumumab in combination with carfilzomib and dexamethasone in patients (pts) with relapsed multiple myeloma (MMY1001): an open-label, phase 1b study","googleId":"LKQJmCBiaB4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1869/71246","googleCitationCount":12,"googleAuthor":"JF San-Miguel","doi":"10.1182/blood.V130.Suppl_1.1869.1869","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase I-IIa clinical trial to assess safety and efficacy of MLM-CAR44. 1, a CD44v6 directed CAR-T in relapsed/refractory acute myeloid leukemia (AML) and multiple …","googleId":"XpjjCNfR7BcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/5790/262976","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-117974","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Safety and efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed and refractory multiple myeloma: final results from GEN501 and SIRIUS","googleId":"W8NhwPcmpygJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3107/80480","googleCitationCount":12,"googleAuthor":"SZ Usmani","doi":"10.1182/blood.V130.Suppl_1.3107.3107","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Nivolumab treatment beyond investigator-assessed progression: extended follow-up in patients with relapsed/refractory classical Hodgkin lymphoma from the phase 2 …","googleId":"-AC7NDB2lIgJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2932/263562","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-114502","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Anti-CD123 targeted therapy with Talacotuzumab in advanced MDS and AML after failing hypomethylating agents-final results of the Samba trial","googleId":"NKbL6lhlFxYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4045/265010","googleCitationCount":9,"googleAuthor":"AS Kubasch","doi":"10.1182/blood-2018-99-113112","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice","googleId":"TS9pIykJ7MsJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/14/1901/35865","googleCitationCount":15,"googleAuthor":"JM Bernitz","doi":"10.1182/blood-2016-11-752923","elsevierAuthor":"Bernitz J.","publicationName":"Blood","elsevierCoverDate":"2017-04-06","elsevierCoverDisplayDate":"6 April 2017","elsevierCitationCount":"13","altmetricAuthors":["Jeffrey M. Bernitz","Michael G. Daniel","Yesai S. Fstkchyan","Kateri Moore"],"twitterCount":10,"altmetricId":18561428},{"title":"Blinatumomab for minimal residual disease (MRD) in adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL): median overall survival (OS) is not …","googleId":"DC71xGP8Q3oJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/554/263122","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-111516","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Successful Plerixafor-mediated mobilization, apheresis, and lentiviral vector transduction of hematopoietic stem cells in patients with severe sickle cell disease","googleId":"5zFWh6zyB84J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/990/83588","googleCitationCount":16,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.990.990","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Updated results of a phase II study of lenalidomide-elotuzumab as maintenance therapy post-autologous stem cell transplant (AuSCT) in patients (Pts) with multiple …","googleId":"r_C1IDoI-IoJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1982/261951","googleCitationCount":9,"googleAuthor":"","doi":"10.1182/blood-2018-99-116464","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A phase 2 study of the safety and efficacy of INCB050465, a selective PI3Kδ inhibitor, in combination with ruxolitinib in patients with myelofibrosis","googleId":"PkqJeEGJol4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/353/264722","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2018-99-111338","elsevierAuthor":"Barraco D.","publicationName":"Drugs in Context","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso (lo) Ne) in older patients with advanced-stage Hodgkin lymphoma: results of a phase II …","googleId":"srCcdOogSJkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/926/266188","googleCitationCount":9,"googleAuthor":"A Fosså","doi":"10.1182/blood-2018-99-119363","elsevierAuthor":"Carter J.","publicationName":"Current Treatment Options in Oncology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"1 May 2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Deep and durable responses with selinexor, daratumumab, and dexamethasome (SDd) in patients with multiple myeloma (MM) previously exposed to proteasome …","googleId":"61i_3CuFYrkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/599/265968","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-117201","elsevierCitationCount":0,"altmetricAuthors":["Cristina J Gasparetto","Suzanne Lentzsch","Gary J. Schiller","William Bensinger","Nizar Bahlis","Heather J. Sutherland","Darrell J. White","Michael Sebag","Rami Kotb","Christopher P. Venner","Richard Leblanc","Christine I Chen","Aldo Del Col","Jatin J. Shah","Jacqueline Jeha","Jean-Richard Saint-Martin","Michael G. Kauffman","Sharon Shacham","Joel G. Turner","Daniel M Sullivan","Brea Lipe"],"twitterCount":0,"altmetricId":54506675},{"title":"Results from the 208-week (4-year) follow-up of RESPONSE trial, a phase 3 study comparing ruxolitinib (Rux) with best available therapy (BAT) for the treatment of …","googleId":"r_uSn8xQ71QJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/322/114732","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.322.322","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Single-arm phase II study of MOR208 combined with lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: L-Mind","googleId":"CKWSLBm9PTYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4123/72857","googleCitationCount":12,"googleAuthor":"GA Salles","doi":"10.1182/blood.V130.Suppl_1.4123.4123","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Gene therapy for Beta thalassemia: preliminary results from the PHASE I/II Tiget-Bthal trial of autologous hematopoietic stem cells genetically modified with GLOBE …","googleId":"M3SgJUkB7mQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/355/114670","googleCitationCount":15,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.355.355","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Endothelial CD99 supports arrest of mouse neutrophils in venules and binds to neutrophil PILRs","googleId":"v0KmlHH35e8J","googleLink":"https://ashpublications.org/blood/article-abstract/129/13/1811/35847","googleCitationCount":14,"googleAuthor":"D Goswami","doi":"10.1182/blood-2016-08-733394","elsevierAuthor":"Goswami D.","publicationName":"Blood","elsevierCoverDate":"2017-03-30","elsevierCoverDisplayDate":"30 March 2017","elsevierCitationCount":"12","altmetricAuthors":["Debashree Goswami","Sigrid März","Yu-Tung Li","Annette Artz","Kerstin Schäfer","Ruth Seelige","Mariana Pacheco-Blanco","Ding Jing","Maria Gabriele Bixel","Masatake Araki","Kimi Araki","Ken-Ichi Yamamura","Dietmar Vestweber"],"twitterCount":4,"altmetricId":16861140},{"title":"Preliminary safety profile of the CD19-directed defined composition CAR T cell product JCAR017 in relapsed/refractory aggressive B-NHL patients: potential for …","googleId":"otdJLRcwEeQJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1552/79812","googleCitationCount":11,"googleAuthor":"JS Abramson","doi":"10.1182/blood.V130.Suppl_1.1552.1552","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Rituximab maintenance after first-line immunochemotherapy in mantle cell lymphoma: long-term follow-up of the randomized European MCL elderly trial","googleId":"aQUmdiP_XHoJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/153/79564","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.153.153","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Validation of clinical prognostic models and integration of genetic biomarkers of drug resistance in CLL patients treated with ibrutinib","googleId":"SkWta7wv4hIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/186/266059","googleCitationCount":9,"googleAuthor":"IE Ahn","doi":"10.1182/blood-2018-99-110326","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Preliminary results of UCART19, an allogeneic anti-CD19 CAR T-cell product in a first-in-human trial (PALL) in pediatric patients with CD19+ relapsed/refractory …","googleId":"4govcajwEnUJ","googleLink":"https://www.cellectis.com/uploads/files/Poster_PALL_ASH.pdf","googleCitationCount":12,"googleAuthor":"W Qasim"},{"title":"ASXL1 mutations gain a function","googleId":"KLkVdimZQIQJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/274/38319","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2017-12-816595","elsevierAuthor":"Kitamura T.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"8","altmetricAuthors":["Toshio Kitamura"],"twitterCount":10,"altmetricId":32070797},{"title":"Results of pivotal phase 2 trial of SL-401 in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)","googleId":"ZjSBOjmpDbUJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1298/116033","googleCitationCount":13,"googleAuthor":"AA Lane","doi":"10.1182/blood.V130.Suppl_1.1298.1298","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Pre-clinical evaluation of B7-H3-specific chimeric antigen receptor T-cells for the treatment of acute myeloid leukemia","googleId":"3NGo4HmN-tMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/701/266136","googleCitationCount":6,"googleAuthor":"","doi":"10.1182/blood-2018-99-113468","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi","googleId":"GLY9QFyJsrAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/11/1357/36459","googleCitationCount":14,"googleAuthor":"ACY Chua","doi":"10.1182/blood-2017-02-764787","elsevierAuthor":"Kosaisavee V.","publicationName":"Blood","elsevierCoverDate":"2017-09-14","elsevierCoverDisplayDate":"14 September 2017","elsevierCitationCount":"10","altmetricAuthors":["Varakorn Kosaisavee","Rossarin Suwanarusk","Adeline C. Y. Chua","Dennis E. Kyle","Benoit Malleret","Rou Zhang","Mallika Imwong","Rawiwan Imerbsin","Ratawan Ubalee","Hugo Sámano-Sánchez","Bryan K. S. Yeung","Jessica J. Y. Ong","Eric Lombardini","François Nosten","Kevin S. W. Tan","Pablo Bifani","Georges Snounou","Laurent Rénia","Bruce Russell"],"twitterCount":10,"altmetricId":21840251},{"title":"Maintenance therapy with the oral proteasome inhibitor (PI) Ixazomib significantly prolongs progression-free survival (PFS) following autologous stem cell …","googleId":"G8QjtImBvNkJ","googleLink":"https://cms.cws.net/content/beta.myelomasociety.org/files/2018ash/Dimopoulos%20ixazomib%20MM3_ASH_21NOV2018.pdf","googleCitationCount":9,"googleAuthor":"MA Dimopoulos"},{"title":"Thymic epithelial cells require p53 to support their long-term function in thymopoiesis in mice","googleId":"nTsSrv_AVQEJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/4/478/37105","googleCitationCount":13,"googleAuthor":"PM Rodrigues","doi":"10.1182/blood-2016-12-758961","elsevierAuthor":"Rodrigues P.","publicationName":"Blood","elsevierCoverDate":"2017-07-27","elsevierCoverDisplayDate":"27 July 2017","elsevierCitationCount":"8","altmetricAuthors":["Pedro M. Rodrigues","Ana R. Ribeiro","Chiara Perrod","Jonathan J. M. Landry","Leonor Araújo","Isabel Pereira-Castro","Vladimir Benes","Alexandra Moreira","Helena Xavier-Ferreira","Catarina Meireles","Nuno L. Alves"],"twitterCount":2,"altmetricId":20745547},{"title":"KD025-208: a phase 2a study of KD025 for patients with chronic graft versus host disease (cGVHD)—pharmacodynamics and updated results","googleId":"SlxCObhdyD4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/602/266021","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-111896","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Emicizumab prophylaxis in adolescent/adult patients with hemophilia A previously receiving episodic or prophylactic bypassing agent treatment: updated analyses …","googleId":"K1d-Nah4ARcJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1071/116325","googleCitationCount":12,"googleAuthor":"MU Callaghan","doi":"10.1182/blood.V130.Suppl_1.1071.1071","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A randomized Phase II study of azacitidine (AZA) alone or with lenalidomide (LEN), valproic acid (VPA) or idarubicin (IDA) in higher-risk MDS: Gfm's' pick a winner'trial","googleId":"hOLQ7MI4GkUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/467/262450","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-111756","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Nivolumab treatment beyond investigator-assessed progression: outcomes in patients with relapsed/refractory classical Hodgkin lymphoma from the phase 2 …","googleId":"7T2m8PYK0CUJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/650/83533","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.650.650","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Long-term efficacy and safety from the copanlisib CHRONOS-1 study in patients with relapsed or refractory indolent B-cell lymphoma","googleId":"QjTjLz6qe44J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1595/272961","googleCitationCount":9,"googleAuthor":"M Dreyling","doi":"10.1182/blood-2018-99-114842","elsevierCitationCount":0,"altmetricAuthors":["Martin Dreyling","Armando Santoro","Luigina Mollica","Sirpa Leppä","George A Follows","Georg Lenz","Won Seog Kim","Arnon Nagler","Panayiotis Panayiotidis","Judit Demeter","Muhit Özcan","Marina Kosinova","Krimo Bouabdallah","Franck Morschhauser","Don Stevens","David Trevarthen","Liana Rodrigues","Florian Hiemeyer","MingLu Wang","Jose Garcia-Vargas","Barrett H. Childs","Pier Luigi Zinzani"],"twitterCount":0,"altmetricId":62774262},{"title":"Blinatumomab+ tyrosine kinase inhibitors with no chemotherapy in BCR-ABL-positive or IKZF1-deleted or FLT3-ITD-positive relapsed/refractory acute lymphoblastic …","googleId":"dAuChLrYu9YJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3884/71680","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.3884.3884","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Results from an ongoing phase 1 study indicate ACDT-301 (camidanlumab tesirine) is well-tolerated in patients with relapsed or refractory CD25-positive acute …","googleId":"f3Lx9-phGSoJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2662/80251","googleCitationCount":10,"googleAuthor":"AD Goldberg","doi":"10.1182/blood.V130.Suppl_1.2662.2662","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"The novel SYK/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in a phase 2a study in relapsed/refractory peripheral T-cell lymphoma …","googleId":"On93ylD8tiUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1001/262522","googleCitationCount":10,"googleAuthor":"SM Horwitz","doi":"10.1182/blood-2018-99-119944","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia","googleId":"ABIKeNdt_0QJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/15/2148/36445","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2016-06-724658","elsevierAuthor":"Nakata Y.","publicationName":"Blood","elsevierCoverDate":"2017-04-13","elsevierCoverDisplayDate":"13 April 2017","elsevierCitationCount":"8","altmetricAuthors":["Yuichiro Nakata","Takeshi Ueda","Akiko Nagamachi","Norimasa Yamasaki","Ken-ichiro Ikeda","Yasuyuki Sera","Keiyo Takubo","Akinori Kanai","Hideaki Oda","Masashi Sanada","Seishi Ogawa","Kohichiro Tsuji","Yasuhiro Ebihara","Linda Wolff","Zen-ichiro Honda","Toshio Suda","Toshiya Inaba","Hiroaki Honda"],"twitterCount":1,"altmetricId":19740510},{"title":"ALX148 is a high affinity SIRPα fusion protein that blocks CD47, enhances the activity of anti-cancer antibodies and checkpoint inhibitors, and has a favorable safety …","googleId":"CmMUui0E0DoJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/112/116420","googleCitationCount":11,"googleAuthor":"TC Kuo","doi":"10.1182/blood.V130.Suppl_1.112.112","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Outcomes for initial patient cohorts with up to 33 months of follow-up in the Hgb-206 phase 1 trial","googleId":"Rkt_1_Wwy0QJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1080/262893","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-113477","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"LYMRIT 37-01: a phase I/II study of 177Lu-lilotomab satetraxetan (Betalutin®) antibody-radionuclide-conjugate (ARC) for the treatment of relapsed non-Hodgkin's …","googleId":"S0JNWfndX9IJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2879/263950","googleCitationCount":8,"googleAuthor":"A Kolstad","doi":"10.1182/blood-2018-99-110555","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Bone marrow–specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis","googleId":"2VPJ6F3pvAAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2053/39484","googleCitationCount":8,"googleAuthor":"N Ahsan","doi":"10.1182/blood-2018-05-848408","elsevierAuthor":"Chorzalska A.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"6","altmetricAuthors":["Anna Chorzalska","John Morgan","Nagib Ahsan","Diana O. Treaba","Adam J. Olszewski","Max Petersen","Nathan Kingston","Yan Cheng","Kara Lombardo","Christoph Schorl","Xiaoqing Yu","Roberta Zini","Annalisa Pacilli","Alexander Tepper","Jillian Coburn","Anita Hryniewicz-Jankowska","Ting C. Zhao","Elena Oancea","John L. Reagan","Olin Liang","Leszek Kotula","Peter J. Quesenberry","Philip A. Gruppuso","Rossella Manfredini","Alessandro Maria Vannucchi","Patrycja M. Dubielecka"],"twitterCount":3,"altmetricId":48818373},{"title":"Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies","googleId":"-_Y7kN58GV8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1353/116192","googleCitationCount":13,"googleAuthor":"AD Goldberg","doi":"10.1182/blood.V130.Suppl_1.1353.1353","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Daratumumab in combination with lenalidomide plus dexamethasone results in persistent natural killer (NK) cells with a distinct phenotype and expansion of effector …","googleId":"kCQQaoR4gpMJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3124/80759","googleCitationCount":10,"googleAuthor":"NWCJ Van De Donk","doi":"10.1182/blood.V130.Suppl_1.3124.3124","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association","googleId":"tARFuLxHn80J","googleLink":"https://ashpublications.org/blood/article-abstract/131/22/2500/37073","googleCitationCount":9,"googleAuthor":"PK Mistry","doi":"10.1182/blood-2018-02-834689","elsevierAuthor":"Weinreb N.J.","publicationName":"Blood","elsevierCoverDate":"2018-05-31","elsevierCoverDisplayDate":"31 May 2018","elsevierCitationCount":"6","altmetricAuthors":["Neal J. Weinreb","Pramod K. Mistry","Barry E. Rosenbloom","Madhav V. Dhodapkar"],"twitterCount":12,"altmetricId":43383877},{"title":"Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients","googleId":"GWHY0GIbKb0J","googleLink":"https://ashpublications.org/blood/article-abstract/131/15/1698/36823","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2017-09-772681","elsevierAuthor":"Mehta-Shah N.","publicationName":"Blood","elsevierCoverDate":"2018-04-12","elsevierCoverDisplayDate":"12 April 2018","elsevierCitationCount":"6","altmetricAuthors":["Neha Mehta-Shah","Nancy L. Bartlett"],"twitterCount":22,"altmetricId":36791915},{"title":"GMI-1271 improves efficacy and safety of chemotherapy in R/R and newly diagnosed older patients with AML: results of a phase 1/2 study","googleId":"qENZd8q7cjEJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/894/83419","googleCitationCount":10,"googleAuthor":"BA Jonas","doi":"10.1182/blood.V130.Suppl_1.894.894","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"An integrated safety analysis of the next generation PI3Kδ inhibitor umbralisib (TGR-1202) in patients with relapsed/refractory lymphoid malignancies","googleId":"Ko3gOuHH-m8J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/4037/72838","googleCitationCount":11,"googleAuthor":"AR Mato","doi":"10.1182/blood.V130.Suppl_1.4037.4037","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Temporal autoregulation during human PU. 1 locus SubTAD formation","googleId":"biaJ8HjTmfEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/25/2643/39578","googleCitationCount":6,"googleAuthor":"","doi":"10.1182/blood-2018-02-834721","elsevierAuthor":"Schuetzmann D.","publicationName":"Blood","elsevierCoverDate":"2018-12-20","elsevierCoverDisplayDate":"20 December 2018","elsevierCitationCount":"4","altmetricAuthors":["Daniel Schuetzmann","Carolin Walter","Boet van Riel","Sabrina Kruse","Thorsten König","Tabea Erdmann","Alexander Tönges","Eric Bindels","Andre Weilemann","Claudia Gebhard","Klaus Wethmar","Chiara Perrod","Julia Minderjahn","Michael Rehli","Ruud Delwel","Georg Lenz","Stefan Gröschel","Martin Dugas","Frank Rosenbauer"],"twitterCount":11,"altmetricId":49653345},{"title":"Patient characteristics and pre-infusion biomarkers of inflammation correlate with clinical outcomes after treatment with the defined composition, CD19-targeted CAR T …","googleId":"5W4YHG8vqZIJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/193/71441","googleCitationCount":10,"googleAuthor":"JS Abramson","doi":"10.1182/blood.V130.Suppl_1.193.193","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Immune mediated mechanisms of resistance to daratumumab","googleId":"bHJfCt5Bl7UJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3201/263617","googleCitationCount":8,"googleAuthor":"A Dona","doi":"10.1182/blood-2018-99-117441","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Dasatinib versus imatinib in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of …","googleId":"LOtXQUSc-VAJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/788/266093","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2018-99-111978","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Emicizumab for the treatment of acquired hemophilia_A: lessons learned from 4 very different cases","googleId":"-85moJq74ZcJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2476/263968","googleCitationCount":9,"googleAuthor":"P Schellongowski","doi":"10.1182/blood-2018-99-116973","elsevierAuthor":"Mazzucconi M.G.","publicationName":"Mediterranean Journal of Hematology and Infectious Diseases","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Patient-reported and neurocognitive outcomes in patients treated with axicabtagene ciloleucel","googleId":"O9J5r5ufHMoJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2289/261910","googleCitationCount":7,"googleAuthor":"HSL Jim","doi":"10.1182/blood-2018-99-111711","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Interim results from the first-in-human clinical trial of Adct-402 (Loncastuximab Tesirine), a novel pyrrolobenzodiazepine-based antibody drug conjugate, in relapsed …","googleId":"4K3GTsEu6XYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/398/265272","googleCitationCount":9,"googleAuthor":"J Radford","doi":"10.1182/blood-2018-99-116081","elsevierAuthor":"Sorensen E.P.","publicationName":"JAMA Dermatology","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Results from the US Life after Stopping TKIs (LAST) study","googleId":"aqJQfESa1zIJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2903/80477","googleCitationCount":10,"googleAuthor":"JP Radich","doi":"10.1182/blood.V130.Suppl_1.2903.2903","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Successful treatment of MYC rearrangement positive large B cell lymphoma patients with R-CHOP21 plus lenalidomide: results of a multicenter phase II HOVON trial","googleId":"pm5f8EPRJYMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/786/266075","googleCitationCount":8,"googleAuthor":"MED Chamuleau","doi":"10.1182/blood-2018-99-110240","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase-1 study of PF-114 mesylate in CML failing prior tyrosine kinase-inhibitor therapy","googleId":"9sTKEBws17sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/790/266127","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-116803","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Effect of rituximab in primary central nervous system lymphoma-results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study","googleId":"cIsCMV854U4J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/582/115581","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.582.582","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Preliminary translational results from an ongoing phase 1 study of flotetuzumab, a CD123 x CD3 Dart®, in AML/MDS: rationale for combining flotetuzumab and anti …","googleId":"WB7Leg7N9Q8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1365/116323","googleCitationCount":14,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.1365.1365","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: pharmacokinetics and pharmacodynamics observed in two phase …","googleId":"t-u4yyg-UsUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/626/266288","googleCitationCount":7,"googleAuthor":"RA Brodsky","doi":"10.1182/blood-2018-99-110858","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Immunodepletion of MDSC by AMV564, a novel tetravalent bispecific CD33/CD3 T cell engager restores immune homeostasis in MDS in vitro","googleId":"5q7EKDGeDjQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/51/81009","googleCitationCount":12,"googleAuthor":"P Cheng","doi":"10.1182/blood.V130.Suppl_1.51.51","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Prospective multicenter phase 3 study comparing 5-azacytidine (5-aza) induction followed by allogeneic stem cell transplantation versus continuous 5-aza according …","googleId":"NpX-XwPMlDsJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/208/261557","googleCitationCount":7,"googleAuthor":"N Kroeger","doi":"10.1182/blood-2018-99-115932","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Acalabrutinib in patients with relapsed/refractory (R/R) and high-risk, treatment-naive (TN) chronic lymphocytic leukemia (CLL)","googleId":"orNny3nfdL4J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4424/275670","googleCitationCount":8,"googleAuthor":"IE Ahn","doi":"10.1182/blood-2018-99-110395","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Subsequent treatment outcomes of multiple myeloma refractory to CD38-monoclonal antibody therapy","googleId":"tM3OdXRptWMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2015/261845","googleCitationCount":7,"googleAuthor":"A Lakshman","doi":"10.1182/blood-2018-99-115078","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Open-label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma","googleId":"tBiH6jOF2KoJ","googleLink":"http://eprints.whiterose.ac.uk/143614/1/Open-Label%2C%20Phase%202%20Study%20of%20Bli...Aggressive%20B-Cell%20Non-Hodgkin%20Lymphoma.pdf","googleCitationCount":8,"googleAuthor":"A Rambaldi"},{"title":"Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA","googleId":"rzZuelJXCNwJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/23/3126/36040","googleCitationCount":12,"googleAuthor":"M Nakamura","doi":"10.1182/blood-2016-06-721712","elsevierAuthor":"Kato I.","publicationName":"Blood","elsevierCoverDate":"2017-06-08","elsevierCoverDisplayDate":"8 June 2017","elsevierCitationCount":"8","altmetricAuthors":["Itaru Kato","Yoko Nishinaka","Masahiro Nakamura","Ayse U. Akarca","Akira Niwa","Hiroki Ozawa","Kenichi Yoshida","Makiko Mori","Dapeng Wang","Makiko Morita","Hiroo Ueno","Yusuke Shiozawa","Yuichi Shiraishi","Satoru Miyano","Rajeev Gupta","Katsutsugu Umeda","Kenichiro Watanabe","Katsuyoshi Koh","Souichi Adachi","Toshio Heike","Megumu K. Saito","Masashi Sanada","Seishi Ogawa","Teresa Marafioti","Akira Watanabe","Tatsutoshi Nakahata","Tariq Enver"],"twitterCount":11,"altmetricId":19236779},{"title":"Results from the Hgb-207 (Northstar-2) Trial: a phase 3 study to evaluate safety and efficacy of lentiglobin gene therapy for transfusion-dependent β-thalassemia (TDT …","googleId":"wlCwELMbmAAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/526/80904","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.526.526","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Safety and efficacy data for combined checkpoint inhibition with ipilimumab (Ipi) and nivolumab (Nivo) as consolidation following autologous stem cell transplantation …","googleId":"QPJMsAQBVOkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/256/264413","googleCitationCount":8,"googleAuthor":"R Korngold","doi":"10.1182/blood-2018-99-113586","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Updated phase 1 results of Zuma-3: Kte-C19, an anti-CD19 chimeric antigen receptor T cell therapy, in adult patients with relapsed/refractory acute lymphoblastic …","googleId":"iqHVE5EAodcJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/897/266310","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-111531","elsevierCitationCount":0,"altmetricAuthors":["William G. Wierda","Michael R. Bishop","Olalekan O. Oluwole","Aaron C. Logan","Maria R. Baer","William B. Donnellan","Kristen M. O'Dwyer","Januario E. Castro","Gary J. Schiller","Houston Holmes","Mehrdad Abedi","Armin Ghobadi","Martha L. Arellano","Adriana K. Malone","John M. Pagel","Armen Mardiros","Tong Shen","Remus Vezan","Rajul K. Jain","Bijal D. Shah"],"twitterCount":0,"altmetricId":52751981},{"title":"Pralatrexate in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in previously untreated patients with peripheral T-cell lymphoma …","googleId":"dCVZvqY7dsgJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/818/83528","googleCitationCount":12,"googleAuthor":"SK Barta","doi":"10.1182/blood.V130.Suppl_1.818.818","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Safety and efficacy of Adct-402 (Loncastuximab Tesirine), a novel antibody drug conjugate, in relapsed/refractory follicular lymphoma and mantle cell lymphoma …","googleId":"LLCPAPTpZDEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2874/263899","googleCitationCount":8,"googleAuthor":"P Caimi","doi":"10.1182/blood-2018-99-118133","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Safety and preliminary clinical activity of REGN1979, an anti-CD20 x anti-CD3 bispecific antibody, in patients with B-NHL previously treated with CD20-directed …","googleId":"JPdJq2Fq210J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1550/79791","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.1550.1550","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ixazomib-lenalidomide-dexamethasone (IRd) combination before and after autologous stem cell transplantation (ASCT) followed by ixazomib maintenance is a safe …","googleId":"SZhY4GAaf2QJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2021/71531","googleCitationCount":10,"googleAuthor":"A Perrot","doi":"10.1182/blood.V130.Suppl_1.2021.2021","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A phase Ib study of isatuximab in combination with bortezomib, cyclophosphamide, and dexamethasone (VCDI) in patients with newly diagnosed multiple myeloma …","googleId":"2hOLQAd5pOsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/3160/114539","googleCitationCount":9,"googleAuthor":"EM Ocio","doi":"10.1182/blood.V130.Suppl_1.3160.3160","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Front-line ibrutinib therapy for chronic lymphocytic leukemia (CLL) in the real world: responses, toxicity, outcomes and subsequent therapies","googleId":"E2rHa1_j8l4J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3011/80746","googleCitationCount":10,"googleAuthor":"AR Mato","doi":"10.1182/blood.V130.Suppl_1.3011.3011","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A randomized, double-blind, placebo-controlled phase 1 study of the pharmacokinetics and pharmacodynamics of REGN3918, a human antibody against complement …","googleId":"274ZQq446eIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1039/262930","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-112262","elsevierCitationCount":0,"altmetricAuthors":["Jonathan Weyne","Yan Ni","Richard DelGizzi","Stephen Godin","Lori Morton","Srinivasa Prasad","Andrew J Rankin","Melissa Simek-Lemos","ming-Dauh Wang","Ronda Rippley","Olivier Harari"],"twitterCount":4,"altmetricId":56194127},{"title":"Durable responses observed with JAK inhibition in T-cell lymphomas","googleId":"UZjtDdiN3_MJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2922/263945","googleCitationCount":8,"googleAuthor":"JH Schatz","doi":"10.1182/blood-2018-99-112123","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Study of AUTO3, the first bicistronic chimeric antigen receptor (CAR) targeting CD19 and CD22, followed by anti-PD1 consolidation in patients with relapsed/refractory …","googleId":"sPlf185ZpDkJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1679/272906","googleCitationCount":7,"googleAuthor":"M Al-Hajj","doi":"10.1182/blood-2018-99-119197","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Extended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysis","googleId":"o2J09wx4aSoJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/5/653/36139","googleCitationCount":14,"googleAuthor":"DL Tao","doi":"10.1182/blood-2016-10-747931","elsevierAuthor":"Tao D.","publicationName":"Blood","elsevierCoverDate":"2017-02-02","elsevierCoverDisplayDate":"2 February 2017","elsevierCitationCount":"11","altmetricAuthors":["Derrick L. Tao","Jeffrey Y. Bien","Thomas G. DeLoughery","Joseph J. Shatzel"],"twitterCount":9,"altmetricId":14899340},{"title":"Preference for emicizumab over prior factor treatments: results from the HAVEN 3 and HAVEN 4 studies","googleId":"MasJUbiiWuMJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1187/262613","googleCitationCount":6,"googleAuthor":"I Paz-Priel","doi":"10.1182/blood-2018-99-118132","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Disparities in survival by insurance status in follicular lymphoma","googleId":"LV-T6381k84J","googleLink":"https://ashpublications.org/blood/article-abstract/132/11/1159/39365","googleCitationCount":9,"googleAuthor":"X Han","doi":"10.1182/blood-2018-03-839035","elsevierAuthor":"Goldstein J.","publicationName":"Blood","elsevierCoverDate":"2018-09-13","elsevierCoverDisplayDate":"13 September 2018","elsevierCitationCount":"8","altmetricAuthors":["Jordan S. Goldstein","Loretta J. Nastoupil","Xuesong Han","Ahmedin Jemal","Elizabeth Ward","Christopher R. Flowers"],"twitterCount":8,"altmetricId":45814529},{"title":"Impact of bortezomib-or lenalidomide-based induction treatment on high risk cytogenetic transplant-ineligible patients with newly diagnosed multiple myeloma …","googleId":"xNEC15tPatAJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/744/83672","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.744.744","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"HLH: genomics illuminates pathophysiological diversity","googleId":"TTCWnf1fqM0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/1/5/39284","googleCitationCount":8,"googleAuthor":"B Tesi","doi":"10.1182/blood-2018-05-845818","elsevierAuthor":"Tesi B.","publicationName":"Blood","elsevierCoverDate":"2018-07-05","elsevierCoverDisplayDate":"5 July 2018","elsevierCitationCount":"4","altmetricAuthors":["Bianca Tesi","Yenan T. Bryceson"],"twitterCount":2,"altmetricId":44894092},{"title":"Radiographic and high-throughput sequencing (HTS)-based response assessment after brentuximab vedotin (BV) plus ifosfamide, carboplatin, and etoposide (ICE) …","googleId":"9X98QjCTLe8J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/2806/80358","googleCitationCount":9,"googleAuthor":"AJ Cowan","doi":"10.1182/blood.V130.Suppl_1.2806.2806","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Frequency of PAR4 Ala120Thr variant associated with platelet reactivity significantly varies across sub-Saharan African populations","googleId":"8fd-4b1p6y0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/19/2103/39471","googleCitationCount":6,"googleAuthor":"TL Lindahl","doi":"10.1182/blood-2018-05-852335","elsevierAuthor":"Heenkenda M.K.","publicationName":"Blood","elsevierCoverDate":"2018-11-08","elsevierCoverDisplayDate":"8 November 2018","elsevierCitationCount":"7","altmetricAuthors":["Menikae K. Heenkenda","Tomas L. Lindahl","Abdimajid Osman"],"twitterCount":2,"altmetricId":51183389},{"title":"Daratumumab monotherapy for patients with relapsed or refractory (R/R) natural killer/T-cell lymphoma (NKTCL), nasal type: an open-label, single-arm, multicenter …","googleId":"Sbkom2KEnXYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1617/273215","googleCitationCount":7,"googleAuthor":"WS Kim","doi":"10.1182/blood-2018-99-111885","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Radiotherapy priming chimeric antigen receptor T cell therapy is a safe and promising approach in relapsed/refractory diffuse large B cell lymphoma patients with high …","googleId":"Uwal8ZcL48oJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2961/263859","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-113979","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Daratumumab efficiently targets NK/T cell lymphoma with high CD38 expression","googleId":"TpmJVz5PMrkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2814/80426","googleCitationCount":12,"googleAuthor":"N Mustafa","doi":"10.1182/blood.V130.Suppl_1.2814.2814","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"FLT3mutation Assay Laboratory Cross Validation: Results from the CALGB 10603/Ratify Trial in Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid …","googleId":"QniLgfHhB_gJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2800/263578","googleCitationCount":6,"googleAuthor":"C Thiede","doi":"10.1182/blood-2018-99-112127","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells","googleId":"TuJdbbgCvd4J","googleLink":"https://ashpublications.org/blood/article-abstract/131/16/1833/36846","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2017-05-787226","elsevierAuthor":"Shima H.","publicationName":"Blood","elsevierCoverDate":"2018-04-19","elsevierCoverDisplayDate":"19 April 2018","elsevierCitationCount":"6","altmetricAuthors":["Haruko Shima","Emi Takamatsu-Ichihara","Mika Shino","Kazutsune Yamagata","Takuo Katsumoto","Yukiko Aikawa","Shuhei Fujita","Haruhiko Koseki","Issay Kitabayashi"],"twitterCount":3,"altmetricId":32590310},{"title":"Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine","googleId":"CX287NdligEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/7/761/39436","googleCitationCount":9,"googleAuthor":"","doi":"10.1182/blood-2018-04-846493","elsevierAuthor":"Manwani R.","publicationName":"Blood","elsevierCoverDate":"2018-08-16","elsevierCoverDisplayDate":"16 August 2018","elsevierCitationCount":"7","altmetricAuthors":["Richa Manwani","Sajitha Sachchithanantham","Shameem Mahmood","Darren Foard","Faye Sharpley","Tamer Rezk","Thirusha Lane","Cristina Quarta","Marianna Fontana","Helen J. Lachmann","Julian D. Gillmore","Carol Whelan","Philip N. Hawkins","Ashutosh D. Wechalekar"],"twitterCount":20,"altmetricId":43955311},{"title":"Phase 1 study of venetoclax in combination with dexamethasone as targeted therapy for t (11; 14) relapsed/refractory multiple myeloma","googleId":"nZ3xgk3rEBcJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3131/80767","googleCitationCount":10,"googleAuthor":"JL Kaufman","doi":"10.1182/blood.V130.Suppl_1.3131.3131","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Median 3.5-year follow-up of ibrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: a pooled analysis","googleId":"k4HQajZ9X_IJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/151/79823","googleCitationCount":10,"googleAuthor":"M Dreyling","doi":"10.1182/blood.V130.Suppl_1.151.151","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Ibrutinib and fungus: an invasive concern","googleId":"ltz8st7pXK8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/17/1882/36762","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-02-832154","elsevierAuthor":"Rogers K.","publicationName":"Blood","elsevierCoverDate":"2018-04-26","elsevierCoverDisplayDate":"26 April 2018","elsevierCitationCount":"7","altmetricAuthors":["Kerry Rogers"],"twitterCount":24,"altmetricId":39345236},{"title":"Mutation-enhanced international prognostic systems for essential thrombocythemia (MIPSS-ET) and polycythemia vera (MIPSS-PV)","googleId":"3vQRfNjEX2sJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/578/263344","googleCitationCount":7,"googleAuthor":"P Guglielmelli","doi":"10.1182/blood-2018-99-109715","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin Lymphoma demonstrates limitations of PET-adapted approach","googleId":"xXWsaoGtQAAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/929/266214","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-113034","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial","googleId":"HauUETMFZ5gJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/2/214/36717","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood-2017-01-759258","elsevierAuthor":"Kelly A.M.","publicationName":"Blood","elsevierCoverDate":"2017-07-13","elsevierCoverDisplayDate":"13 July 2017","elsevierCitationCount":"8","altmetricAuthors":["Anne M. Kelly","Stephen F. Garner","Theodora Foukaneli","Thomas R. Godec","Nina Herbert","Brennan C. Kahan","Alison Deary","Lekha Bakrania","Charlotte Llewelyn","Willem H. Ouwehand","Lorna M. Williamson","Rebecca A. Cardigan"],"twitterCount":8,"altmetricId":20395435},{"title":"A single autologous stem cell transplant (ASCT) followed by two years of post-transplant therapy in recently diagnosed elderly multiple myeloma (MM) patients. Safety …","googleId":"HcUsG23K6DkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2153/261875","googleCitationCount":6,"googleAuthor":"K Nadiminti","doi":"10.1182/blood-2018-99-118443","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"No added benefit of eight versus six cycles of CHOP when combined with rituximab in previously untreated diffuse large B-cell lymphoma patients: results from the …","googleId":"aPmnI7URzNUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/783/266048","googleCitationCount":6,"googleAuthor":"DJ Culligan","doi":"10.1182/blood-2018-99-116845","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Venetoclax (Ven) with Azacitidine (Aza) for untreated elderly Acute Myeloid Leukemia (AML) Patients (Pts) unfit for induction chemotherapy: Single center clinical …","googleId":"bRmCuR4JFxcJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/181/79391","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.181.181","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Long term efficacy, safety and PK/PD profile of the anti-C1s antibody (BIVV009) in primary cold agglutinin disease patients","googleId":"LQPb2LZlCSkJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/703/83662","googleCitationCount":11,"googleAuthor":"U Jaeger","doi":"10.1182/blood.V130.Suppl_1.703.703","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy of daratumumab in combination with standard of care regimens in lenalidomide-exposed or-refractory patients with relapsed/refractory multiple myeloma …","googleId":"1cYbZZ0NqqMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3288/264510","googleCitationCount":9,"googleAuthor":"SZ Usmani","doi":"10.1182/blood-2018-99-112669","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Spirit 2: final 5 year analysis of the UK national cancer research institute randomized study comparing imatinib with dasatinib in patients with newly diagnosed chronic …","googleId":"99KJ2TaCDakJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/457/275807","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-110128","elsevierAuthor":"Clark R.E.","publicationName":"British Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"November 2020","elsevierCitationCount":"0","altmetricAuthors":["Stephen O'Brien","Leanne Cork","Valeria Bandeira","Ruth Bescoby","Letizia Foroni","Lynn Alaily","Wendy Osborne","Helen Bell-Gorrod","Nicholas Latimer","Jane Apperley","Corinne Hedgley","Richard Syzdlo","Jennifer Byrne","Christopher Pocock","Bernard Ramsahoye","Thomas Zwingers","James Wason","Mhairi Copland","Richard Clark"],"twitterCount":1,"altmetricId":77384157},{"title":"Gemtuzumab ozogamicin in NPM1-mutated acute myeloid leukemia (AML): results from the prospective randomized AMLSG 09-09 phase-iii study","googleId":"5JBhlT2CT5MJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/81/266344","googleCitationCount":6,"googleAuthor":"RF Schlenk","doi":"10.1182/blood-2018-99-113442","elsevierCitationCount":0,"altmetricAuthors":["Richard F. Schlenk","Peter Paschka","Julia Krzykalla","Daniela Weber","Silke Kapp-Schwoerer","Verena I. Gaidzik","Claudia Leis","Walter Fiedler","Thomas Kindler","Thomas Schroeder","Karin Mayer","Michael Lübbert","Mohammed Amen Wattad","Katharina S. Götze","Heinz A. Horst","Elisabeth Koller","Gerald Wulf","Jan Schleicher","Martin Bentz","Richard Greil","Bernd Hertenstein","Jürgen Krauter","Uwe Martens","David Nachbaur","Maisun Abu Samra","Michael Girschikofsky","Axel Benner","Felicitas Thol","Michael Heuser","Arnold Ganser","Konstanze Döhner","Hartmut Döhner"],"twitterCount":1,"altmetricId":67552592},{"title":"Efficacy and safety following dose reduction of bosutinib or imatinib in patients with newly diagnosed chronic myeloid leukemia: analysis of the phase 3 BFORE trial","googleId":"Ih52cHgR0-cJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3005/263897","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-110543","elsevierAuthor":"Copland M.","publicationName":"Current Hematologic Malignancy Reports","elsevierCoverDate":"2019-08-15","elsevierCoverDisplayDate":"15 August 2019","elsevierCitationCount":"4","altmetricAuthors":[],"twitterCount":0},{"title":"Benefits and limitations of long-term eculizumab treatment for paroxysmal nocturnal hemoglobinuria (PNH): Real-world data from large cohort study in Russia","googleId":"yBMN0evgOYsJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2589/264219","googleCitationCount":6,"googleAuthor":"","doi":"10.1182/blood-2018-99-120139","elsevierAuthor":"Tarasova Y.V.","publicationName":"Gematologiya i Transfusiologiya","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"The SMART Anti-hC5 antibody (SKY59/RO7112689) shows good safety and efficacy in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)","googleId":"BsSDoMlrBKQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/535/265551","googleCitationCount":6,"googleAuthor":"Z Nagy","doi":"10.1182/blood-2018-99-113274","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Enrollment of older adults in clinical trials evaluating patients with hematologic malignancies-the Food and Drug Administration (FDA) experience","googleId":"HiV743RpS2YJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/861/83583","googleCitationCount":11,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.861.861","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"High Prevalence of BTK Mutations on ibrutinib therapy after 3 years of treatment in a real-life cohort of CLL patients: a study from the French Innovative Leukemia …","googleId":"26o8Jb3a8ZQJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/584/263038","googleCitationCount":8,"googleAuthor":"LM Fornecker","doi":"10.1182/blood-2018-99-114027","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Incidence of vascular thromboembolic events in patients receiving immunotherapy: A single institution experience","googleId":"f5wd1ZbHSiYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4864/72519","googleCitationCount":12,"googleAuthor":"M Machiorlatti","doi":"10.1182/blood.V130.Suppl_1.4864.4864","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Durability of responses on continuous therapy and following drug cessation in deep responders with venetoclax and rituximab","googleId":"e1zblRtM4c0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/183/273119","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-183","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Sickle cell trait is not associated with an increased risk of heart failure or abnormalities of cardiac structure and function","googleId":"dKaVMfYKhRMJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/6/799/36331","googleCitationCount":14,"googleAuthor":"NA Bello","doi":"10.1182/blood-2016-08-705541","elsevierAuthor":"Bello N.A.","publicationName":"Blood","elsevierCoverDate":"2017-02-09","elsevierCoverDisplayDate":"9 February 2017","elsevierCitationCount":"9","altmetricAuthors":["Natalie A. Bello","Hyacinth I. Hyacinth","Nicholas S. Roetker","Samantha R. Seals","Rakhi P. Naik","Vimal K. Derebail","Abhijit V. Kshirsagar","Nigel S. Key","James G. Wilson","Adolfo Correa","Robert J. Adams","Leonard D. Egede","W. T. Longstreth","Gaurav Choudhary","Beatrice E. Gee","Austin L. Hughes","Amil M. Shah","JoAnn E. Manson","Matthew Allison","Gregory L. Burke","Aaron R. Folsom","Cara L. Carty","Alexander P. Reiner","Scott D. Solomon","Suma H. Konety"],"twitterCount":7,"altmetricId":16271202},{"title":"Emerging clinical activity of REGN1979, an anti-CD20 x anti-CD3 bispecific antibody, in patients with relapsed/refractory follicular lymphoma (FL), diffuse large B-cell …","googleId":"4KokDyuEXBQJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1690/273046","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-113328","elsevierCitationCount":0,"altmetricAuthors":["Rajat Bannerji","Jon E. Arnason","Ranjana Advani","Jennifer R. Brown","John N. Allan","Stephen M. Ansell","Jeffrey Barnes","Susan M. O'Brien","Julio C. Chavez","Johannes Duell","Israel Lowy","Robert Charnas","David Sternberg","Srikanth Ambati","Lieve Adriaens","Melanie Ufkin","Xiaoyu Yan","Jingjin Li","Mark Navarro","Peter Gasparini","Vladimir Jankovic","Nathalie Fiaschi","Wen Zhang","Sara Hamon","Gavin Thurston","Max S. Topp"],"twitterCount":0,"altmetricId":100350884},{"title":"Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL","googleId":"bWSeOnzCrqcJ","googleLink":"https://ashpublications.org/blood/article-abstract/129/2/188/36078","googleCitationCount":12,"googleAuthor":"LT Chen","doi":"10.1182/blood-2016-04-713719","elsevierAuthor":"Kuo S.H.","publicationName":"Blood","elsevierCoverDate":"2017-01-12","elsevierCoverDisplayDate":"12 January 2017","elsevierCitationCount":"11","altmetricAuthors":["Sung-Hsin Kuo","Li-Tzong Chen","Chung-Wu Lin","Kun-Huei Yeh","Chia-Tung Shun","Yi-Shin Tzeng","Jyh-Ming Liou","Ming-Shiang Wu","Ping-Ning Hsu","Ann-Lii Cheng"],"twitterCount":5,"altmetricId":13925545},{"title":"A phase 1 dose escalation study of ARQ 531 in selected patients with relapsed or refractory hematologic malignancies","googleId":"42dLdmS7PcIJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/3136/263890","googleCitationCount":7,"googleAuthor":"FT Awan","doi":"10.1182/blood-2018-99-116338","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A phase 1/2 study of oral 5-azacitidine and romidepsin in patients with lymphoid malignancies reveals promising activity in heavily pretreated peripheral T-cell …","googleId":"tP5gC-qKhfsJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1515/79408","googleCitationCount":9,"googleAuthor":"L Falchi","doi":"10.1182/blood.V130.Suppl_1.1515.1515","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Sequential CD19-and CD22-CART cell therapies for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation","googleId":"PAdc6C84TD8J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2126/261582","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-111856","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Long-term efficacy and safety (5 years) in RESPONSE, a phase 3 study comparing ruxolitinib (rux) with best available therapy (BAT) in hydroxyurea (HU)-resistant …","googleId":"9cmEa1moZmYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1753/273242","googleCitationCount":7,"googleAuthor":"F Pane","doi":"10.1182/blood-2018-99-115129","elsevierAuthor":"Griesshammer M.","publicationName":"Annals of Hematology","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"10","altmetricAuthors":[],"twitterCount":0},{"title":"Results from the phase 3 DUOTM trial: a randomized comparison of duvelisib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia or …","googleId":"1i-7bRp-fJQJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/493/80997","googleCitationCount":9,"googleAuthor":"P Hillmen","doi":"10.1182/blood.V130.Suppl_1.493.493","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Aspirin may be inadequate thromboprophylaxis in multiple myeloma","googleId":"S43pKKi_z7EJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3419/114607","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.3419.3419","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Response-adapted therapy with nivolumab and brentuximab vedotin (BV), followed by BV and bendamustine for suboptimal response, in children, adolescents, and …","googleId":"r57u0OxTWMEJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/927/266199","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-111279","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis","googleId":"lD1s2lZ8OJwJ","googleLink":"https://ashpublications.org/blood/article-abstract/131/3/365/38296","googleCitationCount":14,"googleAuthor":"D Giannarelli","doi":"10.1182/blood-2017-09-806034","elsevierAuthor":"Molica S.","publicationName":"Blood","elsevierCoverDate":"2018-01-18","elsevierCoverDisplayDate":"18 January 2018","elsevierCitationCount":"7","altmetricAuthors":["Stefano Molica","Diana Giannarelli","Rosanna Mirabelli","Luciano Levato","Neil E. Kay","Tait D. Shanafelt"],"twitterCount":36,"altmetricId":28154010},{"title":"A novel point-of-care whole blood coagulation assay to monitor emicizumab therapy in patients with hemophilia","googleId":"FVeepYAuUm0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/2475/264456","googleCitationCount":6,"googleAuthor":"MA Suster","doi":"10.1182/blood-2018-99-113623","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Double blind randomized control trial of postoperative low molecular weight heparin bridging therapy for patients who are at high risk for arterial thromboembolism …","googleId":"4lvNyMp2cGEJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/424/275575","googleCitationCount":7,"googleAuthor":"M Rodger","doi":"10.1182/blood-2018-99-109964","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase II study of high dose cytarabine followed by pembrolizumab in relapsed/refractory acute myeloid leukemia (AML)","googleId":"YCdsxMKyoPwJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1349/116142","googleCitationCount":11,"googleAuthor":"JF Zeidner","doi":"10.1182/blood.V130.Suppl_1.1349.1349","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase 1 results of ZUMA-3: KTE-C19, an anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients with relapsed/refractory acute lymphoblastic …","googleId":"tk0kjOs-h5EJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/888/83345","googleCitationCount":9,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.888.888","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Baseline suvmax did not predict histological transformation from follicular lymphoma to aggressive lymphoma in the phase III GALLIUM study","googleId":"oV24HwMwyyYJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4160/275688","googleCitationCount":9,"googleAuthor":"SF Barrington","doi":"10.1182/blood-2018-99-116686","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Hematopoietic stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial infections","googleId":"_bPIQ-_kgi8J","googleLink":"https://ashpublications.org/blood/article-abstract/131/5/533/104434","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood-2017-10-812859","elsevierAuthor":"Hetzel M.","publicationName":"Blood","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"6","altmetricAuthors":["Miriam Hetzel","Adele Mucci","Patrick Blank","Ariane Hai Ha Nguyen","Jan Schiller","Olga Halle","Mark-Philipp Kühnel","Sandra Billig","Robert Meineke","Daniel Brand","Vanessa Herder","Wolfgang Baumgärtner","Franz-Christoph Bange","Ralph Goethe","Danny Jonigk","Reinhold Förster","Bernhard Gentner","Jean-Laurent Casanova","Jacinta Bustamante","Axel Schambach","Ulrich Kalinke","Nico Lachmann"],"twitterCount":21,"altmetricId":30439227},{"title":"Effect of ropeginterferon alfa-2b in prefibrotic primary myelofibrosis","googleId":"Ent2ZbVJmb8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3029/263666","googleCitationCount":6,"googleAuthor":"M Schalling","doi":"10.1182/blood-2018-99-119268","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"GWAS of osmotic hemolysis in 12,352 healthy blood donors identifies red cell genetic variants associated with steady state hemolysis in patients with sickle cell …","googleId":"RJ6F2IQ6i-sJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1117/116387","googleCitationCount":8,"googleAuthor":"G Page","doi":"10.1182/blood.V130.Suppl_1.1117.1117","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Mass cytometry of Hodgkin lymphoma reveals a CD4 (+) exhausted T-effector and T-regulatory cell rich microenvironment","googleId":"Kw4xxlM5mpMJ","googleLink":"http://shipplab.dfci.harvard.edu/wp-content/uploads/2018/06/Blood-2018-04-843714-full.pdf","googleCitationCount":8,"googleAuthor":"X Hu"},{"title":"Anti-CD30 chimeric antigen receptor T cell therapy for CD30+ relapsed/refractory Hodgkin lymphoma and anaplastic large cell lymphoma patients","googleId":"eEDHX4Z4RYYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1660/273228","googleCitationCount":7,"googleAuthor":"L Huang","doi":"10.1182/blood-2018-99-116741","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Starting T cell and cell product phenotype are associated with durable remission of leukemia following CD19 CAR-T cell immunotherapy","googleId":"Y9cWbhftBuAJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/4022/265257","googleCitationCount":8,"googleAuthor":"R Gardner","doi":"10.1182/blood-2018-99-117493","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Management of joint replacement in hemophilia A with inhibitors during emicizumab prophylaxis","googleId":"qALaC3ojrskJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2360/80230","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2360.2360","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis","googleId":"bDsXM36jB7AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0006497120321583","googleCitationCount":6,"googleAuthor":"LS Kean","doi":"10.1182/blood-2018-02-785881","elsevierAuthor":"Kean L.S.","publicationName":"Blood","elsevierCoverDate":"2018-06-14","elsevierCoverDisplayDate":"14 June 2018","elsevierCitationCount":"3","altmetricAuthors":["Leslie S. Kean"],"twitterCount":6,"altmetricId":43752647},{"title":"Minimal residual disease status with venetoclax monotherapy is associated with progression-free survival in chronic lymphocytic Leukemia","googleId":"KByUWev1icMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3134/263873","googleCitationCount":7,"googleAuthor":"AW Roberts","doi":"10.1182/blood-2018-99-110183","elsevierAuthor":"Juárez-Salcedo L.","publicationName":"Drugs in Context","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"12","altmetricAuthors":[],"twitterCount":0},{"title":"Double immune checkpoint inhibitor blockade with nivolumab and ipilimumab with or without azacitidine in patients with myelodysplastic syndrome (MDS)","googleId":"UBG9AVP2x7UJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1831/273138","googleCitationCount":7,"googleAuthor":"G Garcia-Manero","doi":"10.1182/blood-2018-99-118948","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A …","googleId":"W5FkSn3tEe8J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3087/80701","googleCitationCount":9,"googleAuthor":"E Terpos","doi":"10.1182/blood.V130.Suppl_1.3087.3087","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"In vitro, in vivo, and parallel phase I evidence support the safety and activity of duvelisib, a PI3K-δ, γ inhibitor, in combination with romidepsin or bortezomib in …","googleId":"qVgEIMrwexYJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/819/83537","googleCitationCount":13,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.819.819","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia","googleId":"oAbmF7RkNoUJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1433/262925","googleCitationCount":10,"googleAuthor":"AD Goldberg","doi":"10.1182/blood-2018-99-117772","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"High rate of sustained minimal residual disease negativity predicts prolonged survival for the overall patient population in the phase 2 KRd plus autologous stem cell …","googleId":"lW2YXz0sqSsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4533/72181","googleCitationCount":9,"googleAuthor":"R Vij","doi":"10.1182/blood.V130.Suppl_1.4533.4533","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Longer term follow-up on the first patients with severe Hemoglobinopathies treated with Lentiglobin gene therapy","googleId":"7obOCdcO2YsJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/4609/72554","googleCitationCount":10,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.4609.4609","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Eltanexor (KPT-8602), a second-generation selective inhibitor of nuclear export (SINE) compound, in patients with refractory multiple myeloma","googleId":"2hWyln9gF38J","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/3134/80784","googleCitationCount":8,"googleAuthor":"CC Hofmeister","doi":"10.1182/blood.V130.Suppl_1.3134.3134","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Pembrolizumab for the treatment of disease relapse following allogeneic hematopoietic cell transplantation","googleId":"sZAcj2U8mnkJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3415/264928","googleCitationCount":6,"googleAuthor":"J Kline","doi":"10.1182/blood-2018-99-115108","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Efficacy of combined ruxolitinib and decitabine in patients with accelerated and blast-phase myeloproliferative neoplasms: results of a phase II study (MPN-RC 109 …","googleId":"ARTEhEtwY78J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/3027/263644","googleCitationCount":6,"googleAuthor":"","doi":"10.1182/blood-2018-99-111935","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Initial treatment with lenalidomide plus rituximab for mantle cell lymphoma: 5-year follow-up and correlative analysis from a multi-center phase II study","googleId":"FZFc_m2XvcEJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/154/79660","googleCitationCount":8,"googleAuthor":"L Cerchietti","doi":"10.1182/blood.V130.Suppl_1.154.154","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (PTCL) in previously untreated young and elderly patients: pooled analysis of the …","googleId":"e32KUFN9tPMJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1622/273276","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood-2018-99-112076","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Interim results of the Canadian tyrosine kinase inhibitor discontinuation trial for 2nd attempt of treatment free remission: treatment free remission accomplished by …","googleId":"d7DHA05y4_oJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/1622/79655","googleCitationCount":8,"googleAuthor":"D Kim","doi":"10.1182/blood.V130.Suppl_1.1622.1622","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"AVID200, a potent trap for TGF-β ligands inhibits TGF-β1 signaling in human myelofibrosis","googleId":"uHOIiTqKEh4J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1791/273182","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood-2018-99-116474","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase I/IB study of azacitidine and hedgehog pathway inhibition with sonidegib (LDE225) in myeloid malignancies","googleId":"iAuEd6bSG5EJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/2629/79876","googleCitationCount":7,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.2629.2629","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Outcomes of ibrutinib therapy given after prior venetoclax therapy in ibrutinib-naïve patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)","googleId":"s-y9zHZapk0J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/5556/263295","googleCitationCount":6,"googleAuthor":"","doi":"10.1182/blood-2018-99-116942","elsevierCitationCount":0,"altmetricAuthors":["Jennifer R. Brown","Matthew S Davids","Julie Chang","Shuo Ma","Juliana Biondo","Mehrdad Mobasher","Yong Mun","Anthony R Mato"],"twitterCount":2,"altmetricId":61555793},{"title":"Preclinical evaluation of Hdp-101, a novel anti-Bcma antibody-drug conjugate, in multiple myeloma","googleId":"EYM4O106mjQJ","googleLink":"https://heidelberg-pharma.com/files/ASH2018_HDP101.pdf","googleCitationCount":9,"googleAuthor":""},{"title":"Hepcidin suppression by momelotinib is associated with increased iron availability and erythropoiesis in transfusion-dependent myelofibrosis patients","googleId":"bQYBIbdelTYJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/4282/275580","googleCitationCount":6,"googleAuthor":"V Gupta","doi":"10.1182/blood-2018-99-111349","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Resistance to SL-401 in AML and BPDCN is associated with loss of the diphthamide synthesis pathway enzyme DPH1 and is reversible by azacitidine","googleId":"pHU5STBB3BYJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/797/83277","googleCitationCount":8,"googleAuthor":"K Togami","doi":"10.1182/blood.V130.Suppl_1.797.797","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Encouraging early results from the first in-human clinical trial of ADCT-402 (loncastuximab tesirine), a novel pyrrolobenzodiazepine-based antibody drug conjugate, in …","googleId":"Unr5WZfybr8J","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/187/71259","googleCitationCount":10,"googleAuthor":"M Hamadani","doi":"10.1182/blood.V130.Suppl_1.187.187","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Mechanisms of adaptation to ibrutinib in high risk chronic lymphocytic leukemia","googleId":"7heNOPR9CY0J","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/585/263142","googleCitationCount":7,"googleAuthor":"V Spina","doi":"10.1182/blood-2018-99-116739","elsevierAuthor":"Merli M.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"1","altmetricAuthors":[],"twitterCount":0},{"title":"Assessment of emicizumab-driven clot stability in hemophilia A model","googleId":"9dayJvP4pa8J","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/2478/263997","googleCitationCount":6,"googleAuthor":"","doi":"10.1182/blood-2018-99-118379","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Phase 1 Study of MDR1 inhibitor plus brentuximab vedotin in relapsed/refractory Hodgkin lymphoma","googleId":"PgMIUUoBLCIJ","googleLink":"https://ashpublications.org/blood/article-abstract/132/Supplement%201/1636/272939","googleCitationCount":6,"googleAuthor":"AF Herrera","doi":"10.1182/blood-2018-99-110403","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Pharmacokinetics and pharmacodynamics of Ionis-FXIRx, an antisense inhibitor of factor XI, in patients with end-stage renal disease on hemodialysis","googleId":"qWbzA6gQauwJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/1116/116382","googleCitationCount":8,"googleAuthor":"M Walsh","doi":"10.1182/blood.V130.Suppl_1.1116.1116","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Targeting primary pre-B cell acute lymphoblastic leukemia and CD19-negative relapses using trivalent CAR T cells","googleId":"iy6PPV8JPAAJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/4614/72130","googleCitationCount":9,"googleAuthor":"X An","doi":"10.1182/blood.V130.Suppl_1.4614.4614","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Clonal suppression of TP53 mutant MDS and oligoblastic AML with hypomethylating agent therapy improves overall survival","googleId":"OSCRVD2BtTUJ","googleLink":"https://ashpublications.org/blood/article/132/Supplement%201/1817/272984","googleCitationCount":5,"googleAuthor":"S Yun","doi":"10.1182/blood-2018-99-117297","elsevierAuthor":"Deng J.","publicationName":"European Journal of Haematology","elsevierCoverDate":"2020-11-01","elsevierCoverDisplayDate":"1 November 2020","elsevierCitationCount":"0","altmetricAuthors":[],"twitterCount":0},{"title":"Phase 1 clinical safety, pharmacokinetics (PK), and activity of apilimod dimesylate (LAM-002A), a first-in-class inhibitor of phosphatidylinositol-3-phosphate 5-kinase …","googleId":"fWFSSmqdiFsJ","googleLink":"https://ashpublications.org/blood/article/130/Supplement%201/4119/72807","googleCitationCount":8,"googleAuthor":"","doi":"10.1182/blood.V130.Suppl_1.4119.4119","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma","googleId":"jEKaBwG5PmoJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/Supplement%201/734/83557","googleCitationCount":10,"googleAuthor":"A Kumar","doi":"10.1182/blood.V130.Suppl_1.734.734","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0},{"title":"Sustained disease control for adult patients with relapsed or refractory diffuse large B-cell lymphoma: an updated analysis of Juliet, a global pivotal phase 2 trial of …","googleId":"vPw42Z-XU0MJ","googleLink":"https://kups.ub.uni-koeln.de/16514/","googleCitationCount":37,"googleAuthor":"C Tam"},{"title":"Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients","googleId":"N0fcXcBfBCYJ","googleLink":"https://ashpublications.org/blood/article-abstract/130/13/1535/36530","googleCitationCount":30,"googleAuthor":"G Guenechea","doi":"10.1182/blood-2017-03-774174","elsevierAuthor":"Río P.","publicationName":"Blood","elsevierCoverDate":"2017-09-28","elsevierCoverDisplayDate":"28 September 2017","elsevierCitationCount":"21","altmetricAuthors":["Paula Río","Susana Navarro","Guillermo Guenechea","Rebeca Sánchez-Domínguez","Maria Luisa Lamana","Rosa Yañez","Jose A. Casado","Parinda A. Mehta","Maria Roser Pujol","Jordi Surrallés","Sabine Charrier","Anne Galy","José C. Segovia","Cristina Díaz de Heredia","Julián Sevilla","Juan A. Bueren"],"twitterCount":26,"altmetricId":24161365},{"title":"Final analysis of the front-line phase III randomized ACT-1 trial in younger patients with systemic peripheral T-cell lymphoma treated with CHOP …","googleId":"3BwPDdcUjWQJ","googleLink":"https://portal.findresearcher.sdu.dk/en/publications/final-analysis-of-the-front-line-phase-iii-randomized-act-1-trial","googleCitationCount":12,"googleAuthor":"","doi":"10.1182/blood-2018-99-110429","elsevierCitationCount":0,"altmetricAuthors":[],"twitterCount":0}]